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ABSTRACT 
This thesis investigates the effectiveness of occupational therapy interventions for patients 
undergoing primary total hip replacement for osteoarthritis using two research 
methodologies. 
A systematic review and meta-analysis assessed the effectiveness of occupational therapy 
interventions delivered either pre-admission, during hospital stay, or post-discharge.  
Findings indicated the interventions reduced anxiety, improved pre-surgery and long-term 
function, and reduced length of stay. Small sample sizes, high levels of clinical and statistical 
heterogeneity and lack of specific occupational therapy studies reduced the strength of 
findings. The PROOF-THR feasibility study (ISRCTN38381590) recruited 44 participants to 
investigate recruitment and randomisation processes, acceptance of group allocation, 
fidelity of the intervention, and appropriateness of outcome measures and data collection 
methods. The intervention group received a bespoke pre-surgery home visit by an 
occupational therapist; the control group received treatment as usual. The intervention was 
delivered successfully with no withdrawals or crossovers, and reasonable retention rates 
indicating a definitive trial could be conducted following the feasibility methodology, 
although methods to improve follow-up data collection should be implemented. 
This thesis concluded that higher quality occupational therapy specific research is needed to 
establish the efficacy and effectiveness of occupational therapy practices. A complex 
rehabilitation intervention can be successfully investigated by following established 
procedures.  
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1 INTRODUCTION  
1.1 Chapter overview 
This chapter will first provide a working definition of osteoarthritis (OA). Although it is 
beyond the scope of this thesis for a full discussion on the complex pathophysiology of OA, 
an overview of the disease is then provided. The clinical significance of this disease is 
illustrated by explaining its prevalence and the associated health care costs. The implications 
of the method of diagnosis are discussed and how this affects estimates of prevalence. 
Factors likely to affect the prevalence such as the ageing population are also discussed. 
Within the sections on prevalence, diagnosis and costs, information on OA in general is 
provided first followed by information specific to hip OA. 
Due to OA being one of the most common disability causing diseases (Zhang et al, 2007), a 
plethora of different treatments exist; thus a comparative overview of non-surgical 
management is presented. As the focus of this thesis concerns the rehabilitation of people 
following total hip replacement, more detailed aspects of OA specifically relating to the hip 
joint are presented and then information on the surgical option of the total hip replacement 
is explained in more detail. 
The last section of the introduction summarises the current state of knowledge regarding 
general rehabilitation of patients following THR for OA in the UK. Finally, rehabilitation 
therapies provided by occupational therapists will be discussed, as OT interventions are 
investigated in both the subsequent systematic review and clinical trial.  
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1.2 What is osteoarthritis 
OA is an inflammatory disease that affects joints and the surrounding musculoskeletal tissue. 
Although multiple different types of inflammatory arthritic conditions exist, OA accounts for 
approximately 95% of all these (NHS, 2014). OA is a disease that affects animals as well as 
humans with evidence of its existence dating back 100 -130 million years in fossil remains 
(Dequeker and Luyten, 2008; Rothschild et al, 2012). 
The disease name ‘osteoarthritis’ comes from prefix terms ‘osteo’ and ‘Arthro’ pertains to 
bone and joint respectively, and are both derived from ancient Greek. The suffix ‘itis’ is 
derived from New Latin and is used as a suffix for any disease that is characterised by 
inflammation. The name therefore suggests a disease that affects the bones and joints of the 
body that is characterised by inflammatory signs. However, although the term OA is widely 
used, it can be considered to be somewhat problematic as it inherently suggests that it is 
predominantly an inflammatory condition which does not correspond to the pathology of 
the disease; alternative names for the disease have therefore been proposed such as 
osteoarthrosis or degenerative joint disease (Dequeker and Luyten, 2008).  
Additionally, as OA is responsible for the fourth most common cause of years lost to 
disability worldwide (WHO, 20002), any discussion relating to the disease needs to take in to 
account the effect it may have on the individual suffering with this disease 
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1.2.1 Definition of osteoarthritis  
Many previous definitions of OA exist (Felson and Zhang, 1998) which have generally been 
criticised for being either too simplistic or focusing primarily on the pathophysiology of the 
disease (Hunter and Felson, 2006; Dequeker and Luyten, 2008; Brandt et al., 2008). The 
definition below by Lane et al, (2011) was formulated in response to a call for a working 
definition by the United States Food and Drugs Administration (FDA) to reflect the 
heterogeneity of the disease and thus improve the appropriateness of research outcomes 
measured in clinical trials (Lane et al, 2011). This definition takes in to account the 
complexity of the structures that may be affected, the underlying pathophysiology, the 
symptoms experienced and the causative factors:   
“Osteoarthritis is usually a progressive disease of synovial joints that represents failed 
repair of joint damage that results from stresses that may be initiated by an 
abnormality in any of the synovial joint tissues, including articular cartilage, 
subchondral bone, ligaments, menisci (when present), periarticular muscles, 
peripheral nerves, or synovium. This ultimately results in the breakdown of cartilage 
and bone, leading to symptoms of pain, stiffness and functional disability. Abnormal 
intra-articular stress and failure of repair may arise as a result of biomechanical, 
biochemical and/or genetic factors. This process may be localized to a single joint, a 
few joints, or generalized, and the factors that initiate OA likely vary depending on 
the joint site” (P 479). 
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1.2.2  Pathophysiology of osteoarthritis 
It is beyond the scope of this thesis to provide a comprehensive and detailed discussion on 
the pathophysiology and pathogenesis of OA; however, an overview of the pathophysiology 
is provided below. 
OA is characterised by a failure of the repair process of joint cartilage due to biomechanical 
and biochemical changes to the joint cartilage and synovium, with associated changes in the 
subchondral bone of eburnation (change in subchondral bone in which it is converted into a 
dense substance with a smooth surface like ivory), osteophyte (bony spurs that grow around 
the joint margins) and enthesophyte (bony spur growing into a tendon or ligament where it 
attaches to the bone) formation (Ashkavand et al, 2013; Bijlsma et al, 20011; Felson et al, 
2000; Rogers et al, 1997). The destruction of the cartilage, joint space loss and the formation 
of the bony osteophytes are such characteristic pathophysiological processes associated 
with OA, that presence of these changes is required by the American College of 
Rheumatology for a diagnosis of OA to be made (Felson & Neogi, 2004).  
The progressive degradation of the articular cartilage and the resultant changes to the 
underlying bone form the basis of the widely accepted Osteoarthritis Research Society 
International (OARSI) grading system (Pritzker et al, 2006); this system is presented in Table 
1 below. Grades 1 - 4 of this grading classification relate to cartilage changes alone; the last 
two grades 5 - 6, relate to destructive changes to underlying bone. This OARSI grading 
system reflects the long held consensus that the first signs of OA changes are the 
biochemical changes to the cartilage (Madry et al, 2012). However, Felson & Neogi (2004) 
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argue that the bony changes can occur first in some people without any cartilage 
destruction. Furthermore, due to the variety of presentations of the pathophysiological 
changes associated with OA, and the different risk factors and pathophysiological changes 
attributed to different joints, Felson et al (2000) question whether OA is a single distinct 
disease, or several disorders with a final common pathway.   
Table 1 OARSI osteoarthritis pathology assessment and grading system 
OARSI 
grade 
Description Associated criteria 
0 No arthritis Cartilage surface intact; matrix normal; cells intact and appropriate 
orientation.  
1 Surface 
intact 
Matrix: superficial zone intact, oedema and/or superficial 
fibrillation (abrasion), focal superficial matrix condensation 
Cells: death, proliferation (clusters), hypertrophy, superficial zone 
Reaction must be more than superficial fibrillation only 
2 Surface 
discontinuity 
As above, plus 
Matrix: discontinuity at superficial zone (deep fibrillation) 
Cells: death, proliferation (clusters), hypertrophy 
3 Vertical 
fissures 
As above, plus 
Matrix: vertical fissures into mid zone, branched fissures 
Cells: death, regeneration (clusters), hypertrophy, cartilage domains 
adjacent to fissures 
4 Erosion Cartilage matrix loss: delamination of superficial layer, mid layer 
cyst formation 
Matrix: loss of superficial layer and mid zone (excavation) 
5 Denudation Surface: sclerotic bone or reparative tissue including fibrocartilage 
within denuded surface. Microfracture with repair limited to bone 
surface 
6 Deformation Bone remodelling (more than osteophyte formation only). Includes: 
microfracture with fibrocartilaginous and osseous repair extending 
above the previous surface 
OARSI: osteoarthritis research society international    
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Figure 1 illustrates X-ray images of the area around the hip bone and the pelvis.  The three 
images show different stages of osteoarthritis, from healthy hip joint (left) to fully developed 
osteoarthritis (right).  
Figure 1 Radiographic images of osteoarthritis progression at the hip joint  
 
1a) Normal healthy hip 1b) Mid stage 
osteoarthritis  
1c) advanced 
osteoarthritis  
Image reproduced with permission from the Swedish Hip Arthroplasty Register. 
Figure 1a shows a radiographic image of a normal healthy hip joint. In figure 1b, the characteristic 
decreased joint space between the femoral head and the acetabulum is seen along with sclerosis. 
Figure 1c shows the complete loss of joint space, osteophyte formation at the rim of the acetabulum, 
increased sclerosis and flattening of the femoral head.  
 
Alongside the bone and cartilage changes, OA is also characterised by inflammatory joint 
swelling and effusion due to thickening of the synovium and inflammation (Berenbaum, 
2013). Additionally, Joint capsule tightening (Bijl et al, 1998), and muscle atrophy as a result 
of both pain inhibition and muscle wasting occurs as a result of progressive inactivity 
(Wieland et al, 2005). An additional specific feature of advanced hip OA (OARSI grade 3+) is a 
flattening of the femoral head (Harrison et al, 1953). As a consequence of the capsular 
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tightening of the hip, the load bearing is concentrated on a small section of the femoral 
head; this then leads to micro-fracture under the load and collapse of the trabecular 
structure. Once the femoral head starts to flatten, this further limits the movement available 
at the joint surfaces, and thus an increased rate of micro-fracturing and further flattening 
(Harrison et al, 1953).  
This variety of physiological changes affecting various biological systems highlights the 
complex pathophysiology of OA.  
1.3 Causes of osteoarthritis 
The causes of OA are referred to as being ‘primary’ or ‘idiopathic’ when there is no known 
extrinsic cause. The term ‘secondary’ OA is used when the onset of OA occurs at a younger 
age than normally anticipated as a consequence of a known risk factor such as 
biomechanical abnormality, disease or trauma to the joint (Cooper et al, 2013). A synopsis of 
the seven main risk factors associated with OA and, where applicable, with specific relation 
to hip OA, is presented below. 
Age 
Age is the strongest risk factor for the development of OA with the prevalence and incidence 
considerably increasing with age (Cooper et al, 2013). As the likelihood of an individual 
getting OA increases with age without any known secondary factors, age is generally seen as 
the main primary cause of OA (Ashkavand et al, 2013). Figure 2 shows the relationship 
between age and OA at various joints reported by Oliveria et al (1995). For the production of 
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this age related data Oliveria et al (1995) re-assessed approximately 130,000 initial health 
records of patients attending a general community hospital between 1988 and 1991 for 
evidence of the first radiographic diagnosis of OA of x-rays taken for any purpose. Although 
the hospital provided a range of services (mental health, respiratory care, radiotherapy, 
ophthalmology, medicine etc.), the x-rays would only have been taken based on clinical 
need, so they may not be representative of the general population. 
Gender 
The incidence of OA in women increases at menopause suggesting a possible hormonal 
cause (Cooper et al, 2003). A subsequent meta-analysis by Srikanth et al (2005), which 
contained 34 studies, also found a greater incidence of OA in women; however, no 
association to hormonal levels could be identified. In this review by Srikanth et al (2005), 
men had an overall RR of 0.93 C.I. 0.80-1.08 compared to women of developing OA in any 
body region. The risk ratio analysis by joint region was lower in men than women for the 
knee (0.55 C.I.  0.32-0.94) and hip (0.64 C.I. 0.48-0.86). The results also revealed the severity 
of knee OA was significantly worse in women than men (SMD 0.20 C.I. 0.11-0.82, p<0.001) 
but not in the hip (SMD 0.20 C.I. -0.07 - 0.10, p=0.65). However, women appear to have a 
higher prevalence of OA at all ages so the effect of hormone levels seems unlikely. 
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Figure 2 incidence of OA by joint  
 
Figure reproduced under the US National Library of Medicine Openi service 
Ethnicity and genetics  
Although the prevalence of OA varies between different ethnic groups, no one ethnic group 
has systematically less prevalent OA; in some joints the prevalence compared to another 
group is lower, but in other joints higher usually as a result of cultural norms such and 
practices such as squatting or prolonged kneeling (Cooper et al; 2003). However, the 
systematic review by Srikanth et al (2005), found OA in any joint to be lower in people of 
Caucasian origin compared to non-Caucasians (RR 0.84: C.I. 0.72 – 0.99).  Ashkavand et al, 
(2013) report that between 39% and 65% of OA in the general population can be attributed 
to genetic factors. 
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Obesity 
Obesity has long been considered as one of the most important risk factors for the 
development of OA (Cooper et al, 2003). The link to knee OA is well established, mainly due 
the additional weight transferred through the joint (Toivanen et al, 2010). Yet despite the 
hip joints also bearing greater stress with increased body mass index (BMI), the relationship 
between hip OA and BMI is not certain. Lievense et al (2002) conducted a systematic review 
of five longitudinal and seven cross-sectional studies and reported moderate evidence of a 
positive association (OR ≥ 1.25) between increased BMI and the risk of developing hip OA 
compared to healthy weight individuals. Holliday et al (2011) in a case-control study also 
found a positive association (OR≥1.65, 95% CI 1.46-1.87). However, several other studies 
show no association between increased BMI and hip OA. Gelber et al (1999) in an 
observational study assessed BMI in 1,271 male medical students who trained between 1948 
and 1964 (aged 20-29). The participants were then followed up by questionnaire at 5 year 
periods until 1995, for a median of 36 years. A total of 1185 people completed the study. 
The self-reported BMI of the participants was then averaged of the study period. Figure 3 
shows those in the higher BMI category (>24.7) had a threefold risk of developing knee OA 
compared to those in the lowest BMI group (<22.7). However, this study found no 
relationship between the incidences of hip OA and BMI over the study period. Although this 
study had good retention and was able to follow up for 36 years, the participants were all 
doctors and therefore the results may not be transferrable to the general population. 
Additionally, all the participants were male, so the data may not be generalisable to women. 
A general population epidemiological study was conducted in Norway by Grotle et al (2008) 
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but this only had a 10 year follow-up. An initial 2891 agreed to join the study, of which 1854 
(64%) responded to the follow-up survey 10 years later. The results show a high BMI (>30) 
was significantly associated with knee OA (OR 2.81 C.I. 1.32-5.96), hand OA (OR 2.59 C.I.  
1.08–6.19) but not for hip OA (OR 1.11 C.I. 0.41–2.97). 
 Figure 3 Cumulative incidence of knee osteoarthritis by body mass index 
 
Figure reproduced under the US National Library of Medicine Openi service 
Bone density 
The evidence on the relationship between bone density and OA is not well understood. 
Although it has long been known that people who suffer with osteoporosis have a 
considerably lower incidence of OA, and increased bone density is risk factor for the 
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development of both hip and knee OA, (Foss and Byers, 1972), the physiological reason for 
this is not yet fully understood (Tarantino et al, 2014). This is an area where more research is 
needed.  
Joint injury, abnormality and altered joint biomechanics 
Injury is one of the strongest risk factors for development of OA to any joint (Cooper et al, 
2003). Development disorders of the hip which alter the normal biomechanics such as Legg-
Calvé-Perthes disease (Ganz et al, 2008), developmental dysplasia (Hadley et al, 1990), and 
actual or sub-clinical slipped capital femoral epiphysis (Goodman et al, 1986) are clinically 
recognised causes of secondary OA. Froberg et al (2011) contacted 167 adults at a mean 
follow-up period of 47 (range 37-58) since they were conservatively treated for Legg-Calvé-
Perthes disease (LCPD) and compared them to an age and gender matched control. The 
percentage of the LCPD having THR (13%) or OA (7%) was greater than the control; THR (0%) 
and OA (1%). Femoroalacetabular impingement has also been suggested as a cause of 
secondary OA (Beck et al, 2004; Imam and Khanduja, 2011).  Ganz et al (2008) suggest that 
plain radiographs were unable to detect minor developmental deformities, and if they were 
detected, they were generally overlooked, thus their link to OA went unrecognised until 
imaging techniques improved. With the causal link to minor biomechanical abnormalities 
now established, many researchers now believe that most hip OA should be classified as 
secondary (Harris, 1986; Solomon, 1976). 
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Occupation or hobbies 
The repetitive loading of any joint as a consequence of hobbies, sports or occupations 
increases the risk of developing OA (Cooper et al, 2003). However, the link between sporting 
activity and OA is still not well understood (Buckwater, 2003) though excessive loading in 
activities such elite long distance running puts participants at a high risk of developing knee 
and/or hip OA, yet regular recreational activity does not (Buckwater and Lane, 1997).  
1.4 Prevalence and future predictions of hip osteoarthritis 
This section will provide details of how estimates of the prevalence of OA are dependent on 
the method of diagnosis and predicted rise of prevalence due to an aging population. 
1.4.1 The problem of diagnosis 
Although there are many types of arthritic diseases; OA is by far the most common form of 
arthritic joint disease responsible for reduced functional independence and disablement in 
older adults (Zhang et al, 2007). Arden & Nevitt (2006) also suggest it is the most common 
joint disorder in the world, the most frequent cause of pain, loss of function and disability in 
adults, and second most common cause of health related lost days at work. However, 
understanding of the actual prevalence of OA is problematic due to variations in diagnostic 
criteria; these can be based on radiological changes alone, by signs and symptoms alone, by 
a combination of both or by self-reporting (Croft et al, 1990; Pereira et al, 2011; Zhang et al, 
2007). A systematic review has examined the effect of OA definition on prevalence and 
incidence of hip OA (Pereira et al, 2011). This review contained 27 studies on the prevalence 
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of hip OA published up to 2010. Of these 27 included studies 19 used radiological diagnosis 
alone, with a mean prevalence of 9.75%; 4 studies used self-reported measures with mean 
prevalence of 6.85%; and 4 studies used symptomatic reporting (combination of 
radiographic and clinical findings) resulting in a mean prevalence of 3.73%. This review 
reveals both that radiological diagnosis alone is by far the most common method used in 
prevalence studies, and that different prevalence rates are found depending on the 
diagnostic criteria employed. Additionally, the proportion of the population not seeking 
treatment for OA is also unknown. Kellgren and Lawrence (1952) studied coal miners and 
dock workers routinely screened for occupational health purposes; of those who showed 
definitive radiological signs on x-ray of OA in the knee, only 24% had ever previously 
reported any symptoms of the disease. This was the first study to highlight that radiological 
changes may occur without symptoms or prior to the development of symptoms.  It is now 
quite widely accepted that there is only a weak association between the clinical signs and 
symptoms of OA and radiographic findings (Bedson and Croft, 2008; Kinds et al, 2011).  
1.4.2 Radiological diagnosis 
Although hip OA can be diagnosed by magnetic resonance imaging (MRI), (Waldschmidt et 
al, 1999) or by computerised tomography (CT) (Turmezei et al, 2014) they are not widely 
employed. The radiological plain X-ray is still the main imaging method employed clinically 
(Braun & Gold, 2011) due to it being widely available, cheap and providing instant results 
that can be quickly interpreted (Kinds et al, 2011). Due to the combination of its clinical 
effectiveness and almost ubiquitous use, in 1961 the World Health Organisation (WHO) 
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designated radiological diagnosis as the gold-standard method of determining the presence 
of OA (Hart & Spector, 1995). 
The occupational cohort studies reported by Kellgren and Lawrence (1952) were the first 
large scale epidemiological studies of OA and from this work they defined a grading scale of 
OA which now carries their name; The Kellgren-Lawrence scale (see Figure 4). This is now the 
most widely used scale both clinically and in epidemiological studies (Felson et al, 2011). 
Despite is wide usage, this scale is criticised for two main reasons. First it was originally  
based on the presence of osteophytes which are not always be present, and second, the 
minor radiological differences between grade 0 or 1 is subject to subjective interpretation 
(Reijman et al, 2004; Felson et al, 2011; Terjesen & Gunderson, 2012). Felson et al (2011) 
also suggests this difficulty in assigning radiographs to either grade 0 (no arthritis) or grade 1 
(arthritis) may be responsible for the wide variations in prevalence of OA in different 
epidemiological studies. 
Initially the Kellgren-Lawrence scale was developed specifically for knee OA. However, 
following the 1961 decision by the WHO in designating radiological diagnosis of OA as the 
gold-standard, the Kellgren-Lawrence scale became the accepted diagnostic scale for the 
presence and/or severity of OA for most synovial joints (Hart & Spector, 1995). However, 
since its initial acceptance, modifications of the Kellgren-Lawrence scale and new joint 
specific scales have been developed (Arden & Nevitt, 2006). Croft et al (1990) developed the 
first variation of the Kellgren-Lawrence scale specifically for the hip and named this the Croft 
scale (see Figure 5). Croft et al (1990) also found that joint space narrowing alone was a valid 
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and reliable indicator of low grade hip OA and Croft el al (1994) proposed a new grading 
system based on this alone (see Figure 6) 
Figure 4 The Kellgren-Lawrence radiographic grading scale  
OA Grade Radiographic Criteria 
Grade 0 No osteoarthritis 
Grade 1 Doubtful narrowing of joint space and possible osteophytic lipping. 
Grade 2 Minimal definite osteophytes, definite minimal/little narrowing of joint space. 
Grade 3 
Moderate multiple osteophytes, definite narrowing of joints space narrowing 
of at least 50%, some sclerosis and possible deformity of bone contour. 
Grade 4 
Large osteophytes, severe loss of joint space, severe sclerosis and definite 
deformity of bone contour. 
 
Figure 5 The ‘Croft Grade’ modification of the Kellgren-Lawrence system 
OA Grade Radiographic Criteria 
Grade 0 No change 
Grade 1 Definite osteophytes only 
Grade 2 Joint space narrowing only (defined as an minimal joint space of 2.5 mm) 
Grade 3 
Presence of two of the following: joint space narrowing, osteophytosis, 
subchondral sclerosis (of >5 mm), cyst formation 
Grade 4 
Presence of three of the following: joint space narrowing osteophytosis, 
subchondral sclerosis (of >5 mm), cyst formation 
Grade 5 
Same as grade 4, but with deformity of the femoral head or total hip 
replacement due to OA (verified by record view) 
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Figure 6 The Croft minimal joint space grading system 
OA Grade Radiographic Criteria 
Grade 0 Minimum joint space > 2.5mm 
Grade 1 Minimum joint space of > 1.5 mm ≤ 2.5mm 
Grade 2 Minimum joint space ≤ 1.5mm 
 
Reijman et al (2004a) conducted a study of the validity, reliability, and applicability of these 
three radiographic definitions of hip OA from 148 x-rays. The K-statistic was used to 
determine inter-rater reliability. The highest K statistic 0.68 (0.44 – 0.92) was for the 
Kellgren-Lawrence (at ≥ grade 2), followed by then the minimum joint space (≤ 2.5mm) at 
0.62 (0.43 – 0.81), followed by the Croft grade (≥ grade 3) at 0.51 (0.35 – 0.67). They 
reported that the Kellgren and Lawrence grade and the minimum joint space had a higher 
positive correlation with the clinical symptoms of pain and disability reported by the 
participants than the Croft grading system. Although other radiological grading systems do 
exist for hip OA, these three measures are the most widely employed both clinically and in 
epidemiological studies (Reijman et al, 2004b). However, this study by Reijman et al, (2004b) 
reveals issues that make relying on radiological diagnosis alone problematic. Inter-rater 
reliability of the interpretation of radiological findings is poor, even at the higher grades 
where the clinical signs are more definitive and even less reliable at the lower grades where 
changes are more subtle. Additionally, there is no correlation with the symptoms. 
Consequently, in epidemiological studies where determining the presence or absence of OA 
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is critical, radiographic evidence alone cannot give accurate predictions of societal 
symptomatic burden.  
1.4.3 Symptomatic diagnosis 
An algorithm for the symptomatic diagnosis of hip OA without use of radiographs was 
developed in 1991 by The American College of Rheumatology (ACR) (Altman et al, 1991). 
This classification required: 
 the patient to complain of hip pain, have active internal rotation of ˂15°, and 
erythrocyte sedimentation rate (ESR) of ≤45 mm/hour, or if ESR is unavailable, 
 the patient to complain of hip pain, have active internal rotation of ˂15° and active 
hip flexion ≤115°, or  
 the patient to complain of hip pain, have active internal rotation of ˂15° and active 
hip flexion ≤115°, and pain on internal rotation, and morning stiffness, and ˃50 years 
of age.  
They found this classification based on symptom reporting to have a sensitivity of 86% and a 
specificity of 75%. 
When ESR and radiographs are available, the ACR recommended the clinical diagnosis of OA 
as: hip pain, and presence of osteophytes (femoral or acetabular) on radiograph or ESR 
≤20mm/hour, and axial joint space narrowing on radiograph. This combined approach of 
including patient reported symptoms, radiographs and laboratory tests yielded a sensitivity 
of 91% and a specificity of 89% compared to using the clinical criteria alone. 
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An analysis of general practitioner consultations using the Consultations in Primary Care 
Archive (CiPCA) database has recently been undertaken by Arthritis Research UK (2013) in 
collaboration with the Arthritis Primary Care Centre at Keele University, UK. Extrapolation 
for this data set estimated 2.12 million people having symptomatic hip OA and revealed the 
hip was only second to the knee as the most common joint for which people sought 
treatment.   
1.4.4 Diagnosis by self-reporting 
Edwards et al (2014) conducted a European study in six countries by randomly contacting 
individuals between the ages of 65-85 until they had recruited 2,294 participants and 
assessed the relationship between self-reporting of hip, knee, or hand OA. Participants were 
simply asked “do you have OA”. If they said yes, they were then asked to tick all the relevant 
areas on a body chart, which had the 10 most common sites of OA identified, at which joints 
their OA was sited. Participants were then classified as self-reporting of hip, knee or hand OA 
if they indicated one of these sites. All participants were then assessed for OA at the hip, 
knee and hand using the ARC clinical diagnosis criteria without radiographs (Altman et al, 
1991). This European study revealed self-reported rates of OA were much higher than 
clinical OA: individuals with clinically diagnosed hip OA (n=171) were highly likely to self-
report OA (n=119, 70%) but of those who self-reported OA (n=593), only a fifth (n=119, 20%) 
had a clinical diagnosis (see Figure 7). 
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Figure 7 Diagram of the overlap between definitions of self-reported and clinical hip OA  
 
 
 
 
 
 
Total n=971 
 
1.5 Disease progression  
Despite being such a common disease, the natural progression and prognosis for OA is 
poorly understood (Spector et al, 1992) though disease progression is usually slow, occurring 
over years or decades (Lohmander, 2000). Due to the time taken for disease progression, 
long term longitudinal studies are difficult to conduct and expensive (Wolfe and Lane, 2002). 
Wolf and Lane (2002) also highlight that old radiographs, other than those used in clinical 
trials, are now routinely sold due the high value of the silver in the films. As a consequence, 
retrospective studies are also difficult due to this. However, the studies which have been 
conducted are reviewed below. The current gold standard for measuring disease progression 
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of hip (Altman et al, 2004) and knee (Ornetti et al, 2009) OA is the rate or percentage of joint 
space narrowing (JSN). 
Dieppe et al (1997) conducted a 3 year longitudinal study of OA disease progression of 500 
patients attending a rheumatology clinic. At the 3 year conclusion to the study, 415 
participants were asked how they thought their OA had progressed; 243 (58.3%) reported an 
overall worsening of their OA, 87 (21.0%) with no change, and 85 (20.5%) reported an overall 
improvement. However, there was no significant change (p=0.82) in VAS pain score but 
there was a significant deterioration in function (p˂0.001) measured using the Steinbrocker 
score (Steinbrocker et al, 1949). Radiographs at the start and conclusion of the study were 
only available for 145 participants with knee OA. Changes in joint space narrowing of ˃2mm 
were used as the minimal significant change, and this was only recorded in 30% of the knee 
radiographs at 3 years follow-up. The participants in this study had a mean age of 65.6 (24-
88) at the start of the study and had ‘relatively severe OA’ (Grade of OA not defined) as they 
were already attending a rheumatology clinic. 
Spector et al (1992) also conducted a longitudinal study on the progression on knee OA with 
fewer participants than the Dieppe et al (1997) but with a longer time frame. Participants 
(n=167) originally enrolled on two different clinical trials conducted in 1975 and 1976 were 
contacted 11 years latter to obtain consent for new radiographs. A total of 63 subjects (126 
knees) were paired with radiographs taken for the initial studies and re-analysed using the 
same protocol. With the minimal significant change set a one grade change in the Kellgren-
Lawrence scale, after 11 years 51 knees (40%) were assed as having no grade change, 12 
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(10%) had improved by at least one grade, and 63 (50%) had deteriorated by at least one 
grade. When the minimal significant change was increased to 2 grades in the Kellgren-
Lawrence scale, 95 (75%) were assed as having no change, no knees improved, and only 19 
(30%) had deteriorated. The mean age of the participants at follow-up was 69 (52-87) and all 
the subjects were again already attending a rheumatology clinic when they were recruited to 
the original clinical trials. 
Dougados et al (1996) conducted a longitudinal study on participants with hip OA. The 
participants had to fulfil the American College of Rheumatology (ARC) criteria for the 
diagnosis of hip OA and be between the ages of 50-75. Information is not provided on where 
the participants were recruited and whether they were seeking treatment. However, in 
order to fulfil the ARC criteria, the patient pain had to be poorly controlled and impact on 
their daily function. The mean age of the patients at baseline was 63 (S.D. 7.0). Of the initial 
508 patients recruited, 476 underwent radiological evaluation 1 year later. Using change in 
joint space as the indicator of progression, after 1 year, only 102 (22%) showed any disease 
progression. Further analysis on the correlation between age at onset of OA and the risk of 
progression, revealed progression in 15% of patients aged ˂55 and 55-60, 20% for those 
aged 60-65, 27% for those aged 65-70, and 33% for those aged ˃70 at time of disease onset. 
Although this study only followed up at participants at 1 year, the results indicated that the 
older someone is when the disease first becomes symptomatic, the quicker the disease 
progresses. 
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All three of these previously reported studies on disease progression either recruited 
participants that were already in attendance at rheumatology clinics (Dieppe et al, 1997; 
Spector et al, 1992) or those whose pain was not adequately managed by pharmacological 
or conservative interventions (Dougados et al, 1996). These therefore only provide 
information in to rate of progression of the disease in its advanced symptomatic phase 
where people’s function is already compromised.  
Wolfe and Lane (2002) conducted a much larger longitudinal study following some 
participants for up to 23 years. Initially recruitment started in 1976 of patients attending a 
specialist arthritis care centre in the USA for knee OA.  The study then expanded in 1996 to 
recruit participants for 3 years from the community (n=657) with symptomatic knee OA who 
had not yet sought treatment. In total 2,400 participants were recruited of which 1,507 had 
paired ‘before and after’ radiographs at the end of the study. The mean age of the 
participants at time of recruitment was 63.4 (S.D. 11.8). The community participants were 
given three follow up radiographs between 1985 and 1999; those attending the arthritic care 
centre received additional radiographs as part of their routine care. Kaplan-Meier survival 
analyses to obtain rates and prediction of progression to ‘joint failure’. Joint failure was 
defined as a Kellgren-Lawrence joint space narrowing (JSN) score of 3 which is highly 
significant in the USA as this is the grade at which a patient should be offered a joint 
replacement.  Of the 1,507 participants with paired radiographs, 1,232 had grades 0-2 when 
first assessed. The results present the 75th and 50th survival time (to JSN score of 3). For 
those with an initial grade = 0, the 75th and 50th survival times are 11.27 and 17.84 years, 
for those with grade = 1 at onset, 7.41 and 12.03 years, and for those with grade = 2, 4.49 
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and 7.44 years.  A Cox regression revealed the rate of progression is greatest in those with 
established radiographic changes. This suggests the once the disease has progressed from 
grade 0 to grade 2 or more, the rate of disease progression then accelerates. 
1.5.1 Age and the increased prevalence of hip OA 
The Office of National Statistics estimates that the number of people over state pension age 
will increase by 28% in the UK; from 12.2 million in 2010 to 15.6 million in 2035 (see Figure 
8).  
Figure 8 Actual 2010, and projected 2035 age structure in the United Kingdom (ONS, 2011) 
 
Reproduced under the open government licence:  
(http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/) 
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Due to OA being a disease that primarily affects older people; as people live longer and the 
proportion of the population over 60 increases, more people will be living with OA (Cross et 
al, 2010; Pereira et al, 2011). Murphy et al (2010) analysed longitudinal data (n=3068) from a 
population based study in North Carolina, USA and estimated the lifetime risk of developing 
hip OA by age of 85 is 25.3% (95% CI; 21.3-29.3%).  
1.6 Current concepts of conservative management 
Recent guidelines have been released involving non-pharmacological conservative 
management of osteoarthritis by four authorities and influential organisations: The 
Osteoarthritis Research Society International (OARSI) (Zhang et al, 2010); The American 
College of Rheumatology (ACR) (Hochberg et al, 2012); The European League Against 
Rheumatism (EULAR) (Fernandes et al, 2013); and The National Institute for Health and Care 
Excellence (NICE, 2014).  
The ACR grading (Hochberg et al, 2012) of recommendation used four categories (Strong, 
Conditionally, No recommendation, and Strong recommendation not to use) based on the 
strength of evidence supporting the modality coupled with the extent to which the benefits 
were considered to outweigh any possible harm. ‘Strongly recommend’ required high quality 
evidence of any benefits to greatly outweighing any potential harm. Most informed patients 
would choose this management and clinicians should offer this treatment. ‘Conditionally 
recommend’ inferred the absence of high quality evidence and/or small difference between 
benefit. This can be offered if the patient prefers these options to the strongly 
recommended ones. ‘No recommendation’ was made when there were no RCTs and no 
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evidence of benefit. ‘Strong recommendation not to use’ was made when there were no 
RCT’s and/or in opinion of the expert panel potential harm may outweigh any benefits. A 
different approach is taken in the EULAR guideline (Fernandes et al, 2013) which is based on 
providing the user with the grade of evidence supporting each conservative intervention but 
no specific recommendation for its implementation is made. The level of research evidence 
graded in to four categories. Grade 1 evidence is subdivided in to level 1a (meta-analysis of 
RCTs) and level 1b (at least one RCT). Grade 2 is also subdivided in to 2a (at least one 
controlled clinical trial) or 2b (at least one quasi-experimental study). The lower level 
categories are Grade 3 (observational studies) and Grade 4 (expert opinion or experience of 
respected authorities). The OARSI recommendations (Zhang et al, 2010) were based on 
synthesis of evidence from published systematic reviews (64), RCTs (266) and economic 
evaluations (21) up to January 2009; a dichotomous approach to ‘recommend’ or ‘not 
recommend’ is used. The NICE guidelines (NICE, 2014), which specifically relate to the UK, 
use a best available evidence approach  to provide a strength of recommendation to health 
care providers; wording denoting certainty with which the recommendation is made such as 
‘offer’ or ‘consider’. Three interventions are considered as core treatments (education, 
activity & exercise, weight loss) which should be offered to all people with clinical 
osteoarthritis. The ACR, OARSI and EULAR guidelines provide recommendations for hip OA 
separately which are those presented in Table 2 below. The NICE guidelines do not 
differentiate their recommendations by affected joint, though mention is made if the 
evidence does relate to a specific joint only.  
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Table 2 shows that all four guidance documents agree that education and self-management 
and exercise are considered as the main conservative treatments that should be offered. The 
evidence for other management options is less clear and dependent upon the review 
strategy used by the various guideline production teams. For example, the OARSI (2010) 
recommend the use of acupuncture but not electrotherapy, whereas in contrast, NICE 
(2014) recommend acupuncture should not be offered but state transcutaneous electrical 
nerve stimulation electrotherapy should be considered, yet neither of these conservative 
interventions are addressed by the ARC (2012) or  EULAR (2013) guidelines. 
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Table 2 Summary of the recommendation for the management of hip osteoarthritis  
 OARSI (2010) ACR (2012) EULAR (2013) NICE (2014) 
Education and 
self-
management 
Recommended 
Education, self-management 
and provision of information 
on OA is a core 
recommendation  
Conditionally Level 1b Offer (core treatment)  
Accurate verbal and written 
information and education on 
OA. This should be part of an 
overall management plan, not 
a single event. 
Thermotherapy 
(Heat or Cold) 
Not addressed Conditionally Not addressed Consider 
Local heat and cold as adjunct 
to core treatment 
Exercise Recommended 
Exercise regime that included 
strengthening and aerobic 
exercises. Land based class 
based exercises are more cost-
effective than home based or 
aquatic based exercises.  
Strong 
Cardiovascular and/or 
resistance exercises and/or 
aquatic exercises. 
 
No recommandation 
Balance exercices, tai chi 
Level 1a  
People with hip OA should be 
taught a regular individualised 
exercise regime that included 
strengthening exercises for 
both legs. This should include 
range of movement/stretching 
exercises. 
Offer (core treatment) 
Recommended irrespective of 
age, comorbidity, pain or level 
of disability. Exercise should 
include local muscle 
strengthening and general 
aerobic fitness. Delivery 
should be based on individual 
circumstances. 
Manual 
Therapy 
Not addressed Conditionally 
In combination with 
supervised exercise. 
No recommendation  manual 
therapy alone  
Not addressed Consider 
Manipulation and stretching as 
adjunct to core treatment, 
particularly for hip OA. 
Electrotherapy Not recommended Not addressed Not addressed Consider 
Transcutaneous electrical 
nerve stimulation (TENS) as 
adjunct to core treatment 
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Acupuncture Recommended Not addressed Not addressed Do not offer 
Assistive 
devices 
Not addressed Conditionally 
Walking aids as needed 
Level 1b 
Walking aids and assistive 
technology (hand rails, walk-in 
showers, increase height 
chairs) as part of an 
intervention package.  
 
Level 3  
If provided not part of an 
intervention package. 
Offer 
Advice on appropriate 
footwear with shock absorbing 
properties.  
Consider 
Assistive devices/walking aids 
Weight Loss (if 
overweight) 
Not recommended 
Good evidence exists for 
weight reduction for people 
with knee OA, no evidence is 
available to support this 
intervention for people with 
hip OA  
Strong Level 1b Offer (core treatment) 
Orthotics Not addressed Not addressed Level 1b  
foot orthotics 
Consider 
 
Psychosocial 
interventions 
Not addressed Conditionally Level 3  
Counselling on change of work 
task, altering work hours, use 
of assistive technologies at 
work, workplace modification, 
commuting. 
Not addressed 
OA; osteoarthritis
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1.7 The total hip replacement 
The NICE (2014), OARSI (2010) and the ARC(2012) guidelines for the care and management 
of OA recommend that conservative treatment should be offered first, but the decision for 
people to be considered for THR is not based on the extent of the pathophysiological 
progression of the disease, but on patient symptoms alone. Consideration for a THR should 
be given once people have ongoing pain, joint stiffness, reduced function and poor quality of 
life that are not managed by conservative means. The THR is probably one of the most 
successful orthopaedic surgical procedures and has been described as one of the greatest 
successes of medical care (Bunker et al, 1994). At one year post surgery, several studies have 
shown that quality of life indices for people with a THR are similar to age matched people 
without hip OA (Zhang et al, 2008). It is generally accepted that primary THR is a cost-
effective treatment (NAO, 2003) and the cost for quality-adjusted life years (QALYs) 
compares favourably with other health interventions (Holzwarth & Cotogno, 2012).  
Although the THR is considered a clinical and cost effective intervention, all health systems 
constantly strive to increase quality and reduce costs.  Joint registries were initially set up to 
enable this (Holzwarth & Cotogno, 2012) by providing continuous feedback. The 
Scandinavian counties were the first to adopt national registers, soon followed by most 
other European countries (Holzwarth & Cotogno, 2012). The National Joint Registry (NJR) of 
England and Wales started a systematic approach to recording all joint replacement 
procedures performed in 2004. Table 3 shows the steady year on year increase in the 
number of THR procedures performed in England & Wales. The compliance rate is calculated 
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by the NJR from data provided to UK Department of Health by joint prostheses 
manufacturers on implants sold in England & Wales compared to the number of operative 
procedures reported. The number of primary THR procedures (excluding hip resurfacing) is 
then multiplied by the compliance rate to estimate the total number of primary THR 
procedures; these data are presented in Figure 9. 
Table 3 Estimates of primary THR procedures for England & Wales by the NJR 2004-13 
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2004 0.43 32,221 - 32,221 50,458 
2005 0.69 56,454 1694 54,760 71,955 
2006 0.82 60,027 6003 54,024 63,965 
2007 0.81 67,380 6064 61,316 73,211 
2008 0.95 70,636 5651 64,985 68,039 
2009 0.92 71,000 4260 66,740 72,346 
2010 1.00 73,155 2195 70,960 70,960 
2011 1.00 75,916 1518 74,398 74,398 
2012 0.90 79,792 798 78,994 86,657 
2013 0.91 80,194 802 79,392 86,537 
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Figure 9 Estimates of primary THR surgery rates in England & Wales using NJR data 
 
Table 3 shows a drop in compliance for 2012 (90%) and 2013 (91%) compared to the 100% 
for 2010 and 2011. Consequently, these compliance figures are expected to be revised 
upwards in subsequent NJR reports due to the long time delay in reporting the use of the 
registered prosthesis.  
The Swedish Hip Arthroplasty Registry was the first national database to be set up and has 
records going back to 1967 making it the longest national record. As reporting is mandatory 
for all state funded hospitals, and all private hospitals are included in the data collection, it 
also makes it one of the most complete national records of hip replacement activity. The 
annual number of hip replacements performed in Sweden is shown in Figure 10 below 
(Swedish Hip Arthroplasty Registry, 2012). 
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Figure 10 Swedish hip arthroplasty data from 1967 to 2012  
 
Reproduced with permission of the Swedish arthroplasty registry  
 
1.8 Overview of current UK rehabilitation practice  
1.8.1 Rehabilitation providers 
Rehabilitation in health care settings usually refers to the processes and interactions which 
aid the physical or mental recovery after injury or disease and also to the management of 
long-term conditions. Medline and the US National Library of Medicine state rehabilitation is 
regaining strength, relearning skills or finding new ways of doing things. The Charted Society 
of Physiotherapy (CSP, 2015) defines rehabilitation as: 
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“Rehabilitation aims to optimise patient function and well-being, to help integrate 
that patient back into their chosen lifestyle activities whether at home, work or 
leisure. Rehabilitation should focus on changes to functional disability and lifestyle 
restrictions based on the patient’s own goals for functional improvement” 
Khan et al (2009) in a review of multidisciplinary rehabilitation following hip or knee 
replacement state that the three main aims of rehabilitation are to prevent problems such 
as deep vein thrombosis or dislocation, to regain lost strength due to long term 
deconditioning, and to regain independence and participation in society.  They also suggest 
that for most people without any comorbidities, rehabilitation by a single health professional 
may be sufficient, but those with more comorbidities may require several professionals such 
as doctors, nurses, physiotherapists and occupational therapists (OT). 
In the UK, the main profession providing rehabilitation after THR is OT (Drummond et al, 
2012) though this is not the same in other countries. Although the world federation of 
occupational therapists (WFOT, 2015) list 59 full member counties and 18 associate member 
counties in their organisation, professional boundaries of practice vary between and within 
countries depending on the regulatory framework for that profession. It is not unusual for 
specialist rehabilitation nurses or physiotherapists to perform the same interventions with 
regards to rehabilitation following THR as would be performed by an OT within the UK. 
Increasingly within the NHS many aspects of routine pre-admission therapy services and 
rehabilitation interventions are administered by generic rehabilitation assistants who deliver 
a range of cross discipline interventions. As a consequence, it is important to differentiate 
the therapy intervention from the profession of the person delivering it in order to allow 
research to be inclusive of international differences in health care delivery.   
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1.8.2 Rehabilitation practice in the United Kingdom 
This section will provide a general overview of rehabilitation of patients undergoing THR. A 
more detailed discussion of OT practice is contained within chapter 2.    
Although he built on previous work by other orthopaedic surgeons around the world, the 
English surgeon Sir John Charnley is credited with development of the first effective THR 
procedure in the 1950’s. His pioneering work included not only the design and 
manufacturing of the prosthesis, but also the development of the cement fixation method 
and the first effective clean air operating theatres required to reduce the risk of infection 
(Reynolds & Tansey, 2006). In this history of development of the THR, Reynolds & Tansey 
(2006) do not provide details of the rehabilitation provided; however, they do state that 
“The patient remained in bed for ten or 12 days, until the wound was healed, and stayed in 
hospital for maybe three or four weeks (p 11)”. Despite the very limited information available 
on rehabilitation procedures in this period (Khan et al, 2009), the importance placed on 
rehabilitation can be evidenced by a correspondence to the British Medical Journal in 1954 
by Sir John Charnley, commenting on a previous article discussing surgical procedures for 
treating OA hips.  
“In the future surgery of the hip joint the quality of the surgery will be inversely 
proportional to size of the physiotherapy department…..with the new look surgery 
[referring to a THR] the physiotherapist of the future will still be at the right hand of 
the surgeon but she will get her results merely by assisting the patient to take the first 
steps and, which is even more important, by dispelling the fears and uncertainties 
which beset the patient during the many hours when the surgeon is absent.” (p 1564) 
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As the volume of surgical procedures increased and the quality of surgical procedures 
improved, the length of stay (LOS) in hospital following surgery reduced. In the 1990’s the 
American Academy of Orthopaedic Surgeons were recommending a typical LOS should be 
about 12-14 days for uncomplicated patients (AAOS, 1991). This initial reduction in LOS was 
mainly driven by the need to reduce hospital acquired functional decline which is a 
recognised problem with prolonged stay for people over 65 years of age (Hoogerduijn et al, 
2005; Roos et al, 2003). However, in the UK hospitalisation of 10 days or more post THR was 
still routine practice in the UK prior to 2000 (The National Audit Office, 2003). Since 2000, 
primarily as a consequence of economic pressures (Cookson & Laudicella, 2011), the LOS has 
been further reduced to the now typical stay of only 3-4 days.  
The Musculoskeletal Service Framework (Department of Health, 2006) recommends that 
patients with hip or knee pain should have access to multi-professional rehabilitation 
services prior to, and after discharge from hospital, following elective joint replacement 
procedures (see Figure 11) which is endorsed by the British Association of Orthopaedics 
(BOA) guide to good practice (2006). Despite these recommendations that patients should 
receive rehabilitation, no national guidelines exist as to the nature or amount of 
rehabilitation that should be offered (Westby et al, 2006; COT; 2012). Westby et al (2008) 
suggest that as a consequence of the absence of clinical guidelines and lack of high quality 
evidence, most rehabilitation programmes that do exist follow clinical experience, surgeon 
preference or anecdotal reports. Additionally, since the development of the first THR the 
‘traditional’ rehabilitation for patients undergoing elective THR has occurred in the post-
surgery hospitalisation recovery stage. Now that uncomplicated patients are routinely 
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discharged after 3-4 days, very little time exists for rehabilitation to occur in the acute care 
setting. (Westby et al, 2006). 
To gain an understanding of current UK national practice, a Chartered Society of 
Physiotherapy (i-CSP) internet survey question was posted in October 2010 requesting 
information on current pre- and post-operative practice for lower limb joint replacement 
(Appendix I). Although a small sample (n=6), the results showed the variability in current UK 
practice with some NHS trusts providing pre-operative advice packages in accordance with 
the BAO and DH guidance on good practice, whereas others provided none whatsoever. 
Discussion with clinicians reinforced this variable picture. This variability in practice shown 
by this small i-CSP survey was reinforced in a subsequent observational study by Artz et al 
(2012). This observational study of rehabilitation practice in 24 high volume NHS 
orthopaedic centres in England and Wales revealed that no routine rehabilitation is offered 
following discharge to patients undergoing THR.  
Due to national variability in practice and the identified lack of high quality research specific 
to rehabilitation, the optimum amount of rehabilitation needed to enable the recipient to 
fulfil their maximum quality of life is unknown. Correspondently, the minimum amount of 
rehabilitation required to reduce of the adverse consequences of dislocation is also 
unknown. 
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Figure 11 Flow chart adult elective patients with hip or knee pain 
 
Reproduced under the open government licence (http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/) 
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1.8.3 Current occupational therapy practice in the UK 
Although UK practice is variable, occupational therapists are the main health professionals 
associated with providing rehabilitation services to patients undergoing THR. A recent survey 
of OT practice in the UK (Drummond et al, 2012) found that OTs who work in an orthopaedic 
setting spent approximately 40% of their working time treating people who have had a THR. 
Dislocation is the second most common complication (other than aseptic loosening) 
following THR with incidence reported as ranging between 0.5% - 10%. (Blom et al, 2008). 
Therefore, a substantial component of this practice was providing assistive devices and 
advice in order to prevent dislocation of the new prosthetic hip. The incidence of dislocation 
is particularly high in the first few months following surgery with a smaller risk persisting 
throughout life (Lübbeke et al, 2009). Consequently, in the first few vulnerable months 
following surgery, patients are routinely advised to restrict the range of motion of the 
prosthetic hip (Restrepo et al, 2011). Advice usually includes avoiding hip flexion of more 
than 90°, internal and external rotation more than 20°, adduction past the midline and 
specifically the combined movement of flexion/adduction which occurs during sitting cross 
legged (Peak et al, 2005, Lübbeke et al, 2009). The time period these movement restrictions 
are in place varies due to surgical approach and style of prosthesis fixation, but is usually 
between 6-12 weeks (NHS Choices, 2014). The 6 week minimum is to allow tissue healing of 
the joint capsule, ligaments and muscles which normally stabilise the hip that have to be cut 
during surgery. If more extensive tissue is cut using a different surgical approach, or an 
uncemented prosthesis fixation method is used then the time frame for all the tissues to 
heal can take up to 12 weeks. There is also some element of ‘surgeon preference’ that 
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dictates these time frames (Westby et al, 2006). Adherence with these movement 
restrictions has negative consequences on many normal functional activities of daily living 
(ADL). As a result, OTs (or OT assistants) routinely provide adaptive equipment and 
functional aids to patients, along with comprehensive education in their usage, to help with 
ADLs and prevent dislocation of the new prosthesis during the critical first few months. Due 
to the age of the cohort undergoing THR, many patients have a range of other physical and 
psychological co-morbidities which further complicates their functional capabilities. As a 
consequence, OTs will provide specific assistive devices tailored to the individual’s needs and 
educate them in their usage.  
When OTs perform home visits, the home environment is assessed for safety, with trip 
hazards being one of the fundamental aspects of this assessment. The NICE (2004) falls 
prevention guidelines recommend that a multifactorial risk assessment should be routinely 
performed on all people considered at risk of falling, with a home safety assessment being 
one of the recommended elements. This guideline also suggests altered gait, balance and 
mobility, and muscle weakness are potential causes of falls which are all typically found in 
people with OA hip.  
Despite the variety of practice previously discussed, the majority of patients in the UK are 
still provided with assistive devices just before they are ready for discharge (McMurray et al, 
2000). However, as a result of economic pressures to reduce length of stay (LOS) in hospital, 
the time to discharge has decreased: The National Audit Office (NAO 2003) report found 
average LOS had reduced from 11 days in 1999 to 8 days in 2002. An audit of NHS records 
from 2001 to 2007 by Cookson and Laudicella (2011) showed a year on year reduction in 
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average LOS following THR from 10.86 days in 2001 to 7.14 days in 2007. The NHS choices 
website (2014) suggests current anticipated in-patient LOS is between 3-5 days; with 
patients eligible for rapid discharge schemes returning home 1-3 days following surgery. As a 
consequence, time for in-patient rehabilitation, education and counselling has decreased. 
This ever decreasing in-patient rehabilitation period has resulted in patients having to learn 
about precautions and adaptive equipment within one to two days following surgery when 
anxiety and stress levels are still high (Butler et al, 1996; Crowe and Henderson, 2003; 
Spalding 2003) and cognitive ability may be impaired. Moller et al (1998), in a study of the 
effects of anaesthetic gases in older (>60 years) patients (n=1218) undergoing cardiac 
surgery, found significant (p<0.0001) cognitive dysfunction was still present in 25.8% (CI 
23.1-28.5%) at 1 week post-surgery, and was still significant (p>0.0037) in 9.9% (CI 8.1-12.05) 
at three months after surgery compared to age matched controls. Additionally, the analgesia 
used may also still be affecting cognitive function and the processing of information 
(William-Russo et al, 1992). Therefore, pre-admission services are now increasingly 
important to aid post-discharge planning (Westby et al, 2009) and improving the patient 
experience (Spalding 2003).  An important corollary of this reduced length of stay is the time 
available for recuperation, in-patient rehabilitation, education and discharge procedures 
(Westby et al 2009).  Although some variation in practice does occur, it is usual practice in 
the UK for occupational therapists to provide assistive devices, together with education of its 
use, in this short post-surgery/pre-discharge period. Pre-surgery home based provision has 
been identified as desirable by patients and possibly assist functional rehabilitation (Orpen & 
Harris, 2011). 
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1.9 The patient experience of the THR 
A search was conducted for qualitative articles regarding patient’s experiences of 
undergoing a THR which resulted in 12 articles.  Studies that interviewed patient prior to 
undergoing THR revealed that people expected the hip replacement to relive the pain and 
enable them to return back to higher levels of function, especially re-engagement with 
societal participation (Fielden et al, 2003; Grant et al, 2009; Manusco et al, 1997). The 
studies that interviewed participants after their THR revealed the participants were generally 
satisfied with their lives. However, they also expressed that they had to modify their pre-
operative expectations in terms of returning to higher levels of function and/or the rate of 
recovery (Fielden et al, 2003; Grant et al, 2009; Gustafsson et al, 2009; Manusco et al, 1997). 
In the Gustafsson et al (2009) study, participants spoke of a ‘naïve understanding’ pre-
operatively that could unexpectedly lead to negative outcomes of bitterness and despair if 
their recovery did not progress as expected. Concerns about coping post-operatively were 
expressed in three studies (Heine et al, 2004; Hunt et al, 2009; Soever et al, 1010). Lack of 
access to post-operative rehabilitation was identified in two studies (Hunt et al, 2009; Soever 
et al, 1010) as a source of concern; participants thought they may not be able to return back 
to their desired levels of function without this. The importance of pre-operative education 
was identified in five studies (Fielden et al, 2003; Heine et al, 2004; Orpen and Harris, 2010; 
Spalding, 2003; Soever et al, 2010) in terms of reducing pre-operative anxiety, but also 
informing them of what to expect after discharge. In the study by Orpen and Harris (2010) 
participants also expressed the desire for the adaptive equipment to be delivers pre-
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operatively due it being of assistance while living with OA prior to surgery. Also, it would give 
them confidence to use it post-surgery.   
1.10 Economic cost of general osteoarthritis in the United 
Kingdom 
Despite its prevalence, there is very little published information relating to the economic 
costs of OA to the UK economy (Chen et al., 2012). Instead, the majority of health economic 
research on the cost of musculoskeletal disorders has focused on the cost to the individual 
(March and Bachmeier, 1997). Additionally, gaining a realistic economic cost of OA is 
compounded as it is primarily a disease affecting older persons who are also likely to have 
other comorbidities attracting health care and societal costs. However, using a variety of 
published data, March and Bachmeier (1997) estimated the cost of OA in various developed 
countries as generally being between 1% - 2.5% of the gross national product (GNP), with 
the estimate for the UK being 1.1% (£4 billion in 1986). With the present GNP of the UK 
economy being estimated at approximately 2.5 trillion US$ (World Bank, 2014), this estimate 
of 1.1% of the UK GNP would now equate to ~£17 Billion. A more recent study by Oxford 
Economics (2010) (commissioned for the Arthritis Research Council (ARC)) attempted to 
estimate the full economic cost of arthritis to the UK economy. A prevalence of 6.65m 
people with OA (see Figure 12) was assumed. The results of this analysis only presented 
separately values specific to OA for the estimates of ‘value of healthy life lost’ and the ‘direct 
health costs’; all other costs were combined estimates for OA and rheumatoid Arthritis (RA). 
However, as OA accounts for approximately 95% of all possible types of arthritic disease 
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(NHS, 2014), these figures would not be greatly reduced if economic data for OA could be 
isolated. Chen et al (2012) provide a breakdown of the component parts (drug costs, 
iatrogenic drug costs, arthroscopy, and joint replacement) used to estimate their direct 2010 
health cost for the UK (see Figure 13). From this, it can be seen that the most significant 
direct cost is associated with joint replacement which accounts for £852m (85%) on the total 
direct costs of £1007.7m. However, this analysis has not taken in to account the cost of 
cortioco-steroid injections which are widely used for pain relief (Hirsch et al, 2013) and 
conservative treatments provided before joint replacement surgery is considered. With the 
increasing age demographic in many developed countries, all these components of the full 
economic costs of OA will increase.  
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Figure 12  Full economic cost of arthritis in the UK (Oxford Economics, 2010)  
 
Figure 13 Direct costs of treating OA (from Chen et al, 2012) 
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1.11 Economic cost of hip osteoarthritis  
    Direct costs 1.11.1.1
The GP consultation study by Arthritis Research UK (2013) estimated there were 2.12 million 
people in the UK with hip OA, and hip OA accounted for 24% of all GP consultations 
concerning pain of OA origin. Figure 14 illustrates a breakdown of the estimated direct costs. 
If an assumption is made that 24% of all pain relieving medication for OA is therefore related 
to the treatment of hip OA, using the figures provided by Chen et al (2012) it can be 
estimated that this then accounts for £36.8 million (at 2010 prices). The NICE technology 
appraisal for THR (2014) calculated the average cost (2012 prices) of prosthesis (£2517), sum 
cost of performing the surgery (£2805) and the average in-patient stay following surgery 
(£1678) as costing the NHS £7,063 per person. In 2013 there were 80,194 THR procedures 
recorded (NJR, 2014); the direct cost of performing this number of hip joint replacements 
can be calculated as costing £566.4 million. The (2014) NICE technology appraisal also 
calculates the average 12 month follow–up cost for outpatient appointments, primary and 
community care costs as being £394 per person. This adds another £31.6 million to the 
direct costs.  
In their economic analysis, Chen et al (2012) did not include revision surgery. However, as 
>90% of all primary THR is performed due to OA, the cost of revision should realistically be 
included. Revision surgery is more complex and the average age of the patient is older (70.7 
years) for revision surgery compared to primary surgery (68.8 years) so the cost per 
procedure is higher (NJR, 2014). NICE (2014) calculate the total cost of revision at £16,571 
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plus an additional £394 per person for average postoperative complications cost. This 
equates to £16,965 per procedure. In 2013 there were 9,751 revision procedures (NJR, 2014) 
giving an additional overall cost of £165.4 million. 
This analysis is probably an underestimate of the true direct cost as it does not include 
patients who need longer episodes of hospital care nor the cost of steroid injections which 
are recommended by the American College of Rheumatology (Hochberg et al, 2012) for the 
management of hip OA.   
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Figure 14 Estimate of direct costs for hip osteoarthritis 
 
Note: these cost estimates are based on 2010 prices. Where data was not available for 2010, inflation factors 
were used to calculate 2010 prices from most recent available data. 
    Indirect costs 1.11.1.2
There is not enough information to make any form of estimate of the proportion of the 
overall indirect costs as reported by Chen et al (2012) or by Oxford Economics (2010) that 
can be attributed specifically to hip OA. However, either hip or knee OA, when analysed 
together, are the principal causes of mobility related disability in an elder population (Felson 
et al, 2000) and form the two most common large joints affected (ARUK, 2013). It is 
therefore reasonable to assume that the contribution of hip OA to the overall indirect cost is 
at least proportional to its reported 24% representation of all OA (ARUK, 2013). 
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1.12 Summary of current evidence regarding occupational 
therapy practice for patients undergoing THR 
This section will present a summary of current evidence from systematic reviews focused on 
THR rehabilitation. 
1.12.1 Rehabilitation for patients undergoing THR 
  Pre-operative interventions 1.12.1.1
Fortin et al conducted a two centre observational study of 379 participants undergoing 
elective THR or TKR due to OA (Fortin et al (1999). This study found that functional activity at 
both 3 and 6 after surgery was positively correlated with pre-operative functional status. 
Since this initial observational study, several other studies have been conducted to see if 
pre-operative exercises aimed at improving pre-surgery function can affect post-surgical 
outcomes. A systematic review of physiotherapy interventions prior to patients undergoing 
their THR or TKR was conducted by Ackerman and Bennet (2004). This review only contained 
two studies relating to THR patients, of which both are contained in the more recent review 
and meta-analysis by Gill & McBurney (2014). This review by Gill & McBurney (2014) 
contained at total of 18 studies of which six related to patients undergoing THR. This review 
found a significant improvement, with a medium size effect, in favour of the pre-operative 
exercises for both pain (SMD 0.45; C.I. 0.15 – 0.75, p=0.0004) and function (SMD 0.46; C.I. 
0.20 - 0.72, p=0.006) measured prior to admission. The heterogeneity I2 statistic was zero for 
both of the meta-analyses indicating confidence in interpreting these findings. This review 
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searched 4 electronic databases (CINAHL, MEDLINE, Embase, and Cochrane Library) and had 
good methodology and discussion, though the results lacked clear reporting of the study 
characteristics (size, follow-up periods, and specific content of the interventions). However, 
the authors do state that several of the included studies did not provide specific details of 
the exercise based interventions. As a consequence, they were also unable to make any 
specific recommendation as to the type, intensity or duration of pre-operative the exercise 
programs.  
McDonald et al (2014) conducted a review of pre-operative education which contained 18 
studies (1463 participants), thirteen of which involved people undergoing a THR. The main 
outcomes of this review were preoperative anxiety, though some complex interventions 
were included that also measured long term outcomes of pain and function. All of these 
studies are contained in the systematic review reported in chapter 2 of this thesis so the will 
discussed later.   
   Post-operative interventions  1.12.1.2
Three systematic reviews have been conducted on the effect of post-operative exercise (Di 
Monaco et al, 2009; Di Monaco and Castiglioni, 2013; Minns-Lowe et al, 2009).  
The Minns-Lowe et al (2009) review searched 8 electronic databases plus hand searched 
three journals and conference proceedings up to April 2007 resulting in it containing 8 
studies. Only two of the studies enclosed had data presented suitable for meta-analysis. The 
outcomes were self-reported function, walking (speed or timed distance), hip range of 
motion, muscle strength, and quality of life.  The review was of high quality with all elements 
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of the PRISMA (Moher et al, 2009) checklist clearly reported. Minns-Lowe et al (2009) 
concluded that due to the diversity of outcomes used, and the poor quality of the included 
clinical trials, that it was not possible to establish the effectiveness of post discharge 
exercises. In contrast, the review by Di Monaco et al (2009), published in the same year and 
contained nine studies, concluded  that ‘convincing evidence’ for the effectiveness of partial 
weight bearing treadmill training, resistance training of the quadriceps muscle on the 
operated side, and use of an arm ergometer when included in general exercise programmes. 
However, this review is of much lower quality than the one by Minns-Lowe et al (2009). The 
search strategy only involved electronic searching of MEDLINE, only one person assessed 
eligibility criteria, and only the final PEDro score was presented for the quality appraisal, and 
no study selection diagram is presented. Additionally, the method of evidence synthesis 
used to arrive at the conclusions of the effectiveness of the interventions is not reported, 
nor does any actual method of synthesis appear to be employed. The finding of this review 
must therefore be considered with caution and more emphasis placed on the findings of the 
Minns-Lowe et al (2009) review. 
Di Monaco and Castiglioni (2013) updated the Di Monaco et al (2009) review and this was 
conducted and reported to a higher quality (Moher et al, 2009) though it still lacked some 
important aspects of quality (Moher et al, 2009). The search was widened to include 4 
electronic databases (MEDLINE, PEDro, Cochrane library, Cinahl) and included 8 RCTs 
published after January 2008 to December 2012. Two reviewers assessed inclusion eligibility, 
a flow diagram is presented, but again, only the final PEDro scores are presented. Again, a 
narrative review was undertaken but no apparent method of synthesising the information 
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was employed. The review concludes that robust evidence is available for ergometer cycling 
and resistance training in the early stages of rehab, and weight bearing exercises in the later 
stages. However, although this review is of higher quality than the one it updated, caution 
still has to be applied in interpreting these findings. Together, these three systematic 
reviews suggest there is insufficient evidence to determine the effectiveness of post-surgery 
exercise for patients who have had a THR. 
Khan et al (2008) conducted a high quality systematic review on post-operative 
multidisciplinary programmes for THR and TKR patients which included 5 studies. No meta-
analysis was undertaken, thus a strength of evidence method (Tugwell et al, 2004) was used 
to synthesise the findings. A level of evidence approach was taken form conclusions. This 
review concluded that there was silver level evidence that early multidisciplinary 
rehabilitation can improve function in THR patients at six months following surgery. It also 
concluded that there was a lack of evidence regarding rehabilitation, and the evidence that 
was available, was of a low to moderate quality.   
   Combined preoperative and post-operative interventions 1.12.1.3
Skoffer et al (2014) conducted a systematic review with a wider search of 9 electronic 
databases (PubMed, Embase, Cochrane Library, Web of Knowledge, PEDro, Cinahl, SveMed+, 
SPORTDiscus and Bibliotek.dk) to investigate the effectiveness of progressive resistance 
training (PRT) programs conducted both pre-surgery, and continued post-surgery, on 
strength and function before and after TKR or THR. This review contained 4 RCT’s with 136 
participants undergoing THR, though the authors report that the quality of reporting in the 
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included studies made meta-analysis unfeasible, so a strength of evidence synthesis 
approach was taken. The results in this review were poorly reported; the flow diagram 
reports 14 studies were included but only 7 are contained in the outcome of the review and 
only percentages changes were presented, not the original data. Also, although the authors 
discuss risk of bias, the bias associated with each study is not presented. Although the 
review suggests a weak-to-moderate beneficial effect of PRT in strength and functional 
capacity was found, the actual evidence synthesis methodology used is not reported. These 
results should therefore be treated with caution. 
1.12.2 Occupational therapy and rehabilitation following THR  
The UK College of Occupational Therapists recently recognised the lack of practice guidelines 
and released the first clinical guidelines for occupational therapists working with patients 
undergoing elective THR (COT, 2012). An overview of systematic reviews of the efficacy of 
OT in different conditions found none relating to rehabilitation following THR (Steultjens et 
al, 2005). The most recent published systematic review (Hand et al, 2011) relating to OT is 
specific to community based OT interventions for chronic conditions and the search strategy 
did not include articles relating to OT for THR surgery. However, a previous systematic 
review by Steultjens et al (2004) concluded that strong evidence exists for the efficacy of OT 
practice of provision and advice in use of assistive devices as part of a home hazards 
assessment to maintain functional ability in elderly community dwelling adults. The 
provision of assistive devices is a key aspect of OT involvement in THR rehabilitation, yet 
none of the included studies specifically included this. Despite the endorsements by NICE 
(NICE 2003) and the British Orthopaedic Association (BOA, 2006) for OT interventions of 
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people undergoing THR, the evidence base required to underpin effective rehabilitation 
programs has not been established; this has resulted in existing protocols being based either 
on ‘clinical experience, surgeon preference or anecdotal reports’ (Westby et al, 2006). This 
review will help to address the limited review based evidence that currently exists for a 
condition that has high prevalence (Drummond et al, 2012), wide variation in current clinical 
practice (Khan et al, 2012) and substantial economic implications (Chen et al, 2012). The 
completed review will strengthen the evidence base, help clinicians determine optimum 
rehabilitation strategies and enable patients to make informed choices about their 
rehabilitation following a THR. 
1.13 Rationale for study 
The evidence surrounding pre-operative education involving OTs, coupled with the pressure 
to reduce length of stay suggested it may be more effective to provide ADL adaptive 
equipment, and education in their use, pre-surgically in the familiarity of patients’ own 
homes. This would alleviate the need for this to happen in the immediate aftermath of 
major surgery and had the potential to improve patients’ worries and anxieties about 
returning home. Organisation of patients for discharge can be a complex scenario with many 
professions involved. Anecdotal reports from practicing OTs suggested that the delay in the 
supply of OT assistive devices can contribute to delayed discharge, especially if discharge is 
due at a weekend; McMurray et al (2000) found only 5% trusts surveyed provided any OT or 
assistant cover at weekends. Supply of assistive devices, together with education in their use 
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in the patient’s own home prior to surgery may also streamline discharge and improve 
patient outcomes. 
1.14 Chapter summary 
This chapter has introduced the basic pathology of OA and the debate that still exists 
regarding risk factors for developing hip OA. It reveals that defining the epidemiology of hip 
OA is highly dependent on the diagnostic method used and that more research is needed 
into quantifying risk factors. A summary was presented showing the variation in 
recommendations for conservative therapies by stakeholder organisations. More detailed 
summary information was provided on the economic cost of OA and specifically hip OA 
when there was enough information to provide this detail. The chapter then discussed the 
rehabilitation of THR and the role within this usually provided by occupational therapists. A 
brief summary was then provided on previous research in to OT rehabilitation interventions 
which revealed more research is needed in to the effectiveness of OT intervention in relation 
to patients undergoing THR due to OA. 
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2 SYSTEMATIC REVIEW 
2.1 Chapter overview 
This chapter presents a systematic review and meta-analysis that was undertaken regarding 
the efficacy and effectiveness of occupational therapy interventions in relation to patients 
undergoing primary THR due to osteoarthritis. The conduct of this review was done in 
accordance with the guidance provided by the Cochrane handbook (Higgins & Green, 2011) 
and is reported following the PRISMA guidelines (Moher et al, 2009). Following the meta-
analysis, a GRADE approach (GRADE working group, 2004) has been taken to synthesise the 
findings. The review was undertaken in order to inform the clinical trial reported in chapter 3 
of this thesis. Additionally, a version of this review (without the studies by Peak, 2005; 
Ververeli, 2009 and Wong, 1990) also forms part of the final report submitted in November 
2014 to the NIHR for the project “Improving patients’ experience and outcome of total joint 
replacement” grant number RP-PG-0407-10070.  
2.1.1 Aims 
The aims of this review are to evaluate the efficacy and effectiveness of all pre- and post-
operative OT interventions for patients undergoing elective primary or revision THR using 
patient centred outcomes.  
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2.2 Methods 
 Search strategy 2.2.1.1
Electronic databases were used to perform a standardised search in order to identify 
relevant published studies. Search dates were set to start in all electronic searches from 1st 
January 1980; studies published prior to this were excluded on the basis that the low quality 
reporting of older studies and their lack of relevance to current clinical practices (Cochrane, 
1999). The first electronic search was undertaken in December 2011 then repeated again 
prior to the final write up of this review in July 2013. The electronic databases searched are 
as follows: 
 Cochrane Register of Controlled Clinical Trials (CENTRAL) via the Cochrane library, 
 MEDLINE via Ovid, EMBASE via Ovid, 
 CINAHL plus (Cumulative Index to Nursing and Allied Health Literature) via EBSCO, 
 AMED (Allied and Complementary Medicine Database) via EBSCO, 
 PEDro (Physiotherapy Evidence database) http://www.pedro.org.au/, 
 ERIC (Education Resources Information Centre) via ProQuest,  
 CIRRIE (Centre for International Rehabilitation Research Information & Exchange) 
via http://cirrie.buffalo.edu/database/,  
 OTDbase via http://www.otdbase.org/,  
 Web of Science via http://apps.webofknowledge.com/ 
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The electronic search strategy developed for MEDLINE is available in Appendix 2. Search 
terms for the other databases were developed to match this.   
In addition to the standard electronic databases, other electronic platforms were searched 
to identify unpublished articles. On-going trials were searched through national registers and 
their respective web sites; Controlled Clinical Trials (www.controlled-trials.com) and the 
National Institute of Health Trial Registry (http://clinicaltrials.gov) and the International 
Clinical Trial Registry Platform of the World Health Organisation 
http://apps.who.int/trialsearch/); grey literature was searched using the OpenGrey database 
(http://www.opengrey.eu/). 
Citation checks of the included articles were performed using the Web of Science citation 
search facility. National and international experts in OT orthopaedic research were 
contacted for knowledge of on-going studies, published data not available electronically, or 
unpublished work. 
2.2.2 Inclusion and exclusion criteria 
 Types of studies 2.2.2.1
Randomised controlled trials (RCTs) are considered as the ‘gold standard’ of clinical research 
(Moher, 2010). Due to this, many literature reviews limit the inclusion criteria to RCT’s only. 
However, due to the anticipated limited quantity of evidence available if the search was 
restricted to RCTs alone, the search was expanded to include controlled clinical trials (CCTs). 
To be included, CCTs had to have a concurrent comparator. Clinical trials without a 
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concurrent comparator or trials comparing OT provision of services against other professions 
delivering the same services were excluded because outcomes could be affected by other 
differences in care provided (anaesthetic, operative procedures, antibiotics etc.) 
 Types of participants 2.2.2.2
The search strategy focused on comparative trials of patients undergoing primary or revision 
THR surgery for osteoarthritis. Excluding studies that have included a minority of participants 
who have received a THR for reasons other than OA could limit the available information to 
be included in this review; whereas including studies where the majority of participants 
received THR for conditions other than OA (e.g. rheumatoid arthritis, trauma) would bias the 
results. Therefore, studies were included providing that 50% or more of participants 
received THR surgery due to osteoarthritis. All types of prosthesis, fixation methods and 
surgical approaches were considered for inclusion. Studies relating to participants receiving 
hemi-arthroplasties or resurfacing procedures were excluded. 
 Types of interventions 2.2.2.3
For the purpose of this review, OT was defined as a rehabilitation programme that addresses 
all, some, or one of the following interventions: 
 Assessment, facilitation, practice and/or re-assessment of function. This included 
self-care activities of daily living tasks (ADL’s) to foster independence and skills in 
these activities. 
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 Training of societal participation or extended activities of daily living (EADL) skills 
aimed at improving social reintegration. This included specific training to facilitate 
activities beyond personal or self-care ADL’s. This therefore included activities 
such as gardening, shopping, return to work, sport and social pursuits. 
 Hip precautions: this was defined as any form of counselling, advice on ADL’s, 
practise with participants, or the provision of, or education in their use of 
assistive devices (raised toilet seats, furniture raises, dressing aids, perching 
stools, long handled reachers and commodes) used to avoid the specific 
movements thought to be associated with increased risk of hip dislocation 
(flexion, adduction, external rotation).  
 Education sessions designed to inform patients of their expected pathway from 
the operative procedure to recovery at home, to reduce anxiety, or preparation 
for discharge. This may therefore include education on activity pacing and 
avoidance of specific joint positions associated with joint dislocation (hip flexion 
beyond 90°, adduction beyond the mid-line and to avoid internal and external 
rotation beyond 20° from neutral (Lucas 2008).  
 Environmental adaptations such as removal of trip hazards, layout of furniture to 
improve access around the home, layout of specific rooms such as bathrooms, 
the kitchen and bedroom, and installation of hand rails or grab rails. 
These interventions applied pre- or post-operatively, in a health care setting or in any 
community setting, or provided by therapy assistants under the supervision of qualified OT 
staff were also accepted. In several countries, the specific profession of OT does not exist, 
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though other health professionals such as nurses or physiotherapists carry out interventions 
equivalent with OT practice. Therefore, interventions provided by health care staff other 
than designated occupational therapists, which are commensurate with UK OT practice were 
accepted. Professor Avril Drummond (AD), a specialist in OT research at the University of 
Nottingham, assessed any studies of this nature to ensure the intervention met accepted OT 
practice.  
In the clinical environment, rehabilitation is generally multidisciplinary; consequently, many 
clinical trials on rehabilitation are pragmatic in nature and do not isolate individual practices. 
In order to maximise the number of included studies, OT interventions provided as part of a 
multidisciplinary package were included if the nature of the OT intervention was adequately 
described and formed a substantial element of the overall rehabilitation, or the outcome 
could be assessed independently. 
These OT based interventions were compared to routine care, no OT, or alternative/novel 
OT approaches. 
 Types of outcome measures 2.2.2.4
The World Health Organisation has developed an International Classification of Function, 
Disability and Health (ICF) (WHO, 2001). This original ICF classification of ‘function’ contained 
various levels of human activity from basic movements to full societal activity. Jette et al 
(2003) initially proposed that this classification of function should be divided into two 
distinct categories of ‘activities’ and ‘participation’ which is now widely used.  OT 
involvement in elective THR primarily addresses the impact of disease according to this ICF 
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classification at the levels of ‘activity limitation’ and ‘restriction in participation’.  For this 
review, the primary outcomes were selected to concur with this stratification of function as 
identified below.    
 Primary outcomes 2.2.2.5
Function  
For this review ‘function’ was defined as the basic activities which everyone undertakes to 
maintain a personal level of care (e.g. feeding, toileting, washing, bathing, transfer in/out 
bed/chair, mobilising). This addresses the ICF ‘activity’ classification in which activity is 
defined as the execution of a task or action by an individual (WHO, 2001). 
Societal participation 
For this review, societal participation relates to the ability of an individual to carry out their 
life habits in their environment such as home, work place, local neighbourhood, and wider 
social circles (INDCP, 2014). This incorporates the higher functional skills required to live 
independently and manage a dwelling (e.g. preparing own meals, doing housework, 
managing own money, shopping). This outcome also includes activities sometimes termed as 
societal reintegration or discretionary activities, which involve higher function activities such 
as driving, using local services, return to work or sport, using public transport, socialising 
with friends, attending social or cultural events. This addresses the ICF ‘restriction’ 
classification. 
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Health related quality of life 
Health related quality of life (HRQoL) is an important concept to both clinicians and policy 
makers (Guyatt, 1993) with outcomes often used to measure the effectiveness or cost-
effectiveness of therapeutic interventions. The underlying principle of HRQoL is how the 
individual rates the quality of their life. A THR is a major surgical procedure specifically 
designed to both reduce pain and improve HRQoL. Additionally, an underlying principle of 
OT practice is to improve overall quality of life, hence the inclusion of this outcome.     
Anxiety 
Despite the common nature of the THR, it is still a major life decision for an individual to 
choose to have a THR which evokes feelings of fear and anxiety as well as hope for the 
future (Gustafsson, 2010). One of the main aims of pre-operative education is to reduce the 
anxiety associated with major surgery and the preparedness for return home afterwards. 
(McDonald et al, 2004).  
Pain 
Only data collected by previously validated outcomes for pain were accepted for inclusion in 
the review. These could be discrete measures of pain including the visual analogue scale, or 
with tools such the McGill Pain Questionnaire (Melzack, 1971). Subsections of other 
validated measures, which have a domain of pain, were also accepted if the validation 
extended to subsection analysis. 
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Dislocation 
The frequency of total hip replacement dislocation are reported as the number of incidences 
where a participant required a manipulation under anaesthetic to reduce a dislocated hip 
prosthesis, or the requirement of a revision procedure due to recurrent hip dislocation. 
Length of Stay 
Length of stay (LOS) following surgical procedure. Time spent in any form of sub-acute 
rehabilitation facility following discharge from the acute hospital where the THR surgery 
occurred is not included in the analysis. 
 Selection of studies 2.2.2.6
All levels of study selection were performed by two independent reviewers (PJ & NB). If 
necessary, authors were contacted for further information to determine if the study met the 
inclusion criteria or for additional information not reported in the published articles.  
Professor AD was consulted in cases of uncertainty regarding the OT involvement in the 
study or equivalent practice by other health care professionals. If a consensus could not be 
achieved by the two primary reviewers about suitability for inclusion, this was resolved by 
consultation with an independent third person with expertise in systematic reviewing (AB). 
The reviewers were not masked to the name(s) of the author(s) or publication source at any 
level of the review.  
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2.2.3 Assessment of risk of bias 
Many clinical trials, including randomised controlled trials regarded as the highest standard 
of clinical trial, are often poorly conducted and/or inadequately reported. When conducting 
a systematic review it is important to consider the risk of bias otherwise incorrect conclusion 
may be reached, i.e. ‘garbage in: garbage out’ (Hróbjartsson, 2013). Many methods are 
available to assess the risk of bias of clinical trials though no consensus exists as to which is 
the best approach (Jüni, 2001). The Cochrane risk of bias tool (Higgins, 2011) was used to 
assess the quality of the included studies. As recommended by Cochrane, the assessment of 
bias was conducted by two independent authors using a standard format.  Each bias domain 
was determined as being subject to either a low, high, or unclear risk of bias. Authors were 
contacted for additional information to clarify allocation of the correct bias and information 
from previous Cochrane reviews was used in cases of bias allocation uncertainty. 
Blinding is considered one of the most important sources of bias in clinical trials (Karanicolas, 
2010). In rehabilitation trials, it is not usually possible for the participants or the study 
personnel to remain blinded from the intervention: hence, the ‘blinding of participants and 
personnel’ domain was not used for assessment of bias in this review. Blinding of the 
outcome assessor is practicable, and is considered highly important when using subjective 
outcomes (Boutron, 2006) hence the risk of bias for blinding was based entirely on the 
reported status of the outcome assessor. 
If the overall loss to follow up was less than 20% (Altman, 2000), the domain addressing the 
analysis of incomplete outcome data was automatically assigned a low risk of bias. If loss to 
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follow up was greater than 20%, the risk of bias assessment was judged high if a per-
protocol analysis was performed (Higgs & Green, 2011).  If an intention to treat analysis was 
performed (participants being analysed in the group to which they were originally allocated) 
a low risk of bias was attributed. If the method of analysis could not be determined, a 
judgement of an unclear risk of bias was allocated. If the two independent reviewers were 
unable to reach consensual agreement about bias allocation, this was resolved by discussion 
with an independent third person Andrew Beswick (AB); an expert in systematic reviewing. 
2.3 Quality of studies 
A GRADE approach (GRADE working group, 2004) was used to rate the quality of evidence in 
this review. Using this approach, all the RCT’s are initially ranked as providing a high quality 
level of evidence and the CCT’s ranked as providing low quality evidence. Review authors are 
then required to make an overall judgement on whether the quality of evidence for an 
outcome warrants adjustment on the basis of the outcome of the risk of bias assessment. As 
RCTs are initially ranked as high quality, any adjustment can only be a downgrade; on rare 
occasions observational studies may be upgraded. To maintain the objectivity of this review, 
a methodology was pre-defined before undertaking the risk of bias assessments for this 
grade adjustment. The mean time since the studies included in this review were conducted 
is 11.5 years ago (mode 11, range 6-24). Although the first CONSORT guidelines were 
introduced in 1996, a large proportion of potentially well conducted studies were still poorly 
reported in the subsequent years (Altman et al, 2001) which is the time period 
commensurate with the majority of the studies in this review. Consequently, the GRADE 
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methodology presented in section 12.2 of Cochrane (Higgins & Green, 2011) was slightly 
adapted as presented (see Figure 15). This adjusted approach allows slightly more potential 
sources of bias in the non-critical domains (loss to follow-up, selective outcome reporting 
and other sources of bias) to be tolerated than in the Cochrane guidance.  
 
Figure 15 Adjusted GRADE approach to downgrading the level of evidence following the 
risk of bias assessment.  
Randomised controlled trials 
High quality No high risk of bias, or one domain identified high risk of bias 
other than randomisation, allocation concealment or blinding. 
Moderate quality Any two domains identified as high risk of bias, or one domain if 
this includes randomisation, allocation concealment or blinding. 
Low quality Three, or more, domains identified as high risk of bias, or if any 
two out of the three domains of the randomisation, allocation 
concealment or blinding identified as high risk of bias. 
Clinical controlled trials 
(1)
 
Low quality One or less domains, identified as high risk of bias, unless the one 
domain is blinding. 
Very low quality  The domain of blinding identified as high risk of bias, or any other 
two domains. 
Note (1): In the risk of bias analysis, the CCT’s were automatically allocated a high risk of bias for 
randomisation and allocation concealment. Therefore, these domains were not used to grade the 
quality of the studies. 
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2.4 Meta-analysis 
Data for the meta-analysis was extracted in to data extraction tables and was checked by a 
second person prior to meta-analysis (Appendix 3). In studies in which confidence intervals 
were not presented, the effect size was calculated using the formula advocated by the 
Centre for Evidence Based Medicine (CEBM calculator, 2013). Once all the data had been 
extracted from the included studies, and checked for errors, data pertaining to the pre-
determined outcomes were tabulated in an Excel spreadsheet in preparation for the meta-
analyses using RevMan 5.2, the Cochrane Information Management System. Due to the wide 
variety of outcomes and interventions acceptable for this review, some a priori meta-
analysis guidelines were adopted. This is considered good practice (Higgs & Green, 2011) as 
it limits the extent of possible sub-group analyses and prevents spurious findings from 
multiple analyses.  
Outcome measures 
 If studies measured the same outcome using different instruments, in such circumstances, 
the following hierarchy was adopted: patient reported outcome (single outcome) > patient 
reported outcome (domain of multi-outcome instrument)>researcher measured>surgeon 
measured.  
Timing of interventions effects 
Rehabilitation interventions are provided to either improve the overall health status of 
patients prior to admission; at the point they are discharged from the care setting back in to 
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the community, and to improve their long term health status. The effects of the 
interventions provided were therefore measured at three time points: 
1. Pre-surgery: This time point was set to measure the effect of any pre-admission 
intervention. 
2. At point of discharge: This time point was set to measure the effect of any 
intervention delivered pre-admission or during admission. 
3. Long-term follow up (>3 months): this time point measured the long-term effect of 
all intervention delivered prior to admission, during hospitalisation, or post 
discharge.       
Heterogeneity 
Assuming that clinical diversity (also termed clinical heterogeneity) has been accounted for 
by selecting appropriate studies to combine for meta-analysis, the observed effects between 
groups may be more different than one would expect from chance alone; this is referred to 
as statistical heterogeneity (Higgins & Green, 2011). The Cochrane handbook (Higgins & 
Green, 2011) indicates the following guide to interpreting statistical heterogeneity which is 
termed the ‘I2’ statistic.  
• 0% - 40%  may not be important 
• 30% - 60%  may represent moderate heterogeneity 
• 50% - 90%  may represent substantial heterogeneity 
• 75% - 100%  considerable heterogeneity 
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The I2 statistic also gives guidance on the most appropriate modelling method for meta-
analysis. If the I2 statistic is <60% this indicates only a moderate level of heterogeneity may 
be present and indicates that a fixed effect meta-analysis model could be appropriate. 
Above this figure, significant heterogeneity may be present, indicating a random effects 
model is more appropriate. However, this figure can only be used for guidance as studies 
with small sample sizes can appear to give a low I2 statistic, whereas there may well be quite 
large heterogeneity. Higgins and Thompson (2002) suggest some element of heterogeneity is 
always likely to be present in clinical studies so the choice of analytical method used for 
meta-analysis may be irrelevant. Given the Cochrane guidance (Higgins & Green, 2011) 
recommends considering caution if you have small data sets, the inherent diversity in the 
timings and nature of the interventions and comparator groups, random effects modelling 
was chosen for all meta-analyses.  
Analysis method: Standardized mean differences were used for all meta-analyses that 
included outcomes measured by different instruments. When the same instrument was 
employed in all studies to measure the outcome, mean differences were used. If actual 
baseline and follow-up data are not presented in the studies, Higgins & Green (2011) suggest 
it is appropriate to include change from baseline scores in meta-analyses as there is no 
statistical reason why they should not be combined and the inclusion of more data increases 
the strength of the findings; hence, any data reported in such a way has been included.  
Variance: Different formulae exist to transform standard error to standard deviation.  Where 
studies reported variance in terms of standard error, the RevMan 5.2 ‘calculator’ function 
was used to convert to an equivalent standard deviation. Where studies provided no 
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statistical measure of variance other than a mean and range, the range data was used to 
calculate the SD using the formulae of range/4 for studies with ≥ 15 participants in each 
group, or range/6 for studies with > 70 participants in each group as advocated by Hazo et al 
(2005). 
Dichotomous outcomes: Odds ratio modelling was used for the meta-analysis of 
dichotomous outcomes. 
 Presentation of results of the meta-analyses 2.4.1.1
The directionality convention was employed, to assist with clarity for the reader, such that 
all outcome data is presented with a larger numbers representing worse patient outcomes 
and a smaller numbers representing better patient outcomes. Where outcome scales 
included in the meta-analyses varied from this convention with lower scores indicating 
worse outcomes, their directionality was altered using negative values.   
2.4.2 Final quality of evidence:  study quality adjustment following 
meta-analysis 
Although meta-analysis is an effective way of synthesising health related evidence, the 
approach does not accommodate for the quality of the included trials. This method of data 
synthesis is therefore only acceptable as the sole method of synthesising information when 
all the included studies are of high methodological quality and the heterogeneity between 
studies is not high. However, for many aspects of health research, there is limited research 
and often the studies are of mixed methodological quality, as is the situation in this review. 
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Several methods of synthesising information have been proposed (Slavin, 1995; Van Tulder 
et al, 2003; Treadwell et al, 2012). The GRADE working group (2008) developed the strength 
of evidence approach that allows for aspects of study quality adjusted for bias to be 
combined with results of the meta-analysis to produce a more comprehensive evaluation of 
a body of evidence (Owens et al, 2010). A summary of this strength of evidence approach is 
shown in Figure 16. The full version of this table and the definition of all the terms are 
presented in Appendix 4. In the GRADE approach all RCTs are initially assumed to be high 
quality evidence and observational studies low quality; the approach then allows for RCTs 
and observational studies to be graded by the reviewers on the bias assessment and the 
findings of the meta-analyses. Inconsistency relates to the degree to which reported effect 
sizes from included studies appear to have the same direction of effect.  Indirectness relates 
to whether the evidence links the interventions directly to health outcomes. For a 
comparison of two treatments, directness implies that head-to-head trials measure the most 
important health or ultimate outcomes. Imprecision is the degree of certainty surrounding 
an effect estimate with respect to a given outcome (i.e., for each outcome separately). As a 
meta-analysis was performed, this will be the confidence interval around the summary 
effect size. 
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Figure 16  Summary of the (2008) grading recommendations development and evaluation 
(GRADE) approach to combing quality of evidence with meta-analyses results.  
Study design Quality of evidence Lower if: Higher if: 
Randomised trials  
 
 
 
 
 
 
 
 
 
 
 
Observational studies 
 
 
 
 
 
High 
 
 
 
Risk of bias 
-1 Serious 
-2 Very  serious 
 
Inconsistency 
-1 Serious 
-2 Very  serious 
 
Indirectness 
-1 Serious 
-2 Very  serious 
 
Imprecision 
-1 Serious 
-2 Very  serious 
 
Publication bias 
-1 Likely 
-2 Very  likely 
Effect size 
+1 large 
+2 Very large 
  
Dose response 
+1 Evidence of a gradient 
 
 
All plausible confounding 
+1 would reduce a 
demonstrated effect, or 
 
+1 would suggest a 
spurious effect when 
results show no effect 
Moderate 
 
 
 
 
Low 
 
 
 
 
Very low 
 
 
2.5 Results 
2.5.1 Results of search 
The searches identified 4878 articles, of which 13 duplicates were removed, 4593 were 
excluded by title alone, and 240 after abstract reading. Twenty nine articles were reviewed 
in full. Fifteen articles met the eligibility criteria for inclusion in this review (see Figure 17). 
Twelve of these were randomised controlled trials (Butler, 1996; Crowe, 2003; Ferrara, 2006; 
Gocen, 2004; McGregor, 2004; Munin, 1998; Peak, 2005; Sandell, 2008; Siggeirsdottir, 2005; 
Ververeli, 2009; Weaver, 2003; Wong, 1990) and three were controlled clinical trials with a 
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comparator group (Rivard, 2003; Rosendal, 2000; Tappen, 2002). All eligible articles were 
written in English; four were conducted in Canada (Butler, 1996; Crowe, 2003; Rivard, 2003; 
Wong, 1990), five in the USA (Munin, 1998; Peak, 2005; Tappen, 2003; Ververeli, 2009; 
Weaver, 2003), two in the UK (McGregor, 2004; Sandell, 2008), one in Iceland (Siggeirsdottir, 
2005), one in the Netherlands (Rosendal, 2000), one in Turkey (Gocen, 2004) and one in Italy 
(Ferrara, 2008). The reasons for exclusion of the articles after obtaining the full text are 
outlined in Table 4. 
2.5.2 Risk of bias assessment 
The risks of bias assessments of the included studies are reported in Table 5 to Table 19 
below in study alphabetical order. A summary of the bias associated with all included studies 
is shown in Figure 18.  
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Figure 17: PRISMA Systematic review flow diagram (Moher et al, 2009) 
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Search of multiple electronic databases 
for randomised controlled trials and 
controlled clinical trials. Search also 
included reference lists, citation search, 
key journal hand searching and contact 
with OT experts. 13 Duplicates removed. 
 
(n=4865) 
Full-text articles assessed for eligibility  
(n = 32) 
Included studies 
(n= 15 articles) 
 
Randomised Controlled Trials (RCT) (n = 12)  
Controlled Clinical Trials (CCT)           (n = 3) 
Records excluded on basis of title      
(n= 4593) 
 
Records excluded on basis of 
abstract reading (n= 240) 
Full-text articles excluded        (n=17) 
Reasons:   
Insufficient / no OT input       (n = 7) 
Total hip replacement patients 
less than 50% /Total Knee 
replacements        (n = 4) 
 
No control group         (n= 3) 
Qualitative study            (n=1)  
Outcome measures not  
relevant to aims of this review   (n=1) 
Reliability study 
(Method comparison)          (n =1) 
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Table 4: Reason for exclusion following screening of full article 
Study Reason for exclusion 
Hoffmann ( 2008)   A method comparison reliability study  
Kiefer (2006) Population = TKR, no control group 
Larsen (2008)   Quasi-experimental study analysing coordination and organization of care  
Mahomed (2008)   Population = TKR 
Moffet (2004)   no OT component identified. Population=TKR, intervention=PT exercices. 
Moller (1992)   No OT component identified, Feasibility study of hospital versus home 
care,  
Novalis (2000)   Descriptive study, no intervention or control group 
Petersen (2006)   No OT component identified 
Petersen (2008)   No OT component identified 
Spalding (2003) Qualitative study 
Stevens (2004)   No OT content identified 
Trahey (1991) Outcomes measures do not measure activity or participation. Study 
designed to measure patients' ability to follow instructions e.g. compliance 
with hip precautions and attention to safety issued during activities. 
Woo (2000)   Observational study with cross-sectional analysis, no before-after 
intervention comparisons 
Mancuso (2008) Intervention has no OT input, outcome measures not validated and 
measures expectation, which is not a review outcome.  
Daltroy (1998) Minority THR patients and intervention focus is on psychological profiling 
in to "deniers" and "copers" 
Rodenas-Martinez (2008) 
 
Population = TKR 
Bai (2009) Intervention is predominantly exercise based with insufficient OT content.  
Abbreviations: OT, Occupational therapist; PT, Physiotherapist; TKR, total knee replacement 
Note: all studies are denoted only by the first author for clarity  
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 Risk of bias tables of included studies  2.5.2.1
Table 5 Butler (1996)  
Pre-hospital education: effectiveness with total hip replacement surgery patients (Butler, 1996) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
UNCLEAR  
Uncertain risk of 
bias 
“A patient guide booklet was randomly added to 
half the pre-admission packages mailed out to THR 
patients” (p 192) 
Insufficient information about sequence 
generation method to permit judgement. 
Allocation  
Concealment (selection 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
Author additional information: allocation 
concealed by an admission clerk 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
UNCLEAR  
Uncertain risk of 
bias 
Participants: At the time of booklet mail-out, 
“Patients were not informed of the study at this 
point, and there was no indication that the booklet 
would be evaluated” (p 192) 
Assessor: All patients were told about the purpose 
of the study on the day of admission (except 6 
patients who were approached the following day). 
Content of information given to participants at 
this time is not clear.  
Outcome assessors: no information provided. 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
Low risk of bias Consent obtained after randomisation. 
STAI at admission: 8/80 missing (10%) 
STAI at discharge: 3/80 missing (3.75%) 
LOS: 12/80 missing (15%) 
Data not separated by group assignment. 
Reasons for missing data not provided. 
Method of analysis not mentioned though it 
appears all participants were analysed according 
to group allocation. 
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
No study protocol available which is not unusual 
for studies of this age. 
 
Other bias Low risk of bias 43/123 participants were excluded after 
randomisation as they had previously undergone 
at least 1 THR. Since prior exposure to THR 
education and experience with a THR could be 
expected to weaken the hypothesized influence of 
the booklet, this was not considered a risk of bias. 
Patients in the intervention and control groups 
were not treated differently during their hospital 
stay. During their care, patients in both groups 
received education that paralleled the contents of 
the booklet, so that by the time of discharge, all 
patients had been exposed to the same 
information. 
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Table 6 Crowe (2003) 
Pre-arthroplasty rehabilitation is effective in reducing hospital stay (Crowe, 2003) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
Low risk of bias “Subjects were allocated to one of the two groups 
by means of a random number table” (p 90) 
 
Allocation  
Concealment (selection 
bias) 
Low risk of bias “using a system of sealed envelopes” (p 90) 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
Low risk of bias Participants: blinding of participants is unclear, 
however the review authors judge that the 
outcomes (meeting discharge criteria) are not 
likely to be influenced by lack of blinding the 
participants to group assignment. 
Personnel: Insufficient information to permit 
judgement of ‘yes’ or ‘no’ 
Outcome assessors: “Outcomes (meeting 
discharge criteria) were measured in hospital by 
an investigator who was blinded to group 
allocation" (p 90) 
 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
Low risk of bias From author correspondence: 
Days to meet discharge criteria: Usual care:7/68  
missing, Rehab: 6/65 missing 
LOS: Usual care:1/68  missing, Rehab: 1/65 
missing 
Discharge destination: Usual care:0/68  missing, 
Rehab: 4/65 missing 
Reasons for missing data not given. 
 
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR   
Uncertain risk of 
bias 
No study protocol available which is not unusual 
for studies of this age. 
Other bias (attention 
bias) 
High risk of bias At baseline, the control group were significantly 
more disabled and significantly more anxious. 
The intervention group received more attention 
than the controls, which may have introduced 
attention bias.  
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Table 7 Ferrara (2008) 
Effect of pre-operative physiotherapy in patients with end-stage osteoarthritis undergoing hip 
arthroplasty (Ferrara, 2008) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
Low risk of bias The patients were randomised using a table of 
random numbers. 
Allocation  
Concealment (selection 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
Even numbers were allocated to the control group 
and odd numbers to the intervention group 
Insufficient information on the allocation 
concealment process to permit judgement of ‘yes’ 
or ‘no’ 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
Low risk of bias Participants: unable to be blinded 
Study personnel: Physiotherapists providing pre-
surgery intervention cannot be blinded. 
Physiotherapist delivering post-operative 
rehabilitation was not blinded. This could have led 
to treatment bias with more 
rehabilitation/attention given to the control 
group.  
Outcome assessors: Two research assistants and 
two physicians who were blinded to the group 
allocation administered outcome assessment.  
 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
Low risk of bias Intervention group: all patients entering study are 
analysed in T1 (up to 15 days post-surgery) and T4 
(3 months post-surgery).  
Control group: all patients analysed at T1 (up to 15 
days post-surgery); at T4 (3 months post-surgery) 
2 from 12 (16.66%) patients lost to follow-up. 
Method of analysis not mentioned but 
participants analysed in allocated group 
Loss to follow-up is low enough not to significantly 
affect analysis. 
 
Selective outcome 
reporting (reporting 
bias) 
High risk of bias Only significant data (VAS pain, Hip external 
rotation) is presented at T3 (4 week follow up) in 
form of poorly annotated figure with no actual 
raw data presented. 
No study protocol available which is not unusual 
for studies of this age 
Other bias (selection 
bias) 
High risk of bias Patients with end stage hip osteoarthritis did not 
participate due to difficulties with access and 
ability to carry out exercises. This can lead to 
sampling bias as only more able participants took 
part in the intervention group. 
Patients with mini mental state examination score 
of ≤ 23 were excluded which can also lead to 
sampling bias and population not representative.  
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Table 8 Gocen (2004) 
The effect of preoperative physiotherapy and education on the outcome of total hip replacement: a 
prospective randomized controlled trial (Gocen, 2004) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
Low risk of bias Patients randomly divided in to two groups by 
using a table of random numbers of a computer 
programme (Excel 2000).  
Allocation  
Concealment (selection 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
Even numbers were allocated to the control group 
and odd numbers to the intervention group 
Insufficient information on the allocation 
concealment process to permit judgement of ‘yes’ 
or ‘no’. 
 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
Low risk of bias Participants: not possible 
Study personnel: pre-operatively the 
physiotherapy providing the intervention could 
not be blinded. The physiotherapist providing 
post-operative rehabilitation was blinded. It is not 
reported if other hospital staff were blinded to 
group allocation. 
Outcome assessor: a staff physiotherapist who 
was blinded to the study performed all 
measurements. Results assessed in a blinded 
fashion. 
 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
Low risk of bias All control patients followed up at all 
measurement stages throughout the study. One 
patient dropped out of the intervention group 
following the 8-week assessment. All other 29 
followed up to the end of the study. 
No study protocol available which is not unusual 
for studies of this age. 
 
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR   
Uncertain risk of 
bias 
Absolute pain and hip abduction data is not 
presented on change score from pre-operative 
assessment to discharge. 
Pain is not recorded at 3 month and 1-year follow-
up.   
The authors report patients were assessed at 1 
year which was the last follow-up period in the 
flow diagram. However, no data is presented for 
this measurement stage and Harris Hip Score data 
for a 2-year follow-up period. 
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Other bias (attention 
bias, selection bias, 
recording bias) 
High risk of bias Baseline characteristics only recorded for patients 
in the intervention group. 
Patients in intervention group received a lot more 
attention; therefore, attention bias is possible.   
Patients in intervention group were significantly 
younger than those in the control (p=0.01, (I) 
46.95, SD±11.48; (C) 55.50 SD±14.44) 
The average age of patients in both arms of this 
study is not representative of the typical 
population who undergo THR due to 
osteoarthritis. 
Only one physiotherapist was recording the first 
day of activities. It is therefore possible for 
recoding bias to occur as transfer activates may 
have begun when the physiotherapist was not 
working. 
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Table 9 McGregor (2004) 
Does preoperative hip rehabilitation advice improve recovery and patient satisfaction  
(McGregor, 2004) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
UNCLEAR   
Uncertain risk of 
bias 
“At preadmission, patients were allocated 
randomly into either group A or group B” (p 465) 
“patients were randomized by age and not 
functional status” (p 465) 
Author correspondence: Random blocks 
Allocation  
Concealment (selection 
bias) 
Low risk of bias No information provided 
Author correspondence: Concealed envelopes 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
UNCLEAR   
Uncertain risk of 
bias 
Participants: Not possible 
Personnel: Insufficient information is provided as 
to the blinding status. This is considered low risk 
of bias. 
Outcome assessors: Insufficient information is 
provided as to the blinding status to permit 
judgement of ‘yes’ or ‘no’. 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
Low risk of bias Numbers of participants analysed for each 
outcome are not presented in published article. 
Maximum number of observations taken from 
final report, provided by the author: 
Pre-admission: Group A=16/16, Group B=20/20 
Admission: Group A=14/16, Group B=20/20 
Discharge: Group A=14/16, Group B=20/20 
 
“The data generated were analysed using an 
unbalanced analysis of variance” (p 466) 
 
Author correspondence: An unbalanced ANOVA 
was required as occasionally review assessments 
were missed for varying reasons. Reasons not 
given. 
 
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR  
Uncertain  risk of 
bias 
Protocol for study is not available which is not 
unusual for studies of this age. 
Incomplete reporting of psychological measures. 
Satisfaction and EQ-5D presented as graphs with 
no raw data available. Discussion is in text that all 
unreported data was not significant. 
 
Other bias (selection 
bias, attention bias) 
UNCLEAR  
Uncertain risk of 
bias 
Large differences between groups at baseline. The 
intervention group were younger, had a shorter 
duration of symptoms and spent less time on the 
hospital waiting lists then the control group. 
Intervention group received more attention than 
the controls, which may have introduced 
attention bias. 
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Table 10 Munin (1998) 
Early Inpatient Rehabilitation After Elective Hip and Knee Arthroplasty (Munin, 1998) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
Low risk of bias Random listing of 100 numbers, using zero to 
equal day 3 group and 1 to equal day 7 group, was 
generated in blocks of 10. 
 
 
Allocation  
Concealment (selection 
bias) 
Low risk of bias Generated random numbers were stored in locked 
cabinet and administered by blind executor. 
 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
UNCLEAR   
Uncertain risk of 
bias 
Participants: No information provided 
Personnel: discharge from rehabilitation unit 
determined by interdisciplinary team of clinicians, 
some of whom were not blinded to 
randomization. However, standardized, objective 
criteria used for discharge. 
Outcome assessors: insufficient information to 
permit judgement. 
 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
Low risk of bias Of 86 randomised, 71 completed rehab (15 (17%) 
lost to follow-up).  
FIM 
Days 1-5: study group = 14/14, control group = 
11/12 
Days 6-10: study group = 14/14, control group = 
11/12 
Loss to follow-up balanced between groups 
 
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR   
Uncertain risk of 
bias 
Study protocol is not available which is not 
unusual for studies of this age.  
 
Other bias (attention 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
Clients in the intervention group received more 
rehabilitation than the controls, which may have 
introduced attention bias. 
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Table 11 Peak (2005) 
The role of patient restrictions in reducing the prevalence of early dislocation following total hip 
arthroplasty: a randomized, prospective study (2005). 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
Low risk of bias Participants were randomised using a random 
number table (p 249) 
Allocation  
Concealment (selection 
bias) 
Low risk of bias Randomisation performed pre-operatively. 
Sealed-envelope opened at the end of surgery by 
the study coordinator. Designation of the patient 
“double-blinded until completion of wound closure 
to avoid patient selection bias or alteration in 
surgical technique” (p 249) 
 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
High risk of bias Participants: unable to be blinded  
Personnel: unable to be blinded 
Outcome assessors: Participants self-completed 
questionnaires at 6 weeks and 6 month from 
home and posted them back to the research 
team. “The accuracy of the patient reported 
information was by discussion with family 
members and health care personnel” (p 249) 
No mentioning of assessor blinding and discussion 
of accuracy suggests blinding cannot be assured.  
 
Incomplete outcome 
data (attrition bias) 
 
Low risk All participants who were randomised were 
accounted for in the follow-up data   
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
 
Study protocol is not available which is not 
unusual for studies of this age. 
Other bias (selection 
bias) 
UNCLEAR 
Uncertain risk of 
bias 
“..the number of patients who required a 
rehabilitation stay was significantly higher in the 
restricted group than in the unrestricted group 
(125 hips compared with 100 hips; p < 0.002)” (p 
251).  
 
This could indicate the restricted group were more 
functionally disabled as they would not stay in 
hospital any longer than required or there was 
delay in discharge.  
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Table 12 Rivard (2003) 
The efficacy of pre-operative home visits for total hip replacement clients (Rivard, 2003) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
High risk of bias “The distribution of clients to one or the other 
hospital depended on the retrospective surgeons’ 
admitting privileges” (p 229) 
Allocation  
Concealment (selection 
bias) 
High risk of bias “The clients were assigned to a cohort based on 
the location of their surgery” (p 230) 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
Low risk of bias Participants: length of stay is unlikely to be 
influenced by lack of blinding the participants. 
Personnel: prospective chart review with 
intervention based on hospital location. The 
review authors judge that the primary outcome 
(length of stay) may be influenced by lack of 
blinding of hospital staff.  
Outcome assessors: not blinded but unlikely to 
affect the outcome. 
 
Incomplete outcome 
data (attrition bias) 
 
 
 
Low risk of bias The authors state that all 268 clients who 
consented to participate were included in the 
analysis. However, numbers of participants not 
reported in the results tables. 
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
 
The study protocol is not available but this is not 
unusual for studies of this age 
Other bias (deviation 
from protocol) 
High risk of bias Outcomes (LOS and Discharge destination) 
influenced by hospital (and therefore group) e.g. 
bed pressures. 
“Some clients in the study reported anecdotally 
that they could have been discharged directly 
home if they had been able to remain in the acute 
facility one or two days more. However bed 
pressures were as such that they were discharged 
to the sub-acute facility, and once there, remained 
for an additional 5 days” (p 231)  
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Table 13 Rosendal (2000) 
Can shared care deliver better outcomes for patients undergoing total hip replacement 
(Rosendal, 2000) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
High risk of bias No randomisation. 
“The assignment to either one of the two settings 
is dependent on the place of residence of patients” 
(p 3) 
“Randomisation of patients in order to eliminate 
selection bias within one setting was not possible.” 
(p 7) 
 
Allocation  
Concealment (selection 
bias) 
High risk of bias Investigators enrolling participants could foresee 
assignments and thus introduce a selection bias. 
Control group and intervention group were based 
at two different hospitals so researchers would be 
aware of allocation 
 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
UNCLEAR  
Uncertain risk of 
bias 
Participants: they were blind to intervention 
“They did not know whether their setting was 
considered as the experimental or the control 
setting in this study” (p 2) 
Personnel: Insufficient information to permit 
judgement of ‘yes’ or ‘no’ 
Outcome assessors: Insufficient information to 
permit judgement of ‘yes’ or ‘no’ 
 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
Low risk of bias No missing outcome data 
All patients reported to be involved in study are 
accounted for in outcome measures post 
intervention and at 6 month follow-up 
 
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR   
Uncertain risk of 
bias 
 
The study protocol is not available but this is not 
unusual for studies of this age. 
 
Other bias UNCLEAR  
Uncertain risk of 
bias 
 
Insufficient information to assess if other risks of 
bias exist. 
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Table 14 Sandell (2008) 
A multidisciplinary assessment and intervention for patients awaiting total hip replacement to 
improve quality of life (Sandell, 2008) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
Low risk of bias Randomisation performed using a computer 
generated randomisation table. 
 
Allocation  
Concealment (selection 
bias) 
Low risk of bias Participants given a study number after they had 
agreed to join the trial. The number corresponded 
to a numbered sealed envelope containing the 
group allocation. 
 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
UNCLEAR   
Uncertain risk of 
bias 
Participants: unable to be blinded  
Personnel: unable to be blinded 
Outcome assessors: Insufficient information 
provided as to the blinding status to permit 
judgement of ‘yes’ or ‘no’. 
Incomplete outcome 
data (attrition bias) 
 
 
 
High risk of bias Eighty-nine patients entered the study but only 
sixty-six completed (26% loss to follow-up). Not all 
reason for loss accounted for. 
No intention to treat analysis.   
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
 
The study protocol is not available but this is not 
unusual for studies of this age. 
 
Other bias (attention 
bias, researcher bias) 
High risk of bias  Patients in intervention group received a lot more 
attention than those in the control, which can 
introduce attention bias. 
 
Only one author attributed to study and no 
acknowledgements. Whole study appears to be 
performed by one researcher who inputted 
outcome measure data and performed analysis of 
results. 
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Table 15 Siggeirsdottir (2005) 
Short hospital stay augmented with education and home based rehabilitation improves function 
and quality of life after hip replacement (Siggeirsdottir, 2005) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
UNCLEAR  
Uncertain risk of 
bias 
Participates were randomised in to one of the two 
groups by opening a sealed envelope containing a 
note indicating which group the patient was to be 
allocated. Insufficient information about sequence 
generation method to permit judgement.  
 
Allocation  
Concealment (selection 
bias) 
Low risk of bias 
 
Sealed envelopes used  
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
UNCLEAR  
Uncertain risk of 
bias 
Participants: Participants could not be blinded to 
the intervention as it required home visits to take 
place. Review authors judgement is that the 
outcome is not likely to influenced by this lack of 
blinding as they would be unaware of what was 
the normal care provided 
Personnel: OT & PT staff had to administer the 
intervention. Insufficient information to permit 
judgement of ‘yes’ or ‘no’ as to if they were aware 
of the participants involvement in the study 
Outcome assessors: Insufficient information to 
permit judgement of ‘yes’ or ‘no’ 
 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
Low risk of bias Only 1 participant outcome data missing at the 4 
month follow up. Otherwise, all patients reported 
to be involved in study are accounted for in 
outcome measures at all other measurement 
intervals. 
The missing outcome data not enough to have a 
clinically relevant impact on observed size effect. 
 
Selective outcome 
reporting (reporting 
bias) 
 
UNCERTAIN   
Unclear risk of bias 
The study protocol is not available which is not 
unusual for studies of this age. 
Other bias (deviation 
from protocol) 
High risk of bias Changes were required to the study after the 
original protocol had been accepted as the 
university hospital had a major reorganisation 
affected the study resulting in uneven 
contribution to the study from the two hospital 
sites originally identified. This is a major deviation 
from original protocol 
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Table 16 Tappen (2003) 
Effect of a video intervention on functional recovery following hip replacement and hip 
 fracture repair (Tappen, 2003) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
High risk of bias Randomization to intervention or control groups 
was not possible because of institutional 
constraints and concerns about contamination of 
control subjects potentially viewing the 
videotaping of treatment subjects during therapy 
sessions. 
 
Allocation  
Concealment (selection 
bias) 
High risk of bias Data collected on all comparison subjects before 
the tapings to prevent contamination of the 
intervention group. 
Investigators enrolling participants could foresee 
assignments and thus introduce a selection bias. 
 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
UNCLEAR   
Uncertain risk of 
bias 
Participants: insufficient information to permit 
judgement. However, participants likely to be 
aware. This is considered low risk of bias 
Personnel: unlikely as videos made during 
physiotherapy sessions. This is considered low risk 
of bias 
Outcome assessors: insufficient information to 
permit judgement. 
 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
UNCLEAR  
Uncertain risk of 
bias 
Attrition after admission to study was 39/121 
(32%) due to unavailability for follow-up (26), 
discharge before testing or taping (10), illness/ 
death (3). 
Insufficient information to identify if there is any 
missing data from outcome measures. 
Method of analysis not mentioned though it 
appears all participants were analysed according 
to group allocation. 
 
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR   
Uncertain risk of 
bias 
 
Study protocol is not available which is not 
unusual for studies of this age. 
 
Other bias Low risk of bias The intervention group was significantly older and 
had more chronic illnesses than the control group; 
however, this is accounted for in the analysis. 
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Table 17 Ververeli (2009) 
Evaluation of reducing postoperative hip precautions in total hip replacement: a randomized 
prospective study (2009) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
Low risk of bias “Group assignment were generated by the 
research coordinator using a random number 
table” (p 2) 
Allocation  
Concealment (selection 
bias) 
Low risk of bias Sealed envelopes used  
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
High risk of bias Participants: unable to be blinded  
Personnel: unable to be blinded 
Outcome assessors: Insufficient information 
provided as to the blinding status to permit 
judgement. Method by which follow-up data is 
recorded is very poorly documented and open to 
bias.  
  
Incomplete outcome 
data (attrition bias) 
 
 
Low risk of bias All participants randomised in to the study are 
shown in the results table. Reporting of data is 
generally poor. 
Selective outcome 
reporting (reporting 
bias) 
High risk of bias Very limited data provided on Harris Hip Score, 
Short-Form 12 (mental & physical) or patient 
satisfaction. Not all data for all time points of 
collection was presented in results that were 
reported in abstract. Also in the abstract it is 
mentioned that follow up data is collected at “4 
weeks, 1 month, 3 month and 1 year”. (p 1) 
 
Other bias UNCLEAR   
Uncertain risk of 
bias 
 
Insufficient information to assess if other risks of 
bias exist. Study poorly reported. 
 
  
 ~ 91 ~ 
 
Table 18 Weaver (2003) 
Comparison of two home care protocols for total joint replacement (Weaver, 2003) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
Low risk of bias “Consenting TJR patients were stratified by type of 
procedure (Unilateral TKR, bilateral TKR or THR) 
and randomly assigned within each stratum…” (p 
524) 
 
Allocation  
Concealment (selection 
bias) 
UNCLEAR 
Uncertain risk of 
bias 
The comment “To preserve integrity of the 
intervention and prevent contamination between 
treatment and control conditions, only staff from 
the city-wise agency were trained in the treatment 
protocol” (p 524) suggests allocation concealment 
was considered. However, Insufficient information 
on the sequence generation process is provided to 
permit judgement of ‘yes’ or ‘no’ 
 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
 
UNCLEAR  
Uncertain risk of 
bias 
Participants: blinding to intervention is not 
possible as a home visit before surgery in the 
intervention group had to be pre-arranged with 
the participant. This should not be considered as 
source of bias 
Personnel: Initial home visit by nurse who could 
not be blinded to this as it was not customary 
practice. Insufficient information is provided as to 
the blinding status of the PTs & OTs providing the 
treatment in control & intervention group. 
Outcome assessor insufficient information is 
provided as to the blinding status the personnel 
administering the outcome measurements.  
In summary, the lack of information for all 
personnel associated with this study signifies an 
uncertain risk of bias. 
 
Incomplete outcome 
data (attrition bias) 
 
 
 
 
 
Low risk of bias                           Intervention    Control 
@ baseline          n = 69             n = 67 
@ 1 month FU    n = 65             n = 65 
@ 6 month FU    n = 61             n = 62 
Loss of 2 participants from the intervention group 
and 1 from the control group due to mortality.  
Other losses not explained other than “No 
significant differences were seen in rates of 
attrition by group, and overall attrition was low; 
91% completed 6 month post-test”(p 526) 
The missing outcome data not enough to have a 
clinically relevant impact on observed size effect.  
 
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR   
Uncertain risk of 
bias 
The study protocol is not available which is not 
unusual for studies of this age. 
 
 ~ 92 ~ 
 
Other bias (selection 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
“Main reason for ineligibility for inclusion in the 
study was lack of Medicare coverage” (p 525); 
46% of excluded participants were due to this. 
Most participants were living with person capable 
of assisting with care (86% and 90%). 
This sample groups are not fully representative of 
society limiting the applicability of its findings. This 
is not explored by the author. 
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Table 19 Wong (1990) 
Effects of an experimental program in post-hospital adjustment of early discharged patients 
(Wong, 1990) 
Domain Judgement Description 
Adequate sequence  
generation (selection 
bias)  
 
 
UNCLEAR  
Uncertain risk of 
bias 
“A list of patients scheduled for a total hip 
replacement operation between 1 February 
1986 and 31 December 1987, was secured from 
five orthopaedic surgeons. The patients were then 
randomly assigned to one of three groups” (p 10). 
No information provided on the sequence 
generation  
 
Allocation  
Concealment (selection 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
“The impartial observers (no’s 2 and 3) knew 
neither the specific objectives of the study nor 
whether a patient being observed was in the 
experimental or control group, although they 
occasionally deduced some patients” (p 13). 
This statement indicates there was an attempt to 
maintain allocation concealment though there is 
insufficient information to confirm. 
Blinding 
Participants 
Personnel 
Outcome assessors 
(Performance bias) 
 
Low risk of bias Participants: unable to be blinded  
Personnel: unable to be blinded 
Outcome assessors: impartial observers used (p 
13) 
Incomplete outcome 
data (attrition bias) 
 
 
UNCLEAR  
Uncertain risk of 
bias 
It is not possible to work out if all participants 
were accounted for as only summary statistics are 
presented in the article. Unable to contact author 
for confirmation.  
Selective outcome 
reporting (reporting 
bias) 
UNCLEAR  
Uncertain risk of 
bias 
No study protocol available which is usual for 
studies of this age.  No data presented other than 
p-values.  
 
Other bias (attention 
bias, performance bias) 
High risk of bias Participants in the early discharge group received 
more attention and reinforcement of the 
intervention.  
“During these visits, the research assistant 
reinforced patient learning initiated at hospital, 
assessed these patients’ performance of home 
exercises, and reminded them to carry out 
exercises regularly. Her visits to these patients one 
week after discharge seemed critical, as many of 
them raised numerous questions concerning after-
care. The control patients received some 
information on home exercises, but their learning 
was neither reinforced nor monitored.” (p 16) 
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Figure 18: Summary risk of bias chart (Higgins, 2011) 
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Butler (1996)             
High 
Crowe (2003)             
High 
Ferrara (2008)             
Moderate 
Gocen (2004)             
High 
McGregor (2004)             
High 
Munin (1998)             
High 
Peak (2005)       
Moderate 
Rivard (2003)
(2)
             
Low 
Rosendal (2000)
 (2)
             
Low 
Sandell (2008)             
Moderate 
Siggeirsdottir (2005)             
Moderate 
Tappen (2003)
 (2)
             
Low 
Ververeli (2009)       
Low 
Weaver (2003)             
High 
Wong (1990)       
Moderate 
  
      Low risk of bias 
      Uncertain risk of bias 
      High risk of bias 
 
Note (1): The bias associated with blinding has been determined by the status of outcome 
assessor only.  
Note (2): These are controlled clinical trials. For the risk of bias assessment they have been 
allocated a high risk of bias in the domains of ‘adequate sequence generation’ and 
‘allocation concealment’.   
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The analysis of the included trials shows that only four of the trials were free from at least 
one source of bias (Butler, 1996; McGregor, 2004; Munin 1998; Weaver, 2003). Of these 
four, only the trial by Munin (1998) had three criteria assessed as being a low risk of bias; the 
other studies having only two criteria assessed as low. Despite contact with authors (Munin 
1998, McGregor, 2004, Siggeirsdottir, 2005), many risk categories were still unclear, making 
the overall classification of the quality of the studies uncertain. Additionally, as none of 
these studies had prior protocols published, establishing the risk of bias for selective 
outcome reporting was hard to establish such that an uncertain risk of bias was allocated. 
Only the study by Crowe (2003) had four or more criteria assessed as being of low risk. In 
four studies (Butler, 1996; Peak, 2005, Ververeli, 2009, Weaver, 2003), the outcome 
assessors were not blinded which is considered as a potential source of bias. In the studies 
by Butler (1996) and Weaver (2003), the outcomes were assessed by patient completed 
questionnaires, so both were allocated an uncertain risk of bias. However, in the other two 
studies (Peak, 2005, Ververeli, 2009) some of the outcomes were assessed by members of 
the research team who were aware of group allocation, so these have been graded as 
containing a high risk of bias.  
Overall, six of the 12 RCT’s were graded as high quality studies (Butler, 1996; Crowe, 2003; 
Gocen, 2004; McGregor, 2004; Munin 1998; Weaver, 2003); five moderate quality studies 
(Ferrara, 2008; Peak, 2005; Sandell, 2008; Siggeirsdottir, 2005; Wong, 1990) and one a low 
quality study (Ververeli, 2009). All three CCT’s were graded as low quality (Rivard, 2003; 
Rosendal, 2000; Tappen, 2003). 
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2.5.3 Description of studies 
The characteristics of the included studies are shown in Table 20 and the nature and timing 
of the intervention is shown in Table 21. 
 Participants 2.5.3.1
These trials contained 1,509 participants in total, of which 1396 (92.5%) underwent a THR. 
The number of participants in each trial was small with a median value of 86 (range 23 to 
303) and the mean age of the participants in each trial was similar with a range of mean ages 
from 51.2 to 74.0 (weighted mean 66.2, SD±6.1). Three trials (McGregor, 2004; Tappen, 
2003; Peak, 2005) did not report gender; 424 (28%) of all participants did not have gender 
reported. In the trials that reported gender, 700 (64.5%) of the participants were female and 
385 (35.5%) male. This gender difference was most extreme in the study by Weaver (2003) 
which had 126 (86.3%) females as compared to only 20 (13.7%) males. Only Gocen (2004) 
contained more male 38 (64%) than female 21 (36%) participants.  
The majority of participants underwent joint replacement surgery due to osteoarthritis with 
the exception of Tappen (2003) where 50% of the participants underwent hip fracture repair 
(precise surgical procedure not reported). All participants in Gocen (2004) received a THR, 
with 29 (49%) being due to primary osteoarthritis and 30 (51%) due to secondary 
osteoarthritis; 13 (22%) as a result of development dysplasia, 10 (17%) due to idiopathic 
avascular necrosis of the hip, and 7 (12%) as a result of hip fracture. Eight of the trials 
specifically excluded participants undergoing revision surgery (Butler, 1996; Crowe, 2003; 
Ferrara, 2006; McGregor 2004; Peak, 2005; Rivard, 2003, Ververeli, 2009). In five trials, the 
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inclusion or exclusion of revision surgery is not explicitly reported (Gocen, 2004; Sandell, 
2008; Tappen, 2003; Weaver, 2003; Wong, 1990). Participants undergoing hip revision 
surgery were included in two studies, and both studies contained similar percentages.   
Munin (1998), contained n=4 (28.8%) participants undergoing revision surgery in the 
intervention group, and n=5 (41.5%) in the control; Rosendal (2000), contained n=19 (44%) 
in the intervention group and n=15 (25%) in the control. 
Only two trials included all participants due to undergo surgery as a consequence of hip OA, 
with no other exclusion criteria, which makes these truly representative of the actual 
population receiving total hip replacements (Sandell, 2008; Weaver, 2003). Eight studies 
excluded patients with cognitive impairment; Tappen (2003) excluded participants with a 
Mini Mental Exam score <20 and Ferrara (2008) with a score ≤23. McGregor (2004) excluded 
patients who were ‘mentally confused’ (method of evaluation not reported). Patients with 
Alzheimer’s or dementia were excluded by Peak (2005), Rosendal (2003), Siggeirsdottir 
(2005) Ververeli (2009) and Wong (1990). Wong (2009) also excluded patients with 
“manifest abnormality of mental state” (p 10), though the method of evaluation is not 
reported. The Peak (2005) study included Alzheimer’s disease as an exclusion criterion, 
though the authors state no patients were excluded due to this. As this study had the second 
lowest average age (58.3) of all the included studies, this may explain why no one was 
excluded as the prevalence of all-cause dementia is less than 1% for people under 60 
(Alzheimer’s Society, 2014). However, as the average age of all patients in the Peak (2005) 
study is 7.9 years younger than the overall average age of all patients included in this review 
(66.2), and 9.3 years younger than average for the concurrent time frame of this study in 
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England and Wales (NJR, 2005), this may suggest there was a potential element of 
recruitment bias. Ververeli (2009) also excluded participants who were either under 21, 
weighed greater than 275 pounds and those unable to ambulate greater than 30 feet 
without an assistive device.    
Four studies excluded patients who were not fluent in reading/writing the native language 
(Butler, 1996; McGregor, 2004; Rosendal, 2003; Tappen, 2003). Five studies excluded 
participants with co-morbidities; Gocen (2004) excluded participants with any chronic 
disease, McGregor (2004)excluded  cardiovascular, respiratory and neuromuscular diseases, 
Ferrara (2008) Parkinson’s disease and sensitive neuropathy, Peak (2005) “neuromuscular 
compromise p.248)” such as hyper flexibility syndrome or Parkinson’s Disease, and Wong 
(2009) “severe diseases such as peripheral vascular disease or RA of the lower extremities” 
and “apparent visual and/or auditory impairment (p.10)”. In contrast, the inclusion criteria 
for the Munin (1998) trial were participants who were identified as at risk for delayed 
discharge and therefore would require in-patient rehabilitation (≥70 and living alone, ≥70 
with 2 co-morbidities, or any age with 3 co-morbidities). Crowe (2003) only included patients 
who were not coping well because of their joint dysfunction, and had limited social support 
and/or co-morbid medical conditions. Patients with good social support networks or who 
could cope well alone with activities of daily living were specifically excluded. 
Of the included trials, twelve trials had interventions directed solely at patients undergoing 
THR (Butler, 1996; Ferrara, 2006; Gocen, 2004; McGregor, 2004; Munin, 1998; Peak (2005); 
Rivard, 2003; Rosendal, 2000; Sandell, 2008; Siggeirsdottir, 2005; Ververeli, 2009; Wong, 
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1990); , two directed at THR or TKR patients (Rivard, 2003; Weaver, 2003), and one for THR 
or hip fracture repair (Tappen, 2003).  
 Interventions 2.5.3.2
An inherent characteristic of complex interventions is that they exhibit a wide variation in 
content. Even though the specific content is different they can be classified by the time 
point(s) the interventions were delivered in the trials. Eight studies compared a pre-
admission intervention with the usual care (Butler, 1996; Crowe, 2003; Ferrara, 2006; Gocen 
(2004) McGregor, 2004; Rivard, 2003; Rosendal, 2000; Sandell, 2008). Two of these studies 
(Rosendal, 2000; Weaver, 2003) evaluated home based interventions against the usual care 
situation where the similar rehabilitation services were provided post operatively. Two 
studies (Rivard, 2003; Siggeirsdottir, 2005) evaluated interventions that contained both pre 
and post-surgery components. Three studies compared an alternative post-surgery 
intervention with the usual post-surgery care (Munin, 1998; Tappen, 2003; Wong 1990). The 
Wong (1990) study had two experimental groups; one group received the enhanced post-
surgery education package and home care experimental intervention alongside the normal 
in-patient care and usual LOS, the other experimental group only received the intervention 
package but were discharged earlier than usual. Two studies compared the usual care 
against removal of most post-surgery restrictions with no provision of the adaptive devices 
usually provided by OTs to reduce the risk of dislocation (Peak, 2005; Ververeli, 2009).  
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Table 20 Characteristics of included studies 
Study Study design 
Start date 
Participants Intervention Outcomes Notes 
Butler  (1996) Quasi-RCT 
September 
1993 
I: 32 (18 female, 14 male, mean 
age 63.86) 
100% THR 
C: 48 (22 female, 26 male, mean 
age 61.83) 
100% THR 
F/U Day of Discharge 
 
I: Pre-admission education booklet 
C: Usual care – same information as in pre-
admission booklet given following admission 
State-Trait Anxiety 
Inventory, patient 
satisfaction questionnaire, 
exercise log and details of 
home adaptations, LOS  
 
Country: Canada 
Crowe(1) 
(2003) 
RCT 
Not stated 
I: 65 (51 female, 14 male, mean 
age 66.9) 
THR 55%; TKR 45% 
C: 68 (55 female,13 male, mean 
age 70.7) 
THR 43%; TKR 57% 
F/U Day of admission 
I: Usual care plus pre admission bespoke 
rehabilitation package including education, 
advice, home adaptations, provision of adaptive 
devices, social work and counselling input as 
required. 
C: Usual care –single 7 hour pre-operative clinic 
visit approximately 2 weeks pre-surgery.  
 
State-Trait Anxiety 
Inventory, time to meet 
discharge criteria, LOS 
Country: Canada 
 
Ferrara(1) 
(2006) 
RCT 
January 2006 
I: 11 (7 female, 4 male, mean age 
63.82) 
100% THR 
C: 12 (7 female, 5 male, mean 
age 63.08) 
100% THR 
F/U Day before surgery, 15 days, 
4 weeks, 3 months 
I: 5 day pre-admission intervention package 1 
month before admission consisting of exercise, 
postural advice, advice on movement restrictions 
and prevention of prosthesis dislocation, use of 
devices (crutches, elevated toilet sets, bed raises, 
dressing/undressing adaptive devices), washing 
and bathing(2). 
C: No pre-admission intervention. 
 
WOMAC, SF-36, VAS (pain), 
Barthel, hip strength and 
range of movement. 
Country: Italy 
Gocen(2) 
(2004) 
RCT 
Not stated 
I: 30 (13 female, 16 male, mean 
age 46.93) 100% THR 
C: 30 (8 female, 22 male, mean 
age 55.5±14.44) 100% THR.  F/U 
Day of discharge, 3 months, two 
years  
I: Pre-operative exercises plus OT based 
education class (movement restriction, use of 
adaptive devices, lifting and carrying, washing 
and dressing. 
C: Usual care: no pre-operative intervention 
 
Harris Hip Score, VAS (pain) 
Days to achieve functional 
milestones (Walking, stairs, 
bed transfer, toilet transfer, 
chair transfer 
Country: Turkey 
Demographic data taken 
on day of discharge, not 
baseline, 1 participant 
withdrew before baseline 
taken 
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Table 20 Characteristics of included studies (continued)  
Study Study design 
Start date 
Participants Intervention Outcomes Notes 
McGregor 
(2004)  
RCT 
Not stated 
I: 19 (mean age 70.8) 
100% THR 
C: 20 (mean age 72.8) 
100% THR 
Gender not reported 
F/U Day of admission, discharge, 
3 months 
I: Pre-admission hip class plus education booklet 
C: Usual care – not stated  
WOMAC, Harris Hip Score, 
Barthel ADL, Positive-affect 
Negative-affect scale, 
Helplessness subscale of 
Rheumatology attitudes 
index, Cantril life 
satisfaction ladder, VAS 
(pain, fatigue and function), 
EQ-5D 
 
Country: UK 
Munin  
(1998) 
RCT 
August 1993 
I: 14 (12 female, 2 male, mean 
age 75.7) 100% THR 
C: 12 (10 female, 2 male,  mean 
age 74) 
100% THR 
F/U 4 months 
I: phased post-operative rehabilitation starting 
day 3 post surgery.  
C: Usual care –  rehabilitation starting day 7 post 
surgery 
Functional status Index, 
RAND-36, LOS, 
Complications 
 
Country: USA 
Mixed study of THR/TKR 
with data presented 
separately.  Participants 
high risk for delayed 
discharge home  
 
Peak  
(2005) 
RCT 
March – 
December 
2002 
I: 151  
C: 152  
126 female, 139 male, mean age 
58.3  
100% THR 
F/U 6 weeks, 6 months 
I: Reduced restrictions with advice to only limit 
flexion to <90°, internal and external rotation to 
<45% and no adduction for first 6 weeks. No 
other precautions required. 
C: Usual care - Precautions as for intervention 
group plus use of abduction pillows in bed, 
elevated toilet seats and elevated chairs in the 
hospital, in the rehabilitation facility, and at 
home; and were prevented from sleeping on the 
side, from driving, and from being a passenger in 
an automobile for first 6 weeks. 
 
Dislocation, limp, LOS, Cost. 
Patient compliance, 
satisfaction and time to 
return to activities of daily 
living measured using 
‘standardised 
questionnaire’. 
 
 
 
 
 
Country: USA 
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Table 20 Characteristics of included studies (continued) 
Study Study design 
Start date 
Participants Intervention Outcomes Notes 
Rivard   
(2003) 
CCT 
January 1996 
I:102 (62 female, 40 male,  mean 
age 66.97) 100% THR 
C:104 (61 female, 43 male,  mean 
age 67.4) 100% THR 
F/U Day of discharge 
I: Pre-admission home visit by OT: education, 
advice, home assessment and adaptations, 
discharge preparations made.   
C: Usual care – hospital based OT assessment in a 
group setting. Therapists relied on client/family 
reports detailing their home environment to 
inform discharge planning. 
 
LOS Country: Canada 
Convenience sampling 
from two hospitals. Both 
hospital adopted the same 
in-hospital care map 
Rosendal 
(2000) 
CCT 
December 
1996 
I:56 (45 female, 16 male, mean 
age 69.8) 
100% THR 
C:59 (49 female, 10 male, mean 
age 67.2) 
100% THR 
F/U 6 months 
I: Pre-admission home visit by home care 
coordinator (3): education, advice, home 
assessment. Home adaptations and discharge 
care preparations prior to discharge.   
C: Usual care – any required home adaptations 
and discharge care during hospitalisation or after 
discharge. 
 
Sickness Impact profile-68, 
Hip rating-questionnaire, 
Patient satisfaction 
questionnaire 
 
Country : Netherlands 
Convenience sampling 
from two hospitals with 
comparable social and 
cultural circumstances. 
Primary and revision 
surgery patients included 
 
Sandell  
(2008) 
RCT 
Not stated 
I: 43 (23 female, 10 male mean 
age 70.33) 100% THR 
C: 46 (18 female, 12 male, mean 
age 65.8)  
100% THR 
FU day of admission 
I: Preadmission multidisciplinary intervention by 
physiotherapist (exercises and gait 
improvement), nurse (additional advice). Pre-
operative OT home assessment of functional 
constraints and provision of adaptive devices. 
C: No additional pre-operative treatment by OT 
or PT and standard advice from nurse  
 
Arthritis Impact Measure 
Score 2, Nottingham Health 
Profile.   
Country: UK. Convenience 
sampling from patients on 
waiting list for THR 
surgery. Only 33 
intervention and 30 
control at FU analysis. 
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Table 20 Characteristics of included studies (continued) 
Study Study design 
Start date 
Participants Intervention Outcomes Notes 
Siggeirsdottir 
(2005) 
 
 
 
RCT 
December 
1997 
I: 27 (14 female, 13 male, mean 
age 69)  
100% THR 
C:23 (12 female, 11 male, mean 
age 66)  
100% THR 
F/U 2, 4, 6 months 
I: Pre-admission training and education 
programme. Post discharge home PT/OT/nurse 
input as required   
C: Usual care – not specified 
Oxford Hip Score, 
Nottingham Health Profile, 
Harris Hip Score, Meurle 
d’Abuigne and Postel score 
 
Country: Iceland 
Included THR for RA, hip 
fracture, femoral head 
collapse or Perthes 
disease. 90% of patients 
in intervention and 91% 
in control had THR due to 
OA. Major protocol 
deviation occurred 
during study due to 
hospital reorganisation. 
Tappen(1) 
(2002) 
CCT 
Not stated 
I: 39 (mean age 75.28)  
C: 43 (mean age 69.61)  
51.2% Hip fracture repair, 
48.8% THR. Both groups equal 
proportion. Gender balance not 
reported. 
F/U Day of discharge, 1 week, 3 
months 
  
I: Post surgery psycho-educational video 
(Rehabilitation exercises, home safety and 
adaptations, use of assistive equipment, how 
to perform basic and extended ADL’s whilst 
movement restrictions apply, energy 
conservation, medical, psychological and 
nutritional advice) 
C: Usual care – Not specified 
 
Self-as-carer inventory 
(perceived self-care) 
Functional Independence 
Measure, Jalowiec coping 
scale, 6-min walk, 
Functional life scale, 
Physical activity scale for 
the elderly 
Country: USA 
50% THR, 50% Hip 
fracture repair (method 
not stated). 
Unable to separate data 
Ververeli  
(2009) 
RCT 
2004 -2008 
I: 38 (16 female, mean age 60.8; 
22 male, mean age 58.8 
100% THR 
C: 43 (16 female, mean age 
59.8; 27 male,  mean age 57.4) 
100% THR 
F/U 4 weeks, 1 month,[sic] 3 
months, 1 year 
 
I: Advice on reduced hip precautions and 
outpatient physical therapy on discharge. 
C: Usual care – Standard hip precautions 
advice. Physical therapy 3x week at home for 1 
month after discharge and as an outpatient 
after 1 month.  
Short Form -12, Harris Hip 
Score, days to walk with 
cane, without cane and 
days to driving, Dislocation 
Country: USA 
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Table 20 Characteristics of included studies (continued) 
Study Study design 
Start date 
Participants Intervention Outcomes Notes 
Weaver(1) 
(2003) 
RCT 
Not stated 
I:69 (59 female, 10 male) 
49% THR/51%TKR 
C:67 (67 female, male 10) 
51% THR/49% TKR 
Overall, mean age 72 years. 
F/U 1 and 6 months 
I: Pre-admission home visit (4) (education, 
advice, exercises, home assessment and 
adaptations, provision of assistive devices)   
 
C: Usual care –  home care protocol 
comprising 2 post-op nurse visits and 1-3 PT 
visits per week in weeks 1-9 (THR) or 3-5 PT 
visits per week in weeks 1-9 (THR) 
Barthel self-care Index, 
WOMAC, SF-36, Ware 
satisfaction with care 
scales, Adverse outcomes  
 
Country: USA 
Mixed THR/TKR study 
with   
Wong 
(1990) 
RCT 
February 
1986  to 
December 
1987 
IA: 50 (26 female, 24 male, 
mean age 63.37) 100% THR 
1B: 48 (35 female, 13 male, 
mean age 71.7) 100% THR 
C: 48 (29 female, 19 male,  
mean age 64.8) 
100% THR 
F/U 2 weeks, 6 months  
IA: Early Discharge & enhanced recovery 
(Videotape, pamphlet, advice) 
IB: Conventional discharge & enhanced 
recovery (as 1A) 
C:  Usual care: Conventional discharge and 
traditional rehabilitation program 
Objective Functional 
Capability Index; 
Subjective 
Functional Capability 
Index; Subjective 
Psychosocial Capability 
Index; Knowledge Test 
Post Hip Arthroplasty 
Complications;  Perceived 
Preparedness For 
Discharge Scale; the 
Patient Compliant Scale 
(Behaviour Index and the 
Exercise compliance 
subsets). LOS 
Country: Canada 
90% of participants had 
THR due to OA, 5% for 
RA and 5% due to 
traumatic hip fracture. 
Abbreviations: ADL, activities of daily living; C, control; CCT, controlled clinical trial; F/U follow up; I, intervention; LOS, length of hospital stay; min, minute; OT, 
occupational therapist, PT, physiotherapist, RCT, randomised controlled trial; THR, total hip replacement; TKR, total knee replacement; VAS visual analogue scale; 
WOMAC The Western Ontario and McMaster Universities Arthritis Index. 
Notes: 
(1)
 Included by consensus decision. 
(2)
 Although intervention is delivered by physiotherapist, substantial element of the intervention package was equivalent to 
recognised OT practice.  
(3)
 The service provided by the home care coordinator is equivalent to social services occupational therapist. 
(4)
Although the intervention was 
delivered by a physiotherapist and a specialist nurse, a substantial element of the intervention package was equivalent to recognised OT practice. Inclusion of both 
of these studies was confirmed with Professor Avril Drummond, a professor of occupational therapy at Nottingham University who acted as OT expert for this 
review. 
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Table 21 Intervention characteristics of included studies 
Study Timing  Location Content Number/duration of 
contacts 
Delivered by Notes 
Butler  
(1996) 
(I): Prior to 
admission;  
(6 weeks) 
 
(C): None 
(I): Home 
(C): None 
 
(I):  An 18 page booklet posted to participants. 
Content of book included: anatomy; exercises to 
practice prior to admission; precautions to 
follow post THR; preparing for discharge 
(rearranging furniture, meal preparation, 
community service contact information) 
(C): None 
 
(I): No therapy contact 
(C): None 
(I): 
Multidisciplinary:  
prepared by nurse, 
OT, PT, discharge 
planning and social 
work 
(C): None  
Participants who 
were unable to read 
English to grade 6 
were excluded 
Crowe 
(2003) 
(I): Prior to 
admission(1) 
and post 
discharge(2)  
(C): 2 weeks 
prior to 
surgery 
(I): Hospital, 
outpatient 
clinics, 
rehabilitation 
hospital or 
home as 
required 
(C): Hospital 
 
(I): Bespoke package of individualised education, 
provision of adaptive devices and training of 
their use, provision of non-standard adaptive 
devises as required, home adaptation advice, 
advice on ADL and hip precautions, information 
booklet, physical conditioning programme,  
Home visits by range of health professionals as 
required (post-surgery)   
(C): Standard care: pre-surgery medical checks, 
brief education class about hospital stay and 
immediate post-operative phase, and hip 
precautions 
 
(I): 47% received one PT 
or OT session, 30% 
attended outpatient PT 
or OT, 6% home care PT 
or OT, 9% attended day 
hospital, 6% 
multidisciplinary home 
care. Number and 
duration of contacts not 
reported. 
(C): One standard seven 
hour class 
(I): 
Multidisciplinary:  
OT, PT, social work 
(C): Nurse  
Both groups 
received the same 
preoperative clinic 
medical checks 
 
In intervention 
group, home visits 
were available to 
those that required 
them post discharge 
Ferrara 
(2006) 
(I): Prior to 
admission 
(1 month) 
(C): None 
(I): Hospital 
(C): None 
 
(I):  Individualised flexibility, strengthening, and 
cardiovascular exercise program, postural 
advice, advice on hip precautions post THR, 
practice in use of adaptive devices, advice on 
ADL post-surgery  
(C): None 
 
(I): 20 sessions of 60-
minute duration. Each 
session 40 minutes 
group work and 20 
minutes individually with 
therapist.    
(C): None 
(I): PT only(3)  
(C): None  
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Table 21: Intervention characteristics of included studies (continued) 
Study Timing  Location Content Number/duration of 
contacts 
Delivered by Notes 
Gocen 
(2004) 
(I): Prior to 
admission 
(8 weeks) 
(C): None 
(I): Not 
reported 
(C): None 
 
(I): Flexibility & strengthening home exercise 
program, postural advice, advice on hip 
precautions post THR, practice in use of 
adaptive devices, advice on ADL post-surgery  
(C): None 
 
(I): Home exercises 
evaluated by PT at 2-
week intervals.    
(C): None 
(I): PT only(3)   
(C): None  
Location of PT 
evaluation and 
delivery of other 
elements of 
intervention are not 
documented 
McGregor 
(2004)  
(I): Prior to 
admission 
(2 to 4 weeks) 
(C): None 
(I): Hospital 
(C): None 
 
(I): An advice booklet containing information on 
exercises, hip precautions, ADL post THR, the 
hospital stay and rehabilitation. Content of 
book reinforced during  an education class 
which also contained advice on home 
adaptations and using walking aids 
(C): None 
 
(I): A one off class, 
duration not reported    
(C): None 
(I): PT only(3) 
(C): None  
Author provided 
copy of the advice 
booklet. This was 
requested to 
establish if level of 
OT content 
sufficient to be 
included in this 
review  
Munin 
(1998) 
(I): Post 
surgery 
(C): Post 
surgery 
(I): Hospital 
(C): Hospital 
 
(I): Therapy commenced in the in-patient 
rehabilitation unit 3 days following surgery 
(C): Therapy commenced in the in-patient 
rehabilitation unit 7 days following surgery 
 
(I):  Two 60-minute OT 
and PT sessions daily 
starting day 3 post-op 
(C): Two 60-minute OT 
and PT sessions daily 
starting day 7 post-op 
(I): 
Multidisciplinary; 
PT and OT, 
recreational 
therapist and 
clinical psychologist  
(C): 
Multidisciplinary; 
PT and OT, 
recreational 
therapist and 
clinical psychologist 
Both groups 
received same ward 
based rehabilitation 
of two 30-minute 
PT session starting 
on day 2 and  one 
30-minute OT 
session starting day 
3 (plus one 30-
minute PT session if 
hospital stay 
included a Saturday.  
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Table 21: Intervention characteristics of included studies (continued) 
Study Timing  Location Content Number/duration of 
contacts 
Delivered by Notes 
Peak  
(2005) 
(I): 
Immediately 
prior to 
admission and 
during hospital 
stay 
(C): 
Immediately 
prior to 
admission and 
during hospital 
stay 
(I): Hospital 
(C): Hospital 
I: Reduced restrictions with advice to only limit 
flexion to <90°, internal and external rotation to 
<45% and no adduction for first 6 weeks. No 
other precautions required. 
C: Usual care - Precautions as for intervention 
group plus use of abduction pillows in bed, 
elevated toilet seats and elevated chairs in the 
hospital, in the rehabilitation facility, and at 
home; and were prevented from sleeping on 
the side, from driving, and from being a 
passenger in an automobile for first 6 weeks. 
 
(I): Number and duration 
of contacts not 
documented 
(C):  Number and 
duration of contacts not 
documented 
 
(I): Nurse & PT
(3)
 
(C): Nurse & PT
(3)
 
 
Rivard 
(2003) 
(I): Prior to 
admission 
 (2 weeks) 
and post 
discharge(2)  
(C): Prior to 
admission. 
(1-2 weeks) 
(I): Home 
(C): Hospital 
 
(I): Prior to admission: usual care content 
delivered one-to-one. Additionally, a bespoke 
therapy package provided which included 
individual exercise program, receipt of adaptive 
devices and in-situ training in their use, 
comprehensive home assessment for non-
standard adaptive devices or home alteration 
planning, transfer practice, advice on ADL and 
hip precautions. Information sent to hospital on 
participants’ mobility status, home 
environment, support networks, psycho-social-
mental state and health concerns. 
Post discharge:  Home visit by same OT who 
conducted pre-surgery home visit. Further 
therapy home visits available if required.  
(C): Education, functional assessment, assessing 
adaptive and home adaptation  requirements 
 
(I): Prior to admission: 1 
home visit, duration not 
reported. 
Post discharge: home 
visits available for ‘a few 
weeks’(2)  
(C): one contact only, 
duration not reported. 
(I): prior to 
admission: OT  
Post discharge: OT 
and/or PT   
(C):  None 
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Table 21: Intervention characteristics of included studies (continued) 
Study Timing  Location Content Number/duration of 
contacts 
Delivered by Notes 
Rosendal 
(2000) 
(I): Prior to 
admission 
(2 weeks) 
(C): Post 
discharge 
(I): Home 
(C): Hospital/ 
post 
discharge 
 
(I): Advice, assessment for adaptive devices 
and home adaptations, assessment of support 
requirements. Home adjustment completed 
and support services organised before patient 
discharge. Patient visited while in hospital to 
ensure process is working.      
(C): Adaptive devices given post-surgery 
before discharge. Home adaptation 
requirements assessed and carried out while 
in hospital or after discharge 
 
(I): Number of contacts 
and duration not 
reported   
(C):  Number of contacts 
and duration not 
reported   
(I): Home care 
coordinator
(3)
  
(C): Not reported 
 
Sandell 
(2008) 
(I): Prior to 
admission(1) 
(C): None 
(I): Hospital & 
Home 
(C): None 
 
(I): Education, individualised exercise 
program, training in use of mobility aids, 
home assessment, advice on hip precautions 
post THR, practice in use of adaptive devices, 
advice on ADL post-surgery, advice on pain 
management  
(C): None 
(I): One home visit by 
OT, duration not 
reported.  Number of 
contacts and duration 
of hospital based part 
of intervention not 
reported 
(C): None 
(I): Multidisciplinary; 
OT, PT, orthopaedic 
specialist nurse and 
pain specialist nurse  
(C): None  
Overall OT contacts: 
(I) 3, (C) 4.4 
(duration of each 
contact not 
reported) 
Siggeirsdottir 
(2005) 
 
(I): Prior to 
admission  
(1 month) and 
post discharge 
(up to 2 
weeks) 
(C): None 
(I): Hospital 
(pre-op) & 
Home (post-
op) 
(C): None 
 
(I): Prior to admission: Education on post-op 
rehabilitation, practice of post-op exercises, 
practice use of adaptive devices, illustrated 
brochure on ADL and hip precautions. Post 
discharge: Therapist accompanied patient 
home if required, home therapy visits   
(C): None 
 
 
(I): One pre-op 
education class, 
duration not reported. 
Post-op 2-9 (median 4) 
home visits, duration 
of visits not reported. 
(C): None 
(I): OT and PT   
(C): None  
Author provided 
copy of the 
illustrated booklet. 
This was requested 
to establish if level 
of OT content 
sufficient to be 
included in this 
review 
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Table 21: Intervention characteristics of included studies (continued) 
Study Timing  Location Content Number/duration of 
contacts 
Delivered by Notes 
Tappen (1) 
(2002) 
(I): Post 
surgery 
(C): Post 
surgery 
(I): Hospital 
(C): Hospital 
 
(I):  Usual care plus reinforcement by 
watching video; additional motivational video 
made of progress in rehabilitation. 
Participants given both videos to take home.    
(C): usual care: rehabilitation exercises, use of 
ambulatory aids, ADL training, practice use of 
adaptive devices, discussion of home 
circumstances and planning for home 
adaptations, counselling 
 
(I): Number of contacts 
and duration of 
intervention not 
reported 
(C): Number of 
contacts and duration 
not reported 
 
(I): Nurse & PT(3) 
(C):  Nurse & PT(3) 
 
 
Ververeli  
(2009) 
(I): Post 
surgery & up 
to 3 months 
post-discharge 
(C): Post 
surgery & up 
to 3 months 
post-discharge 
(I): Hospital/ 
Post discharge 
(C): Hospital/ 
Post discharge  
 
I: Reduced restrictions; only instructed to not 
cross legs at thighs. Able to begin outpatient 
physical therapy on discharge. 
C: Avoid hip flexion >90°, riding in a car, 
crossing legs; to use elevated toilet seat, sit on 
elevated chair, to sleep flat on back with 
abduction pillow for 4 weeks. Physical therapy 
at home for 1 month after discharge and as an 
outpatient after 1 month. To avoid flexion 
>90° and adduction >5° for a further 2 
months. 
 
(I): Advice only during 
hospital stay. 
(C): Advice in hospital 
and PT 3 times per 
week for 4 weeks. 
Duration not reported. 
(I): Not documented 
but advice is 
commensurate with 
standard OT practice 
(C): PT
(3)
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Table 21: Intervention characteristics of included studies (continued) 
Study Timing  Location Content Number/duration of 
contacts 
Delivered by Notes 
Weaver(1) 
(2003) 
(I): Prior to 
admission 
(10 days) 
and post 
discharge 
(up to 4 
weeks) 
(C): Post 
discharge (up 
to 9 weeks) 
(I): Home 
(C): Home 
 
(I): Home visit prior to surgery with reduced 
visits post-surgery. Content of pre admission 
home visit: health checks, home assessment 
for adaptive devices and home adjustments, 
advice on ADL and hip precautions, post 
discharge home exercises practiced,  
(C): 'Customary home care program' content 
of which is not reported 
 
(I):  Prior to admission: 
One home visit 
Post discharge: up to 7 
home visit (THR), 
11(TKR). Duration of 
visits not reported. 
(C): Prior to admission: 
None 
Post discharge: two 
nurse visits and 11-47 
therapy visits. Duration 
of visits not reported. 
 
(I): Nurse and PT(3) 
(C): Nurse and PT(3) 
Not clear if nurse 
and PT conduct 
home visits 
together or 
independently. 
Number of visits 
assumes they are 
done 
independently.  
Wong 
(1990) 
(IA): Post-
surgery & post 
discharge  
(1B): Post-
surgery & post 
discharge 
(C): Post-
surgery 
(IA): Hospital 
& home  
(1B): Hospital 
& home 
(C): Hospital 
 
(IA): Early Discharge & enhanced recovery 
(Videotape, pamphlet, advice) 
(4)
. Home visits 
to reinforce education and exercises at each 
follow-up time point. 
(IB): Conventional discharge & enhanced 
recovery (as 1A) 
(4)
 
(C):  Usual care: Conventional discharge and 
traditional rehabilitation program 
(4)
 and 
‘yoked-placebo home visit’ 
(5)
 
 
(IA): Duration and 
number of visits not 
documented 
(1B):  ): Duration and 
number of visits not 
documented 
(C):  Not documented 
 
(IA): 
Multidisciplinary; OT, 
PT, Nurse.  
(1B): 
Multidisciplinary; OT, 
PT, Nurse 
(C): Multidisciplinary; 
OT, PT, Nurse 
 
Two experimental 
groups.  
Nature of the usual 
care program is not 
presented in the 
written article.  
Abbreviations: ADL, activities of daily living; C, control; I, intervention; OT, occupational therapist, Pre-op, preoperatively, Post-op, Postoperatively, PT, 
physiotherapist, THR, total hip replacement; TKR, total knee replacement. 
Notes: 
(1)
 Time before admission is not reported. 
(2)
Time post discharge when therapy occurred is not reported. 
(3)
 Although an OT does not deliver intervention, the 
intervention is recognised as standard OT practice. OT expert Professor Avril Drummond consulted before inclusion. 
(4)
 Duration of the traditional length of stay and 
the enhanced shortened length of stay is not reported. (5) During the ‘yoked-placebo home visit’ the researcher carried out health checks unrelated to the 
intervention. However, contamination did occur as the researcher answered questions related to the intervention if asked by the participant (p 12-13).   
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2.5.4 Meta-analyses 
Table 22 presents all statistical data, including assessment time points and statistical tests 
employed for all the review outcomes.  
Table 22: Description of results of included studies 
Butler (1996) 
Author Description 
Assessment 
points 
Baseline: Day of admission.  
Follow-up: 1 day before discharge. 
 
Statistical 
tests 
No power calculation 
Baseline demographics: t-test (mean age); X
2
 (gender) 
Analyses of results: MANCOVA (with gender used as covariate).  
 
Summary of 
results 
(significant 
outcomes) 
In favour of the intervention 
STAI: on admission (p=0.007) (I) 27.93±25.24, (C) 42.65±29.06, 
at discharge (p=0.007) (I) 21.57±18.44, (C) 31.15±22.93 
Self-reported practicing pre-hospital preparatory exercises: Deep breathing and coughing 
(p<0.001) (I) 55% (C) 7%; Log rolling (p<0.001) (I) 39% (C) 6%; Leg exercises (p<0.001) (I) 
65% (C) 11%. 
Physiotherapy: attendances (p=0.006) (I) 7.29±2.79, (C) 9.42±4.34; time units of contact  
(p=0.001) (I) 32.74±14.55 (C) 45.63±21.46 
Occupational therapy: attendances (p=0.045) (I) 2.21±1.35 (C) 3.07±1.99;  direct time 
units of contact (p=0.033) (I) 11.11±6.51, (C) 15.15±8.52; indirect time units of contact 
(p=0.042)  
(I) 4.35±1.87 (C) 5.78±3.28 
 
Summary of 
results (non-
significant 
outcomes) 
LOS (days): 10.28±4.74 (I), (C) 10.38±5.53 
 
Author’s 
conclusions 
 
The booklet group has less anxiety than the no-booklet group at admission and at 
discharge [which] clearly supports the advantage of pre-hospital education in this 
population. There were no significant differences for LOS between booklet and no-
booklet groups. 
 
Abbreviations: STAI, State-Trait Anxiety Inventory; LOS, length of stay   
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Crowe (2003) 
Author Description 
Assessment 
points 
Baseline data: 1 to 24 weeks prior to admission (mode = 6 weeks).  
Follow-up: day of admission.  
 
Statistical 
tests 
No power calculation 
Baseline demographics: paired t-test (Intervention group were significantly more disabled 
(p=0.009) measured using the OHS, and more anxious measured by the STAI p<0.000. 
X
2 
for gender, arthroplasty procedure, preoperative diagnosis, comorbidities, living 
arrangements and marital status) 
Analysis of results: Unpaired t-test (days to meet discharge criteria, LOS), X
2
 (discharge 
destination) 
 
Summary 
of results 
(significant 
outcomes) 
In favour of intervention 
STAI: Patients less anxious (p<0.000) on admission (I) 39.7 ±4.8 (C) 44.4 ±7.6  
Time to meet discharge criteria: (p=0.021) (I) 5.39 ±3.8, (C) 7.98 ±7.7 
LOS: (p=0.032) (I) 6.55 ±4.2, (C) 10.50 ±14.2 
Other measures 
Function (independently get out of bed): (p=0.05), (I) 4.71±3.4  (C) 5.87±3.2   
Discharge planning (equipment): (p<0.000), (I) 1.95±5.6, (C) 6.06±4.0.  
Discharge planning (meals): (p<0.000) (I) 1.37±1.3, (C) 5.80±4.5.  
Discharge planning (all criteria met): (p=0.021) (I) 5.39±3.8  (C) 7.98±7.7  
Post-operative complications: (p=0.007) (I) 7 (C) 22 
 
Summary 
of results 
(non-
significant 
outcomes) 
Function (Joint flexion) : (p=0.08) (I) 5.12±5.4, (C) 6.54±3.5 
Function (days to walk 30m): (p=0.23) (I) 5.27±5.9 (C) 6.75±7.5. 
Function (climb stairs) : (p=0.61) (I) 5.83±6.6, (C) 6.38±3.4 
Discharge home with no aftercare required (p=0.498) (I) 3.0 (C) 0.0 
 
Author’s 
conclusions 
 
The individually tailored preoperative rehabilitation was effective in reducing the mean 
number of days to reach discharge criteria and the actual length of stay.  
 
Abbreviations: OHS, Oxford hip score; STAI, State-Trait Anxiety Inventory; LOS, length of stay   
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Ferrara (2008) 
Author Description 
Assessment 
points 
Baseline: One month before surgery. 
Follow-up: Up to 15 days, 4 weeks, and 3 months 
 
Statistical 
tests 
No power calculation 
Baseline demographics: Mean and SD values given. No statistical analysis 
Analysis of Results: comparison between groups using Mann-Whitney U-test; within group 
comparison using Wilcoxian test.   
 
Summary of 
results 
(significant 
outcomes) 
In favour of the intervention 
VAS (pain) at 4 weeks (P=0.04) (I) 5.5±2.2 (C) 7.3±2.0; and at 3 months (P=0.03) (I) 0.03±0.48 
(C) 1.27±1.00,  
SF-36- physical composite score at 4 weeks (P=0.048) (I) 34.4±4.05 (C) 27.3±10.3. 
Other measures: 
ROM external rotation  at 4 weeks (P=0.03) (I) 22.27°±7.86° (C) 14.58°±7.82°; and at 3 
months (P=0.02) (I) 33.5°±4.11° (C) 33.64°±4.52°   
 
Summary of 
results (non-
significant 
outcomes) 
WOMAC (pain): at 4 weeks (I) 8.0±3.8 (C) 11.0±3.6; at 3 months (I) 1.70±2.35 (C) 2.20±1.75 
WOMAC (function): at 4 weeks (I) 33.7±13.8 (C) 43.5±9.5; at 3 months (I) 18.30±12.36 (C) 
28.5±10.01 
WOMAC (stiffness): at 4 weeks (I) 4.82±1.88 (C) 4.58±1.62;  
at 3 months (I) 1.00±1.33 (C) 1.3±1.56 
Harris Hip Score: at 4 weeks (I) 43.6±15.7 (C) 34.9±15.5; 
at 3 months (I) 69.47±7.49 (C) 65.2±15.4 
Barthel: at 4 weeks (I) 84.5±6.7 (C) 75.0±16.2, at 3 months (I) 95.00±4.08 (C) 91.82±2.52 
SF-36 physical composite score: at 3 months (I) 46.60±8.95 (C) 52.09±8.11 
SF-36 mental composite score: at 4 weeks (I) 51.1±11.2 (C) 40.9±11.6; 
at 3 months (I) 53.10±6.65 (C) 51.36±9.03 
 
Other measures 
ROM (abduction): at 4 weeks (I) 31.81˚±10.55˚ (C) 32.08˚±11.95˚; 
at 3 months (I) 43.00˚±6.32˚ (C) 39.09˚±4.36˚ 
Quadriceps strength (Oxford Scale): at 4 weeks (I) 4.50±0.59 (C) 4.25±0.45; 
at 3 months (I) 5.0±0.0 (C) 5.0±0.0 
Hip abductor strength (Oxford scale): at 4 weeks (I) 4.68±0.46 (C) 3.90±0.46;  
at 3 months (I) 5.0±0.0 (C) 5.0±0.0 
 
Author’s 
conclusions 
 
Pre-operative physiotherapy does not significantly reduce the overall post-surgery disability. 
It can improve hip rotation and reduce pain in the short term, three months after surgery.  
 
Abbreviations: VAS, Visual analogue scale; SF-36, short form-36; WOMAC, Western Ontario and McMaster 
Universities Arthritis Index; ROM, range of movement.  
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Gocen (2004) 
Author Description 
Assessment 
points 
Baseline: eight weeks before surgery (study group only), immediately before surgery 
(control). 
Follow-up: at discharge, 3 months, two years. 
 
Statistical 
tests 
No power calculation 
Baseline demographics: paired and independent samples t-test where appropriate. 
Analysis of results: paired and independent samples t-test where appropriate. 
 
Summary of 
results 
(significant 
outcomes) 
In favour of intervention 
Days to activity: climbing stairs (I) 6.17±1.69 (C) 7.37±1.02; 
bed transfer (I) 2.93±0.59 (C) 3.33±0.71; toilet transfer (I) 4.24±0.51 (C) 5.07±1.28; 
chair transfer (I) 4.24±0.74 (C) 5.60±1.45 
 
Summary of 
results (non-
significant 
outcomes) 
Harris Hip Score: at discharge (I) 64.46±6.92 (C) 59.36±6.82 
at 3 months (I) 85.30±11.78 (C) 78.70±9.41, 
at 2 years (I) 97.14±4.32 (C) 95.66±6.08 
LOS: author states no significant difference between groups but actual data not presented.  
VAS (pain): author states no significant difference between groups at discharge.  
Only change data presented. 
Effect size (mean ±SE): In favour of control (not significant) 
VAS pain at rest: at discharge change score  (I) 0.28±0.59 (C) 0.04±0.93; ES -0.15±0.26 
VAS pain at activity: at discharge change score  (I) 1.24±1.60 (C) 1.30±1.73; ES -0.04±0.26 
 
Other measures 
Hip abduction: at discharge change score  (I) 17.2˚±12.6˚ (C) 17.3˚±13.8; ES -0.01±0.26 
 
Author’s 
conclusions 
 
The results reveal no major benefit from routine pre-operative physiotherapy and education 
programme. 
Abbreviations: LOS, length of stay; VAS, Visual analogue scale.  
 ~ 115 ~ 
 
McGregor (2004) 
Author Description 
Assessment 
points 
Baseline: 2-4 weeks prior to admission.  
Follow-up:  day of admission, day of discharge, and 3 months.   
 
Statistical 
tests 
No power calculations 
Baseline demographics: not reported 
Analysis of results: unbalanced analysis of variance with restricted maximum likelihood. The 
model contained the fixed effect for study groups and random effect for subjects. The 
baseline preadmission assessment was included in the model as a covariate.   
 
Summary of 
results 
(significant 
outcomes) 
In favour of intervention 
Cantril Life Satisfaction Ladder:  on discharge (p<0.01) (I) 98±4, (C) 84±30; 
at 3 month follow-up; (p<0.01) (I) 98±4 (C) 80±30 
(1)
. 
 
Summary of 
results (non-
significant 
outcomes) 
Barthel: admission (I) 19.2±1.3 (C) 19.0±1.3; discharge (I) 19.8±0.4 (C) 18.7±1.4;  
at 3 months (I) 19.9±0.3 (C) 19.6±0.7 
Harris Hip Score: admission (I) 45.4±11.5 (C) 43.2±16.2; discharge (I) 62.6±7.9 (C) 53.8±12.0; 
at 3 months (I) 74.2±11.7 (C) 68.8±16.2 
WOMAC (Pain): admission (I) 10.2±2.3 (C) 10.3±4.1; discharge (I) 3.2±2.7 (C) 4.5±3.0;  
at 3 months (I) 2.7±2.1 (C) 0.05±04.4 
WOMAC (stiffness): admission (I) 4.3±1.3 (C) 4.1±1.7; discharge (I) 1.6±1.8 (C) 2.0±1.5;  
at 3 months (I) 1.1±1.1  (C) 1.6±1.7  
WOMAC (function): admission (I) 35.8±12.0 (C) 41.0±10.0 
at discharge (I) 25.7±8.3 (C) 28.3±12.1; at 3 months (I) 15.9±10.3  (C) 18.4±13.8 
VAS Pain: admission (I) 7.8±1.5 (C) 7.6±2.0; discharge (I) 2.8±1.7 (C) 3.7±2.1;  
at 3 months (I) 2.1±2.6 (C) 3.1±2.9 
Positive Affect Negative Affect Scale:  no comparative data reported 
Helplessness subscale of the Rheumatology Attitudes Index: no comparative data reported 
Fatigue: no comparative data reported  
 
EQ-5D: admission (I) 69.0±6.0 (C) 59.0±17.25; discharge (I) 77.5±2.5  (C) 77.0±11.75; 
at 3 months (I) 77.25±13.0  (C) 74.5±20.5 (from scaled up graph)  
LOS was reduced by 3 days (I) 15; (C) 18. However, no statistical tests were done on the data 
to show if this is significant. 
Cost analysis: Cost of care of patients (I) £2,842 (C) 3,429 
Occupational therapy costs: control group cost on average £11 more per patient. Actual 
costs per group not reported. 
 
Author’s 
conclusions 
 
The study showed that the inclusion of a preoperative advice class and booklet improves 
patient expectations and satisfaction levels. Patients in both groups had equal 
improvements in pain, function, mood and life satisfaction.  
 
Abbreviations: WOMAC, Western Ontario and McMaster Universities Arthritis Index; VAS, visual analogue 
scale; LOS, length of stay.  
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Munin (1998) 
Author Description 
Assessment 
points 
Baseline: 4 weeks prior to surgery. 
Follow-up: 4 months. 
 
Statistical 
tests 
Power calculation: a sample size of 40 patients per group was determined to have adequate 
statistical power (β=0.8) to detect major effect sizes (SD=0.8) for LOS 
Baseline demographics: analysis of variance and X
2 
showed no significant variance all 
characteristics for THR patients. 
Analyses of results: A MANOVA was used to analyse the RAND-36 and the functional state 
index change scores. A repeated measure MANOVA was used for the functional 
independence measures that were divided into 3 periods. X
2
 analyses were used to analyse 
dichotomous or ordinal measures. A Bonferroni correction was applied to post hoc analyses 
when primary analyses were significant. 
 
Summary of 
results 
(significant 
outcomes) 
 
Large effect 
size ≥0.8 
 
 
 
 
 
 
Effect Size (ES): In favour of intervention (Effect size ±SE)  
 
 
 
LOS: (I) 12.2±2.8, (C) 14.8±2.2; ES -0.99±0.42 
FIM PT (Transfer days 6-10): (I) 4.59±0.97 (C) 4.16±0.43; ES 0.58±0.40 
FIM PT (Distance walked days 1-5): (I) 12.95±9.39 (C) 5.11±3.84; ES 1.03±0.42 
FIM PT (Distance walked  days 6-10): (I) 31.79±15.14 (C) 17.7±8.76; ES 1.08±0.42 
FIM PT (Ambulation days 1-5): (I) 1.54±0.53 (C) 1.17±0.35; ES 0.97±0.41 
FIM PT (Ambulation days 6-10): (I) 3.46±1.58 (C) 1.81±0.81; ES 1.24±0.43 
FIM PT (stairs days 6-10): (I) 2.11±1.34 (C) 1.17±0.33; ES 0.90±0.41 
 
Medium 
effect size 
≥0.5 
 
 
 
FIM PT (Stairs days 1-5): (I) 1.07±0.17 (C) 1.0±0.0; ES 0.54±0.40 
FIM OT (bathing days 6-10): (I) 4.64±0.84 (C) 4.05±0.96; ES 0.64±0.40 
FIM OT (lower extremity dressing days 6-10): (I) 4.54±0.81 (C) 4.02±1.12; ES 0.52±0.40 
 
Small effect 
size ≥0.2 
 
 
 
 
 
 
Large effect 
size ≥0.8 
 
Medium 
effect size 
≥0.5 
 
Small effect 
size ≥0.2 
 
 
FIM PT (stairs days ≥11): (I) 2.83±1.85 (C) 2.22±1.33; ES 0.36±0.40 
FIM OT (bathing days ≥11): (I) 5.4±0.47 (C) 5.26±0.55; ES 0.27±0.40 
FSI (difficulty): (I) 8.73±6.98 (C) 6.92±10.52; SE 0.20±0.39 
RAND-36 (bodily pain): (I) 39.22±22.26  (C) 29.79±24.04; ES 0.40±0.40  
Total cost ($):(I) 28,256±3,545 (C) 29,437±4,352; ES -0.29±0.40 
 
Effect Size: In favour of control (effect size ±SE)  
 
FIM PT (Transfer day’s≥11): (I) 5.12±0.77 (C) 5.72±0.29; ES -0.97±0.42 
 
 
FIM OT (tub or shower transfer days ˃11): (I) 4.54±1.46 (C) 5.15±0.75; ES -0.50±0.40 
 
 
 
FIM PT (Distance walked days ≥11): (I) 39.14±12.73 (C) 43.13±8.57; ES -0.35±0.40 
FIM OT (toilet transfer days ≥11): (I) 5.34±0.54 (C) 5.52±0.42; ES -0.20±0.39 
RAND-36 (physical functioning): (I) 14.06±27.7 (C) 19.58±16.3; ES -0.23±0.39 
FSI (assistance): (I) 4.75±13.48 (C) 2.13±9.68; ES -0.21±0.39 
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Summary of 
results (non-
significant) 
No significant effect size (effect size ±SE) 
 
FIM PT (Transfer days 1-5): (I) 3.2±1.25 (C) 3.33±0.87;     E.S.-0.12±0.39 
FIM PT (Ambulation days≥11): (I) 4.87±1.51 (C) 4.65±1.32; E.S. 0.15±0.39 
FIM OT (lower extremity dressing days ≥11): (I) 5.21±0.64 (C) 5.22±0.7; ES -0.01±0.39 
FIM OT (Tub or shower transfer days 6-10): (I) 3.15±1.64 (C) 3.42±1.59; ES 0.16±0.39 
FIM OT (toilet transfer days 6-10): (I) 4.63±0.87 (C) 4.5±0.67; ES 0.16±0.39 
FSI (pain): (I) 8.07±9.51  (C) 9.25±12.17; SE -0.10±0.39 
RAND-36 (emotional role functioning): (I) 2.08±35.42  (C) 5.56±69.39; SE -0.06±0.39  
RAND-36 (role functioning, physical): (I) 20.31±38.96  (C) 25±33.71; SE -0.12±0.39  
RAND-36 (emotional wellbeing): (I) 3.75±10.38  (C) 5±10.39; SE -0.12±0.39  
 
Author’s 
conclusions 
 
This study supports acute in-patient rehabilitation services beginning on postoperative day 
three for high risk patients unable to make home transition after total joint replacement. 
 
Abbreviations: LOS, length of stay; FIM PT, Physiotherapy functional independence measure; FIM OT, 
Occupational Therapy functional independence measure; FSI, functional status index   
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Peak (2005) 
Author  Description 
Assessment 
points 
Baseline: Prior to surgery (actual time not stated) 
Follow-up: Patients were followed up for a minimum of six months. Satisfaction 
questionnaire completed at six weeks and six months. 
 
Statistical 
tests 
Power calculation: α = 0.05, β = 0.08; historic dislocation rate set at 1%. This indicated 130 
patients in each group were needed to prevent a type-II error. 
Baseline characteristics:  No difference between groups (p=0.34). Statistical method used 
not reported. 
Analysis of results: X2 test with a continuity correction for discrete variables. A one-tailed 
student t-test used for continuous variables with significance set at (α)<0.05 
 
Summary of 
results 
(significant 
outcomes) 
In favour of Intervention 
Time to side sleeping (weeks, range): (I) 3.2 (0 - 12 ), (C) 5.8 (0 – 36), (p<0.001) 
Time to ride as passenger in car (weeks, range): (I) 1.5 (0.3 - 20.0), (C) 1.9 ( 0 – 6.1), (p=0.026) 
Time to drive car (weeks, range): (I) 4.9 (0.5 – 16.0), (C) 6.8 (1.0 – 19.9), (p<0.001) 
Return to work within 6 weeks (%, range)): (I) 50.0% (49 – 98) (C) 18.8% (16 – 85), (p<0.001) 
Time to return to work (weeks, range):(I) 6.5 (0.7 – 20.0), (C) 9.5 (1.0 – 32.0) (p<0.001)  
Ability to perform full ADL at 6 months as a percentile of pre-operative function (%, range): 
(I) 106.4% (25 -350), (C) 96.5 (25 – 200), (p=0.015) 
Satisfaction with rate of recovery: (I) 89.4%, (C) 74.3%, (p<0.001)  
 
Other measures 
Number of patients requiring additional hospital rehabilitation stay: (I) 125, (C) 100 
(p<0.002) in favour of control. 
Compliance with restrictions: (I) 90.0%, (C) 95.7%  (p=0.001) in favour of control 
 
Summary of 
results (non-
significant 
outcomes) 
Limp: at 6 months: (I) 15%, (C) 12.5%, (p=0.80)  
Dislocation: (c) 1, (I) 0 (note; this occurred during transfer from operating table to bed, so 
occurred before the intervention period) 
LOS (days, range): (I) 3.5 (2 – 8), (C) 3.5 (2 – 5), (p=0.88) 
  
Author’s 
conclusions 
 
The imposition of restrictions, other than the limitation of extreme motion, did not influence 
the prevalence of early dislocation of the hip.  
Abbreviations: ADL, activities of daily living; LOS, length of stay.  
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Rivard (2003) 
Author Description 
Assessment 
points 
Baseline: Prior to admission, at approximately 10 days after being placed on waiting list for 
hip replacement. Time to surgery not stated. 
Follow-up: Discharge date  
 
Statistical 
tests 
No power calculation. 
Baseline demographics: X
2
 test for gender and living arrangements.  
 
There was no significant difference between groups for age, co-morbidities and WOMAC 
sores (pain, stiffness, function) – statistical test used not reported 
Analysis of results: X
2
 test for discharge destination (home or sub-acute rehabilitation 
facility).  Analysis method for LOS is not stated
(1)
 
 
Summary of 
results 
(significant 
outcomes) 
None 
Summary of 
results (non-
significant 
outcomes) 
Discharge destination: no significant difference (p=0.74) (I) 64.7% home, 35.5% sub-acute  
(C) 62.5% home, 37.5% sub-acute.  
LOS: no significant difference (p=0.97) between LOS at acute facility (I) 6.89±1.98   
(C) 6.90±1.97; or at sub-acute facility (P=0.73) (I) 9.06±3.82 (C) 9.37±4.01 
  
Author’s 
conclusions 
 
The provision of a pre-operative home visit appears to have no distinguishable impact on 
whether clients are discharged directly home or to a sub-acute rehabilitation facility, nor in 
their overall (acute plus sub-acute) length of stay. 
 
Abbreviations: WOMAC, Western Ontario and McMaster Universities Arthritis Index; LOS, length of stay.  
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Rosendal  (2000) 
Author Description 
Assessment 
points 
Baseline: 2 weeks before surgery. 
Follow-up: at 6 months. 
Statistical 
tests 
No power calculation. 
Baseline demographics: X
2
 test (gender, primary or revision surgery, and living alone) and 
unpaired T- test (age, days waiting to admission) showed no significant differences between 
the two groups.  
Analysis of results: The Mann-Whitney U test, Fisher exact test, X
2
 test, T- test  
Summary of 
results 
(significant 
outcomes) 
In favour of the control 
SIP-68:  mobility subscale (p=0.02) (I) -0.18±2.58 (C) -0.76±1.99;  
SIP-68 overall score (p=0.02) (I) -1.92±7.46 (C) -5.11±6.19. 
Percentage of patients needing home adjustments six months after THR (p=0.02) (I) 62% (C) 
41% (CI: 0.04, 0.40). 
Type of homecare delivered a one month post-surgery: 
- dressing & washing: (p<0.00) (I) 93% (C) 42% 
- nursing (wound): (p<0.00) (I) 60% (C) 16% 
Summary of 
results (non-
significant 
outcomes) 
SIP-68: somatic autonomy (I) 0.18±1.38  (C) -0.03±1.22;  
SIP-68: motor control (I) -1.26±3.32  (C) -2.21±2.43; 
SIP-68 psychological autonomy and communication (I) -0.07±1.17  (C) -0.11±0.65,  
SIP-68: social behaviour (I) -0.70±2.84  (C) -1.38±2.77 
SIP-68: emotional stability (I) -0.12±0.61 (C) -0.38±0.97 
HRQ: overall impact: (I) 7.9±6.11  (C) 7.8±6.50 
HRQ pain:  (I) 7.8±6.22  (C) 9.2±5.86, HRQ walking:  (I) 3.0±5.50 (C) 3.8±4.86 
HRQ function: (I) 1.2±3.36  (C) 2.1±2.46, HRQ total: (I) 18.9±15.64 (C)24.3±14.86 
Patients needing home adjustments: one month after THR (I) 75% (C) 39% (CI: -0.08, 2.5), 
Patients still requiring home care at one month post THR (I) 54% (C) 32% (CI: 0.04, 0.39),  
Patients still requiring home care at six months post THR (I) 20% (C) 11% (CI: -0.13, 0.15). 
Time needed for homecare to start: Same day: (I) 37% (C) 5% (CI: 0.11, 0.51); next day: (I) 
43% (C) 32% (CI: -0.16, 0.39); a few days: (I) 13% (C) 32% (CI:-0.42, 0.06); a week: (I) 3% (C) 
5% (CI: -0.44, 0.02); more than a week: (I) 3% (C) 5% (CI:- 0.14, 0.10) 
Type of homecare delivered one month post-surgery: household (I) 70% (C)74% 
Frequency of home care visits one month after THR: 
-twice a day (I) 33% (C) 5% (CI:0.88, 0.45) 
-once a day (I) 40% (C) 21% (CI:- 0.14, 0.10) 
-few times per week (I) 17% (C) 16% (CI:- 0.20, 0.22) 
-once a week (I) 10% (C) 53% (CI:- 0.67, -0.18) 
-other (I) 0% (C) 5%  
LOS: (I) 12.8±7.4 (C) 13.2±3.5. 
Self-rated satisfaction: no significant difference between groups reported but; actual data 
not provided. 
Author’s 
conclusions 
 
This particular form of shared care is not cost effective. Heath status results at six months 
favour the control.  
 
Abbreviations: SIP-68, sickness impact profile (68 question version); HRQ, hip rating questionnaire; LOS, length 
of stay.  
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Sandell (2008) 
Author Description 
Assessment 
points 
Baseline: Before surgery (Note: author states all potential participants who were invited on 
to the study has a waiting time to surgery of greater than 6 months. However time to 
surgery is not stated). 
Follow-up: day of admission 
 
Statistical 
tests 
Power calculation: power set at 90%, NNT calculated at 30 in each group. 
Baseline characteristics: two sample t-test  
Analysis of results: two sample t-test 
 
Summary of 
results 
(significant 
outcomes) 
 
Medium 
effect size 
≥0.5 
Small effect 
size ≥0.2 
 
 
Medium 
effect size 
≥0.5 
 
Small effect 
size ≥0.2 
 
 
 
 
Effect Size (ES): In favour of intervention (effect size ±SE)  
 
AIMS hand and finger function (I) 0.45±1.63 (C) -0.35±1.05; SE 0.57±0.26 
Nottingham Health Profile social (I) 4.61±14.33 (C) -3.73±14.37; SE 0.57±0.26 
 
AIMS arm function (I) -0.08±1.11 (C) 0.68±1.67; SE 0.42±0.26 
AIMS satisfaction with health (I) -0.04±1.32 (C) -0.38±1.54; SE 0.23±0.25 
 
Effect Size: In favour of control (effect size ±SE)  
 
AIMS arthritis pain (I) -0.09±1.61 (C) 0.74±1.69;  ES -0.50±0.26   
 
AIMS mobility (I) -0.35±1.71 (C) 0.31±1.74; ES -0.38±0.25 
AIMS walking and bending (I) -0.14±2.09 (C) 0.75±1.50; SE-0.49±0.26 
AIMS social activity (I) -0.71±2.01 (C) 0.08±1.37; SE -0.45±0.26 
AIMS support from family (I) -0.03±2.00 (C) 0.52±2.53; SE -0.24±0.25  
AIMS work (I) -0.37±1.71 (C) 0.44±1.62; SE -0.48±0.26 
AIMS arthritis impact (I) 0.00±2.25 (C) 0.58±1.82;SE -0.28±0.25  
Nottingham Health Profile energy (I) -9.48±35.59 (C) 6.67±34.66; SE -0.45±0.26 
Nottingham Health Profile pain (I) -1.46±22.58 (C) 4.93±22.77; SE- 0.28±0.25 
Nottingham Health Profile sleep (I) -5.70±24.54 (C) 5.98±27.02; SE -0.45±0.26 
 
Summary of 
results (non-
significant 
outcomes) 
No significant effect size (effect size ±SE) 
AIMS self-care tasks (I) -0.25±1.79 (C) -0.14±1.95; SE 0.05±0.25 
AIMS household tasks (I) -0.23±1.50 (C) -0.13±1.99; SE-0.06±0.25 
AIMS levels of tension (I) 0.09±1.65 (C) 0.00±1.55; SE 0.06±0.25 
AIMS mood (I) -0.12±1.48 (C) 0.08±1.23; SE -0.14±0.25 
AIMS current and future health (I) -0.61±2.34 (C) -0.44±2.44; SE -0.07±0.25 
Nottingham Health Profile physical (I) -0.47±12.47 (C) 1.44±23.13; SE -0.10±0.25 
Nottingham Health Profile emotional (I) 1.90±13.67 (C) 2.65±18.25; SE -0.05±0.25 
 
Author’s 
conclusions 
The study did not show any definitive conclusions that the intervention was beneficial   
Abbreviations: AIMS, Arthritis Impact Measurement Score 
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Siggeirsdottir (2005) 
Author Description 
Assessment 
points 
Baseline: 1 day preoperatively.  
Follow-up: 2, 4 and 6 months.  
 
Statistical 
tests 
No power calculation 
Baseline demographics: no analysis reported.  
Analysis of results: Freidman test used to compare measurements over time within each 
group. Wilcoxon matched-pairs test was used compare measurements within a group at two 
different times. Mann-Whitney U test used to compare groups at each time point. X
2
 test 
used to compare proportions. 
 
Summary of 
results 
(significant 
outcomes) 
In favour of control. 
LOS: (p<0.001) (I) 6.4±2.4, (C) 10.0±3.5  
OHS: overall score (pain and function) (p=0.03) at 2 months; (I) 19±6.3 (C) 24.0±9.0;  at 4 
months (p=0.007) (I) 15.0±4.2 (C) 22.0±8.7; at 6 months (p=0.001) (I) 14.0±4.3 (C) 21.0±7.2 
Nottingham Health Profile (no data in article. Only p values given. Author contacted but not 
able to supply – presume only significant results presented) 
At 2 months pain (p=0.02) 
At 4 months emotional reaction (p=0.02), social isolation (p=0.01) 
At 6 months pain (p=0.02), social isolation (p=0.03), lack of energy (p=0.007) and physical 
mobility (p=0.003).  
 
Summary of 
results (non-
significant 
outcomes) 
Meurle d’Abuigne and Postel score (no data in article. Author contacted but not able to 
supply. Only p values given). (p=0.05) 
Harris Hip Score at 2 months (I) median 76 IQR 56-93 (C) median 71 IQR 31-83  
Post-operative complications (I) 5 (C) 11 (p=0.3) 
 
Author’s 
conclusions 
 
Function, pain and quality of life can be improved by pre-operative education with home-
based rehabilitation and nursing after discharge. 
 
Abbreviations: LOS, length of stay; OHS, Oxford hip score  
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Tappen (2002) 
Author Description 
Assessment 
points 
Baseline: on admission. 
Follow-up: at discharge, 1 week and 3 months.   
 
Statistical 
tests 
Power calculation indicated that a minimum of sample size of 30 per group was needed to 
obtain desired power of 80% or greater. 
Baseline characteristics: X
2
 test showed the intervention group to be significantly older 
(p=<0.05) (I) 75.28±9.48 (C) 69.61±12.65. No other significant difference was found between 
type of surgery (THR or fracture repair), number of chronic illnesses or medical conditions, 
age, gender of home arrangements (alone or with someone) 
Analysis of results: MANCOVAs with repeated measures as the between subject variable.  
 
Summary of 
results 
(significant 
outcomes) 
In favour of intervention 
6-minute walking test: Distance walked (feet) one week post discharge (p=0.045)  
(I) 128.23±229.59 (C) 26.79±70.40.  
Time walked  (seconds) was significant at baseline (p=0.006) (I) 99.82±200.17 (C) 0.12±55.81; 
at discharge (p=0.014) (I) 124.44±191.48 (C) 49.91±125.35;  
at one week follow-up (p<0.000) (I) 271.47±248.58 (C) 60.81±133.34;  
and at the final 3 month follow-up (p=0.027) (I) 314.79±139.59 (C) 204.77±179.70 
 
Summary of 
results (non-
significant 
outcomes) 
6-minute walking test: Distance walked (feet) at baseline (I) 13.85±46.35 (C) 8.56±55.88, 
6-minute walking test: Distance walked (feet) at discharge (I) 17.18±34.37 (C) 20.30±70.05, 
6-minute walking test: Distance walked (feet) three months post discharge (I) 231.74±169.47 
(C) 162.14±249.17. 
ADL Coping: at baseline (I) 115.03±11.76 (C) 116.49±11.18,  
at discharge (I) 115.69±11.35 (C) 115.00±11.77, 
at 1 week (I) 116.74±9.84 (C) 113.54±11.30, 
at 3 months (I) 117.54±8.01 (C) 114.91±11.76 
ADL Self-care: at baseline: (I) 198.47±33.52 (C) 97.51±26.98,  
at discharge (I) 201.67±36.00 (C) 202.86±26.33, 
at 1 week (I) 207.74±32.35 (C) 206.79±25.83,  
at 3 months (I) 203.33±30.10 (C) 216.09±23.87. 
ADL Functional ability: at baseline  (I) 91.33±14.24 (C) 97.61±13.92,  
at discharge (I) 102.72±11.37 (C) 108.95±9.62, 
at 1 week (I) 106.80±12.95 (C) 111.26±13.55,  
at 3 months (I) 119.51±8.36 (C) 121.35±6.51. 
ADL Independent: at baseline: (I) 142.97±28.78 (C) 142.68±27.05,  
at 1 week (I) 101.38±21.23 (C) 112.44±24.95,  
at 3 months (I) 129.97±23.44 (C) 137.42±27.12. 
ADL Physical activity: at baseline: (I) 67.23±67.53 (C) 73.21±100.92, 
at 1 week (I) 13.99±20.49 (C) 28.13±50.34, 
at 3 months (I) 48.05±47.62 (C) 54.51±69.51. 
Author’s 
conclusions 
Use of video in rehabilitation only has benefits in improving physical functioning. 
Abbreviations: ADL, Activities of daily living   
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Ververeli (2009) 
Author Description 
Assessment 
points 
Baseline: before surgery (time not stated) 
Follow-up:  1 month, 3 months and 1 year  
 
Statistical 
tests 
Power calculation: α = 0.05, β = 0.08; dislocation risk set at 0.33%. This indicated 53 
patients in each group were needed to detect a 3% difference in dislocation prevalence. 
Baseline demographics: no significant differences between the two groups in terms of age 
(p=0.51), or BMI (p=0.32). Statistical method not reported.  
Analysis of results: The Mann-Whitney U test, Fisher exact test, X
2
 test, T- test  
 
Summary of 
results 
(significant 
outcomes) 
In favour of intervention 
Time to ambulate only with a cane (days, ±SD): (I) 12.6±5.5, (C) 16.4±9.5 (Difference in 
means (±95% CI)  3.82±3.49 
Time to ambulate without a cane (days, ±SD): (I) 22.6±11.7, (C) 39.0±15.4 (Difference in 
means (±95% CI)  12.40±6.12 
Time to walk without limp (days, ±SD): (I) 49.9±20.9, (C) 67.3±27.2 (Difference in means 
(±95% CI)  17.33±10.82 
Time to drive car (Days, ±SD): (I) 22.9±11.7, (C) 30.1±8.0 (Difference in means (±95% CI)  
7.27±4.40 
 
Summary of 
results (non-
significant 
outcomes) 
No dislocations occurred. 
Harris Hip Score: at 3 months ES = 0.41, (p=0.07) 
SF-12 (Physical component) at 4 weeks: ES = 0.38, (p=0.09) 
All other Harris Hip Scores and SF-12 scores were not significant at all other time measures. 
(no actual data is provided)  
 
 
Author’s 
conclusions 
 
Hip restrictions provide no additional benefit and limit patients return to activities. A faster 
return to activities of daily living following elective THRs is possible without restrictions. It is 
not possible to conclude if restrictions are a necessary prevent dislocation. 
 
Abbreviations: BMI, body mass index; SF-12, short form (12 questions)   
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Weaver (2003) 
Author Description 
Assessment 
points 
Baseline: before surgery.  
Follow-up: 1 and 6 months. 
 
Statistical 
tests 
No power calculation 
Baseline characteristics: p values reported but statistical method not reported. 
Analysis of results: analysis of covariance. 
 
Summary of 
results 
(significant 
outcomes) 
In favour of intervention 
Reduction in number of days on home care program : (p=0.035) (I) 29.2 (C) 40.6  
Home care reimbursement costs (p<0.001) (I) $1488 (C) $2163. No SD provided. 
 
Summary of 
results (non-
significant 
outcomes) 
Outcome data presented as mean ±SE  
Barthel: at 1 month (p=0.940) (I) 96.7±0.07 (C) 96.6±0.7, 
 at 6 months p=0.121 (I) 98.9±1.3 (C) 96.1±1.2 
SF-36 (general health): 1 month (p=0.361) (I) 77.1±2.1 (C) 74.4±2.1, 
6 months( p=0.984) (I) 78.9±2.5 (C) 78.9±2.4, 
SF-36 (physical function) 1 month (p=0.526) (I) 39.3±2.9 (C) 42.0±2.9  
6 months (p=0.512) (I) 63.4±3.5 (C) 66.6±3.5  
SF-36 (Physical role) 1 month (p=0.720) (I) 31.1±5.0 (C) 33.6±4.9  
6 months (p=0.824) (I) 75.4±4.9 (C) 77.9±4.9  
SF-36 (Emotional role) 1 month (p=0.423) (I) 91.5±2.7 (C) 94.6±2.7  
6 months (p=0.431) (I) 95.0±2.6 (C) 92.0±2.6  
SF-36 (social function) 1 month (p=0.863) (I) 76.2±3.3 (C) 77.1±3.3  
6 months (p=0.969) (I) 91.6±2.2 (C) 91.7±2.2  
SF-36 (bodily pain) 1 month (p=0.4.3) (I) 67.1±3.1 (C) 63.4±3.1  
6 months (p=0.642) (I) 73.4±3.1 (C) 75.4±3.0  
SF-36 (vitality) 1 month (p=0.482) (I) 54.9±2.8 (C) 52.2±2.7  
6 months (p=0.280) (I) 56.3±2.7 (C) 60.4±2.6  
SF-36 (mental health) 1 month (p=0.857) (I) 81.8±1.6 (C) 81.4±1.6  
6 months (p=0.759) (I) 83.4±1.9 (C) 82.6±1.9.  
Satisfaction with care (overall): 1 month (p=0.987)  
(I) 4.3±0.1 (C) 4.3±0.1, 6 month (p=0.676) (I) 4.3±0.1 (C) 4.3±0.0 
WOMAC (pain) 1 month (p=0.661) (I) 4.4±0.1 (C) 4.4±0.1,  
6 month (p=0.925) (I) 4.6±0.1 (C) 4.6±0.0,  
WOMAC (stiffness) 1 month (p=0.125) (I) 3.8±0.1 (C) 4.0±0.1,  
6 month (p=0.775) (I) 4.1±0.1 (C) 4.2±0.0, WOMAC (function) 1 month (p=0.453) (I) 4.2±0.1 
(C) 4.1±0.1, 6 month (p=0.657) (I) 4.5±0.1 (C) 4.5±0.0 
Adverse events: (I) 1 (C) 4 
Total reimbursement costs: (I) $24,663 (C) $24,295 
 
Author’s 
conclusions 
The addition of the preoperative home visit improved patient satisfaction. Reductions in 
home care visits can be made without compromising outcomes for patients undergoing THR 
or TKR. 
 
Abbreviations: SF-36, short form (36 questions); WOMAC, Western Ontario and McMaster Universities 
Arthritis Index. 
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Wong (1990) 
Author Description 
Assessment 
points 
Baseline: before surgery 
Follow-up:  Two weeks & 6 months  
Statistical 
tests 
No power calculation 
Baseline characteristics:  No statistical difference (p <0.05), statistical method not reported. 
Analysis of results: Mann-Whitney for all analyses.(p 13)
(1) 
 
Summary of 
results 
(significant 
outcomes) 
In favour of intervention 
At 2 weeks  
Perceived Preparedness for Discharge Scale: both experimental groups (p<0.01) 
Exercise Compliance Score: both experimental groups (p<0.05) 
Compliant Behaviour Index for experimental group II only (p<0.05) 
 
Summary of 
results (non-
significant 
outcomes) 
At 2 weeks 
Experimental group I 
Compliant Behaviour Index (p = 0.38) 
 
At 6 months  
Experimental group I 
Objective Functional Capability Index (Muscle strength) (p = 0.69) 
Objective Functional Capability Index (Mobility Index) (p = 0.70) 
Objective Functional Capability Index (Walking Ability) (p = 0.55) 
Objective Functional Capability Index (Stair management) (p = 0.46) 
Subjective Functional Capability Index (p = 0.34) 
Subjective Psychosocial Capability Index (p = 0.67) 
 
Experimental group II 
Objective Functional Capability Index (Muscle strength) (p = 0.17) 
Objective Functional Capability Index (Mobility Index) (p = 0.87) 
Objective Functional Capability Index (Walking Ability) (p = 0.71) 
Objective Functional Capability Index (Stair management) (p = 0.50) 
Subjective Functional Capability Index (p = 0.57) 
Subjective Psychosocial Capability Index (p = 0.40) 
 
Author’s 
conclusions 
 
The findings suggest that a programme of after-care that combines educational and follow-
up home-visit strategies for the early discharged patients provides outcomes that are 
comparable to the traditional discharge planning for the conventionally discharged patients. 
 
Notes Experimental group I: Early discharge + educational intervention  
Experimental group II: Conventional discharge + educational intervention  
 
Note 
(1)
: In table 2 & 3 (p 15) for Objective Functional Capability Index (Mobility Index) a ‘t’ 
appears in the test column which would normally indicate a t-test. However, the text and the 
table suggest the Mann Whitney was used throughout.   
 
 
  
Note: In all data extraction tables the effect sizes were designated as "small, d = .2," 
"medium, d = .5," "large, d = .8", based on the classification suggested by Cohen, J (1998)  
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 Presentation of meta-analysis results 2.5.4.1
A table of the meta-analysis results is presented in Table 23. The significant findings (p≤0.05) 
are shown in bold and the directions of the findings are shown in the final column with the 
text stating as to whether they favour the intervention or the control.  
Table 21 and section 2.5.3.2 show the diversity of the types and timings of the interventions 
delivered in the included studies. Therefore, the results of the meta-analysis for each 
outcome shown in Table 24 to Table 32 have been divided in to three sections based on 
time points of outcome measurement: 
Pre-surgery: all studies provide a pre-admission/pre-surgery element to the intervention, 
and the outcome of the intervention has been assessed at a time point prior to the date of 
surgery. 
Discharge: all studies provide a pre-discharge intervention, and/or pre-admission/pre-
surgery intervention, and the outcome of the intervention has been assessed at the point of 
discharge.  
Long term: all studies provide a post discharge intervention, and/or a pre-discharge 
intervention, and/or pre-admission/pre-surgery intervention, and the outcome of the 
intervention has been assessed at a time point post discharge. When studies have measured 
at more than one follow up time point post discharge, the longest follow-up period results 
are used. Four studies (McGregor, 2004; Tappen, 2003; Ferrara, 2008; Gocen, 2004) 
reported long-term outcomes at 3 months post discharge; three other studies 
(Siggeirsdottir, 2005; Weaver, 2003; Rosendal, 2000) used six months; and one study 
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(Munin, 1998) used 4 months. Ververeli (2009) did not use a fixed time point, but measured 
days to achieve long-term functional milestones.               
Studies reporting outcomes at more than one time point of measurement are presented in 
each section. Following the convention outlined previously, studies appearing to the 
left/negative number side of the line are in favour of the intervention and those appearing 
on the right/positive number side of the line represent studies where the outcome favours 
the control. 
The study by Wong et al (2009) is not included in the meta-analysis as no descriptive data is 
presented in the study. Attempts were made to contact the authors to obtain the original 
data but this was not successful. Therefore, a narrative synthesis of the Wong et al (2009) 
study findings is incorporated with the description of the results of the meta-analysis 
findings for all the relative outcomes. 
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Table 23  Summary of meta-analysis results  
Outcome measure Number of 
studies 
Total number 
participants 
Pooled 
estimate 
(SMD) 
95% confidence 
intervals 
Probability 
 (p)  
Heterogeneity 
(I
2
)  
Findings in 
favour of 
Function – patient reported outcomes 
-Pre-surgery 
-Discharge 
-Long-term 
 
4 
1 
5 
 
173 
39 
299 
 
 0.38 
-0.24 
-0.46 
 
-0.68      -0.07 
-0.87       0.39 
-0.87      -0.05 
 
0.02 
0.45 
0.03 
 
1% 
NA 
64% 
 
Intervention 
 
Intervention 
Function – all reported outcomes 
-Pre-surgery 
-Discharge 
-Long-term 
 
5 
3 
10 
 
232 
180 
896 
 
-0.39 
-0.12 
-0.21 
 
-0.65     -0.13 
-0.95      0.17 
-0.52      0.10 
 
0.003 
0.78 
0.18 
 
0% 
86% 
78% 
 
Intervention 
 
 
Pain – VAS based analysis 
-Pre-surgery 
-Discharge 
-Long-term 
 
3 
2 
5 
 
125 
98 
332 
 
-0.37 
-0.20 
-0.20 
 
-0.86     0.13 
-0.61     0.20 
-0.55     0.15 
 
0.15 
0.33 
0.27 
 
44% 
4%  
52% 
 
Pain – WOMAC based analysis 
-Pre-surgery 
-Discharge 
-Long-term 
 
3 
2 
5 
 
125 
98 
332 
 
-0.41 
-0.18 
-0.04 
 
-0.78     -0.03 
-0.59      0.23 
-0.35       0.26 
 
0.03 
0.38 
0.78 
 
5% 
0% 
39% 
 
Intervention 
Health related quality of life 
-Pre-surgery 
-Discharge 
-Long-term 
 
3 
2 
5 
 
125 
121 
291 
 
-0.41 
0.00 
0.25 
 
-1.16      0.34 
-0.35      0.36 
0.20       0.48 
 
0.29 
0.99 
0.03 
 
74% 
0% 
0% 
 
 
 
Control 
Societal participation 
-Pre-surgery 
-Discharge 
-Long-term 
 
1 
1 
3 
 
63 
82 
541 
 
0.57 
0.47 
-0.07 
 
0.07      1.08 
0.03      0.91 
-0.79     0.64 
 
0.03 
0.04 
0.84 
 
NA 
NA 
94% 
 
Control 
Control 
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Table 23:  Summary of meta-analysis results (continued) 
Outcome measure Number of 
studies 
Total number 
participants 
Pooled 
estimate 
(MD) 
95% confidence 
intervals 
Probability 
 (p) 
Heterogeneity 
(I
2
)  
Findings in 
favour of 
Anxiety 
-Pre-surgery 
-Discharge 
 
 
2 
1 
 
 
135 
70 
 
-7.97 
-9.58 
 
 
-15.55   -0.40 
-19.28     0.12 
 
0.04 
0.05
(1)
 
 
45% 
NA 
 
Intervention 
Intervention 
 
Length of Stay 
 
 
8 
 
 
994 
 
-0.12 
 
-1.77      2.01 
 
0.03 
 
76% 
 
Intervention 
Outcome measure Number of 
studies 
Total number 
participants 
Pooled 
estimate 
(Odds Ratio) 
95% confidence 
intervals 
Probability 
 (p) 
Heterogeneity 
(I
2
)  
Findings in 
favour of 
 
Dislocation 
 
 
4 
 
 
553 
 
0.37 
 
0.09       1.48 
 
0.16 
 
0% 
 
Abbreviations: SMD, standard mean difference; MD, mean difference. 
Note
 (1)
: Anxiety at discharge probability is only borderline significant as 95% confidence intervals cross the line of no effect   
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 Description of results of meta-analysis 2.5.4.2
2.5.4.2.1 Function 
Measures reported 
A total of 896 participants were included in the meta-analysis of function. Six studies 
containing 362 participants (see Figure 19) reported function using patient reported 
outcome measures (PROMs). Ferrara (2006), McGregor (2004) and Weaver (2003) reported 
results using the function domain of WOMAC, Siggeirsdottir (2005) using the function 
domain of the Oxford hip score, Rosendal (2000) using the functional domain of the hip 
rating questionnaire and Sandell (2008) using the physical domain of the Nottingham health 
profile. Sandell (2008) also reported function as a domain of the arthritis impact measure 
score; although this is a disease specific measure which would normally be preferential to 
use over a general measure, it contains domains specific to upper limb function, which are 
not directly relevant to this review, and could therefore bias the findings. Therefore, the 
results from the Nottingham health profile were used in preference. Siggeirsdottir (2005) 
also used the Meurle D'Abuigne & Postel score but these results were not presented in the 
published article, nor could the author provide them upon request. Two other studies 
measured function using observational tools of physical function or achievement of 
milestone tasks completed by researchers. Munin (1998) used the functional status index 
and Tappen (2002) a functional index measure.  
A further four studies containing 534 participants reported function using methods other 
than PROM. Gocen (2004) employed the Harris hip score and Rosendal (2000) used the hip 
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rating questionnaire, both of which have a combination of questions and physical measures 
of hip strength and range of movement that require assessment by a researcher. Munin 
(1998) used the Functional Status Index which requires scoring of functional ability by the 
assessor, and Ververeli (2009) used days to achieve functional milestones. The results of 
these additional studies are included in Figure 20. 
Wong (1990) recorded long term function using the Objective Functional Capacity Index and 
the Subjective Functional Capacity Index. As no data on variance about the mean is 
presented in the article, this study could not be used in the meta-analysis. At the six month 
follow up, Wong (1990) reports there was no statistically significant difference between 
those randomised to the enhanced post-operative education and rehabilitation programme 
at early discharge or conventional discharge compared to the conventional discharge and 
traditional rehabilitation programme (P > 0.33). 
Pre-surgery  
Figure 19 and Figure 20 show that the PROMs and all functional outcome analyses have 
similar results and show a significant improvement between groups in favour of the 
intervention. Four studies (Ferrara, 2006; McGregor, 2004; Siggeirsdottir, 2005; Sandell, 
2008) reported interventions that were delivered partially or in-full, and their effects 
assessed at a time point prior to surgery using PROMs. For this analysis, the standard mean 
difference (SMD) between the groups was -0.38 (CI -0.68, -0.07: p=0.02). Addition of the 
(Gocen, 2004) study to the all functional outcomes meta-analysis results in only small 
changes; SMD -0.39 (-0.65, -0.13: p=0.003). A total of 232 participants were included in all 
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measures of function at the pre-surgery time point. The I2 Statistic is only 1% for the PROM 
analysis and 0% for all indicating heterogeneity in these findings is of no concern. 
Discharge 
Three studies containing 180 participants measured function by all measures at the point of 
discharge. Only one study (McGregor, 2004) reported function using PROMs, and two 
studies (Gocen, 2004; Tappen, 2002) using other outcomes. Both sets of analyses are not 
significant with a SMD of -0.24 (-0.78, 0.39: p=0.45) for the PROM analysis, and a SMD of      
-0.12 (-0.95, 0.17: p=0.78) for all reported functional outcomes. As only one study was 
included in the patient reported analysis, and three when using all functional measures, 
these results should be treated with caution. The I2 statistic for the studies using all 
functional measures is 86% Indicating considerable heterogeneity may be present. 
However, the results are not significant.   
Long-term 
Ten studies containing 896 participants measured long term function by all measures. Five 
studies containing 299 participants (Ferrara, 2006; Siggeirsdottir, 2005, McGregor, 2004; 
Weaver, 2003, Rosendal, 2000) report long-term functional effects of the intervention using 
PROMs. A further five studies containing 667 participants (Gocen, 2004; Munin, 1998; Peak, 
2005; Tappen, 2002; Ververeli, 2009) using other measures. Both meta-analyses favour the 
intervention, but only the analysis using PROMs only were statistically significant. The SMD 
was -0.46, (-0.87, -0.05; p=0.03) for PROMs only, and 0.21(-0.52, 0.10; p=0.18) for all 
outcomes.  
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The I2 statistic for long–term effect on functional outcomes using PROMs only was 64% 
indicating substantial heterogeneity may be present, so caution should be applied in 
interpreting these findings.    
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Figure 19 Function: Patient reported outcomes 
 
WOMAC (Function): Ferrara (2006), McGregor (2004), Weaver (2003); Oxford Hip Score (function): Siggeirsdottir (2005); Nottingham Health Profile (Physical): Sandell 
(2008); Hip Rating Questionnaire (function): Rosendal (2000)  
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Figure 20 Function: All outcome measures  
 
WOMAC (function): Ferrara (2006), McGregor (2004), Weaver (2003); Harris Hip Score: Gocen (2004); Functional status index: Munin (1998); Nottingham health profile 
(physical): Sandell (2008); Oxford hip score (function): Siggeirsdottir (2005); Functional index measure (functional ability): Tappen (2002); Hip Rating Questionnaire 
(function): Rosendal (2000) ; Ability to perform ADL’s at 6 months post discharge: Peak (2005) ; Days to walk without limp: Ververeli (2009)  
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2.5.4.2.2 Pain 
Measures reported 
Seven studies containing 489 participants reported pain; Ferrara (2006), Gocen (2004), 
McGregor (2004) used the visual analogue scale, Munin (1998) used the bodily pain domain 
of the RAND-36, Rosendal (2000) used the pain domain of the hip rating questionnaire, 
Sandell (2008) used the pain domain of the arthritis impact measure score and Weaver 
(2003) used the pain domain of the WOMAC. Two of these studies, Ferrara (2006) and 
McGregor (2004), as well as reporting pain using the visual analogue scale (VAS), also 
reported pain by means of the WOMAC pain domain. As both of these are patient self-
reported measures, and the studies report findings at all three time-points used in the 
meta-analysis, a sensitivity analysis was undertaken. The analyses were run using all studies, 
but for those studies which reported pain using both measures, one analysis used the VAS 
data and another used the WOMAC data. Figure 21 (VAS data) presents the results of the 
meta-analysis for pain using the VAS results Figure 22 (WOMAC data) using results from the 
pain domain of WOMAC.  
Pre-surgery 
Three studies containing 121 participants (Ferrara, 2006; McGregor, 2004; Sandell, 2008) 
reported the effect of interventions intended to reduce pre-surgical perception of pain. 
When using the WOMAC pain scores for Ferrara (2006) and McGregor (2004), there is an 
overall significant decrease in pain in favour of the interventions. The SMD between the 
groups was -0.41 (-0.78, -0.03: p=0.03). The results of the pre-surgery analysis using the VAS 
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results also tend to favour the intervention but are not significant; the SMD between groups 
was -0.37 (-0.86, 0.13; p=0.15). The heterogeneity associated with the significant finding for 
reduction of pre-surgery pain using the WOMAC based analysis had an I2 of 5% indicating 
heterogeneity may be of little concern, and therefore findings can be treated with 
confidence. The I2 value for the non-significant VAS based analysis was 44% in indicating 
moderate heterogeneity may be present.  
Discharge 
Only two studies containing 94 participants (Gocen, 2004; McGregor, 2004) reported levels 
of pain at point of discharge. Both the VAS and WOMAC based analyses show that the OT 
interventions have no significant impact on pain. At discharge, the SMD between groups for 
the VAS based analysis was –0.20 (-0.61, 0.02; p=0.33) and -0.18 (-0.59, 0.23: p=0.38) for the 
WOMAC pain domain analysis. The I2 statistic was only 4% for the VAS based analysis and 
0% for the WOMAC indicating the heterogeneity was low in both analyses. However, as only 
two studies were included, caution must be used interpreting the results of this discharge 
time point analysis, as the findings may not be representative. 
Long-term 
Five studies containing 332 participants (Ferrara, 2006; McGregor; Munin, 1998; Rosendal, 
2000; Weaver, 2003) report long-term levels of pain. For the both the VAS and WOMAC 
based analyses, the results tend to favour the interventions but are not significant; the SMD 
between groups was –0.20 (-0.55, 0.15: p=0.27) for the VAS based, and -0.04 (-0.35, 0.26: 
p=0.78) for the WOMAC based. The I2 statistic is 52% for the VAS analysis and 39% 
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suggesting only moderate heterogeneity is present so these results can be treated with 
confidence.  
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Figure 21–Pain (VAS based analyses) 
 
Visual Analogue Scale: Ferrara (2006), Gocen (2004) 
(1)
, McGregor (2004) ; RAND-36 (bodily pain): Munin (1998) ; Hip Rating Questionnaire (pain): Rosendal (2000) 
Arthritis impact measure score (pain): Sandell (2008); WOMAC (pain): Weaver (2003) 
 
Note 
(1)
: Gocen (2004) VAS (on activity) 
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Figure 22–Pain (WOMAC based analysis) 
 
Visual Analogue Scale: Gocen (2004) 
(1)
; RAND-36 (bodily pain): Munin (1998); Hip Rating Questionnaire (pain): Rosendal (2000); Arthritis impact measure score (pain): 
Sandell (2008); WOMAC (pain): Weaver (2003), McGregor (2004), Ferrara (2006), 
 
Note (1): Gocen (2004) VAS (on activity) 
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2.5.4.2.3 Health related quality of life 
Measures reported 
Six studies containing 380 participants (Ferrara, 2006; McGregor; Munin, 1998; Sandell, 
2008; Tappen, 2002; Weaver, 2003) reported quality of life findings; each study using 
different methods or measures (see Figure 23). Ferrara (2006) and Weaver (2003) both 
employed the SF-36, the former aggregating the physical domains and presenting the 
physical composite score whilst Weaver (2003) presented all component scores; the 
physical role results being used in the meta-analysis. McGregor (2004) used the EQ-5D, 
though results were only presented in graphical form requiring the data to read from the 
graph (author contacted for original data but was not able to provide). Munin (1998) 
presented results to evaluate health related quality of life by way of the ‘role functioning 
physical’ domain of the RAND-36, Sandell (2008) the ‘satisfaction with life’ domain of the 
arthritis impact measure score and Tappen (2002) the Jalowiec coping scale. 
Pre-surgery 
Three studies containing 125 participants (Ferrara, 2006; McGregor, 2004; Sandell, 2008) 
reported the findings of interventions at the pre-surgery point of measurement. The results 
were not significant; the SMD between groups -0.41 (-1.16, 0.34; p=0.29). The I2 statistic of 
74% indicating substantial to considerable heterogeneity may be present; and as only three 
studies were included, caution must be used when interpreting the findings. 
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Discharge 
Two studies containing 121 participants (McGregor, 2004; Tappen, 2002) reported results of 
interventions at the point of discharge. These show no effect on health related quality of 
life; the SMD between groups was 0.00 (-0.35, 0.36; p=0.99). The I2 statistic is 0%, indicating 
no heterogeneity. However, as only two studies were included, caution must be used 
interpreting the results of this discharge time point analysis, as the findings may not be 
representative. 
Long-term 
Five studies containing 291 participants (Ferrara, 2006; McGregor; Munin, 1998; Tappen, 
2002; Weaver, 2003) reported long-term results for heath related quality of life. Only the 
McGregor (2004) study showed a weak trend in favouring the intervention; all the others 
showed a trend towards favouring the control, though none were individually significant. 
However, the overall meta-analysis is significant favouring the control; the SMD between 
groups was 0.25 (0.20, 0.48; p=0.03). The I2 statistic for the long-term analysis is 0% 
suggesting heterogeneity is not important; therefore these findings can be treated with 
confidence.    
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Figure 23 –Health related quality of life  
 
SF-36 (physical composite score): Ferrara (2006); EQ-5D: McGregor (2004) (Data Scaled from graph – original data not available); RAND-36: (Role functioning physical): 
Munin (1998); Arthritis impact measure score (satisfaction with life): Sandell (2008); Jalowiec coping scale: Tappen (2002); SF-36 (physical role): Weaver (2003) 
 ~ 145 ~ 
 
2.5.4.2.4 Social Participation 
Measures reported 
Five studies containing 686 participants (Sandell, 2008; Tappen, 2002, Peak, 2005; Rosendal, 
2000; Weaver, 2003) measured social participation using different PROMs (Figure 24). Peak 
(2005) used return to work, Rosendal (2000) presented results using the SIP-68, Sandell 
(2008) the ‘satisfaction with health’ domain of the Arthritis Impact Measure Score, Tappen 
(2002) the functional life scale and  Weaver (2003) the ‘social function’ domain of the SF-36.  
Pre-surgery 
Only Sandell (2008) reported societal participation at the pre-surgery time point with an 
SMD of 0.57 (0.07, 1.08: p=0.03) significantly in favour of the control group.  
Discharge 
Similarly, only one study (Tappen, 2002) reported results at the point of discharge, with 
findings also significantly in favour of the control: the SMD was 0.47 (0.03, 0.91: p=0.04).  
As both of these analyses, measured pre-surgery and at point of discharge, have only one 
study, the results of this analysis may not be representative of the general population and 
must be interpreted with caution. 
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Long-term 
Three studies containing 541 participants (Peak, 2005; Rosendal, 2000; Weaver, 2003) 
reported long-term results for societal participation with an SMD between groups of -0.07  
(-0.79, 0.64; p=0.84). The I2 statistic for the long term societal participation was 
exceptionally high at 94% indicating considerable heterogeneity is present. Such a high level 
of heterogeneity means this finding must be treated with great caution. This level of 
heterogeneity also suggests that these studies may not be suitable for meta-analysis 
(Higgins and Green, 2011).    
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Figure 24 – Social participation  
 
SIP-68: Rosendal (2000); Arthritis impact measure score (satisfaction with health): Sandell (2008); Functional life scale: Tappen (2002) 
SF-36 (social function); Weaver (2003); Return to work: Peak (2005) 
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2.5.4.2.5 Anxiety 
Measures reported 
Two studies containing 135 participants, Butler (1996) and Crowe (2003), measured anxiety 
(Figure 25). As both studies used the same outcome measurement instrument; the state-
trait anxiety inventory mean difference (MD) modelling was used in the meta-analysis.  
Pre-surgery 
Both studies reported significant pre-surgery results from pre-admission interventions. The 
MD between the groups was -7.97 (-15.55, -0.40: p=0.04) in favour of the interventions. The 
I2 statistic was 45% indicating only moderate heterogeneity may be present. 
Discharge  
Only Butler (1996) measured anxiety levels at discharge; the findings were borderline 
significant in favour of the intervention with a MD of -9.58 (-19.28, 0.12: p=0.05) between 
groups. Although, the probability was calculated at 0.05 it is borderline significant (the 
accepted level of significance is <0.05), and the 95% confidence intervals cross the line of no 
effect. 
As only two studies were involved in the pre-surgery analysis and one study at discharge, 
both with small participant populations, the results of this analysis may not be 
representative of the wider population undergoing THR due to OA and therefore must be 
interpreted with caution.  
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Figure 25 Anxiety  
 
State-Trait anxiety inventory: Butler (1996), Crowe (2003)  
 
Study or Subgroup
6.1.1 Pre-Surgery
Butler 1996
Crowe 2003
Subtotal (95% CI)
Heterogeneity: Tau² = 18.10; Chi² = 1.82, df = 1 (P = 0.18); I² = 45%
Test for overall effect: Z = 2.06 (P = 0.04)
6.1.2 Discharge
Butler 1996
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 1.94 (P = 0.05)
Test for subgroup differences: Chi² = 0.07, df = 1 (P = 0.80), I² = 0%
Mean
27.93
39.97
21.57
SD
25.24
4.86
18.44
Total
30
36
66
30
30
Mean
42.65
45.73
31.15
SD
29.06
5.61
22.93
Total
40
29
69
40
40
Weight
24.7%
75.3%
100.0%
100.0%
100.0%
IV, Random, 95% CI
-14.72 [-27.47, -1.97]
-5.76 [-8.35, -3.17]
-7.97 [-15.55, -0.40]
-9.58 [-19.28, 0.12]
-9.58 [-19.28, 0.12]
Intervention Control Mean Difference Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
Favours Intervention Favours control
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2.5.4.2.6 Length of stay 
Nine studies containing 994 participants reported the length of hospital stay (Butler, 1996; 
Crowe, 2003; Munin, 1998; Peak, 2005; Rivard, 2003; Rosendal, 2000; Siggeirsdottir, 2005; 
Tappen, 2002; Wong, 1990) and mean difference modelling was employed (Figure 26). 
Three studies (Crowe, 2003; Munin, 1998; Siggeirsdottir, 2005) reported the intervention 
had a statistically significant effect on reducing the hospital length of stay. The other five 
included studies showed almost no effect. The overall result of the meta-analysis shows a 
statistically significant effect in favour of OT interventions reducing hospital length of stay; 
MD between groups was -0.88 (-1.66, -0.09: p=0.03). However, the I2 statistic was 76% 
indicating substantial to considerable heterogeneity may be present. This suggests the 
results should be treated with a degree of caution. 
The Wong (2009) study provided no data on variance about the mean, so could not be 
included in the meta-analysis. There was no significant statistical difference in length of stay 
in those allocated to the enhanced post-operative education and rehabilitation programme 
(mean: 13.85 days) compared to the conventional discharge and rehabilitation regime 
(mean: 12.75).  
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Figure 26 Length of Stay (days)  
 
2.5.4.2.7 Dislocation 
Four studies containing 553 participants (see Figure 27) report the number of dislocations; 
Crowe (2003), Peak (2005), Siggeirsdottir (2005) and Weaver (2003). As dislocation is a 
dichotomous outcome an odds-ratio modelling was used as the meta-analysis method. 
Although the overall number of dislocations reported were lower in the OT intervention 
groups (n=2) compared with the number in the control groups (n=6), the results of the 
meta-analysis O.R. 0.37 (0.09, 1.48; p=0.16) favour the intervention, but are not significant.  
Figure 27 Prosthesis dislocation  
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2.5.5 Synthesis of meta-analysis results with quality of studies  
The combination of the meta-analysis results with the bias adjusted quality of the studies 
for the various outcomes and time-points are shown in Table 24 to Table 32 below. Non-
significant outcomes have been graded as providing ‘no evidence of effect’ due to the few 
studies with small sample sizes for each outcome. However, the results of the GRADE 
analysis are still reported in parenthesis to illustrate the final quality of the evidence for that 
outcome.  
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Table 24 level of evidence analysis for function (PROM only) 
  
Time 
Point 
Study 
Study 
design 
GRADE Adjustment due to:  
GRADE of Evidence  Initial 
quality of 
evidence 
Consistency Directness Precision Plausible 
confounding 
Strength of 
association 
Pre 
surgery 
Ferrara (2006) RCT Moderate Consistent 
 
No adjustment 
Direct 
 
No 
adjustment 
Precise 
 
No 
adjustment 
NA NA 
Moderate to High 
McGregor (2004) RCT High 
Siggeirsdottir 
(2005) 
RCT Moderate 
Sandell (2008) RCT Moderate 
Discharge McGregor (2004) RCT High 
Consistency 
unknown 
(single study) 
Direct Imprecise 
 
-1 grade 
adjustment 
NA NA 
No Evidence 
(Moderate) 
Long-term 
Ferrara (2006) RCT Moderate Consistent 
 
 
 
No adjustment 
Direct 
 
 
 
No 
adjustment 
Imprecise 
 
 
 
-1 grade 
adjustment 
 
 
 
 
Absent – no 
adjustment 
NA 
Moderate to Very 
low 
McGregor (2004) RCT High 
Siggeirsdottir 
(2005) 
RCT Moderate 
Weaver (2003) RCT High 
Rosendal (2000) CCT Low 
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Table 25 level of evidence analysis for function (all outcome measures) 
 
Time 
Point 
Study 
Study 
design 
Grade Adjustment due to:  
GRADE of Evidence Initial 
quality of 
evidence 
Consistency Directness Precision Plausible 
confounding 
Strength of 
association 
Pre 
surgery 
Ferrara (2006) RCT Moderate Consistent 
 
No 
adjustment 
Direct 
 
No 
adjustment 
Precise 
 
No 
adjustment 
NA NA 
Moderate to High 
Gocen (2004) RCT High 
McGregor (2004) RCT High 
Siggeirsdottir (2005) RCT Moderate 
Discharge 
Gocen (2004) RCT High Consistent 
 
No 
adjustment 
Direct 
 
No 
adjustment 
Imprecise 
 
-1 grade 
adjustment 
 
Absent – no 
adjustment 
NA 
No Evidence 
(Moderate to Very 
low) 
McGregor (2004) RCT High 
Tappen (2002) CCT Low 
Long-term 
Ferrara (2006) RCT Moderate Inconsistent 
 
 
 
-1 grade 
adjustment 
 
Direct 
 
 
 
No 
adjustment 
Imprecise 
 
 
 
-1 grade 
adjustment 
 
 
 
 
Absent – no 
adjustment 
NA 
No Evidence 
(Low to No evidence) 
Gocen (2004) RCT High 
McGregor (2004) RCT High 
Munin (1998) RCT High 
Peak (2005) RCT Moderate 
Rosendal (2000) CCT Low 
Siggeirsdottir (2005) RCT Moderate 
Tappen  (2002) CCT Low 
Ververeli (2009)  RCT Low 
Weaver (2003) RCT High 
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Table 26 Level of evidence analysis for pain (VAS) 
 
  
Time 
Point 
Study 
Study 
design 
Grade Adjustment due to:  
GRADE of Evidence Initial 
quality of 
evidence  
Consistency Directness Precision Plausible 
confounding 
Strength of 
association 
Pre 
surgery 
Ferrara (2006) RCT Moderate 
Inconsistent  
 
No adjustment 
as inconsistency 
not serious  
Direct 
 
 
No 
adjustment 
Imprecise 
 
 
-1 grade 
adjustment 
NA NA 
No Evidence 
(Moderate to Low) McGregor (2004) RCT High 
Sandell (2008) RCT Moderate 
Discharge 
Gocen (2004) 
 
RCT High 
Inconsistent 
 
No adjustment 
as inconsistency 
not  serious 
Direct 
 
No 
adjustment 
Imprecise 
 
-1 grade 
adjustment 
NA NA 
No Evidence 
(Moderate) 
McGregor (2004) RCT High 
Long-term 
Ferrara (2006) RCT Moderate Inconsistent 
 
 
 
-1 adjustment 
as inconsistency 
serious 
Direct 
 
 
 
 
No 
adjustment 
Imprecise 
 
 
 
-1 grade 
adjustment 
Absent  
 
 
 
 
No adjustment 
NA 
No Evidence 
(Low – No evidence) 
McGregor (2004) RCT High 
Weaver (2003) RCT High 
Munin (1998) RCT High 
Rosendal (2000) CCT Low 
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Table 27 Level of evidence analysis for pain (WOMAC) 
 
  
Time 
Point 
Study 
Study 
design 
Grade Adjustment due to: 
GRADE of Evidence 
Initial 
quality of 
evidence 
Consistency Directness Precision Plausible 
confounding 
Strength of 
association 
Pre 
surgery 
Ferrara (2006) RCT Moderate Inconsistent  
 
No adjustment 
as inconsistency 
not serious  
Direct 
 
No 
adjustment 
Imprecise 
 
-1 grade 
adjustment 
NA NA 
Moderate to Low McGregor (2004) RCT High 
Sandell (2008) RCT Moderate 
Discharge 
Gocen (2004) RCT Moderate 
Inconsistent 
 
No adjustment 
as inconsistency 
not  serious 
Direct 
 
 
No 
adjustment 
Imprecise 
 
 
-1 grade 
adjustment 
NA NA 
No Evidence 
(Moderate to Low) McGregor (2004) RCT High 
Long-term 
Ferrara (2006) RCT Moderate Inconsistent 
 
-1 adjustment 
as inconsistency 
serious 
Direct 
 
No 
adjustment 
Imprecise 
 
-1 grade 
adjustment 
Absent 
 
No adjustment 
NA 
 
 
 
 
 
No Evidence 
(Low – No evidence) 
 
 
 
McGregor (2004) RCT High 
Weaver (2003) RCT High 
Munin (1998) RCT High 
Rosendal (2000) 
CCT Low 
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Table 28 Level of evidence analysis for HRQoL 
 
  
Time 
Point 
Study Study 
design 
Grade adjustment due to: 
GRADE of Evidence 
Initial 
quality of 
evidence 
Consistency Directness Precision Plausible 
confounding 
Strength of 
association 
Pre 
surgery 
Gocen (2004) RCT High Inconsistent 
 
-1 adjustment 
as inconsistency 
serious 
Direct  
 
No 
adjustment 
Imprecise 
 
-1 grade 
adjustment 
 NA 
No Evidence 
(Low- No evidence) 
Ferrara (2006) RCT Moderate 
Sandell (2008) RCT Moderate 
Discharge 
McGregor (2004) RCT High Consistent 
 
No adjustment 
Direct 
 
No 
adjustment 
Imprecise 
 
-2 grade 
adjustment 
Absent 
 
No adjustment 
NA 
No Evidence 
(Low – No evidence) Tappen (2002) CCT Low 
Long-term 
Ferrara (2006) RCT Moderate Inconsistent 
 
 
-1 adjustment 
as inconsistency 
serious 
Direct 
 
 
No 
adjustment 
Imprecise 
 
 
-2 grade 
adjustment 
Absent 
 
 
No adjustment 
 
 
 
 
 
 
NA 
Low to No Evidence 
(Control) 
McGregor (2004) RCT High 
Munin (1998) RCT High 
Weaver (2003) RCT High 
Tappen (2002) CCT Low 
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Table 29 Level of evidence analysis for societal participation 
  
 
Time 
Point 
Study Study 
design 
Grade adjustment due to: 
GRADE of Evidence 
Initial 
quality of 
evidence 
Consistency Directness Precision Plausible 
confounding 
Strength of 
association 
Pre 
surgery 
Sandell (2008) RCT Moderate 
Consistency 
unknown (single 
study) 
Direct 
No 
adjustment 
Precise 
No 
adjustment 
 NA 
Moderate (Control) 
Discharge Tappen (2002) CCT Low 
Consistent 
 
No adjustment 
Direct 
 
No 
adjustment 
Precise 
 
No 
adjustment 
Absent  
 
No adjustment 
NA 
Low (Control) 
Long-term 
Peak (2005) RCT Moderate 
Consistent 
 
 
No adjustment 
Direct 
 
 
No 
adjustment 
Imprecise 
 
 
-1 adjustment 
Absent 
 
 
No adjustment 
NA 
No Evidence 
(Moderate to Very 
low) 
Weaver (2003) RCT High 
Rosendal (2000) CCT Low 
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Table 30 Level of evidence analysis for anxiety 
 
Table 31 Level of evidence analysis for length of stay 
Time 
Point 
Study Study 
design 
Grade adjustment due  to: 
GRADE of Evidence 
Initial 
quality of 
evidence 
Consistency Directness Precision Plausible 
confounding 
Strength of 
association 
Pre 
surgery 
Butler (1996) RCT High Consistent 
 
No adjustment 
Direct 
 
No 
adjustment 
Imprecise 
 
No 
adjustment 
NA NA 
High (Intervention) 
Crowe (2003) RCT High 
Discharge Butler (1996) RCT High 
Consistency 
unknown (single 
study) 
Direct 
 
No 
adjustment 
Precise 
 
No 
adjustment 
NA NA 
No Evidence 
(High)  
Study Study 
design 
Grade adjustment due to: 
GRADE of Evidence Initial quality of 
evidence 
Consistency Directness Precision Plausible 
confounding 
Strength of 
association 
Butler (1996) RCT High Inconsistent  
 
No adjustment as 
inconsistency not 
serious 
Direct 
 
No 
adjustment 
Imprecise 
 
No 
adjustment 
Absent 
 
No adjustment 
NA 
Moderate 
(Intervention) 
Crowe (2003) RCT High 
Munin (1998) RCT High 
Peak (2005) RCT Moderate 
Siggeirsdottir (2005) RCT Moderate 
Rivard (2003) CCT Low 
Tappen (2002) CCT Low 
Rosendal (2000) CCT Low 
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Table 32 Level of evidence analysis for dislocation 
Study Study 
design 
Grade adjustment due to: 
GRADE of Evidence Risk of Bias Consistency Directness Precision Plausible 
confounding 
Strength of 
association 
Crowe (2003) RCT High Consistent 
 
 
No adjustment 
Direct 
 
 
No 
adjustment 
Precise 
 
 
No 
adjustment 
Absent 
 
 
No adjustment 
NA 
No Evidence 
(Moderate to High) 
Peak (2005) RCT Moderate 
Siggeirsdottir (2005) RCT Moderate 
Weaver (2003) RCT High 
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2.5.6 Results of the combined evidence synthesis   
 In favour of interventions  2.5.6.1
The results of this meta-analysis show there is high quality evidence from two studies 
(n=205) that occupational therapy interventions delivered pre-admission help to reduce pre-
surgery anxiety.  There is a moderate to high level of evidence from 5 studies (n=232) that 
occupational therapy interventions delivered pre-admission help to improve pre-surgery 
function measured either by patient reported outcomes only or by other methods of 
assessment. There is moderate evidence from 8 studies (n= 994) that occupational therapy 
interventions delivered prior to admission or during the acute hospital stay significantly 
reduce the duration of hospital stay. There is moderate to low levels of evidence from 3 
studies (n=125) that occupational therapy interventions delivered prior to admission 
significantly decrease patients’ experience of pain when the WOMAC pain score is used to 
replace the VAS in studies that reported both outcomes. There is moderate to very low 
evidence from 5 studies (n=229) that occupational therapy interventions delivered either 
prior to admission, during the acute hospital stay or post discharge significantly improve long 
term function measured using patient reported outcome measures. However, there was 
substantial heterogeneity for this outcome which suggests that the interpretation of this 
finding must be treated with caution.  
 In favour of control 2.5.6.2
There is a moderate level of evidence from one study (n=63) that occupational therapy 
interventions delivered prior to admission significantly decrease societal participation prior 
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to admission, and a low level of evidence from 1 study (n=82) that interventions delivered 
prior to admission reduce societal participation measures at point of discharge. There is also 
low to no evidence from 5 studies (n=291) that occupational therapy interventions delivered 
either prior to admission, during the acute hospital stay, or post discharge, significantly 
decrease long term health related quality of life. 
 No evidence of effect 2.5.6.3
There no evidence to support that occupational therapy interventions assist with function at 
time of discharge using all measures, or patient reported outcomes only, or in the long term 
using all reported outcomes. There is also no evidence that occupational therapy 
interventions reduce patients’ perception of pain pre-surgery or in the long term using either 
the WOMAC pain domain or the VAS pain bias method of measurement; also there is no 
evidence that interventions reduce pre-surgery pain using the VAS based outcome. There is 
no evidence that occupational therapy interventions affect heath related quality of life pre-
surgery or at discharge, or long term societal participation, or anxiety at discharge, or the 
rate of prosthesis dislocation. 
2.6 Discussion  
2.6.1 Strengths and weaknesses of included studies 
 Study design 2.6.1.1
Twelve out of the fifteen included studies were RCTs which are considered the highest 
standard of clinical trial (Guyatt et al, 2000). All the included studies experienced minimal 
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loss to follow-up and none were identified as of being at high risk of bias for loss of blinding 
of the outcome assessor. Additionally, none of the 12 included RCTs were considered to 
contain a high risk of bias in the categories of randomisation sequence generation and 
allocation concealment. The majority of the studies were carried out prior to, or soon after 
release, of the original 2001 CONSORT statement (Moher et al, 2001) for parallel arm RCTs. 
It is therefore possible that several categories have been associated with an uncertain level 
of bias due to poor reporting rather than due to poor actual conduct of the trials. 
The sample sizes in many studies were very small with a median value of 86 (range 23 to 
303). Cohen (1998) indicates that for medium effect size of 0.5 (with p=0.05 and 80% 
power), a minimum of 50 participants per group is required: only five studies met this 
sample size minimum value (Crowe, 2003; Rivard, 2003; Peak, 2005; Rosendal, 2000; 
Weaver, 2003). Additionally, most of the studies measured multiple outcomes with no 
statistical plan or corrections applied for the effect this has on further reducing the power of 
the studies to detect a true clinical difference (Revicki et al, 2000). This small sample may 
lead to an underestimation of the efficacy of OT.  
 Occupational therapy involvement 2.6.1.2
The study data in Table 21 shows only two of the included studies were exclusively 
evaluating OT practice, and furthermore, the OT intervention in the Rosendal (2003) study 
was carried out by a home care coordinator. Five studies were mixed therapy interventions 
with significant OT input from a registered occupational therapist, and seven were mixed 
therapy interventions where the person carrying out the recognised OT practice was either a 
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nurse or physiotherapist and not a specialist occupational therapist. The occupation of the 
person performing the recognised OT practice in Ververeli (2009) is not recorded. Although 
the inclusion criteria only allowed studies to be included where the mixed therapy 
interventions contained a significant OT content, this predominance of mixed therapy 
interventions is the major weakness of this review in evaluating the effectiveness of OT 
practice. However, this multidimensional therapy input is more representative of clinical 
practice. Additionally, the inclusion of recognised OT interventions performed by other 
health care professionals makes the finding of this review more internationally applicable, as 
in many countries, no occupational therapy profession exists.  
 Participants 2.6.1.3
The characteristics of the study participants in the review are closely representative of the 
general UK population undergoing THR with the average age of a recipient being 67.2 years, 
and 60% female (NJR, 2012). This makes the results of this study generalisable. 
 Multiple outcome measures 2.6.1.4
Many different outcomes were measured in the studies and recorded by different measures; 
a weakness also noted by Khan et al (2008) in their review of multidisciplinary rehabilitation. 
All the outcomes other than anxiety used multiple measurement instruments measuring the 
same outcome. Although the use of SMD modelling is designed to accommodate this, the 
strength of the review would have been improved if the included studies used standardised 
instruments to measure each outcome. The effect of this variation in outcomes by using 
different PROMs is illustrated by analysis of the results of the two studies reporting pain by 
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both the WOMAC and VAS. The McGregor (2004) study shows the use of the WOMAC or VAS 
produced very similar results at all three time points of measurement. In contrast, the 
findings of Ferrara (2006) show almost identical levels of pain at the pre-surgery time point; 
however, at the long term-term time point, the VAS results are strongly in favour of the 
intervention whereas using the WOMAC data, the findings show almost no effect. 
 Multiple time point of assessment 2.6.1.5
Many of the interventions in the included studies were complex in nature. This can be 
considered as a strength of the studies as they were representative actual OT clinical 
practice.  However, multiple time points of assessment were used which made the meta-
analysis complex. Interventions that were carried out pre-admission sometimes had 
outcomes measured before admission, on admission or the day before surgery. The post 
discharge follow-up period in most studies were varied and were mainly very short term. 
Better consistency in time points of measurement and determination of primary time points 
would improve the quality of research in to rehabilitation.    
 Relevance to the NHS 2.6.1.6
With regards to UK practice and relevance to the NHS, one of the weaknesses of this review 
is that only two of the included studies were carried out in the UK; and in both of these, the 
OT intervention was performed by either a nurse or a physiotherapist. However, in both of 
these studies, the therapist conducting the intervention did so in consultation with 
registered occupational therapists to guide their intervention. Additionally as there is such a 
wide variation in NHS practice (Westby et al, 2006), and all the interventions carried out in 
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the non-UK studies are accepted practice in the UK, the results of this review are relevant to 
NHS practice.  
The three strongest findings from this review relate to improvements in pre-surgery levels of 
pain, function and anxiety which may be important (Fortin et al, 1999) to the eventual long 
term outcome following THR. Fortin et al (1999) conducted an observational study of 379 
participants with OA waiting for elective surgery and found that function at six months was 
better in the participants who had higher levels of preoperative function and lower levels of 
pain. However, they did find that the improvements were much better for those participants 
undergoing TKR compared to THR. Fortin et al (1999) also found that this improved pre-
operative status had no effect on reducing LOS, complications or re-hospitalisation.   
2.6.2 Strengths and weaknesses of the review process 
 Procedural process of the review 2.6.2.1
A major strength of this systematic review is that, at all stages, it has been conducted in 
accordance with the recommendation of the Cochrane Collaboration (Higgins & Green, 
2011). Two people independently screened for duplicate identification, selection or 
exclusion of articles and conducted the risk of bias assessment. If any differences could not 
be agreed on, a third independent person was used to adjudicate. A professor of 
occupational therapy was used to determine whether the content of the interventions was 
commensurate with OT practice. The main deviation from the standard Cochrane procedure 
was the inclusion of the three controlled clinical trials, as the Cochrane guidelines now only 
recommend the inclusion of RCTs. CCTs are more prone to bias and the effect of 
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confounding variables and their inclusion can be considered to weaken the review. However, 
this has to be balanced against the wider body of research evidence that can be 
incorporated to strengthen the findings. The strict quality criteria used to enable the CCTs to 
be included in the review minimised as much as possible the bias associated with using CCTs. 
Additionally, in the risk of bias assessment all three included CCTs were automatically 
allocated a high risk of bias for randomisation and allocation concealment and therefore 
considered as low quality of evidence for the evidence synthesis. However, although the 
review has been done following the rigorous Cochrane process, being a novice researcher is 
a potential weakness of this review.   
One of the major difficulties of this review was due to the complex nature and wide 
variations in the nature of the interventions provided. Previous reviews of interventions for 
patients undergoing THR have either focused on a particular intervention such as pre-
operative education (Mc Donald et al, 2014) or pre-operative exercise regimes (Coudeyre et 
al, 2007; Di Monaco et al, 2009; Dauty et al, 2007; Kuster, 2002), or mixed interventions 
delivered at a particular time point (Khan et al, 2008). To overcome the complexity of this 
review, a priori criteria were defined to classify the outcome time points of measurement as 
either pre-surgery, during hospital stay, or long-term. However, some of the studies had 
complex interventions that had components of the interventions delivered in two (pre-
surgery & during hospitalisation, or during hospitalisation and post discharge) or all three 
phases (pre-surgery, during hospitalisation and post discharge) of the patient journey.  
Although multiple outcome measures were used, a strength of this review process was that 
only outcome measures that have been validated were used.    
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The process of establishing a priori decision algorithms strengthened the systematic process 
and therefore the quality of the review. However, despite the strict methodological process 
taken, due to the complexity of the review undertaken, the novice status of the reviewer in 
synthesising such complex interventions must also be considered a weakness of the review.  
   Reporting 2.6.2.2
A major strength of this review is that it has been reported in accordance with the PRISMA 
guidelines (Moher et al, 2009) for reporting systematic reviews. A PRISMA checklist is 
contained in Appendix 5  
2.7 Conclusions 
2.7.1 Summary of key findings 
 There is a high level of evidence that OT interventions help to significantly improve pre-
surgery anxiety 
 There is a moderate level of evidence that OT interventions help to significantly improve 
pre-surgery function 
 There is a moderate to low levels of evidence that OT significantly helps to reduce pre-
surgery levels of pain. 
 There is moderate to very low evidence that OT interventions reduce the overall length 
of acute facility hospital stay and reduces societal participation pre-surgically and at 
point of discharge. 
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 There is low to very low levels of evidence that OT interventions assist with improving 
long-term function.  
 There is no evidence that OT interventions assist with function at time of discharge, pain 
at point of discharge and long term, health related quality of life pre-surgically, at point 
of discharge or long term, long term societal participation or rates of prosthesis 
dislocation. 
 There was a wide clinical heterogeneity in the types of interventions delivered, the 
duration and intensity of those interventions and a wide variation in the rehabilitation 
received by the comparator group receiving usual care. Although the majority of 
participants were receiving THR due to OA, there were some mixed studies and wide 
variation in exclusion criteria with regards to levels of cognitive impairment. 
 The majority of the studies had small sample sizes, and all outcomes except pain function 
and LOS, had less than four studies to base the findings upon.   
2.7.2 Reduced length of stay  
Although this review concludes there is moderate to very low evidence that interventions 
reduce the overall length of acute hospital stay; the age of the studies do not reflect current 
clinical practice. The typical length of stay at the time the studies were conducted was 
approximately 10 days where patients now typically only reside in acute hospital beds for 
three to four days. Therefore, although these findings are statistically significant, they may 
no longer be clinically significant. 
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2.7.3 Implications for practice 
This review shows overall that there is a moderate to low level of evidence that occupational 
therapy practice can improve the patient experience and functional outcomes. Also, as in 
fifty percent of the included studies, the OT intervention was not carried out by a registered 
occupational therapist; there is an implication that the OT intervention may be effectively 
performed by other therapists or nurses. However, no sub group analysis was performed.  
2.7.4  Recommendations for further research 
The process of undertaking this review has revealed there is a paucity of high quality 
research in to the effectiveness of OT practice for patients undergoing a total hip 
replacement. To overcome the heterogeneity of the outcomes measured and the wide 
variety of outcome assessment instruments used, consensus is required as to which 
outcomes should be measured and what are the most appropriate assessment instruments 
to measure OT practice for patients undergoing total hip replacement. To measure the 
specific efficacy of OT more research is required relating directly to OT interventions. More 
high quality RCTs are required. None of the studies included in the review measured the 
cost-effectiveness of the interventions. A further recommendation is that any future 
research should include cost-effectiveness.  
2.8 Chapter summary 
Chapter 2 reported a systematic review analysing the effectiveness of a wide range of OT 
interventions for people undergoing primary THR due to arthritis. The interventions 
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intended to either improve function, societal participation, and heath related quality of life, 
or decrease anxiety, pain, length of hospital stay or prosthesis dislocation. The findings of 
this review cannot be taken as conclusive but there is an indication that OT interventions 
may help reduce pre-surgery pain, increase function and reduce levels of anxiety both at 
admission and discharge. Although the meta-analyses revealed some significant findings, the 
findings relating to OT practice must be considered with caution as only two of the studies 
assessed unique OT practice. However, as rehabilitation is usually multi-professional, it is 
safer to assume that this review reveals that multi-professional rehabilitation with a 
significant OT component may achieve the aforementioned benefits. The need for further 
research to investigate the efficacy of OT intervention for patient undergoing THR has been 
revealed.  
It also became clear as this review proceeded, that home adaptations and provision of 
adaptive devices to enable patients to gain independence in activities of daily living was a 
core intervention for OTs working in this discipline, and therefore any proposed clinical trial 
of the effectiveness of OT practice, would need to contain these elements in the 
intervention.  
2.8.1 Output from this chapter 
A Cochrane protocol for a more focused review, specifically on interventions to prevent 
dislocation and improve function, has emanated from the work for this review and has been 
published (Jepson et al, 2013); the completed full review is currently with the Cochrane 
editorial board.  
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3 PROOF-THR METHODS 
A feasibility randomised controlled trial of pre-operative occupational therapy to optimise 
recovery for patients undergoing primary total hip replacement for osteoarthritis (PROOF-
THR) 
3.1 Chapter overview 
This chapter presents the randomised controlled feasibility trial of a bespoke pre-surgery 
domiciliary based occupational therapy intervention compared to usual care to optimise 
recovery for patients undergoing total hip replacement for osteoarthritis. Justification for 
the intervention, outcome measures, the methodological approach use, and the associated 
research governance will be explained. This study was registered on the NIHR controlled 
clinical trials database with the international trial registration number: ISRCTN38381590. The 
reporting of this trial will be in accordance with the CONSORT guidelines for parallel RCTs 
(Schulz et al, 2010). This study has been published (Jepson et al, 2015). The following three 
chapters (methods, results and conclusions) include sections of text, diagrams and figures 
from this publication.   
3.2 Rationale for study 
Total hip replacement is considered one of the greatest successes of medical care (Bunker et 
al, 1994). However, restoration of mobility and activity can take anything from one to two 
years, even in the total absence of pain (Vissers et al, 2011; Okoro et al, 2012) and 14-36% of 
patients may have no functional improvement 12 months after total hip replacement (Judge 
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et al, 2010). The health benefits of early mobility are evident in many medical conditions 
(Alder and Malone, 2012) and functional decline in activities of daily living (ADL) due to 
relatively short periods of reduced activity in the older person is well documented (Rasch et 
al, 2009; Hoogerduijn et al, 2007). McWilliams (2008) reports that even young healthy 
individuals confined to bed rest lose approximately 5% of muscle mass per week. The 
current typical stay for THR patients of three to five days has mitigated against complications 
and functional decline due to inactivity (Bandholm and Kehlet, 2012). However, with no post 
discharge rehabilitation normally provided in the UK (Artz et al, 2012) the emphasis is placed 
on the patient to return to functional activities as soon as possible after discharge home.   
There is evidence to suggest that home environment modifications and adaptive devices for 
older people can slow the rate of functional decline (Mann et al, 1999), decrease difficulty,  
increase safety of activities of daily living (Peterson et al, 2008) and reduce certain in-home 
care costs (Mann et al, 1999). Additionally, a Cochrane review reported that home safety 
assessment and modification interventions were effective in reducing falls, especially when 
delivered by occupational therapists (Gillespie et al, 2009). Although this demonstrates 
positive impacts of occupational therapy interventions with older people in general, the 
systematic review undertaken for this thesis revealed there is no evidence relating to the 
pre-admission provision of home-based occupational therapy, without subsequent home 
follow-up, and its effect on long term functional recovery and societal reintegration for 
patients undergoing total hip replacements. The pre-operative domiciliary provision of 
assessment, advice, and appropriate adaptive equipment has been previously identified by 
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patients in a qualitative study as desirable (Orpen and Harris, 2010) and may enhance 
activity and mobility recovery.   
The aim of this study was to assess the feasibility of conducting a large scale randomised 
controlled trial to investigate the clinical effectiveness and cost effectiveness of a pre-
surgery home based occupational therapy intervention versus usual care in accordance with 
guidelines produced by the Medical Research Council (Craig et al, 2008) for conducting 
feasibility studies. 
3.3 Study design and setting 
This feasibility study used a parallel RCT design with randomisation at the level of the 
individual and located in two acute hospital trusts in the West Midlands which provided 
elective Orthopaedic services (The Dudley Group of Hospitals NHS Foundation Trust and The 
Royal Orthopaedic Hospital NHS Trust).  The study was located on two sites to enhance the 
recruitment rate but also to make the results more generalizable (Flynn, 2009). 
The proposed main study would take the form of a RCT as this method of investigation 
reduces confounding variables and thus provides the highest level of evidence available from 
a clinical trial (Abel and Koch, 1999; CEBM, 2009). The feasibility study therefore took the 
same design as the proposed study so the process could be replicated and the willingness of 
participants to be recruited and randomised could be assessed.  
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3.4 Patient identification & recruitment 
All orthopaedic consultants at the recruiting sites gave permission for their patients to be 
approached for inclusion in the trial. The details of patients who had been listed for THR 
surgery were screened by research nurses to match the inclusion criteria. Eligible 
participants were then posted a study invitation pack which contained the patient 
information leaflet (Appendix 6), a copy of the consent form, with the signature sections 
removed (Appendix 7), and an ‘invitation to join the study’ letter which contained 
information on how to contact the research nurses if they wanted to discuss joining the 
study or required more information (Appendix 8). Patients who had not made any contact 
with the research nurses were telephoned at approximately 10-14 days following the posted 
date of their study pack to remind them about the study. During the telephone call, it was 
expressly forbidden for the research nurses to try in any way to persuade the patient to join 
the study. If the patient expressed an interest in joining the study, the research nurse 
arranged to meet the participant at their pre-assessment clinic; normally scheduled six 
weeks prior to the planned admission date.   
This identification and recruitment procedure above was a change to the original proposed 
procedure; hence a substantial ethical amendment was required. The original design was for 
the study invitation pack to be sent to patients prior to attendance at the review clinic along 
with their clinic appointment letter. Patients who had been accepted for THR surgery would 
then be approached by research nurses who would discuss recruitment in the study. The 
ethical approval for the study required the participants to have the minimum of 72 hours to 
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consider consenting to participate, meaning the research nurses could not consent the 
participants at this point. Therefore, a member of the research team would visit the 
potential participant in their home to complete the consent process. However, during a 
team meeting of the orthopaedic consultants, where the study was explained to them, 
several of the consultants voiced concern. It was felt that if the patients received the 
invitation study pack with their appointment letter; this may lead the patients to 
automatically assume the consultant would offer them a THR and consequently make the 
review clinic very difficult if for any reason the consultant felt a THR was not appropriate.  
3.5 Inclusion/exclusion  
The inclusion and exclusion criteria used and the reason for selection are explained in Table 
33 below. 
Table 33 Inclusion and exclusion criteria 
Inclusion Criteria Rationale 
Patients accepted for 
primary THR surgery 
Primary surgery represents approximately 89% of all THR 
surgery (NJR, 2012). Patients having a primary THR also have 
high expectations of the quality of life they can expect 
afterwards. Patients undergoing revision surgery are generally 
more elderly and the complexity of the surgery does not lead 
to high functional expectations. As the Royal Orthopaedic 
Hospital is a regional specialist centre, there is a far higher 
percentage of revision surgery performed than the national 
average of 11%. Inclusion of revision surgery patients would 
therefore reduce the external validity of the findings. 
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No previous lower limb 
joint replacement 
surgery 
Patients who have had previous joint replacement surgery 
would be familiar with the hospital procedure and the surgical 
experience which could impact anxiety levels. Patients would 
also have preconceptions regarding the rehabilitation service 
delivery.     
No planned additional 
lower limb joint 
replacement surgery 
within 12 months 
Patients who already had further planned joint replacement 
surgery are likely to have severe functional limitations which 
may not be expected to be addressed / overcome until the 
subsequent surgery is completed.  
Osteoarthritis as the 
primary indication for 
surgery 
93% of all THR procedures are performed as a consequence of 
osteoarthritis; the other reasons include rheumatoid arthritis 
or congenital dysplasia (NJR, 2012). Both of these client groups 
have different functional requirements to the average THR 
patient. Patients with RA are usually far more functionally 
disabled with many lower limb and upper limb joints affected 
and they require much more intensive OT input. It is usual 
practice that patients having THR for hip dysplasia are aged 30-
40 (NJR, 2012); the patients will therefore have a very different 
function expectation and demands.  As a specialist orthopaedic 
centre, the ROH has a higher caseload of this specialist surgery 
compared to the national average which is only about 2% for 
either condition, inclusion of patients would therefore reduce 
the external validity of the findings. 
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Unilateral surgery Bilateral surgery is not commonly done in the NHS and the 
short term functional disablement requires extensive OT input.   
Sufficient 
understanding of 
English to complete 
questionnaires (or 
proxy completion by 
representative who 
understands English) 
Many of the outcome measures used have not been validated 
in languages other than English. 
Exclusion Criteria  
Patients with 
inflammatory arthritis 
As osteoarthritis accounts for 93% of all THR’s (NJR, 2012) the 
medical notes often lack the specific diagnosis of OA. Patients 
with no specific pathology were therefore initially included. 
When the research nurses approached the patients for 
consent, they checked this diagnosis with the patient and 
excluded if required. 
Primary indication for 
surgery is for pain 
relief with no 
functional 
improvement 
anticipated 
Very occasionally highly disabled people are given a THR purely 
for pain relief and with no expectation that this will enhance 
their functional capacity.   
Patients unable to 
provide informed 
consent 
Provision was provided for patients who could not read English 
or for those lacking mental capacity to be consent by proxy by 
a relative or carer.    
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3.6 Withdrawal criteria 
Any patient wishing to withdraw from the study had the right to do so at any point and was 
not required in any way to justify/explain the reason. If patients withdrew consent prior to 
supply of the OT adaptive devices, they could revert to usual NHS care provided by the 
individual trusts. If home equipment had already being supplied, the patient would not be 
required to return equipment and the normal discharge procedures were followed. Data up 
to the point of withdrawal would be included unless otherwise indicated by the participant. 
3.7 Consent 
In both recruiting centres, potential participants (and carers/relatives) were met at the pre-
assessment clinic by a research nurse and were given a full explanation of the trial. The 
University of Birmingham Department of Primary Care Clinical Sciences Standard Operating 
Procedure (SOP) 12-02 ‘Obtaining Informed Consent (Adults)’ was followed. During the 
consent process all participants and their family and/or other carers were given the 
opportunity to discuss the study. Following consent, the participants were given a copy of 
the UKCRN publication, ‘Understanding Clinical Trials’. As the consent forms were only 
available in English, consent by proxy was accepted from a relative that understood English. 
Arrangements were made for patients who missed the appointment with the research nurse 
or where asked to join the study at the pre-assessment clinic to be consented at home.  
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3.8 Baseline assessment & demographics 
Baseline assessments were taken by the research nurses at the pre-assessment clinic (or at 
patient’s homes) prior to randomisation as recommended in guidelines for good practice in 
clinical trials (Altman et al 2001). A patient demographics form was also completed 
(Appendix 9) 
3.9 Randomisation & allocation concealment 
Participants were randomised between the two groups (50:50) via the University of 
Birmingham Primary Care Clinical Trials Unit randomisation service using a random 
assignment computer algorithm using an 8 block size with stratification for recruitment site 
and age. All trial staff adhered to the University Of Birmingham Department Of Primary Care 
Clinical Sciences SOP 14-01: ‘randomisation and blinding’. 
3.10 Blinding in rehabilitation trials 
All investigators on the trial were blinded to the randomisation and to any information 
indicating group assignment. Group allocation was only revealed to the treating therapists. 
Although lack of blinding is considered one of the most important sources of bias in clinical 
trials (Day & Altman, 2000), it is not possible in rehabilitation trials to blind the study 
personnel who are delivering the intervention or the participants themselves. It is therefore 
important to maintain the assessor and other investigators blind to group allocation in order 
to remove potential bias (Boutron, 2006). Established procedures to conduct rehabilitation 
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trials to avoid bias were followed (Siemonsma and Walker, 1997; Minns-Lowe et al, 2011) 
which included maintaining assessor blinding until the trial was completed, siting research 
staff in separate offices, maintaining study documents in locked cabinets, using an 
established clinical trials unit to securely randomise participants, using codes as patient 
labels on all documents and storing all data in a password protected database.     
3.11 Intervention and control 
3.11.1 Intervention 
Patients randomised to the intervention arm of the study were contacted by the study OT 
and an appointment was made to visit the participant at home. During the home visit the OT 
assessed the individual needs of each participant and their individual home circumstances. 
The required adaptive devices were provided, fitted and their use demonstrated (e.g. toilet 
seat raises, grab rails, furniture height adjustments, shower chairs). The OT also discussed 
the patient’s expectations; any anxieties the patient (or carer) may have; gave explanations 
about the surgery, hospital stay and post-operative rehabilitation as an in-patient. In 
addition, the OT also discussed in depth with the participant how they planned to manage 
when they returned home and liaised with other professionals as they felt appropriate (e.g. 
social services). 
THR patients have several risk factors associated with falls (NICE 2004) which as well as 
predisposing the patient to the usual ill-health consequences associated with falling, it is also 
one of the main reason for prosthesis dislocation. Therefore the OT also performed a 
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structured home safety assessment based on the Westmead Home Safety Assessment form 
(Clemson, 1997) and explained how the home layout could be temporarily or permanently 
adapted to lessen the chance of falling and to prevent accidental dislocation of the hip by 
the patient having to adopt positions of dislocation risk to carry out normal activities of daily 
living.  
All aspects of the complex intervention provided were standard OT practice in the UK and 
included all components of the pre and post-operative services provided by the occupational 
therapists at the recruiting sites. The individualised domically provision of education and 
adaptive devices, time available for discussion, and the home safety assessment are 
additional components received compared to participants randomised to usual care. 
3.11.2 Control 
Patients randomised to this arm of the study received the usual NHS care provided to 
patients undergoing elective THR in the recruiting NHS trust where they received surgery. In 
both trusts patients attended a pre-admission clinic at the hospital where they received a 
20-30 minute group education session deliver by an OT, physiotherapist or therapy assistant 
regarding their hospital admission, stay and discharge. Patients at the Royal Orthopaedic 
Hospital were asked to complete a ‘home assessment’ form prior to attending the clinic in 
which they were asked to provide details such as height of bed, chairs, toilets, access and 
home layout. Based on this form, an OT or OT assistant would order routine assistive devices 
and then these were delivered to the patient’s home by a delivery driver before, or on, the 
final discharge date. No education in their use at home was provided by the delivery driver. 
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At the Dudley Group of Hospitals, a similar ‘home assessment’ form was completed by the 
patients but the assistive devices were given to the patient (carer or ambulance driver) at 
time of discharge for the patient to take home with them. 
3.12 Outcome measures 
3.12.1 Primary Outcomes 
The primary outcome of this study was to assess the feasibility of a full scale RCT.  Feasibility 
studies for complex interventions have been advocated since the publication of the Medical 
Research Council guidelines for the development and evaluation of complex interventions 
(MRC, 2000). In this document, the MRC provide a four step model for complex 
interventions (1. Theoretical / pre-clinical 2. Modelling 3. Exploratory trial 4. Definitive RCT)    
based on the model for clinical drug trials. The feasibility study is the phase three, or 
exploratory phase, in this model. This guidance was updated in 2008 (MRC, 2008) which 
provided more guidance on what the outcomes a feasibility study should measure. The 
primary outcomes listed below for this feasibility are those advocated in this guidance 
document: 
Recruitment procedures and success: Information was collected from screening logs on the 
number of patients eligible for the study, methods of identification, and recruitment and 
retention rates of subjects to the trial.  
Suitability of outcome measures: Refining the choice of outcome measures to be taken 
forward to the main trial.  
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Fidelity of the intervention:  This included practicalities of OT compliance to the 
intervention delivery as designed in the protocol, the quality of the delivery and patient 
adherence with the intervention. An intervention study log was completed by the OTs; a 
method that has been used successfully in previous studies (Sackley et al, 2009; Sackley et al, 
2012). This log contained the detailed the assessment, treatment, assistive devices provided 
and advice given to the participants, plus any deviations in protocol. These logs were 
retained by the NHS Trusts as they were classed as treatment notes containing confidential 
information.  Only deviations from the protocol were reported.     
Effect size & Sample size: To provide data on the effect size, and its variance, to allow a 
more accurate estimate of the sample size required for the main study. 
3.12.2 Secondary outcome measures 
The second outcome of this feasibility study was to measure the clinical effect size and 
directionality of the outcome measure questionnaires. The principle outcome addressed was 
function. The other outcome measures, in addition to function, that were investigated in this 
study were pain and societal participation. These outcomes were assessed by use of a range 
of validated patient administered questionnaires that were posted to the study participants 
at 4, 12 and 26 weeks following surgery.  If any hip dislocations occurred, these data were 
reported as an adverse event. 
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3.13 Patient reported outcome measures (PROMs) 
In clinical trials, choice of the outcome measure to be used is a fundamental aspect of the 
study design. This section will discuss the rationale for the section of the outcomes measures 
used in this study.     
3.13.1 The importance of PROMs 
The preferential use of patient reported outcome measures (PROMs) in all aspects of clinical 
research, audit and practice was one of the key recommendations of the interim Darzi 
(2007) report in to the future of the NHS. Nelson et al, (2015) reiterates the importance of 
using PROMs in research studies as they provide the researcher with information of the 
effectiveness of interventions from the patient perspective rather than efficacy of 
interventions from a health provider’s perspective. PROMs also enable clinicians to measure 
the impact of interventions and provide health care commissioners with validated evidence 
of health from the point of view of the user or patients (Kyte et al, 2015). Additionally, they 
can also enable service development by providing evidence of the outcomes for the 
purposes of audit, quality assurance and comparative performance evaluation (Gibbons and 
Fitzpatrick, 2010). Since the final Darzi (2008) report , many aspects of health care practice in 
the NHS have been required to provide PROM data annually to the Department of Health; 
for patients undergoing primary unilateral THR, the reporting of PROM data is a condition of 
payment under the NHS contract (Gibbons and Fitzpatrick, 2010). 
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3.13.2 Selection of PROMs 
PROMs can be classified into two categories: those which are population or condition 
specific and those measuring generic health statuses. Condition-specific instruments relate 
to a particular disease or health condition (e.g. osteoarthritis), a specific patient population 
(e.g. elderly), or a specific health outcome (e.g. pain, function, ADL). In contrast, generic 
instruments are designed to be relevant to as wide a range of population as possible (e.g. SF-
36, SIP). Gibbons and Fitzpatrick (2010) suggest that generic category can be split in to those 
that measure health status only (e.g. SF-36) and those that measure health status but can 
also provide utilities or values to enable cost-utility analyses of interventions (e.g. EQ-5D). A 
combination of a generic, utility and specific measures are recommended to be used in order 
to assess all aspects of health relevant to the particular population concerned (Gibbons and 
Fitzpatrick, 2010). Despite the importance of using PROMs, there is often no consensus as to 
which instruments should be used (Garratt et al., 2002). Calvert et al (2014) also suggest that 
the guidance that does exist is often conflicting and hard to find; in a recent systematic 
review, only 8 out of 54 guidance documents used in the review were available 
electronically. The health care worker or clinical researcher therefore often has to decide on 
which are the most appropriate PROMs to use. However, a Health Technology Assessment 
(HTA) report (Fitzpatrick et al, 1998) provides guidance on all the aspects that should be 
considered when choosing a PROM in clinical trials and identified 5 intrinsic and 3 extrinsic 
criteria (Table 34). The intrinsic factors of PROMs are determined by comparative trials and 
statistical methodology and it is important that only those that have had these criteria 
evaluated and found to be acceptable are used. The extrinsic criteria are directly related to 
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the populations in which they are employed and the design of the study in which they are 
used need to be assessed in pilot or feasibility studies; hence why this is one of the 
outcomes of this study.  
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Table 34 criteria that investigators should apply to evaluate candidate patient-based 
outcome measures for any specific clinical trial (Fitzpatrick et al (1998) 
Criteria Explanation/definition 
Intrinsic criteria 
Reliability This requires that an instrument is reproducible and internally 
consistent. 
Validity This is involved in judging whether an instrument measures 
what it purports to measure. This has to consider both 
construct validity (the ability of the scale to differentiate 
known groups) and content validity (the extent to which the 
content of a scale is representative of the conceptual domain 
it is intended to cover). 
Responsiveness This addresses whether an instrument is sensitive to changes 
of importance to patients including ‘floor’ and ‘ceiling’ effects.  
Precision This is concerned with the number and accuracy of 
distinctions made by an instrument. 
Interpretability This is how meaningful are the scores from an instrument. 
Extrinsic criteria 
Appropriateness This requires that investigators consider the match of an 
instrument to the specific purpose and questions of a trial. 
Acceptability This is how acceptable is an instrument for respondents to 
complete. 
Feasibility This is concerned with the extent of effort, burden and 
disruption to participants, staff and clinical care arising from 
use of an instrument. 
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3.13.3 Selection of PROMs for the PROOF-THR feasibility study 
Several factors were taken in to account during the selection of the PROMs for the PROOF-
THR feasibility study. As a pre-requisite, any of the PROMs considered for use in the study 
had to have been previously adjudged to be ‘valid & reliable’. The other considerations are 
detailed below. 
 Responsiveness to level of function 3.13.3.1
Following surgery, patients were followed up for six months. Over this time scale, the 
functional ability status of the participants was expected to be wide ranging from a relatively 
low level of function in the first few weeks following surgery, to full societal reintegration at 
six months. Due to this, several functional PROMs were needed to capture this range of 
improvement due to anticipated floor and ceiling effects (Fitzpatrick et al, 1998). 
 Standardisation to overall NIHR programme 3.13.3.2
This feasibility study was part of the patient experience section of a large NIHR programme 
grant incorporating a wide range of clinical studies throughout the pathway of patients 
undergoing THR due to osteoarthritis. In order to standardise the reporting for the final NIHR 
report, all participants included in the clinical trials had baseline WOMAC (Bellamy et al 
1988) scores assessed as this is a validated disease specific (OA) and joint specific (hip or 
knee) PROM. Additionally, NHS guidance (Department of Health, 2008) specified that from 
2009 the Oxford Hip Score (OHS) should be the joint specific PROM and the EQ-5D (EuroQol 
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group, 1990) the generic health status PROM routinely collected for all people undergoing 
THR, these PROM were standardised across all studies.   
 Acceptability, appropriateness and patient burden   3.13.3.3
Prior to ethics application, all the PROMs proposed to be used in the feasibility study were 
first discussed at a trial steering group meeting to ensure they conformed to the 
standardisation requirements as well as assessing them for their likely acceptability, 
appropriateness and burden. Having being agreed, they were then trialled for approval by 
patients at Southmead Hospital who formed the ‘patient partnership in research' (PEP-R) 
group. This public involvement group were asked to comment on the acceptability, 
appropriateness and ease of use of each measure and the overall burden of completion 
when they were grouped together into one questionnaire pack. All members of this group 
had previously received joint replacement surgery. They found the entire questionnaire pack 
took approximately 6-8 minutes to complete which they felt was not an onerous burden. 
They agreed all the proposed PROMs were appropriate and generally acceptable. With 
respect to the Nottingham extended activities of daily living questionnaire (NEADL) they 
reported that two of the questions ‘were demeaning’ and would like these removed. This 
was agreed and a method of imputing the two removed sets of data was developed. As the 
PEP-R group were generally younger than the anticipated age of trial participants, the 
questionnaire burden was also trialled on older volunteers who also agreed that completion 
was not burdensome.  
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3.14 Patient reported outcome measures used  
The justification for the choice of each PROM is provided.   
3.14.1 Oxford hip Score (OHS) 
The OHS (Dawson et al, 1996) is a validated questionnaire (Atchen et al, 2010) designed to 
measure pain and functional outcome from the patient’s perspective following THR. It is a 
self-administered 12 item questionnaire which has two domains of pain and function only.  
On an updated scoring system (Murray et al, 2007), each question scores between 0-4, 
generating an overall score ranging from 0 (worst health status) to 48 (best health status). It 
has been extensively used in orthopaedic literature, has been shown to have good specificity 
and sensitive to change (Murray et al, 2007); and despite there being no psychometric 
properties associated to this questionnaire, it has been shown to correlate well with other 
instruments that measure patient satisfaction (Wylde et al, 2005). The OHS is now widely 
used in the UK and overseas and is currently the PROM designated by the NHS to be used in 
studies relating to THR in England.  
3.14.2 Western Ontario and McMaster universities arthritis index 
(WOMAC) 
The WOMAC was developed by Bellamy et al (1988) as a disease specific measure containing 
a set of standardized questions for hip or knee arthritis, and has since been used extensively 
in osteoarthritis or joint replacement research. It contains 24 questions that assess pain (5 
questions), joint stiffness (2 questions), and physical and social function (17 questions) of a 
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person with osteoarthritis in determining the overall level of disability. Each question is 
scored between 0 (best health status) to 4 (worst health status) giving an overall score range 
of 0 (best health status) to 96 (worst health status).The overall results presentation will be 
transformed by multiplying the final score by 100/96 to transform the scale to go from 0-100 
which is a commonly accepted method to aid interpretation (Roos et al, 1999; Judge et al, 
2010). As well as an overall WOMAC score, each of the 3 subscales is reported 
independently.  
3.14.3  The Aberdeen impairment, activity limitation and 
participation restriction (AIP) measure 
The AIP measure (Pollard et al, 2009) was chosen as it is designed to measure higher levels 
of function than the OHS or WOMAC. It is a self-administered questionnaire developed to 
measure health components as identified by the international classification of function, 
disability and health (WHO, 2001) and specifically relates to osteoarthritis. The measure 
assesses impairment (9 items), activity limitation (17 items) and participation restriction (9 
items). A high score relates to a worse health outcome and a low score, a better health 
outcome. The 3 sections of this outcome measure are analysed separately as a combined 
total score of the 3 sections has not yet been validated. 
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3.14.4 Nottingham extended activities of daily living 
questionnaire (NEADL) 
The NEADL (Nouri & Lincoln, 1987) is a patient reported self-administered questionnaire 
comprising 22 items grouped into 4 categories: mobility, including public transport, (6 
items), kitchen tasks (5 items), domestic tasks (4 items) and leisure activities (6 items). Each 
item has 4 possible responses: 0 (unable to do), 1 (able with help), 2 (able on own with 
difficulty) and 3 (easily managed alone). For scoring purposes the scale can be dichotomised 
into ‘not-independent’ (0, 1) or ‘independent’ (2, 3) giving an overall score of 1 (poor activity 
level) to 22 (good activity level) or can be used as a 0-3 scale giving an overall score of 0 
(worst) to 66 (Best). Although this PROM was originally designed and validated for stroke 
patients, Harwood and Ebrahim (2002) assessed the NEADL for use in patients undergoing 
THR. They found it valid and reliable in people with osteoarthritis of the hip, though it 
underestimated the gain after THR compared to other scales. This PROM was chosen as it 
measures extended levels of activity which are between the low level of function measured 
by the OHS or WOMAC and the societal reintegration of the AIP measure.  
3.14.5  Hospital anxiety and depression scale (HADS) 
The HADS (Zigmond and Snaith 1983) is a 14-item questionnaire which scores anxiety and 
depression on separate seven item subscales scored from 0-21. A higher score represents 
greater levels of anxiety and depression on each responsive subscale. The overall score is 
classified in to three categories; Normal (0-7), borderline abnormal (8-10) and abnormal (11-
21). Although the name of the scale suggests its application is in the hospital environment, 
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many studies have shown it is a useful tool in community settings and primary care (Snaith, 
2003). Two reviews (Bjelland et al, 2002; Herrmann, 1997) have found the HAD scale to be a 
valid and reliable instrument for assessing symptom severity of anxiety and depressive 
disorders in medical and primary care patients. Although the review by Herrmann (1997) is a 
non-systematic literature synthesis, his review contained over 200 international studies 
containing approximately 35,000 participants. As well as finding it both valid and reliable in a 
variety of populations, he also found it to be highly acceptable with 95-100% response rates. 
Bjelland et al (2002) conducted a higher quality systematic review of 71 studies of validity, 
reliability or sensitivity. They also found HADS to be valid and reliable in general practice and 
the general population as well as in psychiatric patients.  
3.14.6 Euro-Qol EQ-5D-3L 
The Euro-Qol EQ-5D-3L (EQ-5D) is a standardized measure of health status developed by the 
EuroQol Group in order to provide a simple, generic measure of health for clinical and 
economic appraisal (EuroQol group, 1990) which is applicable to a wide range of health 
conditions and treatments. It is also the PROM for general health status designated by the 
Department of Health to be collected for patients undergoing THR. It provides a simple 
descriptive profile and a single index value for health status that can be used in the clinical 
and economic evaluation of health care as well as in population health surveys. The EQ-5D-
3L descriptive system comprises the following 5 dimensions: mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no 
problems, some problems, severe problems. It is self-administered and the respondent 
indicates their health state in each of the 5 dimensions. This decision results in a 1-digit 
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number expressing the level selected for that dimension. The digits for 5 dimensions can be 
combined in a 5-digit number describing the respondent’s health state. A utility analysis can 
then be undertaken using the current UK tariff. 
3.14.7 The ICECAP-O 
The ICECAP-O (Coast et al, 2008) is a measure of capability in older people for use in 
economic evaluation. Unlike most profile measures used in economic evaluations, the 
ICECAP-O focuses on wellbeing defined in a broader sense, rather than health. The measure 
covers attributes of wellbeing that were found to be important to older people in the UK. It 
comprises five attributes: attachment, security, role, enjoyment and control and was 
developed using qualitative methods in a best-worst scaling study of older people in 
England.  Each question has four possible answers which correlate with wellbeing in the five 
attributes. This decision results in a 1-digit number expressing the level selected for that 
dimension. The digits for 5 dimensions are combined in a 5-digit number describing the 
respondent’s state of wellbeing; a code of 44444 represents full capability and has a tariff of 
1, a code of 11111 represents worst capability and has a tariff of 0; all other states have a 
value between 0-1 which can then be used to signify 1 of 20 other intermediate states which 
can then be used to perform an economic analysis based on the respondents state of 
wellbeing (Flynn et al, 2008). NICE (2015) accept capability measures as an alternative to the 
EQ-5D when used for social outcomes or those that measure ADL’s. The inclusion of both the 
EQ-5D and the ICECAP-O was to allow for a comparison of the two measures.  
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3.14.8 Client services receipt inventory   
The Client Service Receipt Inventory (CSRI) allows systematic recording of service use in a 
manner commensurate with estimating the costs of support packages (Beecham, 2000). A 
version of the CSRI (Beecham and Knapp, 2001) adapted for this study was used to record 
the frequency and duration with which participants used education, health and social care 
services and supports, including their accommodation and personal care/staff arrangements 
and relevant informal care inputs. It is an established tool for collecting retrospective service 
use information and has been used for a variety of populations (Busse et al, 2011) and in 
over 150 health and social care economic evaluations (Patel et al, 2005) 
3.14.9 Other data collected at baseline 
Other information collected at baseline included participant address, age, GP contact details, 
and whether the patient lived alone or not.  
3.14.10 Adverse events 
A system was devised to report any adverse events. During the pre-operative intervention 
phase of the feasibility study, and adverse event would be reported by the trial OT. Each trial 
OT was issued with a mobile phone and participants were encouraged to contact the OT 
should any equipment malfunction occur. Dislocation of the new prosthesis was the adverse 
event measured after the patient had received surgery. Should any patient in either arm of 
the trial be re-admitted due to dislocation, the lead research nurse at each recruitment site 
would report this to the main researcher.  
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3.15 Assessment time points 
Baseline assessments were conducted prior to randomisation as recommended in guidelines 
for good practice in clinical trials (Altman et al, 2001). This enables identification of whether 
those recruited have characteristics similar to the general population with hip osteoarthritis 
undergoing THR. It also enables imbalances at baseline to be identified which would raise 
concerns about recruitment bias. The patients were followed up for six months following 
their date of surgery. Questionnaire packs were posted to participants with an enclosed pre-
paid envelope for return when completed at 4, 12, and 26 weeks post-surgery; a schedule is 
shown below (see Table 35). 
Telephone calls were made to all non-respondents, at each time point, for a period of two 
weeks following the due date of the follow-up questionnaire. At the final assessment time 
point, a deviation from this protocol occurred and the non–responders were telephoned for 
up to 8 weeks after the 26 week time point. As this method was deviation from protocol, 
only OHS data only were collected to enable more data for the power calculation for the 
main trial which would be primarily based on this outcome. Three participants provided this 
limited additional data.  
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Table 35 Assessment schedule 
 
3.16 Blinding  
Group allocation was concealed from the independent assessors. However, as it was not 
possible to mask the treating occupational therapists or participants. Guidelines developed 
in previous rehabilitation trials (Siemonsma and Walker, 1997; Minns-Lowe et al, 2011) were 
used to minimise any associated bias. The measures undertaken involved the researcher 
being located in a different room to the trial OTs, using a clinical trials unit to set a secure 
database with different levels of password protected access, trial records being kept in 
locked cabinets, and all office staff knowing procedures to engage in telephone conversation 
with participants until the main researcher left the office.  During surgery and recovery in 
hospital the trial participants had an identifier on their medical notes for discharge planning 
purposes so the hospital occupational therapists and discharge planners knew the patients 
Data to be collected 
Baseline 
Assessment 
Prior to 
Randomisation 
and before 
Surgery 
Follow up assessments – from date of surgery 
4 weeks 12 weeks  26 weeks 
Nottingham EADL     
Oxford hip score     
WOMAC     
Aberdeen IAP     
HADS     
ICE-CAP     
EuroQol EQ-5D-3L     
Client Services Receipt Inventory     
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already had all the required adaptive devices fitted at home. Additional guidelines to 
improve independent assessment previously developed by the University of Birmingham 
primary care department through their experience of conducting rehabilitation trials were 
also followed. This included practical measures such as treating therapists and assessors 
being located in separate places. 
3.17 Data analysis of outcome measure  
Prior to the analysis, the guidance documents for each outcome measure were used to 
identify procedures the authors recommend for integrating any missing data in to the final 
analysis. The WOMAC guidelines (Bellamy, 2002) suggest that any participant with greater 
than 3 missing questions should be removed from the analysis. For 3 or less missing 
questions, the average value should be imputed. The OHS has similar guidance (Murray et al, 
2007), though with the exclusion limit set at greater than 2 missing questions. The HADS 
guidance (GL assessment, 2014) recommends that if one item is missing from the depression 
or the anxiety scale, then the item score can be inferred by using the mean of the remaining 
6 items. If more than one item is missing from either scale, then the scale should not be 
scored. No published guidelines are available for the NEADL or the Aberdeen IAP measure. 
The same guidance protocol suggested for the WOMAC was therefore adopted for the 
Aberdeen IAP measure and the NEADLE on the logic that these contain similar amounts of 
questions.   
Although the NEADL has been validated for use with patients who have received THR surgery 
(Harwood & Ebrahim, 2002), it was originally developed for stroke victims and thus contains 
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several items that relate to upper limb function. The version of the NEADL used in the 
questionnaire pack in this study had two items removed; items ‘do you manage to feed 
yourself’ and ‘do you do the washing up’ at the request of the patient and public advisory 
group as they found these questions demeaning. An approach was developed to normalise 
the data by inputting into the missing items the values reported from items ‘do you manage 
to make hot snacks’ and ‘do you manage to wash small items of clothes’ as these were 
considered to be equitable functional tasks and would therefore likely to be scored the 
same. This approach was used in this analysis. The final results can either be analysed 
dichotomously in to ‘unable’ (scores 0 or 1) or ‘able’ (scores 2 or 3), or analysed as a 4 point 
continuous scale of 0-3 giving an overall score range of 0-66.  
The WOMAC has been validated for results of the overall score and for the individual 
subsections (Murray et al, 2007). The data for the subsections pain (0-20), stiffness (0-8) and 
function (0-68) are presented as the aggregate value of the score for those sections. 
However, as the total score available is 0-96, it is usual practice to transform the results in to 
0-100 scale by multiplying the final score by 96/100. This convention has been adhered to in 
the presentation of WOMAC results in this study. The three domains Aberdeen IAP measure 
(Impairment, activity restriction, participation) and the two domains of the HADS (anxiety, 
depression) measure independent constructs so it is not valid to aggregate the domain 
scores in these measures.  
The HADS has been presented with the mean score for each domain. Additionally, the 
number of participants with normal (0-7), mild (8-10), moderate (11-15) or severe (16-21) 
symptoms is presented.   
 ~ 201 ~ 
 
In both the ICECAP-O and EQ-5D-3L, the items 1-3 ticked in each domain have no 
arithmetical value so no method of imputing missing data is available as the full 5 digit code 
is required to be used to translate the responses in to a health state. Therefore in the 
analysis of these data, any responses containing missing data have been removed. The UK 
data set has been used to translate the responses in to the health states for the ED-5D-3L 
and the UK index values available from the University of Birmingham have been used for the 
ICECAP-O.   
Only outcome measures data designated in the protocol were collected and all outcome 
measures collected are reported in the results. All participants remained in their allocated 
group throughout the trial period.  
3.18 Risk assessment 
A risk assessment was conducted prior to the start of the trial and it was considered that the 
trial was low risk. All perceived risks identified were discussed with the 'Patient Experience 
Partnership in Research' (PEP-R) group, a patient representative, and a member of Arthritis 
Research UK who formed part of the trial steering group. All the outcome measures used are 
designed to measure quality of life and are all widely used validated instruments, with the 
exception of the ICECAP-O which is a recently developed instrument used in economic 
evaluations. A small risk was identified that some questions in the quality of life 
questionnaire may cause emotional distress if the participants felt they were not recovering 
as well as anticipated following surgery. In response to this, each participant was given a 
contact number of someone not directly involved in the trial to discuss any issues they had. 
 ~ 202 ~ 
 
If the contact person felt they were not able to deal with the issue the participant was asked 
to contact their GP. 
The main risk identified was considered to be the OT being a lone worker in the community 
and delivering the intervention required them being in the patient’s home for longer than 
would be normal practice. To manage this trial staff adhered to the University Of 
Birmingham Department Of Primary Care Clinical Sciences SOP 21-01: Community Visits and 
Lone Worker Policy. In addition, lone working policy specific to the nature of this trial was 
developed by the candidate (Appendix 10) which included processes to record scheduled 
visits, confirm arrival and departure times with a named contact person during home visits 
and use of an anonymous phrase to be used in a telephone call that indicated the therapist 
is in difficulty and requires the police to be called.   
3.19 Statistical procedure 
A bespoke password protected database was developed by University Of Birmingham 
Department Of Primary Care Clinical Sciences Clinical Trials Unit. All data collected was 
entered in to this database. Data cleaning was used before analysis of the data.  
The primary analysis was the response to all the outcome measures at 4, 12 and 26 weeks 
following surgery in the intervention and control arms of the study. The primary analysis was 
by intention to treat, whereby patients were analysed according to the intervention to which 
they were randomised regardless of whether they complied with this treatment. Distribution 
of the data was analysed for normal distribution, skewness and kurtosis to determine 
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whether the descriptive data should be presented as mean ± SD, or the median and IQR to 
be presented.  The analysis showed the data was not normally distributed indicating the 
median and IQR to be reported as the point vale and variance. However, as a grant proposal 
to the HTA was submitted for funding to expand this feasibility study in to a full RCT, both 
analysis methods were presented so that comparisons could be made at a later date should 
the funding bid be successful. However, In accordance with MRC guidelines (Craig et al, 
2008) on feasibility studies, no p-values are reported as this guidance document expressly 
states that comparative statistical analyses should not be performed. However, a power 
calculation was to be performed to estimate the number of participants that would be 
required to power a full RCT. 
3.20 Data storage 
In accordance with MRC guidelines provision was made at the study sites for all data to be 
stored for at least 20 years after the last patient completed follow-up to allow adequate 
time for review, reappraisal or further research, and allow any queries or concerns about the 
data, conduct or conclusions of the study to be resolved. All electronic data files were 
password protected and paper documentation was securely stored. 
3.21 Research governance and ethics 
The trial was conducted in accordance with the Medical Research Council Guidelines for 
Good Clinical Practice (1998). It also conformed to the Mental Capacity Act (2005). All 
relevant Standard Operating Procedures produced by Birmingham’s PC-CRTU were also 
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adhered to. The trial sponsor was the University of Birmingham. Costs associated with this 
feasibility study were funded by the National Institute for Health Research (NIHR) project 
“Improving patients’ experience and outcome of total joint replacement” grant number RP-
PG-0407-10070. The trial was adopted on to the ISRCTN database (ISRCTN38381590). It was 
also adopted by both the Primary Care and Musculoskeletal Clinical Local Research Networks 
which paid for all costs associated with patient recruitment. The candidate had some backfill 
time paid for by the West Midlands Strategic Health Authority via a nursing, midwifery, and 
allied health professionals research training award.  
3.22 Public and patient involvement 
The NIHR actively promotes public involvement in research through INVOLVE, the UK’s 
national body for patient engagement in research. INVOLVE (2015) define involvement when 
the public are actively involved in research projects or organisations and get involved in 
activities such as identifying research priorities, commenting on and developing patient 
information leaflets or other research materials, or as members of a steering group. 
However, Gooberman-Hill et al (2013) suggest even though the ethical reason for patient 
involvement is clear, and patient involvement in research is here to stay, there is a need to 
evaluate the impact of patient involvement as the gains may be diffuse and hard to quantify. 
The public and patient involvement in this trial was provided by a group of patients willing to 
take an active part in all aspects of research at The Avon Orthopaedic Musculoskeletal 
Research Unit in collaboration with North Bristol NHS Trust known as the 'Patient Experience 
Partnership in Research' (PEP-R) group. The group met regularly provided input in all stages 
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including design of trial protocol, refinement of outcome measure questionnaires and 
dissemination of findings. The PEP-R group had 12 members who elected between 
themselves a patient representative to sit on the trial steering group. Extensive input was 
also put in to the design of this trial by a representative of the Arthritis Research Campaign 
who also sat on the steering group. This active participation of the public adhered to the 
aspirations of INVOLVE. 
3.23 Chapter summary 
This chapter has explained the methods used for the feasibility trial and has discussed some 
of the practicalities of how the quality of conducting rehabilitation trials can be maintained.  
It also explained the governance of the trial and how the requirement to involve the public 
in clinical research was met.    
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4 PROOF-THR RESULTS 
4.1 Chapter overview 
This chapter starts by presenting the CONSORT flow diagram (Schulz et al, 2010) showing 
the flow of participants through the study. Data related to the specific outcomes for 
feasibility studies such as recruitment, retention, and acceptability of the intervention and 
control are presented first. The demographic mix of the participants is also shown. This is 
then followed by presentation of descriptive results for all the secondary outcomes at 
baseline and the follow-up time points.  
4.2 PROOF-THR descriptive statistics 
The study CONSORT flow diagram (Schulz et al, 2010) is presented in Figure 28. In total 491 
patients were screened for inclusion, 337 were excluded prior to being approached for 
inclusion. Of the 172 patients approached, 46 consented to join the study. Following 
consent, one participant withdrew prior to randomisation; another one participant was 
withdrawn following randomisation due to incorrect recruitment (previous THR). Neither of 
these two participants is contained in any of the follow-up statistics. The reasons for these 
exclusions after the patients were approached are detailed in the CONSORT flow diagram 
Table 36 presents a full breakdown on the reasons for exclusion prior to approach in clinic.   
Three additional limited data sets (OHS only) for participants in the intervention group were 
collected by telephone in a time period that constituted a deviation from protocol at the 
final 26 week time point. As these additional data sets are included in the descriptive 
statistics, they are included in all the CONSORT flow diagram. However, as they were 
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collected outside of the main study data collection, these 3 participants are not contained in 
the analysis of retention, missing data and social classification (section 4.6 to 4.8).  
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Figure 28  CONSORT flow diagram (Schulz et al, 2010) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Declined to participate (n=1) 
Follow-up: 
4 weeks    (n=18; 86%) 
12 weeks (n=18; 86%) 
26 weeks (n=15; 71%) 
  
Allocated to intervention (n=21) 
Follow-up: 
4 weeks    (n=19; 83%) 
12 weeks   (n=19; 83%) 
26 weeks   (n= 21; 91%*See note 1) 
  
Allocated to control (n=23) 
Allocation 
Follow-Up 
Randomised (n=45) 
Enrolment 
Analysed:  
4 weeks  (n=18) 
12 weeks (n=18) 
26 weeks (n=18
#
 See note 2) 
Analysed:  
4 weeks  (n=19) 
12 weeks (n=19) 
26 weeks (n=21) 
Analysis 
Excluded (n=1) incorrectly recruited.  
Allocated (n=44) 
*Note 1: Two participants did not receive 12 week follow-up questionnaire but completed 26 week follow-up 
#
Note 2: This includes n=3 participants who completed the OHS by telephone follow-up outside the study period 
Consent given (n=46) 
Patients contacted for inclusion 
(n=154) 
Total screened for Inclusion 
(n=491) 
Excluded prior to being approached for 
inclusion.  (n=337) 
Excluded due to: 
Declined (n=88) 
Participant missed in clinic (n=20) 
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4.3 Recruitment 
Prior to contacting patients for possible inclusion, research nurses screened all patients 
listed for THR surgery against the inclusion and exclusion criteria at the two recruitment 
sites. During the conduct of the study, patients had to be excluded for a variety of other 
reasons prior to initial contact for inclusion. These reasons for exclusion during screening 
against the inclusion criteria and the other reasons are shown in Table 36 below.  
Of the total 491 potential participants listed for surgery, 114 were excluded at the screening 
process for not meeting the inclusion criteria. This accounts for 23.2% of all exclusions. An 
additional nine patients were excluded at screening for reasons not originally identified as 
exclusion criteria. Four patients asked to be taken off the list for surgery, and one patient 
was incorrectly listed for a THR. Another four patients were excluded as they did not have a 
Dudley or Birmingham postcode so the required OT adaptive devices could not be provided 
due to financial reasons. 
A further 223 (45.4%) of all the listed patients were ineligible for other reasons not 
associated with the study exclusion criteria; two main reasons accounted for this. The 
largest reason eligible patients were excluded (N=109) from the PROOF-THR study was due 
to two other contemporaneous studies recruiting patients with very similar inclusion 
criteria. Due to one study nearing completion, and another one being privately funded and 
therefore being financially rewarding to the Trust, both these studies had priority over this 
study. The 109 participants allocated to these other studies accounts for 22.2% of all 
screened participants, and 49% of eligible patients excluded after screening.  
 ~ 210 ~ 
 
Table 36 Reason for exclusion  
Reason for exclusion  Number 
excluded 
Listed patients (n=491) excluded at screening due to not meeting inclusion criteria 
Previous lower limb joint replacement 80 
Scheduled for other lower limb surgery    4 
THR not due to osteoarthritis 16 
Does not speak English 3 
No functional improvement expected 2 
Taken off waiting list for surgery 4 
Out of area postcode  4 
Incorrectly listed for THR (Should have been total knee replacement) 1 
Sub Total excluded at screening 114 
Eligible patients (n= 337) excluded prior to approach for other reasons 
Eligible for other concurrent clinical trials 109 
Insufficient time between pre-operative clinic and surgery to deliver 
intervention  
59 
Insufficient time between pre-operative clinic and surgery to deliver 
intervention following planned appointment being bough forward 
22 
Temporary closure of recruitment due to unavailability of study 
occupational  therapists   
21 
Did not receive participant information sheet 4 
Patient previously screened  1 
Other non-eligible (reasons not documented) 7 
Sub Total excluded for other reasons    223 
Eligible patients (n=154) excluded after contact with research nurse  
Declined to participate  88 
Appointment missed in clinic by research nurses  20 
Sub Total excluded (Declined/missed) 108 
Patients consenting to participate  46 
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The second most common reason participants (n=59, 17.5%) could not be approached for 
recruitment was due to insufficient time between the pre-operative clinics, where patients 
were recruited, to the scheduled date of surgery. The normal scheduled time interval, at 
both recruiting sites, between pre-assessment and surgery was 6 weeks. The main phase of 
recruitment to this trial coincided with one trust undertaking an initiative to boost joint 
replacement surgery numbers due to being behind their planned schedule for the year. This 
had the effect of reducing the time between pre-assessment and surgery to as little as 7-10 
days. As well as the practical difficulties of scheduling and delivering the intervention within 
such a short time frame, In order to standardise the delivery of the intervention, the 
protocol aimed to try to standardise the delivery of the intervention at 3-5 weeks before 
surgery. Therefore, unless the time between surgery and pre-assessment clinic date was 
greater than 4 weeks, patients were excluded. Additionally, a further n=22 had their surgery 
date moved forward after the pre-assessment clinic which was initially within the allotted 
time frame. These patients therefore also had to be excluded even if they had been sent the 
patient information pack to inform them of the study. Overall, this shortened time frame 
between pre-assessment clinic and surgery date resulted in 81 eligible patients having to be 
excluded. This accounts for 16.5% of all screened participants, and 36.3% of eligible patients 
excluded.     
The other main reason for exclusion of screened patients (n=21) was due to a period where 
both occupational therapists and other study staff were unavailable at the same time. Due 
to practical difficulties of administering the intervention which could not be overcome, a 
temporary four week recruitment closure was required. This accounted for only 4.3% of all 
listed patients and 9.4% of eligible patients excluded. 
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Other minor reasons included 4 participants who had been sent the patient information 
pack stated they had not received it when approached in the pre-assessment clinic. As the 
ethics for this study required participants to have 72 hours to consider the documentation 
before consenting, these patients could not be recruited in the pre-assessment clinic. One 
patient was listed twice for the same surgery and 7 others were excluded by the research 
nurses with reason for exclusion not-documented.  
Of the remaining 154 patients, 88 declined to participate, accounting for 17.9% of all 
screened patients, 26.1% of all eligible patients, and 57.4% of patients approached in clinic. 
A further 20 patients who had agreed to discuss participation were unable to be recruited 
due to the research nurses missing the clinic appointment of the patient; this accounted for  
4.1% of all screened patients, 5.9% of all eligible patients, and 13.0% of patients approached 
in clinic. 
4.4  Recruitment rate 
The recruitment phase of the trial lasted for 9 months with the first participant recruited on 
the 30/04/2012. The target in this recruitment phase was for 60 participants, which equated 
to approximately 7 participants per month. The recruitment rate was set at this level as 
initially the study had only had one occupational therapist working part time on the study. 
In October 2012 a second part-time occupational therapist was recruited to increase the 
recruitment rate. However, overall the average recruitment rate achieved was 5 participants 
per month. Although the recruitment rate increased to the target level with the addition of 
the second occupational therapist working on the trial, recruitment was terminated at the 
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intended finish date due to the overall time requirements of the study. The recruitment rate 
is shown in Figure 29 below. 
Figure 29 Recruitment rate 
 
 
4.5 Fidelity of intervention delivery 
A 100% delivery of the intervention was achieved. The occupational therapists allowed 4 
hours for each intervention which included travel time to the patient’s home and collection 
of adaptive devices from the store depot. Deviation from this protocol occurred on only 3 
occasions. On two occasions it was due to the participant requiring special equipment which 
the OT had to order then schedule another appointment to deliver to the participant. On 
one other occasion, the social services store failed to process an equipment order for 
standard equipment, again requiring the OT to re-order the equipment and make a second 
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visit. The OT intervention logs only recorded deviations from protocol when more than 4 
hours were needed to deliver the intervention; no records were kept of the actual time 
taken.  
The OTs delivering the home based intervention made patient treatment notes in which the 
type of equipment delivered was recorded. However, as a condition of each site’s research 
and development permission, the OTs were required to gain temporary contracts with each 
trust and pass these treatment notes to the NHS Trust’s OT department as these were 
considered patient records and thus and to be kept confidential. Despite in section 3 of the 
consent form, the participants agreed for their medical note to be made available to the 
research team. The R&D permission at the recruitments sites did not allow this. As a 
consequence, a record of the adaptive aids delivered is not available. A method to satisfy 
the recruiting NHS trusts that medical records can be viewed by the research team will need 
to be developed for the proposed full RCT so a full economic costing can be performed.  
4.6 Retention 
A total of 46 participants consented to join the study. One participant withdrew from the 
study before completing the baseline questionnaire, prior to randomisation. One participant 
completed the baseline questionnaire but was withdrawn following randomisation due to 
incorrect recruitment, having already received a previous THR. Retention of participants 
throughout the study is evidenced by the return rates of the 4, 12 and 26 week follow-up 
questionnaire shown in Table 37 below. Return rates were very similar (82-84%) at all 
follow-up points. Overall, the loss to follow-up ranges between 16%-18% which is below the 
20% indicated by Sackett et al, (1997) as being a significant source of bias. This retention 
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data is based on the 44 participants correctly recruited and the number of returned 
questionnaires at the end of the study. All the retention data presented in the results is 
based on the number of returned questionnaires at the completion of the study. The 
retention and completion data for the CSRI is discussed separately in section 4.11.  
Table 37 Overall retention and loss to follow-up (excluding CSRI) 
Time Point 
 
Participants 
recruited 
(n) 
Data collected Lost to follow-up 
(%) 
(n) % 
Baseline 44 44 100% 0% 
4 week 44 37 84% 16% 
12 week 44 37 84% 16% 
26 week 44 36 (1) 82% 18% 
Note (1): The three additional OHS sets collected at 26 weeks are not included  
When retention is analysed by group allocation (see Figure 28), it shows very similar rates at 
4 and 12 weeks for both groups, whereas at 26 weeks only 2 participants were lost to 
follow-up in the control group but 6 were lost to follow-up in the intervention group.   
4.7 Missing data 
The following Table 38 to Table 42 report the amount of missing data. Table 38 shows the 
missing baseline data for each outcome measure. The 4, 12 and 26 week missing data is 
shown in Table 39 to Table 41 respectively. Table 42 presents the total amount of missing 
data. The WOMAC and NEADL scales appear to have the most missing data. 
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Table 38 Baseline missing data 
Questionnaire 
(Total no. of 
questions) 
Total questions 
missing 
Max. per 
participant 
Max. per 
question 
No. of 
participants 
with 3+ 
missing 
WOMAC (24) 14 8 2 1 
OHS (12) 3 1 2 0 
Aberdeen I (9) 4 4 2 1 
Aberdeen A (17) 9 4 2 1 
Aberdeen P (9) 0 0 0 0 
NEADL (20) 21 12 2 2 
HADS A (7) 2 2 1 0 
HADS D (7) 1 1 1 0 
EQ-5D-3L (6) 0 0 0 0 
ICECAP (5) 0 0 0 0 
Total 54   5 
 
Table 39 Four week missing data 
Questionnaire 
(Total no. of 
questions) 
Total questions 
missing 
Max. per 
participant 
Max. per 
question 
No. of 
participants 
with 3+ missing 
WOMAC (24) 66 7 8 9 
OHS (12) 8 3 2 1 
Aberdeen I (9) 5 3 2 1 
Aberdeen A (17) 26 4 8 5 
Aberdeen P (9) 3 1 1 0 
NEADL (20) 59 15 8 8 
HADS A (7) 2 1 1 0 
HADS D (7) 2 1 1 0 
EQ-5D-3L (6) 8 5 2 1 
ICECAP (5) 6 3 2 1 
Total 185   26 
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Table 40 Twelve week missing data 
Questionnaire 
(Total no. of 
questions) 
Total questions 
missing 
Max. per 
participant 
Max. per 
question 
No. of 
participants 
with 3+ missing 
WOMAC (24) 30 5 4 5 
OHS (12) 2 1 1 0 
Aberdeen I (9) 1 1 1 0 
Aberdeen A (17) 21 15 4 1 
Aberdeen P (9) 0 0 0 0 
NEADL (20) 13 2 4 2 
HADS A (7) 0 0 0 0 
HADS D (7) 0 0 0 0 
EQ-5D-3L (6) 0 0 0 0 
ICECAP (5) 0 0 0 0 
Total 67   8 
 
Table 41 Twenty six week missing data 
Questionnaire 
(Total no. of 
questions) 
Total questions 
missing 
Max. per 
participant 
Max. per 
question 
No. of 
participants 
with 3+ missing 
WOMAC (24) 12 4 2 2 
OHS (12) 1 1 1 0 
Aberdeen I (9) 1 1 1 0 
Aberdeen A (17) 3 1 1 0 
Aberdeen P (9) 1 1 1 0 
NEADL (20) 12 4 3 2 
HADS A (7) 0 0 0 0 
HADS D (7) 0 0 0 0 
EQ-5D-3L (6) 4 2 1 0 
ICECAP (5) 1 1 1 0 
Total 35   4 
The total questions missing: The sum total of questions missing for the outcome measure.  
Maximum per person: The maximum number of questions missed per outcome measure.  
Maximum per question: The maximum number of times the same question was missed.  
Number of participants with 3+ missing: The number of participants who omitted to answer more 
than 3 questions per outcome measure. 
 
 ~ 218 ~ 
 
The total number of questions requiring response in the questionnaire pack was 116. Table 
42 shows the percentage of the total missing questions per follow-up time period. This 
analysis shows that with the exception of the 4 week time point, the amount of missing data 
ranges between 0.84%- 1.56%. The higher rate of 4.13% at 4 weeks may be due, partly, to 
some questions in the WOMAC and NEADL that are at odds with recommended hip 
precautions e.g. bending or driving a car at four weeks are not advised. Additionally, the 
independent researcher assigned to telephone participants to complete missing data was 
unable to establish contact with the majority of participants at the 4 week follow-up point. 
Despite this, the overall amount of missing data only constituted 1.91% of the total data. 
Table 42 Total amount of missing data from respondents 
Time point Number of 
Participants 
Total responses 
required 
Total Missing 
Questions 
Percentage 
missing 
Baseline 44 5104 54 1.06% 
4 weeks 37 4292 185 4.31% 
12 weeks 37 4292 67 1.56% 
26 weeks 36 4176 35 0.84% 
Total 154 17864 341 1.91% 
 
4.8 Demographic data 
Baseline data (see Table 43) were collected on the following characteristics; age at date of 
surgery, gender and whether the participant lived alone. The postcode data of the 
participants was used to identify the socio-demographic of the participants (Figure 30) using 
the Acorn index of social classification system which informs most other indexes of social 
deprivation (Acorn, 2014). Analysis of the data in Table 44 shows that 26 (59%) of 
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participants lived in areas classified from 3H and above with 12 (27%) living in the highest 
1.A – 1.C groups classified together as ‘affluent achievers’ (Acorn, 2014). Conversely, only 8 
(18%) lived in areas of the lowest socioeconomic classification of 5Q ‘difficult estates’. 
Further analyses of these data using the spider plot showed that 7 of the 8 participants 
living in the lowest socioeconomic area were recruited from Dudley Group of Hospital NHS 
Trust site. The data in Table 44 is presented graphically using a spider plot in Figure 31.  
 
 
 ~ 220 ~ 
 
Table 43  Demographic data 
 Baseline 4 weeks 12 weeks 26 weeks 
 (I) (C) (I) (C) (I) (C) (I) (C) 
Age at surgery  
<50 
50 – 59 
60 – 69 
70 – 79 
>79 
Mean ±SD   
 
1 
5 
6 
6 
3 
67±11.2 
 
2 
2 
10 
8 
1 
65±10.7 
 
1 
4 
6 
6 
1 
65.9±10.3 
 
1 
2 
9 
6 
1 
66.3±9.2 
 
1 
4 
4 
6 
3 
68.1±11.7 
 
1 
0 
9 
8 
1 
68.3±8.1 
 
1 
3 
5 
5 
1 
66±10.7 
 
1 
2 
10 
7 
1 
66.3±8.9 
Living alone 
Yes 
No  
No comment 
 
1 
17 
3 
 
5 
17 
1 
 
1 
14 
3 
 
4 
14 
1 
 
1 
14 
3 
 
5 
13 
1 
 
1 
11 
3 
 
5 
15 
1 
Gender  
Female  
Male 
 
7(33%) 
14(67%) 
 
13(57%) 
10(43%) 
 
7(39%) 
11(61%) 
 
9(47%) 
10(53%) 
 
6(33%) 
12(67%) 
 
11(58%) 
8(42%) 
 
7(47%) 
8(53%) 
 
11(52%) 
10(48%) 
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Figure 30 Social demographic groupings of participants based on the Acorn (2014) classification 
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Table 44 Acorn social classification grouping  
Social Classification Intervention  Control 
1.A Lavish Lifestyle 2 2 
1.B Executive wealth 1 4 
1.C Mature money 1 2 
3.G Successful Suburbs 5 3 
3.H Steady Neighbourhoods 6 0 
3.I Comfortable Seniors 0 2 
4.K Student life/Low income Asian 1 0 
4.M Striving families 1 2 
4.N Poorer pensioners 1 1 
5.O Young hardship 1 0 
5.P Struggling Estates 1 0 
5.Q Difficult circumstances 1 7 
 
Figure 31: Spider plot of Acorn social classification  
 
0
1
2
3
4
5
6
7
1.A Lavish Lifestyle
1.B Executive
wealth
1.C Mature money
3.G Successful
Suburbs
3.H Steady
Neighbourhoods
3.I Comfortable
Seniors
4.K Student life/Low
income Asian
4.M Striving families
4.N Poorer
pensioners
5.O Young hardship
5.P Struggling
Estates
5.Q Difficult
circumstances
Intervention
Control
 ~ 223 ~ 
 
This demographic data (Table 43) show both groups were similar in age with the average 
age of the participants in the intervention group (67 ±11.2) being only 2 years older on 
average than the average age of those in the control (65 ±10.7).  Gender distribution 
between the two groups varied with the proportion of females in the control group (57%) 
being almost twice that of the control (33%). The proportion reporting that they lived alone 
was much higher in the control group (n=5, 21.5%) than in the intervention group (n=1, 
4.8%). The social classification (Table 43) of the participants revealed a far greater 
proportion of the intervention group (71.4%) classified as belonging to the wealthier 
sections of society (social classifications 1-3) compared to the control (56.5%) and more 
participants in the control group (43.5%) living in the economic deprived sections of society 
(social classifications 4-5) compared to the intervention group (28.6%).  
4.9 Outcome measure analysis  
Table 45 shows a summary of the PROMs used identifying the possible range of scores for 
the overall measure and subscales and the directionality of the results. Following conclusion 
of the study, at the request of the principle investigator, participants who had not returned 
the 26 week questionnaire were contacted by telephone and asked for data relating to the 
Oxford hip score only. Three additional participants in the intervention group provided 
completed data which is included in the descriptive data below. The descriptive data for all 
the outcome measures are shown in Table 46 to Table 50 below. Table 46 shows the 
baseline data for both the control and intervention group and Table 47 to Table 49 show the 
outcome measure data at 4, 12 and 26 weeks respectively with the group values for each 
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measure and the between group analysis of the effect size and confidence intervals. Table 
50 shows the within group change scores from baseline at each follow-up time point. 
Table 45 Summary of Scales 
Scale Scoring system  
WOMAC Three dimensions: Pain (5 Qs), Stiffness (2 Qs), Function (17 Qs). Likert 
version – summary score for each aspect (max scores 20, 8 and 68). Then 
converted by 100/98 conversion to 0 (best health) to 100 (worst health) 
scale.  
OHS New method of scoring adding up all values resulting in a scale of 0 (worst 
health) - 48 (best health) 
Ab-IAP Impairment, activity limitation and participation scales scoring 1-5; I scale 
= 9–45, A scale= 17–85, P scale = 9-45. Lower score indicates best health; 
higher score indicates worse health  
NEADL Contains 22 questions, scoring 0-3 where 0 is dependent and 3 is 
independent.  Should relate to final scores of 0 (worst health) – 66 (best 
health) using Likert scale or 0-22 if converted into dependant (0, 1) and 
independent (2, 3). Likert version used as it can detect more subtle 
changes.   
HADS 14 questions: 7 each for anxiety and depression each scored from 0-3 
(best to worst). Anxiety and depression are scored separately from 0 
(best health) – 21 (worst health).  
EQ5D 5 Questions giving an output of collection of numbers e.g. 11111 and 1 
which can be converted into a score between -0.594 (Worst health) and 1 
(full health). There is also a VAS score 0 (worst health) -100 (full health).  
ICECAP 5 Questions giving output of collection of numbers e.g. 11111. This can be 
converted into a score between 0 (Death) and 1 (full health). 
Q, questions; VAS, visual analogue scale 
 
 ~ 225 ~ 
 
Table 46 Baseline descriptive statistics 
Scale 
Control Intervention 
n (Mean) (SD) Median IQR n (Mean) (SD) Median IQR 
WOMAC           
Pain 23 12.76 4.23 12.0 6.00 21 11.35 3.18 11.50 3.25 
Stiffness 23 5.24 1.48 5.0 1.25 21 4.50 1.93 4.50 2.25 
Function 23 42.69 12.60 41.0 16.25 21 38.39 11.8 38.50 15.22 
Total 23 63.22 18.14 59.38 27.34 21 56.50 16.51 56.77 20.28 
OHS           
Total 23 17.00 6.28 18.00 8.50 21 18.79 8.38 20.00 14.00 
Aberdeen IAP           
Ab I 23 32.04 6.15 31.00 8.50 21 30.58 8.93 30.00 13.37 
Ab A 22 52.98 13.82 52.50 16.13 21 48.48 14.46 45.00 21.81 
Ab P 23 22.83 6.36 21.00 6.00 21 20.19 8.16 19.00 12.00 
NEADL           
Total 22 49.63 10.73 53.00 8.44 20 47.13 15.46 51.50 18.37 
HADS           
Anxiety            
Total score 22 6.73 4.61 6.00 4.50 21 6.71 5.33 6.00 6.00 
Normal 13     13     
Mild 5     3     
Moderate 3     3     
Severe 1     2     
Depression           
Total score 23 5.64 2.50 5.00 2.50 21 6.48 4.51 6.00 4.00 
Normal 18     14     
Mild 3     6     
Moderate 2     0     
Severe 0     1     
EQ-5D-3L 
Descriptive system 
VAS 
23 
23 
0.40 
65.86 
0.29 
18.07 
0.59 
70.50 
 
 
0.53 
23.75 
21 
21 
0.33 
67.48 
0.33 
26.41 
 
 
0.20 
79.00 
 
 
0.71 
35.00 
ICECAP-O 
Total 23 0.82 0.11 0.82 
 
0.10 21 0.79 0.26 
 
0.89 
 
0.14 
C.I., 95% confidence interval of the between group effect size; IQR, Inter quartile range; n, number of outcome measures analysed; SD, Standard deviation 
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Table 47 Four week descriptive statistics  
Scale 
Control Intervention Between Group 
n Mean SD Median IQR n Mean SD Median IQR 
Mean 
Difference 
Effect 
Size 
C.I. 
Lower 
C.I. 
Upper 
WOMAC               
Pain 13 4.37 3.98 4.00 1.00 13 5.46 4.59 5.00 6.00 1.09 0.25 -0.53 1.02 
Stiffness 13 2.77 1.69 3.00 3.00 13 2.69 1.70 3.00 3.00 -0.08 -0.05 -0.81 0.72 
Function 13 24.16 10.91 24.00 14.61 13 22.05 14.61 20.00 13.74 -2.11 -0.16 -0.93 0.61 
Overall 13 32.60 15.49 31.25 18.84 13 31.46 21.08 23.96 18.48 -1.14 -0.06 -0.83 0.71 
OHS               
Overall 19 27.83 8.62 29.00 9.00 18 28.73 11.99 32.00 16.00 0.90 0.09 -0.56 0.73 
Aberdeen IAP               
Ab I 19 18.30 5.85 18.00 7.00 18 19.31 9.06 17.00 6.82 1.01 0.13 -0.51 0.78 
Ab A 17 34.36 12.42 29.75 21.50 17 33.84 15.79 29.00 9.00 -0.52 -0.04 -0.71 0.64 
Ab P 19 16.70 5.26 17.00 8.50 18 17.76 7.98 15.94 9.50 1.06 0.16 -0.49 0.80 
NEADL               
Total 16 46.31 15.12 47.50 28.72 15 43.12 12.83 42.00 20.58 -3.19 -0.23 -0.93 0.49 
HADS               
Anxiety               
Total score 19 4.37 3.96 3.00 4.00 18 4.79 4.78 3.50 5.12 0.42 0.10 -0.55 0.74 
Normal 16              
Mild 2              
Moderate 1              
Severe 0              
Depression               
Total score 19 3.79 3.14 3.00 3.00 18 5.18 4.40 4.00 3.75 1.39 0.37 -0.29 1.01 
Normal 16     14         
Mild 0     2         
Moderate 2     1         
Severe 1     1         
EQ-5D-3L 
Descriptive system 
VAS 
17 
19 
0.63 
72.79 
0.29 
17.59 
 
0.69 
79.00 
 
0.18 
25.00 
16 
17 
0.60 
72.82 
0.27 
21.16 
 
0.67 
80.00 
 
0.23 
15.00 
-0.03 
0.03 
 
-0.11 
0.00 
 
-0.79 
-0.65 
 
0.58 
0.66 
ICECAP-O 
Total 19 0.85 0.12 0.88 
 
0.12 14 0.80 0.28 
 
0.90 
 
0.16 -0.05 -0.25 -0.93 0.45 
C.I., 95% confidence interval of the between group effect size; IQR, Inter quartile range; n, number of outcome measures analysed; SD, Standard deviation 
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Table 48 Twelve week descriptive statistics 
Scale 
Control Intervention Between Group 
n Mean SD Median IQR n Mean SD Median IQR 
Mean 
Difference 
Effect 
Size 
C.I. 
Lower 
C.I. 
Upper 
WOMAC               
Pain 12 2.92 3.09 2.50 2.75 16 4.44 4.65 3.50 3.5 1.52 0.37 -0.39 1.12 
Stiffness 12 2.17 1.95 2.00 0.25 16 2.99 1.90 2.00 2.05 0.82 0.43 -0.34 1.17 
Function 12 13.99 10.45 11.50 12.25 16 20.22 14.21 17.55 18.50 6.23 0.49 -0.28 1.23 
Overall 12 19.86 15.36 17.71 15.89 16 28.79 20.42 23.44 21.35 8.93 0.48 -0.29 1.23 
OHS               
Overall 19 36.42 7.94 37.00 9.50 18 34.68 11.42 36.00 13.75 -1.74 -0.18 -0.82 0.47 
Aberdeen IAP               
Ab I 19 15.21 4.66 14.00 5.00 18 17.26 7.90 16.38 6.50 2.05 0.32 -0.34 0.96 
Ab A 18 27.06 8.75 24.97 9.19 18 30.78 15.53 27.50 11.42 3.72 0.30 -0.37 0.95 
Ab P 19 12.00 3.73 11.00 2.00 18 14.94 8.82 11.50 4.75 2.94 0.44 -0.22 1.08 
NEADL               
Total 19 54.02 11.69 54.36 16.00 17 47.94 23.57 59.00 22.00 -6.08 -0.33 -0.98 0.33 
HADS               
Anxiety               
Total score 19 2.68 2.65 2.00 3.50 18 3.89 5.19 2.00 4.50 1.21 0.30 -0.36 0.94 
Normal 18     15         
Mild 1     1         
Moderate 0     1         
Severe 0     1         
Depression               
Total score 19 1.89 1.73 1.00 1.50 18 3.78 4.47 2.00 5.00 1.89 0.56 -0.11 1.21 
Normal 19     16         
Mild O     0         
Moderate 0     1         
Severe 0     1         
EQ-5D-3L 
Descriptive system 
VAS 
19 
19 
0.81 
81.26 
0.17 
16.75 
 
0.80 
16.75 
 
0.33 
10.00 
18 
18 
0.71 
77.11 
0.33 
20.42 
 
0.74 
80.00 
 
0.34 
8.25 
-0.10 
-4.15 
-0.38 
-0.22 
-1.03 
-0.86 
0.27 
0.43 
ICECAP-O 
Total 19 0.90 0.10 
 
0.93 
 
0.08 18 0.84 0.10 
 
0.94 
 
0.16 -0.06 -0.60 -1.25 0.07 
C.I., 95% confidence interval of the between group effect size; IQR, Inter quartile range; n, number of outcome measures analysed; SD, Standard deviation 
  
 ~ 228 ~ 
 
Table 49 Twenty six weeks descriptive statistics 
Scale 
Control Intervention Between Group 
n Mean SD Median IQR n Mean SD Median IQR 
Mean 
Difference 
Effect 
Size 
C.I. 
Lower 
C.I. 
Upper 
WOMAC               
Pain 18 2.46 3.61 1.13 2.75 11 1.73 1.68 2.00 3.00 -0.73 -0.24 -0.99 0.52 
Stiffness 18 1.67 1.61 2.00 2.00 11 1.18 0.87 1.00 1.50 -0.49 -0.35 -1.10 0.41 
Function 18 9.56 11.49 6.00 11.75 11 6.52 6.82 3.00 12.00 -3.04 -0.30 -1.05 0.46 
Overall 18 14.25 16.62 9.90 14.84 11 9.54 8.71 6.25 11.46 -4.71 -0.33 -1.08 0.43 
OHS 
(1)
               
Overall 20 38.88 8.52 41.50 8.75 18 41.17 6.22 42.50 8.50 2.29 0.03 -0.34 0.94 
Aberdeen IAP               
Ab I 20 15.38 6.57 13.50 6.00 15 13.67 3.89 14.00 6.50 -1.71 -0.31 -0.97 0.37 
Ab A 20 26.70 9.67 25.50 10.00 15 22.79 6.09 21.00 9.50 -3.91 -0.47 -1.14 0.22 
Ab P 20 11.45 3.10 10.50 3.25 15 11.33 4.41 9.00 2.50 -0.12 -0.03 -0.70 0.64 
NEADL               
Total 19 57.09 17.20 64.00 8.90 15 62.67 6.66 66.00 4.00 5.58 0.41 -0.28 1.08 
HADS               
Anxiety               
Total score 20 3.30 3.60 1.50 4.25 15 2.87 3.62 1.00 5.50 -0.43 -0.12 -0.79 0.55 
Normal 18     13         
Mild 1     1         
Moderate 1     1         
Severe 0     0         
Depression               
Total score 20 2.05 2.04 2.00 3.00 15 2.67 3.64 2.00 3.50 0.62 0.22 -0.46 0.89 
Normal 20     14         
Mild 0     0         
Moderate 0     1         
Severe 0     0         
EQ-5D-3L 
Descriptive system 
VAS 
19 
20 
0.86 
82.11 
0.13 
15.85 
 
0.81 
87.00 
 
0.25 
13.50 
15 
15 
0.86 
86.47 
0.16 
12.85 
 
0.92 
90.00 
 
0.27 
7.50 
0.00 
4.36 
0.00 
0.30 
-0.68 
-0.38 
0.68 
0.96 
ICECAP-O 
Total 20 0.90 0.11 
 
0.90 
 
0.08 15 0.92 0.15 
 
0.97 
 
0.08 0.02 0.16 -0.52 0.82 
C.I., 95% confidence interval of the between group effect size; IQR, Inter quartile range; n, number of outcome measures analysed; SD, Standard deviation 
Note 
(1)
: Oxford hip score at 26 weeks contains data from the additional 3 patients followed up by telephone after completion of study 
Analysis showed none of the data sets to be normally distributed. Median and IRQ are therefore the indications of point value and variation for tables 46 to 49 
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Table 50 Within group analyses (baseline – 4 weeks)  
 Change: Baseline to 4 Weeks 
 Control Intervention 
 Mean 
Diff 
C.I. 
Low 
C.I. 
Up 
Mean 
Diff 
C.I. 
Low 
C.I. 
Up 
WOMAC Pain 8.39 5.47 11.31 5.89 3.18 8.60 
WOMC Stiffness 2.47 1.37 3.57 1.81 0.48 3.14 
WOMAC Function 18.53 10.05 27.01 16.34 7.05 25.63 
WOMAC Overall 30.62 18.45 42.79 25.04 11.84 38.24 
OHS -10.83 -15.48 -6.18 -9.94 -16.58 -3.30 
Aberdeen I 13.74 9.97 17.51 11.27 5.42 17.12 
Aberdeen A 18.62 10.04 27.20 14.64 4.67 24.61 
Aberdeen P 6.13 2.44 9.82 2.43 -2.83 7.69 
NEADL 3.32 -5.05 11.69 4.01 -5.91 13.93 
HADS (Anxiety) 2.36 -0.35 5.07 1.92 -1.39 5.23 
HADS (Depression) 1.85 0.09 3.61 1.30 -1.60 4.20 
EQ-5D-3L  -0.23 -0.42 -0.04 -0.27 -0.48 -0.06 
EQ-5D-3L (VAS) -6.93 -18.12 4.26 -5.34 -21.36 10.68 
ICECAP-O -0.03 -0.10 0.04 -0.01 -0.20 0.18 
 
Table 51 Within group analysis (baseline to 12 weeks) 
 Change: Baseline to 12 Weeks 
 Control Intervention 
 Mean 
Diff 
C.I. 
Low 
C.I. 
Up 
Mean 
Diff 
C.I. 
Low 
C.I. 
Up 
WOMAC Pain 9.84 7.02 12.66 6.91 4.30 9.52 
WOMC Stiffness 3.07 1.87 4.27 1.51 0.22 2.80 
WOMAC Function 28.70 20.06 37.34 18.17 9.49 26.85 
WOMAC Overall 43.36 30.85 55.87 27.71 15.39 40.03 
OHS -19.42 -23.85 -14.99 -15.89 -22.33 -9.45 
Aberdeen I 16.83 13.37 20.29 13.32 7.81 18.83 
Aberdeen A 25.92 18.36 33.48 17.70 7.96 27.44 
Aberdeen P 10.83 7.48 14.18 5.25 -0.26 10.76 
NEADL -4.39 -11.39 2.61 -0.81 -13.70 12.08 
HADS (Anxiety) 4.05 1.64 6.46 2.82 -0.61 6.25 
HADS (Depression) 3.75 2.38 5.12 2.70 -0.22 5.62 
EQ-5D-3L  -0.41 -0.56 -0.26 -0.38 -0.59 -0.17 
EQ-5D-3L (VAS) -15.40 -26.36 -4.44 -9.63 -25.15 5.89 
ICECAP-O -0.08 -0.15 -0.01 -0.05 -0.18 0.08 
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Table 52 Within group analysis (baseline to 26 weeks) 
 
Change: Baseline to 26 Weeks 
 Control Intervention 
 Mean 
Diff 
C.I. 
Low 
C.I. 
Up 
Mean 
Diff 
C.I. 
Low 
C.I. 
Up 
WOMAC Pain 10.30 7.77 12.83 9.62 7.51 11.73 
WOMC Stiffness 3.57 2.59 4.55 3.32 2.06 4.58 
WOMAC Function 33.13 25.41 40.85 31.87 23.96 39.78 
WOMAC Overall 48.97 37.83 60.11 46.96 36.02 57.90 
OHS (1) -21.88 -26.45 -17.31 -22.38 -27.24 -17.52 
Aberdeen I 16.66 12.74 20.58 16.91 11.90 21.92 
Aberdeen A 26.28 18.82 33.74 25.69 17.61 33.77 
Aberdeen P 11.38 8.22 14.54 8.86 4.14 13.58 
NEADL -7.46 -16.24 1.32 -15.54 -24.20 -6.88 
HADS (Anxiety) 3.43 0.85 6.01 3.84 0.61 7.07 
HADS (Depression) 3.59 2.17 5.01 3.81 0.94 6.68 
EQ-5D-3L  -0.46 -0.61 -0.31 -0.53 -0.72 -0.34 
EQ-5D-3L (VAS) -16.25 -26.79 -5.71 -18.99 -34.01 -3.97 
ICECAP-O -0.08 -0.15 -0.01 -0.13 -0.28 0.02 
C.I. Low; lower 95% confidence interval of mean difference, C.I. Up; upper 95% confidence interval of mean 
difference, Mean Diff; Mean difference 
Note 
(1)
: OHS analysis contains additional 3 participants contacted after end of study by telephone follow-up 
 
 
Inspection of the between group effect size (ES), using the parameters defined by Cohen 
(1998) of ≤0.2 (small ES), ≤0.5 (medium ES) and ≤0.8 (large ES) at all three follow up time 
points none of the outcomes measures show a large effect size. At 4 weeks the between 
group ES ranged from 0.07 to 0.34; at 12 weeks between 0.18 to 0.56; and at 26 weeks 
between 0.00 to 0.47. The within group analysis, using mean differences scores, shows both 
groups improved at each follow-up time point on all outcomes.   
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4.10 ICECAP-O & EQ-5D-3L reporting 
Table 53 to Table 62 below show the number and percentage of respondents choosing each 
response category for both the EQ-5D-3L (Table 53 to Table 57) and the ICECAP-O ( Table 58 
to Table 62). 
Table 53 EQ-5D-3L Anxiety & depression  
Anxiety & 
Depression 
Intervention Control 
1 2 3 1 2 3 
Baseline 13 (62%) 8 (38%) 0 (0%) 16 (70%) 7 (30%) 0 (0%) 
4 Weeks 10 (63%) 6 (38%) 0 (0%) 14 (82%) 3 (18%) 0 (0%) 
12 weeks 13 (72%) 4 (22%) 1 (6%) 18 (95%) 1 (5%) 0 (0%) 
26 weeks 11 (73%) 4 (27%) 0 (0%) 16 (84%) 3 (16%) 0 (0%) 
 
The anxiety and depression item of the EQ-5D-3L show that only 1 participant at 12 weeks in 
the intervention group indicted they were extremely anxious and depressed (3). Between 
62%-73% indicated that they had no anxiety or depression (1) in the intervention group, and 
between 70% - 95% in the control. At both 4 and 26 weeks, the number of participants who 
indicated the best mental health status was greater in the control than in the intervention 
group.  
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Table 54 EQ-5D-3L Pain & discomfort  
Pain & 
Discomfort 
Intervention Control 
1 2 3 1 2 3 
Baseline 0 (0%) 10 (48%) 11 (52%) 0 (0%) 15 (65%) 8 (35%) 
4 Weeks 5 (31%) 10 (63%) 1 (6%) 4 (24%) 12 (71%) 1 (6%) 
12 weeks 7 (39%) 10 (56%) 1 (6%) 9 (47%) 10 (53%) 0 (0%) 
26 weeks 9 (60%) 6 (40%) 0 (0%) 12 (63%) 7 (37%) 0 (0%) 
 
At baseline, more participants in the intervention group (11, 52%) indicated their levels of 
pain and discomfort to be extreme compared to the control (8, 35%). However, (15, 65%) of 
participants rated their level of pain and discomfort in the middle category of moderate (2) 
in the control, compared to (10, 48%) in the intervention group. At all the follow-up points, 
the results for both groups are very similar. 
Table 55 EQ-5D-3L Usual activities  
Usual 
activities 
Intervention Control 
1 2 3 1 2 3 
Baseline 5 (24%) 14 (76%) 2 (10%) 1 (4%) 20 (87%) 2 (9%) 
4 Weeks 5 (31%) 7 (44%) 4 (25%) 4 (24%) 9 (53%) 4 (24%) 
12 weeks 9 (50%) 7 (39%) 2 (11%) 11 (58%) 8 (42%) 0 (0%) 
26 weeks 11 (79%) 3 (21%) 0 (0%) 15 (79%) 4 (21%) 0 (0%) 
 
At baseline five participants (24%) had no problem with their usual activities compared to 
only (1, 4%) in the control. At all the follow-up points, the results for both groups are very 
similar.  
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Table 56 EQ-5D-3L Self care  
Self-care Intervention Control 
1 2 3 1 2 3 
Baseline 11 (52%) 10 (48%) 0 (0%) 5 (22%) 18 (78%) 0 (0%) 
4 Weeks 10 (63%) 6 (37%) 0 (0%) 10 (59%) 7 (41%) 0 (0%) 
12 weeks 14 (78%) 3 (17%) 1 (6%) 14 (74%) 5 (26%) 0 (0%) 
26 weeks 14 (93%) 1 (7%) 0 (0%) 18 (95%) 1 (5%) 0 (0%) 
 
In the intervention group at baseline (11, 52%) indicated they had no problem with self-care 
compared to only (5, 22%) in the control; neither group indicated they were unable to wash 
or dress themselves. Otherwise, at all follow-up time points, the results for both groups are 
very similar.   
Table 57 EQ-5D-3L Mobility   
Mobility Intervention Control 
1 2 3 1 2 3 
Baseline 0 (0%) 21(100%) 0(0%) 0 (0%) 23(100%) 0 (0%) 
4 Weeks 5 (31%) 11 (69%) 0 (0%) 8 (47%) 9 (53%) 0 (0%) 
12 weeks 13 (72%) 5 (28%) 0 (0%) 12 (74%) 7 (26%) 0 (0%) 
26 weeks 13 (87%) 2 (13%) 0 (0%) 12 (63%) 7 (37%) 0 (0%) 
 
Both groups were identical at baseline in that 100% indicated they had some problems with 
mobility. At 4 weeks, the difference is small but at 4 weeks (8, 47%) indicated they had no 
problems with mobility in the control group compared to (5, 31%) in the control. Otherwise, 
at all follow-up time points, the results for both groups are very similar.  
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Table 58 ICECAP-O Independence    
Independence Intervention Control 
1 2 3 4 1 2 3 4 
Baseline 10(48%) 5(24%) 5(24%) 1(5%) 3(13%) 15(65%) 5(22%) 0(0%) 
4 Weeks 3 (18%) 10(59%) 3(18%) 1(6%) 4(21%) 13(68%) 2(11%) 0(0%) 
12 weeks 9 (50%) 6 (33%) 2(11%) 1(6%) 9(47%) 10(53%) 0 (0%) 0(0%) 
26 weeks 11(73%) 3 (20%) 1 (7%) 0(0%) 10(50%) 10(50%) 0 (0%) 0(0%) 
 
At baseline more participants in the intervention group (10, 48%) rated themselves as being 
completely independent compared to only (3, 13%) in the control. In contrast, (15, 65%) 
participants in the control group rated themselves as independent in many things compared 
to (5, 24%) in the intervention. However, the number of participants in the higher affected 
categories 3 and 4 are otherwise similar. At 12 weeks 100% in the control group rate 
themselves in the two higher categories (1 & 2) of independence, whereas only 88% do so in 
the control. At the 4 and 12 week time points, the results for both groups are otherwise very 
similar.     
Table 59 ICECAP-O Enjoyment & pleasure    
Enjoyment 
& Pleasure 
Intervention Control 
1 2 3 4 1 2 3 4 
Baseline 4(19%) 8(38%) 8(38%) 1(5%) 3(13%) 9(39%) 11(48%) 0(0%) 
4 Weeks 4(25%) 6(38%) 5(31%) 1(6%) 5(26%) 6(32%) 8(42%) 0(0%) 
12 weeks 8(44%) 6(33%) 3(17%) 1(6%) 5(26%) 11(58%) 3(16%) 0(0%) 
26 weeks 11(73%) 3(20%) 1 (7%) 0(0%) 7(35%) 12(60%) 1 (5%) 0(0%) 
 
At baseline 4 and 26 week follow-up, both groups rated their enjoyment and pleasure very 
similarly. At 26 weeks (11, 73%) of participants in the intervention group indicate they can 
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have all the enjoyment and pleasure they want compared to only (7, 35%) in the control. 
However, the percentage of participants that rate themselves in the lowest two categories 
is very similar in the control (5%) and the intervention (7%).   
Table 60 ICECAP-O Feeling valued    
Feeling 
valued 
Intervention Control 
1 2 3 4 1 2 3 4 
Baseline 7(33%) 8(38%) 5(24%) 1(5%) 4(17%) 13(57%) 5(22%) 1(4%) 
4 Weeks 4(27%) 8(53%) 2(13%) 1(7%) 5(26%) 10(53%) 4(21%) 0(0%) 
12 weeks 9(50%) 5(28%) 3(17%) 1(6%) 9(47%) 9 (47%) 1 (5%) 0(0%) 
26 weeks 13(87%) 1 (7%) 1 (7%) 0(0%) 7(35%) 12(60%) 1(5%) 0(0%) 
 
At baseline the amount of participants that can do everything (1) or many (2) of the things 
that make them feel valued is very similar with 71% rating in these two highest categories in 
the intervention compared with 74% in the control. However, (7 33%) rated themselves in 
the highest category compared to only (4, 17%) in the control. At 4 weeks, both groups are 
very similar. At 12 weeks 21% of participants in the intervention group indicate they can 
only do a few (3) or any (4) of the things that make them valued compared to only 5% in the 
control. In contrast at 26 weeks (13, 87%) participants in the intervention group are able to 
do everything they want to be feel valued compared to only (7,35%) in the control. 
However, the proportions that rate themselves in the lowest categories of feeling valued are 
very similar in the intervention (7%) and in the control (5%).   
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Table 61 ICECAP-O Thinking about the future    
Thinking 
about the 
future 
Intervention Control 
1 2 3 4 1 2 3 4 
Baseline 8(38%) 9(43%) 2(10%) 2(10%) 3(13%) 14(61%) 3(13%) 3(13%) 
4 Weeks 8(50%) 5(31%) 2(13%) 1 (6%) 5(26%) 11(58%) 2(11%) 1 (5%) 
12 weeks 9(50%) 4(22%) 3(17%) 2(11%) 7(37%) 10(53%) 2(11%) 0 (0%) 
26 weeks 8(53%) 6(40%) 1 (7%) 0 (0%) 7(35%) 9 (45%) 3(15%) 1 (5%) 
 
At all 4 time points of measurement, more participants in the intervention group indicated 
they can think about the future without any concern compared to the control. However the 
percentage of participants in the intervention group rating their ability to think about the 
future in the lowest two categories at baseline (20%) and at 4 weeks (19%) is very similar to 
the control at baseline (26%) and 4 weeks (16%). However, at 12 weeks the percentage in 
these lowest two categories is higher in the intervention (28%) group compared to the 
control (11%). In contrast, (8, 53%) of participants can think about the future with no 
concern compared to only (7, 35%) in the control. Additionally, only 7% of participants in the 
intervention rated their ability to think about the future in the lowest two categories 
compared to 20% in the control.   
Table 62 ICECAP-O Love & friendship    
Love & 
Friendship 
Intervention Control 
1 2 3 4 1 2 3 4 
Baseline 13(62%) 3(14%) 3(14%) 2(10%) 16(70%) 6(26%) 1(4%) 0(0%) 
4 Weeks 10(67%) 2(13%) 2(13%) 1(7%) 7(37%) 11(58%) 1(5%) 0(0%) 
12 weeks 13(72%) 3(17%) 1(6%) 1(6%) 13(68%) 5(26%) 1(5%) 0(0%) 
26 weeks 12(80%) 2(13%) 0(0%) 1(7%) 14(70%) 5(25%) 1(5%) 0(0%) 
Note: In above tables, percentages rounded up to nearest whole number so total may not equal 100% 
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At baseline only 4% of participants in the control group indicated they can have little or 
none of the love and friendship that they want compared to 24% in the intervention group. 
The results are also very similar at 4 weeks with the lowest two categories combined in the 
control being 5% and 20% in the intervention group, at 12 and 26 weeks the results for 
these lowest two categories are similar in both groups. 
4.11 Client services receipt inventory (CSRI) reporting 
The CSRI was only sent out to the participants at the 26 week follow-up time point. Thirty 
one (70%) of forms were returned; and of those 31 returned, only 15 (48%) were fully 
completed. Table 63 identifies the sections where data were incomplete on the returned 
CSRI forms. Approximately twice as many questions in total were missing in the control 
group compared to the intervention. The two sections of the CSRI form, both within and 
between groups, which had the highest levels of missing data were those relating to 
‘medication’ and ‘Friends/relatives help at home’.  
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Table 63 Summary of CSRI questionnaire missing responses 
  Questions Missing ‘n’ (%) 
Question Control Intervention 
Hospital resource use (A&E, Outpatient 
appointments, overnight stays) 
12 (22.2%) 13 (33.3%) 
Service use (e.g. GP, Physiotherapy) 16 (5.5%) 11 (5.3%) 
Medication (type and payment) 51 (40.5%) 26 (28.6%) 
Personal costs incurred for NHS/social services 
(e.g. transport, cleaning, child care) 
23 (25.5%) 16 (24.6%) 
Time off work 4 (4.4%) 1 (1.5%) 
Friends/relatives help at home (how many 
hours of help needed for household tasks) 
106 (53.5%) 29 (20.3%) 
Friends/relatives time off work (how many 
hours taken off work to provide help) 
1 (5.6%) 1 (7.7%) 
Current work situation 3 (2.4%) 0 (05) 
Overall total missing questions 216 (21.8%) 97 (13.8%) 
 
4.12 Chapter summary 
This chapter reports the patient retention throughout the study, how the PROOF-THR trial 
was conducted and the collection of the follow-up data. It revealed that although patient 
retention was acceptable, there was some loss to follow-up. It also showed that some of the 
measures used had better completion rate than others, and that the health economic data 
were subject to low rates of return and high rate of missing questions in the questionnaires 
that were returned.   
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5 PROOF-THR DISCUSSION 
5.1 Chapter overview 
This chapter contains the discussion of the results presented in chapter 4 and compares 
them to other relevant studies. The feasibility outcomes of recruitment, retention, 
acceptability and fidelity of the intervention are discussed together with suggestions of how 
the collection of the follow up data could be improved. Two sets of power calculation are 
then presented. Following this, the strengths and weaknesses of the study are discussed 
then followed by conclusions. In accordance with the MRC guideline (Craig et al, 2008) 
recommendations, no comparative statistical analysis has been undertaken.  
5.2 Recruitment 
Three main factors affected the recruitment process; other planned surgery, recruitment to 
other clinical trials, and change of surgery date. From the initial screening 332 (68%) 
potential participants were identified as meeting inclusion criteria for the trial which 
represents an acceptable rate of participant identification (Craven et al, 2014). Eighty four 
(74%) of the screened patients not meeting the inclusion criteria was due to previous or 
planned additional lower limb joint replacement surgery. Of the 181 participants excluded 
due to ‘other reasons’, this was mainly due to 109 (60%) being eligible for the competing 
trial (adopted prior to this study and therefore prioritised), and to a lesser extent, 58 (32%) 
having their surgery date brought forward precluding recruitment.  
The recruitment rate was 22% of eligible patients which was similar other comparative trials 
(12%) by Rooks et al, (2006) and (25%) by Weaver et al, (2003) but not as high as some 
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other studies (42%) by Peak et al (2005) and (77%) by Rivard et al (2003). The high rates 
achieved by Rivard et al (2003) is potentially due to it being a nested study within a much 
larger study for which participants had already consented to join, so they are already willing 
participants. Also this study was comparing hospital based education versus home based OT 
visits. As this was conducted in Canada participants may long travel distances, they may 
have been more willing to consent to a home visit to negate the need to travel in to the 
hospital for their pre-surgery education session. The main factors affecting recruitment 
identified by Weaver et al (2003) was lack of Medicare coverage (46%) and living out of area 
(19%). Weaver et al (2003) also report 7% of participants were excluded due to the OT being 
unable to schedule home visits, which more favourable to the 17.5% in this study. However, 
this does indicate that in pragmatic health trials, issues such as these are difficult to avoid 
and may need to be taken in to account during sample size calculation. Rooks et al (2006), 
which had the lowest level of recruitment (12%), attributed this to only having one 
recruitment site and the unwillingness of patients to travel to an exercise class. However, no 
numbers or percentages of participants declining for these identified reasons are presented. 
In the studies evaluating reduced restrictions following THR, Ververeli et al (2009) only 
recruited 81 participants over period of 4 years and Peak et al (2005) recruited 42% of 
eligible participants. However, neither study provides any data on eligibility criteria or 
recruitment rates. 
The patient demographic data revealed that a disproportionate amount of participants from 
higher socioeconomic populations were recruited to current the study. This is a recognised 
problem that can affect the generalizability of results from clinical trials (Bartlett et al, 2005; 
Swanson and Ward, 1995). One of the study occupational therapists also commented that 
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she felt “the participants were not [socio-economically] representative of the typical 
patients seen on home visits” (personal comment). In any subsequent full scale clinical trial, 
consideration of how to improve recruitment from lower socio-economic classes should be 
given, to make the results more generalisable to the general population. Lower 
socioeconomic classes often have greater health needs but also poorer access to services 
(UyBico et al, 2007; Liu et al, 2012). 
5.3 Retention 
Seven patients (16%) were lost to follow up at both 4 and 12 weeks, which was reduced to 5 
(12%) at 26 weeks (Table 42). Although methods to reduce attrition should be considered, 
loss to follow up was still less than the 20% level at which significant bias can occur (Sackett 
et al, 1997). This suggests that this trial design could be taken forward into a phase III 
definitive trial. The rates of follow up were good, however, there was more missing data in 
some time points (four week) and for some outcome measures (WOMAC, NEADL) indicating 
that the burden of assessment would need to be considered prior to a main study. Although 
widely used in other studies (Busse et al, 2011), the health economic data collected using 
the CSRI form was poorly completed by participants so it would be worth exploring other 
methods or adaptations for collecting these data. Health economic data can be augmented 
or estimated from indirect means such as from databases of G.P. records (Roddy et al, 2009) 
or Hospital Episode Statistics (Health and Social Care Information Services, 2015) and NHS 
reference costs (Department of Health, 2015).       
At 4 and 12 weeks, both the response rate and number of fully completed questionnaires 
was lower than at the other follow-up time points. Three participants commented on the 
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returned questionnaires that they had specifically not answered some questions, and left 
the responses blank, because the questions in the outcome measures conflicted with the 
routine hip precautions the patients have to comply with after total hip replacements, e.g. 
not to bend more than 90° for six weeks after surgery or not to drive a car. This may also 
explain other missing data on the returned questionnaires. At the week 4 and 12 time 
points, telephone calls were made by the research team if the questionnaire was not 
returned by the expected date. At the 4 week follow-up, several participants could not be 
contacted. Abiding by the ethics agreement, the research team were unable to ask people 
why they were not completing the questionnaire, though some participants voluntarily 
commented they did not ‘feel up to completing it’ as they were more disabled than they had 
anticipated at this point, or they had made alternative living arrangements and not received 
the form in the appropriate timeframe for completion. Telephone, text message, or e-mails 
reminders should be instigated if a main randomised clinical trial is undertaken as these can 
improve response rates (Nakash et al, 2006). Reducing the patient burden by only having 
two follow-up time points may also help improve return rates. However, the retention of 
participants at the end of the study was good, with a follow-up return rate of 88% at 26 
weeks which is comparable with the 78% - 92% retention rates in similar clinical trials 
(Monticone et al, 2014; Vukomanović et al, 2008) using postal PROMs with follow-up 
periods of 6 months or longer. Other THR rehabilitation studies with much higher follow-up 
rates (96-100%) are ones in which participants attend follow-up clinics (Barker et al, 2013; 
Gocen et al, 2004; Gilbey et al (2003); Larsen et al, 2008). 
The proportion of fully completed questionnaires (64%) was slightly lower than noted in 
other trials (Hollis & Campbell, 1997); however, it is not unusual for this type of trial to have 
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some missing outcome data (Wood et al, 2004). Several participants commented that the 
questionnaire pack was too long and repetitive. As one of the aims was to compare a 
number of outcome measures for suitability for a definitive trial, the participant burden of 
completing the questionnaire was anticipated. However, in any future trial, the 
questionnaire pack would need to be shorter which should result in higher rates of response 
(Edwards et al, 2002; Nakash et al, 2006), and less missing data. The scales with the most 
missing questions across the four time points were the WOMAC and the NEADL scale. The 
scales with the least amount of missing data were HADS, ICECAP-O, EQ-5D-3L, and OHS. The 
proportion of missing data in the WOMAC and the NEADL scale, compared to the other 
scales, suggest that use of these as outcome measures in a future definitive trial requires 
careful consideration. The PEP-R patient group did not identify any of the PROMs being 
more difficult to complete than others and the reason for why some of the PROMs had 
more missing data than others was not followed up by patient interviews. This is therefore 
an identified weakness which would have to be ameliorated before any definitive trial.    
The CSRI health resource use questionnaire had both a poor rate of return (70%), and 
completion with only 15 (34%) of the 44 participants returning a correctly completed form 
which is not unusual for health economic information (Marques, 2013). However, the rate 
of return does compare with other studies; (76%) Patel et al (2005), 66% (Critchley et al, 
2007). Patel et al (2005) used the CSRI to collect retrospective health resources usage over a 
6 month period and compared its accuracy against GP records and they had a 76% return 
rate. However, to achieve this return rate, they sent out a second copy after two weeks to 
non-responders, then after an additional two weeks further non-responders were 
telephoned and data was collected via a telephone interview. Although they found good 
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agreement between self-completion via the CSRI to actual GP consultations, the participants 
in this study were only asked to complete the number and duration of GP visits. In an 
evaluation of physiotherapy costs associated with treating chronic pain, 66% of participants 
completed the CSRI at 18 months follow-up but this was not self-reported; the information 
was collected by telephone interviews (Critchley et al, 2007).  
This suggests that for a future definitive trial, methods to improve data capture by the CSRI 
will need to be implemented. This may include the need for telephone follow-ups to be 
established, and possibly the form adapted to make it simpler to complete by removing 
information that can be captured from other sources such as primary care visits and 
hospitalisation usage. Another method which should be considered is the use of resource 
use diaries which have been shown to increase the quality of data captured (Marques et al, 
2013), or sending more frequent questionnaires to capture data rather than asking people 
to recollect contact over 6 months. These changes would make it easier for participants to 
recall the information on social care resource usage provided by friends and relatives.  
Due to the lower response rates at 4 and 12 weeks, possibly as a result of some questions 
contradicting hip precautions, and altered domestic arrangements possibly affecting the 4 
week questionnaire response rates, the 26 week time point should be used as the primary 
time point in any future study. 
At 26 weeks, all domains of the WOMAC show a small effect size (E.S. 0.24 to 4.71) in favour 
of the intervention, whereas the OHS does not (E.S. 0.03). The Aberdeen IAP also shows 
small effect size (E.S. 3.91) in favour of the intervention at the activity level, as does the EQ-
5D-3L VAS pain score (E.S. 3.0) and the HADS (depression) (E.S. 0.22). In contrast, the NEADL 
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shows a small effect size in favour of the control (E.S. 0.41).  All other effect sizes are below 
the 0.2 threshold. Although the effect sizes are small, the majority of those that are above 
the 0.02 threshold favour the intervention at 26 weeks, which suggests it may be worth 
progressing to a full scale trial.    
5.4  Power calculation 
For sample size calculations based on observed standard deviations from pilot/feasibility 
studies, the data must be at interval or ratio level (Sim & Lewis, 2011). Cox & Torgerson 
(2013) suggest that a sample size calculation should only be undertaken from pilot studies 
where the methodology is a replica of the intended main trial and not conducted from 
feasibility where the focus is on the development of the intervention and the outcome 
measures and the main methodology may be subject to change. Both these criteria have 
been met.    
In the feasibility study, the difference between the standard deviation (SD) between groups 
at baseline and 26 weeks ranged from 2% to 46% SD for all measurement outcomes that 
have data at a minimum of interval level. From inspection of the data in Table 64, it is 
reasonable to assume a one third standard deviation difference (Sim & Lewis, 2011) 
between the two arms (i.e. the potential intervention effect size) is appropriate to use for 
the sample size calculation. The data in Table 64 shows that with the exception of the 
Aberdeen (Participation) the observed differences in SD are similar.  
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Table 64 Sample size calculation per arm of study 
Scale (Scale 
Range) 
SD at 
baseline 
1/3 SD SD at 26 
weeks 
Difference 
in SD (%) 
Number of 
participants 
required per arm of 
study 
WOMAC 14.50 4.83 -3.04 21% 358 
OHS 7.30 2.43 3.52 48% 68 
Aberdeen 
(Impairment) 
7.40 2.47 -1.71 23% 294 
Aberdeen 
(Activity) 
14.20 4.73 -3.91 28% 208 
Aberdeen 
(Participation) 
7.30 2.43 -0.12 2% 58093 
NEADL 12.50 4.17 5.58 45% 79 
 
Basing the power calculations on the WOMAC data, which has the lowest observed SD 
difference at 26 weeks (excluding the Aberdeen-Participation), will provide a conservative 
estimate of the minimum number of patients required to power a main study. With a 1-
beta= 80%, alpha=0.05 (two sided) and a 0.33 SD difference between arms, 358 subjects are 
needed per arm, and a total sample size of 716. However, the feasibility study had an 18% 
attrition rate from baseline assessment to 26 week measurement. Therefore, based on this 
observed rate, the number of participants giving consent would need to be increased to 
873. Anticipating only 25% of the patients who are approached to join the study, 3358 
potential participants would have to be approached. Again, in accordance with the findings 
of this study, where only 9% of patients initially screened were selected for approach, this 
would require 9702 eligible patients to be initially screened if the same recruitment 
procedures were repeated in a full RCT. No other Inflation factors proposed have been used 
in these calculations (Sim & Lewis, 2011).  
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However, the WOMAC was one of the outcome measures that suffered from a high rate of 
missing questions and may therefore be excluded from any future definitive trial. If the 
Oxford Hip Score was to be used as the main measure of function, it is appropriate to also 
report a power calculation based on this outcome measure. Using the same calculation 
criteria 68 participants are needed per arm, or 136 in total. Allowing for the same 18% 
attrition rate, this would require the number to be increased to 166. With the same 25% 
consent rate and 9% of screened patients eligible to be approached, 638 patients would 
have to be approached and 1843 patient’s notes screened. 
It is important for statistical procedural accuracy that the power calculation should be based 
on the primary outcome to be used in the proposed future full RCT. The submission to the 
HTA was based on using the OHS as the primary outcome. This was why additional OHS data 
only was collected, in method requiring a deviation of protocol, such that the power 
calculation could be based on more data. All the PROMs used in this feasibility study were 
acceptable to the patient group involved. However, INVOLVE also encourage that patients 
views should also be considered in choosing which should be the primary outcome 
(INVOLVE, 2015). 
As previously discussed, the low conversion rate of patients screened to those approached 
was influenced by the presence of a large competitor study that had been previously 
adopted by the NIHR so therefore had precedence on access to patients. If no such 
competing clinical trial was anticipated, the number of patients requiring screening would 
be greatly reduced.  
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5.4.1 Recommendation to improve recruitment 
With the presence of competing clinical trials being the main reason for patients screened 
not being eligible for recruitment, it is recommended that the sites chosen for a main RCT 
should take this into consideration. As the PROOF-THR study was a small feasibility study, if 
a larger RCT was commissioned, the extra number of patients to be recruited may make it 
more attractive to the trust. However, due to the impact that a competing trial had, this 
should still be a major consideration in choosing the recruitment site. 
The NJR (2014) report shows that 92.7% of all THR surgery is undertaken by 60% of the 
surgeons registered to perform THR surgery. Four regions in England were identified (BOA, 
2015) in 2015 as having the most active surgeons: Birmingham and the Black Country; 
Bristol and Avon; London; Surry and Sussex. Artz et al (2012) also identified the 22 highest 
volume orthopaedic surgery hospitals in England and wales. It is therefore recommended 
that high volume hospitals should be used. 
The power calculation based on the OHS calculation required 1843 patient’s notes to be 
screened is almost equal to the number of hip replacements undertaken, as the screening 
list contains all the patients listed by surgeons for replacement hip surgery. The 22 high 
volume NHS orthopaedic hospitals identified by Artz et al (2012) performed 16,309 THRs in 
2014 (NJR statistics online, 2015) with an average of 776 (range 274 – 1658) per trust per 
annum which equates to 64 THRs per site each month. A study with a six month recruitment 
period would therefore require 14 sites, or 7 sites with a 1 year recruitment period. The five 
most active trusts in 2014 were the Nuffield Orthopaedic Centre, Oxford (1104), the Robert 
Jones & Agnes Hunt Hospital, Oswestry (1658), the Royal Devon and Exeter Wonford 
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Hospital (1004), the Royal Orthopaedic Hospital, Birmingham (1379), and the Elective 
Orthopaedic Centre, Epsom (1398) which averaged 1,308 THRs per annum. If as many of 
these hospitals could be included, this would potentially speed up the recruitment rate and 
thus the time to complete the study. 
5.5 Discussion of experimental methodology 
5.5.1 Strengths  
This study had several strengths. It was conducted following the SOPs of a clinical trials unit 
which performed the randomisation and maintained the data in a secure bespoke database. 
All the outcomes used were validated PROMs and their appropriateness, acceptability and 
burden of completion were trialled on a patient population prior to use in the study. 
Allocation concealment and outcome assessor blinding was maintained until point of 
analysis by following established procedures for rehabilitation trials (Siemonsma and 
Walker, 1997; Minns-Lowe et al, 2011). There were no participant withdrawals after 
allocation, no crossover from the intervention to control arm and all participants allocated 
received the occupational therapy intervention. The aim to deliver the occupational therapy 
intervention between 2 to 4 weeks before surgery was achieved, which demonstrated that 
the delivery of the intervention in both content and time of delivery is feasible. Despite 
competition from another large trial recruiting total hip replacement patients at the same 
recruitment sites, the screening, identification and recruitment procedures were successful 
and participants were recruited at an acceptable rate. The study had infrastructure support 
as it was adopted by both the primary care and musculoskeletal clinical research networks 
and was part of an NIHR programme grant. Throughout the trial, there were no deviations 
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from protocol and no adverse events were reported by the research nurses. The conduct 
and reporting of the study have been conducted and reported in accordance with the 
CONSORT (Schulz et al, 2010) and MRC guidelines for complex interventions (Craig et al, 
2008). A CONSORT checklist is provided in Appendix 11. 
5.5.2 Weaknesses 
The main weaknesses of the trial are the rate of return of questionnaires and the amount of 
missing data in those returned; this was particularly so for the health resource usage data. 
This was partially as a consequence of the questionnaire being too long and repetitive, 
which will be need to be addressed in future.  
Another considerable weakness was the lack of economic data collected so the comparative 
costs of the intervention compared to the routine care cannot be estimated. This is 
potentially the most important weakness in regards to planning a future trial. Although 
procedures were established for recording home visits that lasted longer than 2 hours, 
recording the exact duration of each OT home visit would have been more useful to 
estimate actual treatment costs. The research OTs kept a record of all the equipment 
delivered to the intervention group but this was delivered to the Trusts as part of the 
patient’s records which were not available to the researcher; as was the records of 
equipment delivered to the control group by the Trust’s OTs. Robust systems to record this 
treatment cost data will have to be clearly established if a main study is conducted.     
Although patients preferring pre-surgery domiciliary OT was one of the main findings of the 
recent qualitative study (Orpen & Harris, 2010) and the PROMs used were trialled on a 
patient population prior to use, determination of the acceptability of the specific 
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intervention delivered, and the PROMs used, would have been greatly enhanced by the use 
of qualitative feedback from the participants. The researcher aimed to conduct qualitative 
interviews at the 4 week follow-up point but this part of the initial protocol was declined by 
the reviewing ethics panel (on grounds of over-burdening the participants) despite that it is 
now recommended practice in RCT’s (O’Cathain et al, 2014). 
The social classification groupings, supplemented by anecdotal comments by the study OTs, 
indicated the participants in this study did not represent the full diversity of the population 
having THRs. This is recognised problem in clinical trials due to the over-representation of 
predominantly white higher socioeconomic classes (Swanson and Ward, 1995). This 
imbalance in socioeconomic status may also be contained in the patient experience 
partnership in research group (PEP-R) group which were based in Bristol; the main study site 
for the NIHR programme grant. Dudley and Birmingham have an overall lower 
socioeconomically status that the Bristol and Avon area (ONS, 2013). It is therefore 
recommended that the public involvement in a main trial should be far more representative 
of the recruiting sites in terms of ethnicity, socioeconomic status, and literacy. If multiple 
sites are used, the public involvement should represent the populations of each recruiting 
site.  
5.6 Study conclusions 
By following established procedures for rehabilitation trials, the study successfully 
randomised participants, maintained allocation concealment until all participants had been 
recruited, and outcome assessor blinding was maintained until the follow-up phase 
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completed therefore confirming that recruitment, randomisation, and delivery of the 
intervention could be successfully achieved. 
The true acceptability of allocation to the intervention or the control group cannot be 
determined due to the absence of any qualitative interviews. On a basic level, it can be 
inferred that group allocation was not wholly unacceptable as group allocation was 
maintained throughout. A recommendation is therefore that qualitative interview must be 
included in any main is commissioned.  
As there were no major protocol deviations and no adverse effects reported, this feasibility 
study has shown that a pre-surgery home based occupational therapy intervention is safe, 
feasible to deliver and acceptable to participants.  
Participants were recruited over a wide geographical area from two from two sites and the 
educational component of the intervention was delivered at home. It is therefore highly 
unlikely that there was any contamination of this element.  
Although retention was sufficient to not be a cause of bias, methods to improve retention 
should be considered. Due to movement restrictions and potential altered domiciliary 
arrangements on discharge, 26 weeks should be the primary time point of analysis.   
It has been demonstrated that a fully powered randomised controlled trial of pre-operative 
occupational therapy for patients receiving total hip replacement is feasible.  
The PROOF-THR feasibility study took a pragmatic approach, which can be considered a 
strength of the design as it had the advantage of reflecting the variations that actually take 
place in clinical practice (Roland and Torgersen, 1998). Although both sites provided almost 
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the same rehabilitation as usual care, information any deviations in the usual care provided 
was not collected, so it was not possible to determine the exact care received by the control 
group. From an economic analysis perspective, this may be considered a weakness. 
Conducting an economic analysis was not an aim of this feasibility study, so no data was 
collected for by the researcher on the equipment that was provided to both the control and 
the intervention group. However, it is recommended that this would need to be collected in 
a future definitive trial so that a full economic analysis can be performed.  
5.7 Chapter summary 
This chapter revealed that the methods for identification and recruitment of patients were 
practicable and that patients could be recruited at an acceptable rate. It also revealed 
randomisation to either the control or intervention group was acceptable to the participants 
and the intervention could be effectively delivered. A key weakness of the study was 
revealed to be the return rate and completion rate of the follow-up questionnaires. Reasons 
for this were discussed and suggestions were presented as to how this could be improved, 
and what the main time point of analysis should be, if a full scale RCT were to be conducted.  
The power calculations showed that if the WOMAC (Bellamy et al, 1998) data was used, this 
would give a conservative value to the number of patients required at the 26 week point of 
analysis to power a trial (n=873). However, as the WOMAC was one the questionnaires 
subject to high non-completion rates, the OHS (Dawson et al, 1996) was suggested as being 
the main outcome measure to be used. A power calculation based on this only required 
(n=166) patients to complete the study at 26 weeks which is far more feasible and less 
costly.  
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The key finding of this chapter is that this study has shown it is feasible to conduct a full 
scale RCT using the methodology developed, though robust methods will be needed to 
collect economic data.  
The results of the PROM measures show that the THR is very effective in relieving pain.  
Analysis of all the functional measures, show that at 4 weeks the deficit from full function is 
approximately 30%, and at 12 weeks, 20%. Even at 26 weeks, none of the participants, in 
either group, achieve full functional status with the residual deficit from full function being 
approximately 10%. Although this shows function improves without any further intervention 
after the surgical event, the rate of functional improvement, or the overall level of 
improvement, may be improved with some post-surgery rehabilitation. What would 
constitute the most effective post-surgery rehabilitation may worthy of further research. 
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6 THESIS CONCLUSIONS   
This section will summarise the main findings and conclusions in the preceding chapters of 
this thesis. 
6.1 Introduction 
The introductory chapter revealed a substantial economic cost to the NHS to provide total 
hip replacements for people with osteoarthritis. This cost is expected to increase annually 
due to the ageing population demographics and potential increase in some risk factors 
associated with developing OA. It also revealed with the average typical stay of only 3-4 
days for hip replacement surgery, hospital based rehabilitation has decreased and the 
emphasis has moved to the patient needing to continue their rehabilitation after discharge. 
A summary of the evidence revealed that there is generally a lack of good quality evidence 
relating to rehabilitation of patients following THR, and that more, better quality research is 
needed.   
6.2 Systematic review and meta-analysis 
The results of the systematic review revealed that although occupational therapists have a 
substantial role in the rehabilitation of patients; with interventions carried out pre-
admission, during hospital stay and after discharge, there is a limited amount of evidence 
regarding the efficacy or effectiveness of occupational therapy interventions.  Of the studies 
included in the review, only 4 studies were specific to occupational therapy. The other 
studies were either multidisciplinary or had ‘occupational therapy equivalent practice’ 
delivered by nurses or physiotherapists. Most of the studies were over 10 years old and had 
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small sample sizes limiting their generalizability to modern health care practice. Further high 
quality research in to the effectiveness of occupational therapy intervention with patients 
undergoing total hip replacement is recommended. 
The meta-analysis revealed significant findings for occupational therapy interventions: there 
is a moderate level of evidence that interventions help to significantly improve pre-surgery 
function, pre-surgery anxiety and anxiety at point of discharge; moderate to low levels of 
evidence that interventions help to reduce pre-surgery levels of pain;  moderate to very low 
evidence that interventions reduce the overall length of acute facility hospital stay and 
reduce societal participation pre-surgically and at point of discharge; low to very low levels 
of evidence that interventions assist with improving long-term function. There is insufficient  
evidence to determine if occupational therapy interventions assist with function at time of 
discharge, pain at point of discharge and long term, health related quality of life pre-
surgically, at point of discharge or long term, long term societal participation or rates of 
prosthesis dislocation. 
This section of the thesis also revealed the need for more standardisation of the outcome 
measures used. Function was measured in 9 different ways and pain by 4 different PROMs, 
both by either exclusive measures or as sub-domains of others. Additionally, different 
follow-up time points were used to assess the effect of interventions. Standardisation of 
follow-up time points and outcome measures would improve the quality of the synthesis of 
findings and thus their clinical value and meaning.   
There is a need to estimate the cost-effectiveness of OT interventions for patients 
undergoing THR. The review revealed the real cost to the patients of not providing OT 
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services could result in increased anxiety, pain and decreased long term function. The cost 
to the NHS could include increased LOS and dislocation rates. It is therefore important to 
address if OT is cost-effective or whether other health professionals could deliver the same 
quality of intervention at reduced cost.    
This review identified lack of available data on current OT practice for patients undergoing 
THR, and especially research conducted in the UK.   
6.3 The feasibility study 
The feasibility study showed that the identification and recruitment methods were feasible, 
the recruitment rate was acceptable and the intervention could be delivered and was 
acceptable to the participants. It also revealed methods to improve the retention of patients 
and the return of questionnaires need to be considered. Due to problems identified with 
collection of the 4 week data, 26 weeks should be the primary time point of analysis. 
Overall, this feasibility study therefore revealed that a full randomised controlled trial 
following this methodology is practical.  
The power calculation showed if a conservative estimate is taken based on the WOMAC 
data, 716 patients will be required in total (358 each arm) at point of analysis, or 136 in total 
(each arm 68) will be needed in each arm of the study if an estimate is based on the findings 
of the Oxford Hip Score.  
Future clinical trial may want to consider the most effective time point to deliver 
rehabilitation. Also, whether combing pre-operative and post-operative rehabilitation may 
be more effective in returning patients back to function quicker. Additionally, this thesis 
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revealed different health professionals are routinely involved in rehabilitation of patients 
undergoing THR. Future studies may want to investigate if routine therapy provision by 
qualified OTs is required, and may effective services be delivered by therapy assistants. The 
need for cost effectiveness to be included was revealed as any change to rehabilitation 
practice will have cost implications. Robust methods for capturing the data required must 
be considered in the design phase of the study. The results of this study showed none of the 
participants had full function measure by the PROMs used at 6 months; it is therefore not 
know if further improvements are achieved. It is therefore important that long term 
outcomes are measured up to at least one year. 
This thesis was originally designed to follow the framework of the MRC guidance for 
complex interventions and meet the requirements of a PhD. Due to the downscaling to an 
MPhil; some intended elements of the original investigation were therefore not conducted. 
This specifically affected collection and analysis of the health economic information. 
Additionally, the original trial protocol submitted to ethics contained a request to conduct 
qualitative interviews with the participants at the 4 week follow-up time point which was 
denied. The glossary of the NIHR Evaluation, Trials and Studies website (2015) provides their 
definition of the differences between what is a ‘feasibility study’ and a ‘pilot study’. From 
these definitions, the clinical trial does not quite fulfil all the elements required of a 
feasibility study mainly as a consequence of the omission of the health economics and 
qualitative data, and resembles more closely the NIHR definition of a pilot study. However, 
several studies have shown this is often the case with the only absolute difference being 
that a feasibility study should not evaluate the treatment effect (Arain et al; 2010; Leon et 
al, 2011; Whitehead et al 2014).          
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6.4  Overall thesis 
This thesis produced the first comprehensive systematic review and meta-analysis to 
evaluate the effectiveness of occupational therapy interventions with respect to patients 
undergoing THR. It therefore successfully contributes to new knowledge in this field. The 
feasibly study was the first RCT of pre-surgery domiciliary occupational therapy for patients 
undergoing THR due to osteoarthritis. It has shown a full RCT is feasible using the method 
developed in this trial. Additionally, as the first trial of its kind, it has also contributed new 
knowledge in the area of rehabilitation following THR surgery.   
This thesis also showed the importance of following the MRC guidance for the development 
and evaluation of complex intervention. The introductory chapter revealed the gaps in areas 
of knowledge. The systematic review investigated a clinical question and was conducted 
following recognised methods to reveal what is known, and what may require further 
research, with regards to current OT practice for patients undergoing THR. The feasibility 
clinical trial was based on the findings of the systematic review. This feasibility study 
identified that a full scale trial is possible using the methodology employed. It also revealed 
several weaknesses, especially with regards collecting follow up data and specifically health 
economic data that will need improving if a full scale trial is conducted. Full scale clinical 
trials are expensive and it is a moral responsibility that health research money is spent 
effectively and participants aren’t recruited to poorly designed trials which may not lead to 
improved health care. Identifying these weaknesses at this point is therefore important so 
they can be addressed.   
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One of the limitations on this thesis is the lack of the patient’s voice. Although a summary of 
qualitative research from patients undergoing THR was included in chapter 1, this does not 
replace the requirements for gaining the patients perspective on this particular 
intervention. Any future clinical trial should include a nested qualitative study.  
  
6.5 Clinical messages 
 More high quality research is required to investigate the efficacy of 
occupational therapy practice in the area of rehabilitation of patients 
undergoing THR de to osteoarthritis. 
 
 Pre-surgery domiciliary occupational therapy assessments and interventions 
can be effectively delivered and were well received. 
 
 The costs and benefits of this method of service delivery need to be 
established.  
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Appendix 1 – i-CSP Survey 
This small survey provides a brief synopsis of NHS practice regarding pre-operative advice & 
post-operative rehabilitation. These are replies received from a question posted on the 
interactive CSP site in October 2010. 
  Pre- surgery Post-surgery Notes 
1 None 
Discharged day 3-6 based on 
range of movement & 
independently mobile. Given 
information/exercise booklet.  
Community/intermediate care if 
needed 
Routine out-patients 
for TKR but not THR  
2 
Physiotherapist, Occupational 
Therapist, Nurse 
Home visits 2-3 times week for 3-
5 weeks. Then option to refer to 
specialised TKR or lower limb 
conditioning class once per week 
for 6 weeks 
Extremely high patient 
satisfaction scores 
3 
Pre-admission clinic led by 
therapists who assess muscle 
strength, ROM, Quality of Life. 
questionnaires, use of crutches 
Out-patients 2 weeks after 
discharge for TKR and after 3 
weeks for THR for about 4 weeks. 
Group exercise class plus 
individual time with therapists. 
  
4 
All patients seen on 1:1 basis. THRs 
seen by occupational therapist 
who does home visit to assess 
equipment needs. TKR's seen by 
physiotherapist. 
No details supplied 
currently investigation 
Pre-op class instead of 
1:1 
5 
Nurse (fitness for Surgery) 
Individual physiotherapy 
assessment. Written information 
booklet (exercise, surgery, home 
aids & hip precautions) 
Discharged day 4. 
TKR usually have 
physiotherapy out-
patients, THRs at ward 
physiotherapist’s 
discretion. 
6 Assessed by postal questionnaire Discharged 3-7 days 
No routine follow-up 
THR or TKR unless 
problem identified 
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Appendix 2 – Medline search strategy 
First phase search: Study design and participants  
1. randomized controlled trial.pt. 
2. controlled clinical trial.pt. 
3. randomized.ab. 
4. placebo.ab. 
5. randomly.ab. 
6. trial.ab. 
7. groups.ab. 
8. (animals not (humans and animals)).sh. 
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 
10. 9 not 8 
11. Arthroplasty, Replacement, Knee/ or Arthroplasty, Replacement, Hip/ 
12. exp Arthroplasty, Replacement, Hip/ or exp Hip Prosthesis/ or hip replacement.mp. 
13. 11 or 12 
14. exp Arthroplasty, Replacement, Knee/ or exp Knee Prosthesis/ or knee replacement.mp. 
15. knee prosthesis.mp. or exp Knee Prosthesis/ 
16. 14 or 15 
17. 16 or 13 
18. hip prosthesis.mp. or exp Hip Prosthesis/ 
19. 18 or 17 
20. total hip.tw. 
21. total knee.tw. 
22. 21 or 20 or 19 
23. Orthopedic Procedures/ or orthopaedic surgery.mp. 
24. 22 or 23 
25. 10 and 24 
26. exp preoperative care/ 
27. preoperative period.mp. or Preoperative Period/ 
28. pre-surg$.tw. 
29. presurg$.tw. 
30. before surg$.tw. 
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31. pre-operat$.tw. 
32. preoperat$.tw. 
33. 26 or 27 or 28 or 29 or 30 or 31 or 32 
34. 25 and 33 
 
Second Phase search: intervention 
1. OCCUPATIONAL THERAPY.sh. 
2. SELF-HELP DEVICES.sh. 
3. SPLINTS.sh. 
4. (occupational adj1 therap$).ti,ab. 
5. splint$.ti,ab. 
6. ((assist$ or help$) adj5 (device$ or technolog$)).ti,ab. 
7. ((sel$ or home$) adj5 (care$ or manage$)).ti,ab. 
8. ((environment$ or home$ or domestic$ or house$) adj5 (adapt$)).ti,ab. 
9. ((daily or domestic$ or house$ or home$) adj5 (activit$ or task$ or skill$ or chore$)).ti,ab. 
10. or/1 9 
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Appendix 3 – Data extraction check table 
The data extracted for the meta-analysis was checked for accuracy by an independent person Andrew Beswick. This was the comments made 
on the initial data extraction. 
 Physical function Pain Length of stay HRQoL Social participation Anxiety 
Butler X x In McDonald 2004 
they use n= 30/40 
but I haven’t 
changed this 
x X OK 
Crowe X x OK x X OK 
Ferrara OK OK.  VAS used but 
WOMAC available? 
X SF36PCS Direction 
changed 
X x 
Gocen OK OK.  Pain at rest  X x X x 
McGregor Intervention N 
changed to 15 (4 
with no data) 
Intervention N 
changed to 15 (4 
with no data 
(author’s thesis).   
“Pain” used but 
WOMAC was 
available? 
X 
No variance - we did 
contact author but 
not available 
Sign changed - was 
this EUROQOL 
measured from 
graph? I can check 
this 
X x 
Munin SF-36 added to 
PROM plot. Sign 
changed (>change 
is improvement) 
Check (>change is 
improvement) 
OK Direction changed.  
Rand36 role 
functioning physical 
X X 
Peak OK X OK X OK X 
Rivard X X OK x X x 
 ~ 295 ~ 
 
Rosendal Direction changed. 
Higher score 
higher health 
status. Greater 
increase in hip 
rating scale in 
control group 
Direction changed. 
Higher score better 
pain. Greater 
increase in control 
group 
OK x OK. SIP. "patients in 
the control group 
improved more 
compared to 
patients in the 
shared care group" 
x 
Sandell NHP – higher 
better? A negative 
change is 
therefore an 
improvement. 
Direction changed 
Check X AIMS Satisfaction 
with health 
NHP social 
 
x 
Siggeirsdottir OK Could request a pain 
outcome? 
OK x X x 
Tappen Not checked Not checked Not checked Not checked Not checked Not 
checked 
Ververeli OK X X X X X 
Weaver SEs changed to SDs SEs changed to SDs no variance Add in an SF36 
outcome - I wasn't 
sure which so I put 
in Physical role 
(may need to 
change) 
Direction changed 
SF36 social function 
x 
Wong No extractable data 
X = Outcome not contained in study  
 
 ~ 296 ~ 
 
Appendix 4 – Grading the strength of evidence U.S. agency for healthcare research and quality guidelines - 
additional domains (Owens et al, 2010) 
Domain Definition and elements Score and application 
Risk of bias Risk of bias is the degree to which the included studies for a given 
outcome or comparison have a high likelihood of adequate 
protection against bias (i.e., good internal validity), assessed 
through two main elements: 
Study design (e.g., RCTs or observational studies) 
Aggregate quality of the studies under consideration. 
Information for this determination comes from the rating of 
quality (good/fair/poor) done for individual studies 
 
Use one of the three levels of aggregate risk of bias: 
Low risk of bias 
Medium risk of bias 
High risk of bias 
Consistency The principal definition of consistency is the degree to which reported effect 
sizes from included studies appear to have the same direction of effect. This 
can be assessed through two main elements: 
Effect sizes have the same sign (that is, are on the same side of ‘‘no effect’’) 
The range of effect sizes is narrow 
Use one of the three levels of consistency: 
Consistent (i.e., no inconsistency) 
Inconsistent 
Unknown or not applicable (e.g., single study) 
As noted in the text, single-study evidence bases (even 
mega-trials) cannot be judged with respect to consistency. In 
that instance, use ‘‘Consistency unknown (single study)’’ 
 
Directness The rating of directness relates to whether the evidence links the 
interventions directly to health outcomes. For a comparison of two 
treatments, directness implies that head-to-head trials measure the most 
important health or ultimate outcomes. Two types of indirectness, which can 
coexist, may be of concern. 
Evidence is indirect if: 
It uses intermediate or surrogate outcomes instead of ultimate health 
outcomes. In this case, one body of evidence links the intervention to 
intermediate outcomes and another body of evidence links the intermediate 
to most important (health or ultimate) outcomes 
It uses two or more bodies of evidence to compare interventions A and B e.g., 
Score dichotomously as one of two levels directness: 
Direct 
Indirect 
If indirect, specify which of the two types of indirectness 
accounts for the rating (or both, if that is the case) namely, 
use of intermediate/surrogate outcomes rather than health 
outcomes, and use of indirect comparisons. Comment on 
the potential weaknesses caused by, or inherent in, the 
indirect analysis. The EPC should note if both direct and 
indirect evidence was available, particularly when indirect 
evidence supports a small body of direct evidence. 
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studies of A vs. placebo and B vs. placebo, or studies of A vs. C and B vs. C but 
not A vs. B. 
 
Indirectness always implies that more than one body of evidence is required 
to link interventions to the most important health outcomes. 
Directness may be contingent on the outcomes of interest. EPC 
authors are expected to make clear the outcomes involved when assessing 
this domain. 
 
Precision Precision is the degree of certainty surrounding an effect estimate with 
respect to a given outcome (i.e., for each outcome separately). If a meta-
analysis was performed, this will be the confidence interval around the 
summary effect size. 
Score dichotomously as one of two levels of precision: 
Precise 
Imprecise 
A precise estimate is an estimate that would allow a 
clinically useful conclusion. An imprecise estimate is one for 
which the confidence interval is wide enough to include 
clinically distinct conclusions. For example, results may be 
statistically compatible with both clinically important 
superiority and inferiority (i.e., the direction of effect is 
unknown), a circumstance that will preclude a valid 
conclusion. 
 
Dose-response 
association 
This association, either across or within studies, refers to a pattern of a larger 
effect with greater exposure (dose, duration, adherence) 
This additional domain should be rated if studies in the 
evidence base have noted levels of exposure. Use one of 
three levels: 
Present: dose-response pattern observed 
Not present: no dose-response pattern observed (dose-
response relationship not present) 
NA (not applicable or not tested) 
 
Plausible 
confounding that 
would decrease 
observed effect 
Occasionally, in an observational study, plausible confounding factors would 
work in the direction opposite to that of the observed effect. Had these 
confounders not been present, the observed effect would have been even 
larger than the one observed. In such 
This additional domain should be considered if plausible 
confounding exists that would decrease the observed effect. 
Use one of two levels: 
Present: confounding factors that would decrease the 
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a case, an EPC may wish to upgrade the level of evidence. observed effect may be present  
Absent: confounding factors that would decrease the 
observed effect are not likely to be present 
 
Strength of 
association 
(magnitude of 
effect) 
Strength of association refers to the likelihood that the observed effect is 
large enough that it cannot have occurred solely as a result of bias from 
potential confounding factors. 
This additional domain should be considered if the effect 
size is particularly large. Use one of two levels: 
Strong: large effect size that is unlikely to have occurred in 
the absence of a true effect of the intervention 
 Weak: small enough effect size that it could have occurred 
solely as a result of bias from confounding factors 
 Publication bias indicates that studies may have been published selectively 
with the result that the estimated effect of an intervention based on 
published studies does not reflect the true effect. The finding that only a small 
proportion of relevant trials (or other studies) has been published or reported 
in a results database may indicate a higher risk of publication bias, which in 
turn may undermine the overall robustness of a body of evidence. 
Publication bias need not be formally scored. However, it 
can influence ratings of consistency, precision, magnitude of 
effect (and, to a lesser degree, risk of bias and directness). If 
EPCs identify unpublished trials, and if those results differ 
from those of published studies, they can take these factors 
into account in their rating for consistency and in calculating 
a summary confidence interval for an effect. We encourage 
authors to comment on publication bias when circumstances 
suggest that relevant empirical findings, particularly negative 
or no difference findings have not been published or are not 
otherwise available. 
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Appendix 5 – PROOF-THR Patient Information sheet 
 
 
 
 
Study Number: UKCRN 11294  
Study Title:  ‘a pilot randomised controlled trial of occupational therapy to optimise 
recovery of patients undergoing primary total hip replacement for osteoarthritis’ PROOF-
THR 
What is the purpose of the study? 
This is a small scale (pilot) study which is going to be used to work out the best method of 
running a much larger trial in the future. The aim of the overall study is to assess how the 
adaptive aids (E.g. raised toilet seats; grab rails; shoe horns; sock dressing aid) provided by 
occupational therapists, that are required for a short period following a Total Hip 
Replacement, can be best delivered to improve the overall experience of patients. Usually, 
these adaptive aids are provided after your surgery. Previous studies have found education 
sessions before patients undergo joint replacement surgery improve patients’ satisfaction 
with the service they have received and reduces overall anxiety levels which can lead to 
improved rehabilitation afterwards. However, no study in the UK has so far looked at 
providing adaptive aids before surgery.  
 
Why have I been chosen?  
Your consultant has decided that the best treatment now for your hip pain is to have a Total 
Hip Replacement. You have been asked to take part in this study because the pain in your 
hip is due to osteoarthritis and you have not had any other joint replacement surgery.  
 
Do I have to take part? 
A researcher from the hospital will telephone you to ask if you would like to take part in this 
study. They will not in any way try to influence you to join the study or not; it is up to you to 
decide whether or not to take part. If you do decide to take part, a researcher will contact 
you when you come to the pre-assessment clinic and will ask you to sign a consent form. If 
you decide to take part you are still free to withdraw at any time and without giving a 
reason.  This would not affect the standard of care you receive.  
 
What would happen to me if I take part? 
Everyone who agrees to take part in the study will be visited by a researcher who will ask 
you to fill in some questionnaires about your pain, activity levels and satisfaction with life.  A 
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computer will then randomly decide, as if by the toss of a coin, which arm of the study you 
will be in. 
 
If you are put in the control group, you will be treated just like everyone else having total hip 
replacement surgery that is not in the study. The occupational therapist will give you the 
adaptive devices in hospital after you have had your joint replacement. 
 
If you are put in the other group, an occupational therapist will come to visit you at home 
and will provide you with the same adaptive aids you would receive in the control group. 
The occupational therapist will explain to you (and your partner/carer if you wish) how to 
use these adaptive devices and will leave them with you so they are at home when you are 
discharged from hospital. You will also be able to discuss with the occupational therapist any 
questions you have about your hospital stay or your rehabilitation afterwards.  
 
What do I have to do afterwards? 
If you decide to take part, you will be asked to fill in a further set of the same questionnaires 
3 more times: these will be at 4 weeks, 3 months, and finally at 6 months following your 
surgery. 
 
The researcher would also like to record your mobility activity once you are back home after 
the surgery. You will also be asked to wear a small digital activity monitor on your unaffected 
ankle (similar to the size of a wrist watch) or to carry a pedometer (the size of a matchbox) 
for 8 days which counts the amount of steps you take each day. You will be asked during the 
consent process to indicate if you are willing to do this and to indicate your wishes on the 
consent form. It is possible to take part without consenting to this activity measurement. 
 
What are the disadvantages or risks of taking part? 
Occupational Therapy is not thought to put individuals at risk. The same adaptive devices 
that are routinely provided in the NHS will be supplied to everyone in the study. The main 
disadvantage of taking part is the possibility that the home education service provided by 
the therapist may have no measurable benefits. 
 
 
What are the advantages of taking part? 
We hope that we can demonstrate that the provision of the required adaptive devices by an 
occupational therapist prior to surgery will improve the experience of patients having a total 
hip replacement. We also hope to demonstrate that if patients have a better experience; this 
may also lead to better functional rehabilitation afterwards.  The information we get from 
this study may help us to determine the most effective way to deliver services in the NHS 
which will benefit everyone in the future who requires a hip replacement. 
 
What if new information becomes available? 
This is the only study of this kind so far in the UK and any new study will add to our 
knowledge, but other studies may be necessary before practice is changed. If information 
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becomes available from other work, it will add to our knowledge, but this study will continue 
as planned. 
 
What happens when the research study stops? 
The occupational therapy service provided by this study only affects patients up to the point 
of discharge. When the participation in the study is over, no further services are provided by 
the study team. You should contact the usual NHS and/or social services if you have any on-
going rehabilitation requirements.  
 
What if something goes wrong? 
Occupational therapy is a low risk intervention and it is unlikely that any harm will come 
from involvement in this study. If for any reason the occupational therapist is unable to 
provide their service prior to surgery, you will automatically return to usual NHS care. 
 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements.  If you are harmed due to someone’s negligence, then you may have grounds 
for a legal action but you may have to pay for it.  Regardless of this, if you wish to complain 
about any aspect of the way you have been approached or treated during the course of this 
study, the normal NHS complaints mechanisms is be available to you by contacting PALS on 
the following numbers (The Royal Orthopaedic Hospital NHS Trust - 0121 685 4128; The 
Dudley Group of Hospitals NHS Trust - 0800 073 0510). 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions.  If you remain unhappy and 
wish to complain formally, you can do this by contacting  (Trial Manager) on  
   
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential. The questionnaires you fill in will be anonymous. Any information about 
you that leaves the hospital/surgery will have your name and address removed so that you 
cannot be recognised from it. Your General Practitioner (GP) would be notified that you are 
taking part in the study (with your permission). The occupational therapist and nurses that 
organise your discharge from hospital will need to know if you were in the study. Your 
contact details would be stored in a locked filing cabinet in a secure, restricted access 
building in the department of Primary care Clinical Sciences at the University of Birmingham. 
Information stored electrically would be saved as password protected documents on 
network restricted computers.  Other personal information such as past medical history, 
medication and any hospital or clinic assessments (if applicable), would have your name and 
address removed so that you cannot be identified from it – we use a unique code instead. 
The questionnaires would also be anonymised.  
No identifying information would appear in our published results 
 
Who might have access to my personal information?  
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Named members of the study team would have access to the information that is collected 
about you during the study including your medical history. By signing a written informed 
consent form you authorise such access. To monitor the quality and conduct of research, 
studies might be chosen at random for audit. There is a chance that this study would be 
subject to review, in which case members of the Independent Review Board / Research 
Ethics Committee (REC)/ regulatory authorities would be granted direct access to your 
personal information and medical records for verification of clinical trial procedures and/or 
data collection. These authorities would treat any information about you as strictly 
confidential. 
 
What will happen to the results of the study? 
The results of this small study may be used to inform a much larger study. The study may 
also be written up as part of a PhD thesis by the main researcher in the team and may also 
be published in a scientific journal. No literature, presentation nor publication will identify 
individuals who participated in the study. (If you would like copies of the publications please 
inform  at the address below). 
 
Who is organising and funding the research? 
The study is being funded by the National Institute for Health Research, part of the NHS. 
 
Who has reviewed this study? 
NRES West Midlands - Solihull NHS Research Ethics Committee have provided ethical 
approval for this study 
 
Who do I contact for further information? Please contact  
 or at Primary Care Clinical Sciences, University of Birmingham, Edgbaston, 
Birmingham, B15 2TT for more information. You will be given a copy of the information 
sheet and a signed consent form to keep.  
 
Thank you for reading this 
 
Professor Catherine Sackley PhD, MSc, MCSP, FCOT  
Professor of Physiotherapy 
Chief investigator   
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Appendix 6 – PROOF-THR Consent form 
 
 
 
Study Title:  ‘A PILOT RANDOMISED CONTROLLED TRIAL OF OCCUPATIONAL THERAPY TO OPTIMISE 
RECOVERY OF PATIENTS UNDERGOING PRIMARY TOTAL HIP REPLACEMENT FOR OSTEOARTHRITIS’ 
PROOF-THR 
Centre ID:  
Patient ID:  
Patient Initials:   
Researcher:   
1.  1. I confirm that I have read and understood the information sheet, dated 21/03/2012 version 
3.1 for the above study. I have had the opportunity to consider the information, ask 
questions, and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, and without my medical care or legal rights being affected. 
 
3. I understand that relevant sections of my medical notes and data collected during the 
study may be looked at by members of the PROOF THR research team, regulatory 
authorities, or the NHS Trust, where this is relevant to my taking part in this research. I give 
permission for these individuals to have access to my records. 
 
4. I agree to my GP being informed of my participation in this study. 
 
 
5. I agree to take part in the PROOF THR study. 
 
 
6. I agree to the information gathered in this study being moved from the NHS to the 
Universities participating in this study (Birmingham, Bristol and East Anglia) 
 
 
7. I agree that my data gathered in this study may be stored (after it has been anonymised) in a 
specialist data centre and may be used for future research. 
 
      
Name of Patient  Date  Signature 
 
      
Name of Person taking Consent  Date  Signature 
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Appendix 7 – PROOF-THR Invitation to join study letter 
STUDY TITLE: ‘A PILOT RANDOMISED CONTROLLED TRIAL OF OCCUPATIONAL THERAPY TO OPTIMISE 
RECOVERY OF PATIENTS UNDERGOING PRIMARY TOTAL HIP REPLACEMENT FOR OSTEOARTHRITIS’. 
STUDY NUMBER: UKCRN 11294 
 
Dear Sir/Madam 
 
Information about a research project 
 
You have received this letter because your consultant has put you on the waiting list to 
receive a total hip replacement and is involved in a research project. 
 
Before you decide if you would like to take part, it is important for you to understand why 
the research is being done and what it will involve. Please take time to read the information 
in the enclosed leaflet carefully and discuss it with friends, relatives and your GP if you wish. 
Do ask us or the researcher (details below) if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take part.  
 
A researcher will contact you to discuss the study. If you choose to take part, the researcher 
will contact you again at your pre-assessment clinic appointment and you can formally 
consent to take part then. A copy of the consent form is also enclosed to ensure you have 
plenty of time to consider everything before deciding to take part.  
 
As with any research conducted within the NHS you can choose to take part or not and it will 
not influence any other aspects of your care. You can drop out at any time and all 
information collected is treated confidentially.  
 
 
Yours sincerely  
 
 
Professor Catherine Sackley PhD, MSc, MCSP, FCOT 
 
Contact details: 
 
Primary Care Clinical Sciences 
University of Birmingham 
Birmingham B15 2TT 
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Appendix 8 – PROOF-THR patient demographic form 
 
 
 
 
Family Name  
First Name  
Male or Female  Date of Birth DD/MM/YYYY 
 
Address 
House name/number  
Street name  
Line 1  
Line 2  
Line 3  
Postcode          
Telephone numbers  
Home  Mobile 
 
GP details 
Name  
Address  
Practice name  
Line 1  
Line 2  
Line 3  
Postcode          
Telephone number  
Hospital site  
Lives alone (yes or no)  
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Appendix 9 – PROOF THR Lone worker policy 
 
Emergency phrase: “.......extension 13” 
 
Lone Worker Policy 
This study policy is written for any person undertaking lone community visits as part of the 
PROOF-THR study. This policy has been written to supplement SOP 21-01 (version 3) 
‘Community Visits’ and SOP 02-05 (version2) ‘Risk Assessment’ and should be used in 
conjunction with this policies. 
1.  All individuals undertaking lone community visits must provide a mobile telephone 
number, car registration number and an emergency code word which should be recorded on 
the ‘Community visits log’ QCD 21-02. 
2. Any person undertaking the role of ‘researcher’ or ‘Guard’ must mutually agree in 
advance of their visit the designated guard. The guard should make sure they are aware of 
the duties required of the guard and any subsequent action that may be required. The 
documentation is available in paper version in a black file labelled ‘PROOF-THR Lone Worker 
File’ in my office (room 232) and can also be accessed on-line at T:\Physiotherapy 
Translational Research Group\PROOF THR\Lone Worker Documentation 
 
3. Before each visit: 
3.1 Any researcher undertaking a community visit must complete the named ‘Community 
visits log’ on-line in advance of their visit. The patient study ID must be included. This should 
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be completed as soon as the visit details have been finalised. The form can be completed 
electronically and is located at: T:\Physiotherapy Translational Research Group\PROOF 
THR\OT intervention    
3.2 The time entered on the log should be the time the visit is expected to end, NOT the time 
expected back in to the office. This arrangement accommodates researchers who may be 
doing multiple visits in one day or returning home after a visit.  
3.3 The researcher should organise in advance who will act as the guard and the guard must 
agree to taking on this role. It must not be assumed that if someone is asked they will 
perform this duty.   
3.4 The ‘Guard’ must be made aware by e-mail or telephone of every new event entered in 
to the community visits log. If times of the visit are communicated they MUST be identical to 
those entered in the community visit log. 
3.5 If multiple visits are being undertaken on one day, each visit must be entered as a 
separate event on the community visit log.     
4. On day of Visit 
4.1 The lone worker should contact the ‘Guard’ in advance to let them know the visit is going 
ahead and make them aware of any circumstances that may vary from the details entered in 
to the community visits log.  
4.2 The guard must confirm that they are still able to fulfil their responsibilities (or have 
organised another person to take this role). 
4.3 When the researcher arrives at the community visit destination, they should telephone 
the guard to inform that they have arrived.   
4.4 At the end of the visit, the researcher must telephone the guard to let them know that 
the visit has been completed and the researcher has safely left 
4.5 A dedicated mobile phone number will be provided for the researcher to call which will 
be held by the designated guard for the duration of the visit 
4.6 If the researcher has not telephoned within 30 minutes of the expected completion time 
of community visit; the guard must then telephone the researcher. If they obtain no 
response, they should telephone again in 10 minutes.  
4.7 If there is no response from the second phone call, the guard should inform the CI or 
most senior member of staff available, and seek guidance on what action should be taken. 
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4.8 IF the emergency code word/phrase is used in any call, the police should be contacted 
immediately. 
4.9 The researcher must inform the guard of any changes to agreed finish time or any other 
pre-agreed changes which occur while undertaking the community visits. 
5. Variations in agreed policy 
5.1 This policy must be adhered to by all staff working on the PROOF-THR study 
5.2 In areas of poor mobile phone signal the researcher should agree in advance with their 
guard alternative arrangements. If the patient has a phone, the standard variation of 
procedure should be that the guard telephones the patient and asks to speak to the 
researcher at a specific agreed time. 
6. Dedicated Mobile Phone  
6.1 The mobile phone must remain in the presence of the guard until the communication 
with the community researcher has been made to establish the visit has concluded safely. 
6.2 More than one person can be the guard for a community visit. However, a clear 
handover of duties and expected call time must be done when the mobile phone is 
transferred to the new guard. It is preferential that one person is the guard. 
6.3 The person holding the mobile phone should indicate this on the white board in the main 
office (room 248). 
 
7. Personal responsibility 
7.1 Everyone is expected to take personal responsibility for their adherence to this policy in 
accordance with their role as ‘community worker’ or ‘guard’. 
7.2 Any variation in practice to this policy MUST adhere to the basic principles of the 
Guard/researcher duties and MUST be acceptable to both the guard and the community 
researcher. 
7.3 Usually, a community visit should not be carried out if this policy cannot be adhered to.  
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Appendix 10 – PROOF-THR Questionnaire 
 
 
A pilot randomised controlled trial of occupational therapy to optimise recovery following 
total hip replacement for osteoarthritis 
 
 
 
 
 
 
 
 
Participant Questionnaire Booklet 
 
 
 
Participant ID Number: 
 
    
 
 
 
 
 Baseline 4-weeks 12-
weeks 
26-
weeks 
 
Assessment     
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PART 1A 
The following questions concern the amount of pain you have recently experienced in each 
of your hips.  For each question, please tick the amount of pain you have experienced 
during the PAST 4 WEEKS. Please () tick one column for each hip. 
 
A1. How much pain do you have walking on a flat surface? 
 
 None 
 
Mild Moderate Severe Extreme 
           a. Replaced Hip 
 
 
     
           b. Other hip 
 
 
     
 
A2. How much pain do you have going up or down stairs? 
 
 None Mild Moderate Severe Extreme 
           a. Replaced Hip 
 
 
     
           b. Other hip 
 
 
     
 
A3. How much pain do you have at night while in bed? 
 
 None Mild Moderate Severe Extreme 
           a. Replaced Hip 
 
 
     
           b. Other hip 
 
 
     
 
A4. How much pain do you have sitting or lying? 
 
 None Mild Moderate Severe Extreme 
           a. Replaced Hip 
 
 
     
           b. Other hip 
 
 
     
 
A5. How much pain do you have standing upright? 
 
 None Mild Moderate Severe Extreme 
           a. Replaced Hip 
 
 
     
           b. Other hip 
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PART 1B 
 
The following questions concern the amount of hip stiffness (not pain) you have experienced 
during the PAST 4 WEEKS in your replaced hip. Stiffness is a sensation of restriction or 
slowness in the ease with which you move your joints. Please tick () one box only. 
 
How much stiffness do you have after… 
 
 
Section C 
 
The following questions concern your physical function. By this we mean your ability to move 
around and look after yourself. For each of the following activities please tick the degree of 
difficulty you have experienced during the PAST 4 WEEKS due to your replaced hip. Please tick 
() one box only. 
 
What degree of difficulty do you have with... 
 
 None Mild Moderate Severe Extreme 
C1.   ...descending stairs? 
 
     
C2.   ...ascending stairs? 
 
     
C3.   ...rising from sitting? 
 
     
C4.   ...standing? 
 
     
C5.   ...bending to floor? 
 
     
C6.   ...walking on flat? 
 
     
C7.   ...getting in/out of car? 
 
     
C8.  ...going shopping? 
 
     
C9.   ...putting on socks/stockings? 
 
     
C10.  ...rising from bed? 
 
     
 9 None Mild Moderate Severe Extreme 
C18. ..first waking in the morning? 
 
     
C19. ..sitting, lying or resting later in the day? 
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 None Mild Moderate Severe Extreme 
C11.  ...taking off socks/stockings? 
 
     
C12.  ...lying in bed? 
 
     
C13.  ...getting in/out of bath/shower? 
 
     
C14.  ...sitting? 
 
     
C15.  ...getting on/off toilet? 
 
     
C16.  ...heavy household chores? 
 
     
C17.  ...light household chores? 
 
     
 
 
PART 2 
    
The following questions ask about any problems you may have been experiencing with 
your replaced hip over the PAST 4 WEEKS.  Please tick () one box for every question. 
 
During the past 4 weeks……. 
 
How would you describe the pain you usually had from your hip? 
 
None Very mild Mild Moderate Severe 
 
 
    
 
 
Have you had any trouble with washing and drying yourself (all over) because of 
your hip? 
 
No trouble at 
all 
Very little 
trouble 
Moderate 
trouble 
Extreme 
difficulty 
Impossible to 
do 
 
 
    
 
 
Have you had any trouble getting in and out of a car or using public transport 
because of your hip? 
 
No trouble at 
all 
Very little 
trouble 
Moderate 
trouble 
Extreme 
difficulty 
Impossible to 
do 
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Have you been able to put on a pair of socks, stockings or tights? 
 
Yes, easily With little 
difficulty 
With moderate 
difficulty 
With extreme 
difficulty 
No, impossible 
 
 
    
 
 
Could you do the household shopping on your own? 
 
Yes, easily With little 
difficulty 
With moderate 
difficulty 
With extreme 
difficulty 
No, impossible 
 
 
    
 
 
For how long have you been able to walk before pain from your hip becomes 
severe? (with or without a stick) 
 
No pain/ More 
than 30 
minutes 
16 to 30 
minutes 
5 to 15 
minutes 
Around the 
house only 
Not at all – 
pain severe on 
walking 
 
 
    
 
 
Have you been able to climb a flight of stairs? 
 
Yes, easily With little 
difficulty 
With moderate 
difficulty 
With extreme 
difficulty 
No, impossible 
 
 
    
 
After a meal (sat at a table), how painful has it been for you to stand up from a chair 
because of your hip? 
 
Not at all 
painful 
Slightly painful Moderately 
painful 
Very painful Unbearable 
 
 
    
 
Have you been limping when walking, because of your hip? 
 
Rarely/ never Sometimes, or 
just at first 
Often, not just 
at first 
Most of the 
time 
All of the time 
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Have you had any sudden, severe pain – ‘shooting’, ‘stabbing’ or ‘spasms’ – from the 
affected hip? 
 
No days Only 1 or 2 
days 
Some days Most days Every day 
 
 
    
 
 
How much has pain from your hip interfered with your usual work (including 
housework)? 
 
Not at all A little bit Moderately Greatly Totally 
 
 
    
 
 
Have you been troubled by pain from your hip in bed at night? 
 
No nights Only 1 or 2 
nights 
Some nights Most nights Every night 
 
 
    
 
PART 3 
 
The following questions ask you about the amount of pain and stiffness you have 
experienced due to your hip joint problem. Please enter the amount of pain or stiffness 
experienced in the LAST 4 WEEKS. Please tick () one box for every question and think 
about the hip joint that you have had replaced. 
 
 
1. How would you describe the pain you usually have from your joint? 
     
None Mild Moderate Severe Extreme 
     
 
 
    
2. How often have you had severe pain from your arthritis? 
     
Never Occasionally Quite often Most of the 
time 
All of the time 
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3. Does remaining standing for 30 minutes increase your pain? 
Never Occasionally Quite often Most of the 
time 
All of the time 
     
     
4. How active has your arthritis been? 
     
Not at all Mildly Moderately  Severely Extremely 
     
     
5. Have you been troubled by pain from your joint in bed at night? 
     
No nights Occasional 
nights 
Quite often Most nights Every night 
     
     
6. How long has your morning stiffness usually lasted from the time you wake up? 
     
No morning 
stiffness 
Less than 30 
minutes 
30 minutes to 
1 hour 
1 to 2 hours Over 2 hours 
     
     
7. Have you had any sudden, severe pain - ‘shooting’, ‘stabbing’ or ‘spasms’ - from 
the affected joint? 
     
Never Occasionally Quite often Most of the 
time 
All of the time 
     
     
8. Have you felt that your knee or hip might suddenly “give way” or let you down?   
     
Never Occasionally Quite often Most of the 
time 
All of the time 
     
 
9. How severe is your stiffness after first wakening in the morning? 
     
None Mild Moderate Severe Extreme 
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The following questions ask about your physical function. By this we mean your 
ability to move around and look after yourself. For each of the following activities, 
please indicate the degree of difficulty you have experienced in the LAST 4 
WEEKS. Please tick () one box for every question and think about the hip 
joint that you have had replaced. 
 
1. Do you need someone to help you when you are walking? 
     
Never Occasionally Quite often Most of the 
time 
All of the time 
     
     
2. Do you need someone to help you go upstairs? 
     
Never Occasionally Quite often Most of the 
time 
All of the time 
     
     
3. What degree of difficulty do you have rising from sitting? 
     
None Mild Moderate Severe Extreme 
     
     
4. What degree of difficulty do you have bending to the floor? 
     
None Mild Moderate Severe Extreme 
     
     
5. What degree of difficulty do you have walking on the flat? 
     
None Mild Moderate Severe Extreme 
     
     
6. What degree of difficulty do you have rising from bed? 
     
None Mild Moderate Severe Extreme 
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7. What degree of difficulty do you have taking off socks/stockings? 
     
None Mild Moderate Severe Extreme 
     
     
 
8. What degree of difficulty do you have lying in bed? 
     
None Mild Moderate Severe Extreme 
     
 
9. What degree of difficulty do you have sitting? 
     
None Mild Moderate Severe Extreme 
     
     
10. What degree of difficulty do you have getting on/off toilet? 
     
None Mild Moderate Severe Extreme 
     
     
11. What degree of difficulty do you have climbing up and down one flight of stairs? 
     
None Mild Moderate Severe Extreme 
     
     
12. What degree of difficulty do you have climbing up and down several flights of 
stairs? 
     
None Mild Moderate Severe Extreme 
     
     
13. What degree of difficulty do you have dressing yourself (except shoes and 
socks)? 
     
None Mild Moderate Severe Extreme 
     
     
14. What degree of difficulty do you have putting on/off shoes? 
     
None Mild Moderate Severe Extreme 
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15. What degree of difficulty do you have washing and drying yourself? 
     
None Mild Moderate Severe Extreme 
     
     
16. What degree of difficulty do you have washing your hair? 
     
None Mild Moderate Severe Extreme 
     
     
 
17. What degree of difficulty do you have lifting?  
     
None Mild Moderate Severe Extreme 
     
 
 
 
 
 
The following questions ask about your social and work life. For each of the 
following situations, please indicate how restricted you have been because of 
your hip in the LAST 4 WEEKS. Please tick () one box for every question and 
think about the hip joint that you have had replaced. 
 
    
1. How does your joint problem restrict you getting on with people (friends and 
family)? 
     
Not at all A little Moderately Severely Extremely 
     
 
2. How does your joint problem restrict you having friends or relatives over to your 
home? 
     
Not at all A little Moderately Severely Extremely 
     
     
3. How does your joint problem restrict you visiting friends or relatives? 
     
Not at all A little Moderately Severely Extremely 
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4. How does your joint problem restrict you telephoning friends or relatives? 
     
Not at all A little Moderately Severely Extremely 
     
     
 
5. How does your joint problem restrict you showing affection? 
     
Not at all A little Moderately Severely Extremely 
     
     
6. How does your joint problem restrict you doing your usual social activities? 
     
Not at all A little Moderately Severely Extremely 
     
     
7. How does your joint problem restrict your opportunities for leisure activities? 
     
Not at all A little Moderately Severely Extremely 
     
     
8. How does your joint problem restrict you affording things you need? 
     
Not at all A little Moderately Severely Extremely 
     
 
9. How much of the time has your physical health or emotional problems interfered 
with your social activities (like visiting with friends, relatives, etc.)? 
     
All of the time Most of the 
time 
Some of the 
time 
A little of the 
time 
None of the 
time 
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PART D 
The following questions are deigned to assess how well you are now able to perform your usual 
daily activities.  Please think about how you are able to perform these activities NOW.  Please tick 
() one box for every question. 
 
 
10 Do you…. 
 
 
 
Not at all 
 
With help 
 
On your 
own with 
difficulty 
On your 
own easily  
Walk around outside? 
 
    
Climb stairs? 
 
 
 
    
Get in and out of a car? 
 
    
     
Walk over uneven ground? 
 
 
 
    
Cross roads? 
 
    
Travel on public transport? 
 
    
     
Manage to make yourself a hot drink? 
 
    
Take hot drinks from one room to another?  
 
    
 
Make yourself a hot snack? 
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Do You... 
 
Manage your money when you’re out 
 
Wash small items of clothing? 
 
Not at all 
 
 
With Help 
 
On your 
own with 
difficulty 
 
On your 
own easily 
 
Do your own housework? 
 
    
Do your own shopping? 
 
    
Do a full clothes wash? 
 
    
Read newspapers or books? 
 
    
Use the telephone? 
 
    
Write letters? 
 
    
Go out socially? 
 
    
Manage your own garden? 
 
    
     
Drive a car? 
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SECTION E 
The following set of questions ask about your emotions and mood.  Please answer them 
honestly and in a way that describes how you have been feeling over the PAST WEEK. 
 
 
[A] Do you feel tense or ‘wound up’? 
 
Most of the time   
 
A lot of the time   
 
From time to time   
 
Not at all   
 
 
 
[D] Do you still enjoy the things you used to enjoy? 
 
Definitely as much   
 
Not quite so much   
 
Only a little   
 
Hardly at all   
 
 
 
[A] Do you get a sort of frightened feeling as if something awful is about to 
happen? 
 
Very definitely and quite badly   
 
Yes, but not too badly   
 
A little, but it doesn’t worry me   
 
Not at all   
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[D] Do you laugh and see the funny side of things? 
 
As much as I always could   
 
Not quite so much now   
 
Definitely not so much now   
 
Not at all   
 
 
 
 
[A] Do worrying thoughts go through your mind? 
 
A great deal of the time   
 
A lot of the time   
 
From time to time but not too often   
 
Only occasionally   
 
 
 
 
[D] Do you feel cheerful? 
 
Not at all   
 
Not often   
 
Sometimes   
 
Most of the time   
 
 
 
[A] Can you sit at ease and feel relaxed? 
 
Definitely   
 
Usually   
 
Not often   
 
Not at all   
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[D] Do you feel as if you are slowed down? 
 
Nearly all the time   
 
Very often   
 
Sometimes   
 
Not at all   
 
 
 
[A] Do you get a sort of frightened feeling like ‘butterflies’ in the stomach? 
 
Not at all   
 
Occasionally   
 
Quite often   
 
Very often   
 
 
 
 
[D] Have you lost interest in your appearance? 
 
Definitely   
 
You don’t take so much care as you should   
 
You may not take quite as much care   
 
I take just as much care as ever   
 
 
 
 
[A] Do you feel restless as if you have to be on the move? 
 
Very much indeed   
 
Quite a lot   
 
Not very much   
 
Not at all   
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[D] Do you look forward with enjoyment to things? 
 
As much as you ever did   
 
Rather less than you used to   
 
Definitely less than you used to   
 
Hardly at all   
 
 
 
 
[A] Do you get sudden feelings of panic? 
 
Very often indeed   
 
Quite often   
 
Not very often   
 
Not at all   
 
 
 
[D] Do you enjoy a good book or radio/ TV programme? 
 
Often   
 
Sometimes   
 
Not often   
 
Very seldom   
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PART F 
The following questions ask about your health state TODAY.  Please tick one box for each 
question below to indicate which statements best describes your own health state today. 
 
Mobility 
 
 
I have no problems in walking about 
 
 
 
I have some problems in walking about 
 
 
 
I am confined to bed 
 
 
 
Self-Care 
 
 
I have no problems with self-care 
 
 
 
I have some problems washing or dressing myself 
 
 
 
I am unable to wash or dress myself 

 
 
Usual Activities (e.g. work, study, housework, family or leisure 
activities) 
 
 
I have no problems with performing my usual activities 

 
 
I have some problems with performing my usual activities 

 
 
I am unable to perform my usual activities 

 
 
Pain/Discomfort 
 
 
I have no pain or discomfort 

 
 
I have moderate pain or discomfort 

 
 
I have extreme pain or discomfort 

 
 
Anxiety/Depression 
 
 
I am not anxious or depressed  
 
 
 
I am moderately anxious or depressed 

 
 
I am extremely anxious or depressed 
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To help people say how good or bad a health state is, we 
have drawn a scale (rather like a thermometer) on which 
the best state you can imagine is marked 100 and the 
worst state you can imagine is marked 0. 
 
We would like you to indicate on this scale how good or 
bad your own health is today, in your opinion. Please do 
this by drawing a line from the box below to whichever 
point on the scale indicates how good or bad your health 
state is today.
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
   Worst 
    imaginable 
     health state 
0 
Best  
imaginable 
health state 
Your own 
health state 
today 
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PART F 
The following questions ask about your about QUALITY OF LIFE.  By placing a tick () in ONE box in 
EACH group below, please indicate which statement best describes your quality of life at the 
moment. 
1. Love and Friendship   
I can have all of the love and friendship that I want   
I can have a lot of the love and friendship that I want   
I can have a little of the love and friendship that I want    
I cannot have any of the love and friendship that I want   
   
2. Thinking about the future   
I can think about the future without any concern   
I can think about the future with only a little concern   
I can only think about the future with some concern   
I can only think about the future with a lot of concern   
   
3. Doing things that make you feel valued   
I am able to do all of the things that make me feel valued   
I am able to do many of the things that make me feel valued   
I am able to do a few of the things that make me feel valued    
I am unable to do any of the things that make me feel valued    
   
4. Enjoyment and pleasure   
I can have all of the enjoyment and pleasure that I want   
I can have a lot of the enjoyment and pleasure that I want   
I can have a little of the enjoyment and pleasure that I want   
I cannot have any of the enjoyment and pleasure that I want    
   
5. Independence   
I am able to be completely independent   
I am able to be independent in many things   
I am able to be independent in a few things   
I am unable to be at all independent    
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THANK YOU FOR COMPLETING THE QUESTIONNAIRE BOOKLET 
 
Please could you check you have completed all the questions and return the booklet.  
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Appendix 11 Client services receipt inventory 
Firstly, please tell us about the health care you have received for your new Total Hip 
Replacement 
 
1) In the last 6 months, since you were discharged home from you Total Hip Replacement, have you 
been to hospital because of your Total Hip Replacement?  
Note: Do not include physiotherapy or occupational therapy appointments 
 
Please tick 'yes' or 'no' for each line. If you answer 'yes' to any of them, please tell us how many times you used the 
service. 
 No    Yes  
Been to accident and emergency (casualty)        Total number of visits:…………. .. 
     
Stayed in hospital overnight        Total number of nights:…………… 
Had a hospital outpatient appointment        Total number of appointments:.…......…... 
2) In the last 6 months, have you used any of the services below because of your Total Hip Replacement?  
 
Please tick 'yes' or 'no' for each line. If you answer 'yes' to any of them, please tell us how many times you used the 
service, how long your contact with that person lasted (on average if more than once) and when applicable tick if the 
service was private. 
 
GP and practice nurse 
No    Yes  Number of 
times 
On average, how many minutes 
did you see/talk to them for? 
Saw GP at the surgery         ............... ..................... 
Saw GP at home         ............... ..................... 
Phoned GP for advice          ............... ..................... 
Saw practice nurse          ............... ..................... 
Phoned practice nurse for advice         ............... ..................... 
Got a repeat prescription (without seeing doctor)         ...............  
Social services     
Got meals on wheels          ...............  
Home help came around         ............... ..................... 
Saw social worker         ............... ..................... 
Physiotherapist  Private   
Saw at the hospital          ............... ..................... 
Saw at home         ............... ..................... 
Saw at the GP surgery or a clinic         ............... ..................... 
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Occupational therapist     
Saw at the hospital         ............... ..................... 
Saw at home         ............... ..................... 
Saw at the surgery or a clinic         ............... ..................... 
Other services     
Others (e.g. alternative therapies, voluntary services, 
orthotics) 
 
        ............... ..................... 
 
We would now like to know about what your Total Hip Replacement has cost you 
and others 
 
3) In the last 6 months, what medicines have you used for your arthritis and how did you pay for them 
altogether? (Include homeopathic/herbal medicines) 
   
     Please tick all that apply and fill in any relevant gaps  
 I did not have any medicines   
 I got …………. free prescriptions in the last 6 months 
 I used someone else’s medicine 
 I used a pre-payment certificate which cost me £.… for …... months 
 I paid £.................... for prescriptions in the last 6 months 
 I paid £.......…......... for non-prescription medicines in the last 6 months 
 
 
 
 
 
4) In the last 6 months, have you, your relatives/friends, the NHS or social services paid for any of the 
following because of your Total Hip Replacement?  
 
Please tick 'yes' or 'no' for each line and tell us how much it cost 
 No    Yes How much has this 
cost altogether 
in the last 6 
months? 
Who paid for 
this? 
Employing extra help (e.g. childcare or cleaning)     
 
................... ................... 
Transport to get healthcare (e.g. to go to your GP surgery or 
hospital) 
    
 
................... ................... 
List all medicines you are taking here 
because of you hip 
(Copy name from the bottle/packet) 
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Changes to your home (e.g. moving bathroom downstairs, stairlift)     
 
................... ................... 
Special equipment     
 
................... ................... 
Any other costs due to your Total Hip 
Replacement........................…...........................................
......... 
........................................................................….................
......... 
    
 
................... 
 
................... 
 
5) In the last 6 months, have you taken any time off work because of your Total Hip Replacement?  
Note: Include any time taken off because you were suffering due to you new THR or using any health services 
such as those listed in questions 1 & 2. 
 
Yes                                                                              If yes: Please give details below 
No                                                                               
I have not been employed in the last 6 months   
   Please tell us either the number of days or the number of 
hours you took off in the last 6 months 
 No       Yes Number of whole working days Number of hours 
Took sick leave from work        ....................... .......................... 
Used your paid holiday time from 
work 
       ........................ ....................... 
Took unpaid leave from work        ....................... ....................... 
Just made up the time at work        ...................... ....................... 
Other arrangement (please describe below) 
 
       ....................... ........................ 
Have you lost any pay because of this time off work?     
Yes  If yes:  How much gross income you have lost in the last 6 months?  £.............................                              
No   
 
6) In the last 6 months, have friends and relatives helped you with tasks at home which you couldn't do 
because of your new Total Hip Replacement? 
 
Yes   If yes: Please tick below the tasks they helped you with and for how many hours per week. 
No  
 
Did anyone help you with this task? 
 
No                    Yes Typically, how many hours per week? 
Personal care (e.g. bathing, dressing)                   .......................... 
Care of dependants (e.g. partner or child)                   .......................... 
Housework / laundry                   .......................... 
Providing transport/taking you out                   .......................... 
Preparing meals                   .......................... 
Gardening                   .......................... 
Shopping                   .......................... 
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Looking after pets                   .......................... 
Generally providing support                   .......................... 
Other (Please describe below)                    .......................... 
 
  
 
7) In the last 6 months, have friends and relatives stayed off work to help you because of your Total Hip 
Replacement? 
 
Yes  If yes: How many days did they take off work in the last 6 months?   ………… 
No      
 
Now please tell us something about yourself 
 
8)  Which of the following best describes your current situation? 
 
Please read the whole list first and then write '1' in the box that applies. If other categories apply, write ‘2’, '3' etc. to 
indicate the order that best describes your situation. 
 
Working full time (30 hours or more per week)   
Working part time (less than 30 hours per week)  
Unemployed and looking for work    
Volunteer       
At home and not looking for work     
(e.g. looking after home and/or family) 
Unable to work      What is the reason for this?    
             
      Your THR     Other illness  Other reason   
 
Made redundant/took early retirement            What is the reason for this?............................  
Due to your Hip   Other illness   Other reason   
Retired           
Other               Please describe .............................................................................. 
. 
 
             
Thank you for completing this questionnaire 
Please return it in the stamped addressed envelope provided  
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Appendix 12 Ethics favourable opinion
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Appendix 13 Ethics substantial amendment favourable opinion 
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